APPROVED DRUG PRODUCTS

Transcription

CUMULATIVE
SUPPLEMENT 12
DECEMBER 2013
APPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS 33rd EDITION
Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research
Office of Generic Drugs
2013 Prepared By Office of Generic Drugs Center for Drug Evaluation and Research Food and Drug Administration APPROVED DRUG PRODUCTS
with
THERAPEUTIC EQUIVALENCE EVALUATIONS
33rd EDITION
Cumulative Supplement 12 December 2013
CONTENTS
PAGE
1.0 INTRODUCTION ........................................................................................................................................ iii
1.1 How to use the Cumulative Supplement ........................................................................................... iii
1.2 Cumulative Supplement Content....................................................................................................... iv
1.3 Applicant Name Changes................................................................................................................... v
1.4 Levothyroxine Sodium ....................................................................................................................... .v
1.5 Availability of the Edition ................................................................................................................... vi
1.6 Report of Counts for the Prescription Drug Product List .................................................................. vii
1.7 Cumulative Supplement Legend ......................................................................................................viii
DRUG PRODUCT LISTS Prescription Drug Product List ....................................................................................................... 1-1 OTC Drug Product List .................................................................................................................. 2-1 Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research List................................... 3-1 Orphan Product Designations and Approvals List ......................................................................... 4-1 Drug Products Which Must Demonstrate in vivo Bioavailability
Only if Product Fails to Achieve Adequate Dissolution ............................................................. 5-1 PATENT AND EXCLUSIVITY INFORMATION ADDENDUM
A. Patent and Exclusivity Lists ................................................................................................... A-1 B. Patent and Exclusivity Terms ................................................................................................ B-1 APPROVED DRUG PRODUCTS
with
THERAPEUTIC EQUIVALENCE EVALUATIONS
33rd EDITION
CUMULATIVE SUPPLEMENT 12 December 2013 1.0 INTRODUCTION
1.1
HOW TO USE THE CUMULATIVE SUPPLEMENT
This Cumulative Supplement is one of a series of monthly updates to the
Approved Drug Products with Therapeutic Equivalence Evaluations, 30th
Edition (the List). The List is composed of four parts: approved
prescription drug products with therapeutic equivalence evaluations;
over-the-counter (OTC) drug products that require approved applications
as a condition of marketing; drug products with approval under Section
505 of the Act administered by the Center for Biologics Evaluation and
Research; and products that have never been marketed, are for
exportation, are for military use, have been discontinued from marketing
or that have had their approvals withdrawn for other than safety or
efficacy reasons.
The Cumulative Supplement provides, among other things, information on
newly approved drugs and, if necessary, revised therapeutic equivalence
evaluations and updated patent and exclusivity data. The Addendum
contains appropriate drug patent and exclusivity information required of
the Agency by the "Drug Price Competition and Patent Term Restoration Act
of 1984" for the Prescription, OTC, and Drug Products with Approval under
Section 505 of the Act Administered by the Center for Biologics
Evaluation and Research Lists.
Because all parts of the publication are subject to changes, additions,
or deletions, the List must be used in conjunction with the most current
Cumulative Supplement. Users may wish to mark to the left of the
ingredient(s) in the List to indicate that changes to that entry appear
in the Cumulative Supplement. Drug product information is provided in
each Cumulative Supplement for completeness to assist in locating the
proper place in the List for the revision.
The presence of any therapeutic equivalence code indicates that the drug
product is multisource; the deletion of a therapeutic equivalence code
indicates that the drug product has become single source. (An infrequent
exception exists when a therapeutic equivalence code is revised. In that
case, the deletion of the therapeutic equivalence code is followed
immediately by the addition of the revised one.)
Products that have never been marketed, are for exportation, are for
military use, or have been discontinued from marketing or that have had
their approvals withdrawn for other than safety or efficacy reasons, will
be flagged in this Cumulative Supplement with the "@" symbol to designate
their non-marketed status. All products having a "@" symbol in the 12th
Cumulative Supplement of the 32nd Edition List will then be added to the
"Discontinued Drug Product List" appearing in the 33rd Edition. The
current Edition Section 2., How To Use The Drug Product Lists, describes
the layout and usage of the List.
iii
New additions to the Prescription Drug Product List and OTC Drug
Product List are indicated by the symbol >A>. The Patent and Exclusivity
List new additions are indicated by the symbol >A> to the left of Patent
Number or Exclusivity Code. The >A> symbol is then dropped in subsequent
Cumulative Supplements for that item.
New deletions to the Prescription Drug Product List and OTC Drug Product
List are indicated by the symbol >D> (DELETE) to the left of the line.
The information line with the >D> symbol is dropped in subsequent
Cumulative Supplements for that item.
The Patent and Exclusivity List is arranged in alphabetical order by
active ingredient name(s) and trade name. The trade name will follow the
active ingredient name separated by a dash symbol. Also shown is the
application number and product number (FDA's internal file number) for
reference purposes. All patents with their expiration dates are
displayed for each application number. Drug substance and drug product
patents are indicated as such with DS or DP in the Patent codes column.
Use patents are indicated with the symbol "U" followed by a number
representing a specific use. Exclusivity information for a specific drug
is indicated by an abbreviation followed by the date upon which the
exclusivity expires. Refer to the Exclusivity Terms, Section B, in the
Patent and Exclusivity Information Addendum for an explanation of all
codes and abbreviations. Refer to Section 1.3 for internet access to the
most current list of Patent and Exclusivity terms.
1.2
CUMULATIVE SUPPLEMENT CONTENT
Since February 2005, we have been providing daily Electronic Orange Book
(EOB) product information for new generic drug approvals. Daily generic
updates provide the consumer with the current list of approved generic
products which is important for substitution purposes. Previously, a
first-time-generic product approved early in the month would not be
published in the Cumulative Supplement (CS) for several weeks.
The CS monthly update publish goal is by the end of the following month’s
second work week (e.g., November’s supplement will be updated by the end
of the second full work week in December).
Currently, the monthly PDF CS includes:

Generic product ANDA (Abbreviated New Drug Approval) approvals as of
the date of publication.

All product changes received and processed as of the date of
publication.
o Refer to CS Section 1.8 Cumulative Supplement Legend for
types of changes
o Discontinued products will be processed as of the date of
publication. There will be circumstances where a product is
discontinued in one month, however, it will be reported in
a different month's CS. For example, the Orange Book Staff
received a letter November 7 that the product has been
discontinued from manufacturing and marketing. The Orange
Book subsequently publishes the October CS on November 14.
The product will show in the October CS that it is
discontinued even though the date of discontinuance is the
day that the Orange Book Staff receives notification (November 7).

New Drug Application (NDA) approvals appear in the CS month they were
approved.
iv

Patent information, also updated daily in the EOB, is current to
the date of publication.

Exclusivity information is updated monthly and current to the date of
publication.
Every effort is made to ensure the Cumulative Supplement is current and
accurate. Applicant holders are requested to inform the FDA Orange Book
Staff (OBS) of any changes or corrections. The OBS can be contacted by
email at [email protected]. Send Changes by FAX: 240-276-8974;
mail to:
FDA/CDER Orange Book Staff
Office of Generic Drugs, HFD-610
7620 Standish Place
Rockville, MD 20855-2773
1.3
APPLICANT NAME CHANGES
It is not practical to identify in the Cumulative Supplement each and
every product involved when an applicant transfers its entire line of
approved drug products to another applicant, or when an applicant changes
its name. Therefore, the cumulation of these transfers and name changes
will be identified in this section only. Where only partial lines of
approved products are transferred between applicants, each approved
product involved will appear as an applicant name change entry in the
Cumulative Supplement.
It is also not practical to identify each and every product involved when
an applicant name is changed to meet internal publication standards
(e.g., MSD or Zenith [Former Abbreviated Names] are changed, respectively
to Merck Sharp Dohme or Zenith Labs [New Abbreviated Names]). When this
occurs, each product involved (either currently in the Cumulative
Supplement or in the following year's edition) will reflect the new
abbreviated name. Consequently, it will not appear as an applicant name
change entry in the Cumulative Supplement nor will the cumulation of
these name changes appear in this section. The Electronic Orange Book
Query, updated monthly, will contain the most current applicant holder
name.
FORMER APPLICANT NAME
(FORMER ABBREVIATED NAME)
1.4
NEW APPLICANT NAME
(NEW ABBREVIATED NAME)
BIONICHE PHARMA USA LLC
(BIONICHE PHARMA USA)
MYLAN INSTITUTIONAL LLC
(MYLAN LLC)
BOCA PHARMACAL INC
(BOCA PHARMA)
BOCA PHARMACAL LLC
(BOCA PHARMA LLC)
LEVOTHYROXINE SODIUM
Because there are multiple reference listed drugs of levothyroxine sodium
tablets and some reference listed drugs' sponsors have conducted studies
to establish their drugs' therapeutic equivalence to other reference
listed drugs, FDA has determined that its usual practice of assigning two
or three character TE codes may be potentially confusing and inadequate
for these drug products. Accordingly, FDA provides the following
explanation and chart of therapeutic equivalence evaluations for
levothyroxine sodium drug products.
v
Levothyroxine Sodium (Mylan ANDA 76187) and Levo-T (Alara NDA 21342)
tablets have been determined to be therapeutically equivalent to
corresponding strengths of Unithroid (Jerome Stevens NDA 021210) tablets.
Levo-T (Alara NDA 021342), Levothyroxine Sodium (Mylan ANDA 76187),
Unithroid (Jerome Stevens NDA 021210), and Levothyroxine Sodium (Merck
KGAA ANDA 76752)tablets have been determined to be therapeutically
equivalent to corresponding strengths of Synthroid (Abbott NDA 021402)
tablets.
Levo-T (Alara NDA 021342), Unithroid (Jerome Stevens NDA 021210),
Levothyroxine Sodium (Mylan ANDA 076187), and Levothyroxine Sodium (Merck
KGAA ANDA 76752) tablets have been determined to be therapeutically
equivalent to corresponding strengths of Levoxyl (King Pharms NDA 021301)
tablets.
Levothyroxine Sodium (Mylan ANDA 76187) tablets have been determined to
be therapeutically equivalent to corresponding strengths of Levothroid
(Lloyd NDA 021116) tablets.
The chart outlines TE codes for all 0.025mg products. Other product
strengths may be similar. Therapeutic equivalence has been established
between products that have the same AB+number TE code. More than one TE
code may apply to some products. One common TE code indicates therapeutic
equivalence between products.
Trade Name
Applicant
Potency
Appl No
Product No
UNITHROID
LEVOTHYROXINE
SODIUM
LEVOXYL
SYNTHROID
LEVO-T
STEVENS J
MYLAN
0.025MG AB1
0.025MG AB1
21210
76187
001
001
KING PHARMS 0.025MG AB1
ABBOTT
0.025MG AB1
ALARA PHARM 0.025MG AB1
21301
21402
21342
001
001
001
SYNTHROID
LEVOTHYROXINE
SODIUM
LEVO-T
UNITHROID
ABBOTT
MYLAN
0.025MG AB2
0.025MG AB2
21402
76187
001
001
ALARA PHARM 0.025MG AB2
STEVENS J
0.025MG AB2
21342
21210
001
001
LEVOXYL
LEVO-T
UNITHROID
LEVOTHYROXINE
SODIUM
LEVOTHYROXINE
SODIUM
KUNG PHARMS
ALARA PHARM
STEVENS J
MYLAN
AB3
AB3
AB3
AB3
21301
21342
21210
76187
001
001
001
001
MERCK KGAA 0.025MG AB3
76752
001
LEVOTHROID
LEVOTHYROXINE
SODIUM
LLOYD
MYLAN
21116
76187
001
001
0.025MG
0.025MG
0.025MG
0.025MG
TE Code
0.025MG AB4
0.025MG AB4
1.5 AVAILABILITY OF THE EDITION
Since 1997, the Electronic Orange Book Query (EOBQ)
http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm, has been
available on the internet and has become the updated-every-month Orange
Book. The Query provides searching of the approved drug list by active
ingredient, proprietary name, applicant holder, applicant number or patent
number. Product search categories are: prescription, over-the-counter,
discontinued drugs. There are links to patent and exclusivity information
that may be applicable to each product.
vi
Commencing with the 25th edition, the Annual Edition and monthly
Cumulative Supplements have been provided in downloadable Portable
Document Format (PDF) at the EOB home page by clicking on Publications.
The PDF annual and cumulative supplements duplicate previous paper
versions. Over time, there will be an archive for the annuals and each
year's December Cumulative Supplement.
The downloaded Annual Edition and Cumulative Supplements are also
available in a paper version (Approved Drug Products with Therapeutic
Equivalence Evaluations, ADP) from the U.S. Government Printing Office:
http://bookstore.gpo.gov; toll free 866-512-1800.
There are historical lists of Orange Book cumulative supplement product
monthly changes at
http://www.fda.gov/Drugs/InformationOnDrugs/ucm086229.htm. There are
ASCII text files of the Orange Book drug product, patent, and exclusivity
data at http://www.fda.gov/Drugs/InformationOnDrugs/ucm129689.htm. The
drug product text files are provided in eobzip.zip format. The files are
updated concurrently with the monthly cumulative supplements. The annual
Orange Book Edition Appendices A, B, and C in PDF format are updated
quarterly.
Effective August 18, 2003, patent submissions for publication in the
Orange Book and Docket *95S-0117 need to be submitted on form FDA-3542
which may be downloaded from the FDA Forms List,
http://www.fda.gov/opacom/morechoices/fdaforms/default.html.
The current listing of the Orphan Product Designations and Approvals is
available at http://www.fda.gov/orphan/designat/list.htm.
1.6 REPORT OF COUNTS FOR THE PRESCRIPTION DRUG PRODUCT LIST
DESCRIPTION OF REPORT
This report provides summary counts derived from the product information
in the Prescription Drug Product List and the current Cumulative
Supplement. Products included in the counts are domestically marketed
drug products approved for both safety and effectiveness under section
505 of the Federal Food, Drug, and Cosmetic Act. Excluded are approved
drug products marketed by distributors; those marketed solely abroad; and
those now regarded as medical devices, biologics or foods.
The baseline column (Dec 2012) refers to the products in the Prescription
Drug Product List. For each three-month period, a column of quarterly
data is added which incorporates counts of product activity from the
previous quarter(s) with those in the baseline count.
DEFINITIONS
Drug Product
For this report, a drug product is the representation in the Prescription
Drug Product List of an active moiety (molecular entity and its salts,
esters and derivatives) either as a single ingredient or as a combination
product provided in a specific dosage form and strength for a given route
of administration with approval for marketing by a firm under a
particular generic or trade name.
New Molecular Entity
A new molecular entity is considered an active moiety that has not
previously been approved (either as the parent compound or as a salt,
ester or derivative of the parent compound) in the United States for use
in a drug product either as a single ingredient or as part of a
combination.
vii
REPORT OF COUNTS FOR THE PRESCRIPTION DRUG PRODUCT LIST COUNTS CUMULATIVE BY QUARTER CATEGORIES COUNTED
DEC 2012
SEPT 2013
DEC 2013
DRUG PRODUCTS LISTED
SINGLE SOURCE
15343
2400
(15.9%)
15445
2467
(16.0%)
15408
2440
(15.8%)
15472
2502
(16.2%)
15711
2517
(16.0%)
MULTISOURCE
12825
(83.6%)
12900
(83.5%)
12890
(83.7%)
12970
(83.8%)
13194
(84.0%)
THERAPEUTICALLY
EQUIVALENT
12683
(82.7%)
12758
(82.6%)
12750
(82.7%)
12827
(82.9%)
13055
(83.1%)
NOT THERAPEUTICALLY
EQUIVALENT
142
(0.9%)
142
(0.9%)
140
(0.9%)
143
(0.9%)
139
(0.9%)
EXCEPTIONS1
78
(0.5%)
78
(0.5%)
78
(0.5%)
78
(0.5%)
78
(0.5%)
NEW MOLECULAR ENTITIES
APPROVED
NUMBER OF APPLICANTS
17
835
MAR 2013
JUN 2013
9
5
8
844
841
832
20
866
1
Amino acid-containing products of varying composition (see Introduction, page xx of the
List).
1.7 CUMULATIVE SUPPLEMENT LEGEND
The List is sorted by Ingredient(s) and, within each grouping, by the
Dosage Form; Route and then by trade name.
The individual product record contains the Therapeutic Equivalence Code,
Reference Listed Drug symbol, applicant holder, strength(s), New Drug
Application number, product number, and approval date. The application
number preceded by “N” is a New Drug Application (NDA or innovator). The
application number preceded by an “A” is an Abbreviated New Drug
Application (ANDA or generic). The last two columns describe the action.
The Action Month is the CS month the action occurred. The OB Action is
the type of change that has occurred.
New ingredient(s), new dosage form; route(s), new trade names, and new
product additions are preceded by >A> during the action month. The change
month is the current CS month; the change code for new approvals is NEWA.
Following months will display the same information without the >A>.
Changes to currently listed products will list two records. The deleted
product record will be proceeded by >D>. The product record change
addition being made will be preceded by >A>. Following months will
display only the >A> record without the >A>. All changes that occur to
the product through the Annual year will be listed. The change month and
change code will document the change.
The change code and description:
NEWA
CAHN
New drug product approval usually in the supplement
month.
Applicant holder firm name has changed.
viii
CAIN CDFR CFTG CMFD CMS1
CMS2
CPOT
CRLD
CTEC
CTNA
DISC
Change. There has been a change in the Ingredient(s)
name. All products will be deleted under the old name and
all products will be added under the changed ingredient(s)
name.
Change. Dosage Form; Route of Administration.
Change. A first time generic for the innovator product. A
TE Code is added.
Change. The product is moved from the Discontinued Section
due to a change in marketing status.
Change. Miscellaneous addition to list.
Change. Miscellaneous deletion from list.
Change. Potency amount/unit.
Change. Reference Listed Drug.
Change. Therapeutic Equivalence Code.
Change. Trade Name.
Discontinued. The Rx or OTC listed product is not
being marketed and will be moved to the discontinued
section in the next edition.
ix
PRESCRIPTION DRUG PRODUCT LIST
RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT
AB
AB
AB
AB
AB
AB
AB
AB
AB
ABACAVIR SULFATE
TABLET;ORAL
ABACAVIR SULFATE
HETERO LABS LTD III
12
EQ 300MG BASE
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
TABLET;ORAL
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
LUPIN LTD
EQ 300MG BASE;150MG;300MG
TRIZIVIR
+
VIIV HLTHCARE
EQ 300MG BASE;150MG;300MG
ACAMPROSATE CALCIUM
TABLET, DELAYED RELEASE;ORAL
ACAMPROSATE CALCIUM
BARR LABS DIV TEVA
333MG
GLENMARK GENERICS
333MG
CAMPRAL
+
FOREST LABS
333MG
ACARBOSE
TABLET;ORAL
ACARBOSE
VIRTUS PHARM
25MG
50MG
100MG
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
CAPSULE;ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
@ WEST WARD
500MG;50MG;40MG
ESGIC-PLUS
+
MIKART
500MG;50MG;40MG
TABLET;ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
@ MIRROR PHARMS LLC
500MG;50MG;40MG
@ WEST WARD
500MG;50MG;40MG
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
CAPSULE;ORAL
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
@ MIKART
356.4MG;30MG;16MG
@ WRASER PHARMS LLC
356.4MG;30MG;16MG
TABLET;ORAL
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
@ MIKART
712.8MG;60MG;32MG
AA
AA
AA
AA
ACETAMINOPHEN; CODEINE PHOSPHATE
TABLET;ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
AUROLIFE PHARMA LLC
300MG;15MG
300MG;30MG
300MG;60MG
@ MIKART
300MG;30MG
@
650MG;30MG
@
650MG;60MG
ACETAMINOPHEN; HYDROCODONE BITARTRATE
CAPSULE;ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
@ MIKART
500MG;5MG
@
500MG;5MG
SOLUTION;ORAL
PAI
325MG/15ML;7.5MG/15ML
TABLET;ORAL
CO-GESIC
@ UCB INC
500MG;5MG
33RD
-
EDITION
December
1 -1
2013
A 091560
001 Sep 13, 2013
Aug NEWA
A 202912
001 Dec 05, 2013
Nov NEWA
N 021205
001 Nov 14, 2000
Nov CFTG
A 200143
A 202229
001 Nov 18, 2013
001 Jul 16, 2013
Nov NEWA
Jul NEWA
N 021431
001 Jul 29, 2004
Jul CFTG
A 091343
A 091343
A 091343
001 Oct 17, 2013
002 Oct 17, 2013
003 Oct 17, 2013
Sep NEWA
Sep NEWA
Sep NEWA
A 040261
001 Oct 28, 1998
Jul DISC
A 040085
001 Mar 28, 1996
Jul CTEC
A 040883
A 040336
001 Dec 23, 2008
001 Aug 18, 1999
Feb DISC
Aug DISC
A 040109
A 040688
001 Aug 26, 1997
001 Apr 03, 2007
Feb DISC
Jun DISC
A 040316
001 Apr 28, 1999
Feb DISC
A 202800
A 202800
A 202800
A 089238
A 089231
A 089363
001
002
003
001
001
001
Apr
Apr
Apr
Jun
Feb
Feb
A 081067
A 089008
001 Nov 30, 1989
001 Feb 21, 1986
Feb DISC
Jun DISC
A 040838
001 May 10, 2013
Apr NEWA
A 087757
001 May 03, 1982
Nov DISC
Apr
Apr
Apr
Feb
Mar
Sep
15,
15,
15,
25,
03,
09,
2013
2013
2013
1986
1986
1991
NEWA
NEWA
NEWA
DISC
DISC
DISC
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
>A>
>A>
>A>
>A>
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AP
>D> AP
>A> AP
>D> AN
>A> AN
AB
AB
AB
AB
AB
AB
AB
TABLET;ORAL
CARACO
325MG;5MG
325MG;7.5MG
325MG;10MG
500MG;5MG
500MG;7.5MG
500MG;10MG
650MG;7.5MG
650MG;10MG
660MG;10MG
750MG;7.5MG
+
MIKART
325MG;2.5MG
@
500MG;2.5MG
@
650MG;5MG
TRIS PHARMA INC
325MG;5MG
325MG;7.5MG
325MG;10MG
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
TABLET;ORAL
OXYCODONE AND ACETAMINOPHEN
ACTAVIS ELIZABETH
325MG;2.5MG
325MG;5MG
325MG;7.5MG
325MG;10MG
AUROLIFE PHARMA LLC
325MG;2.5MG
325MG;5MG
325MG;7.5MG
325MG;10MG
CARACO
325MG;2.5MG
325MG;5MG
325MG;7.5MG
325MG;10MG
@ MIKART
400MG;2.5MG
VINTAGE PHARMS
325MG;2.5MG
325MG;7.5MG
325MG;10MG
ROXICET 5/500
@ ROXANE
500MG;5MG
12
-
December
1 -2
2013
A 090118
A 090118
A 090118
A 090265
A 090265
A 090265
A 090380
A 090380
A 090380
A 090380
A 040846
A 089698
A 040849
A 202214
A 202214
A 202214
001
002
003
001
002
003
001
002
003
004
001
001
001
001
002
003
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Jun
Aug
Jun
Mar
Mar
Mar
23,
23,
23,
23,
23,
23,
23,
23,
23,
23,
09,
25,
09,
27,
27,
27,
2008
2008
2008
2008
2008
2008
2008
2008
2008
2008
2010
1989
2010
2013
2013
2013
May
May
May
May
May
May
Jun
Jun
Jun
Jun
Jul
Feb
Feb
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CRLD
DISC
DISC
NEWA
NEWA
NEWA
A 201447
A 201447
A 201447
A 201447
A 201972
A 201972
A 201972
A 201972
A 090535
A 090535
A 090535
A 090535
A 040679
A 090733
A 090734
A 090734
001
002
003
004
001
002
003
004
001
002
003
004
001
001
001
002
Apr
Apr
Apr
Apr
Jul
Jul
Jul
Jul
Dec
Dec
Dec
Dec
May
Jul
Jul
Jul
12,
12,
12,
12,
15,
15,
15,
15,
26,
26,
26,
26,
16,
11,
11,
11,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2006
2013
2013
2013
Apr
Apr
Apr
Apr
Jul
Jul
Jul
Jul
Dec
Dec
Dec
Dec
Jul
Jul
Jul
Jul
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
DISC
NEWA
NEWA
NEWA
A 089775
001 Jan 12, 1989
Aug DISC
ACETAZOLAMIDE
TABLET;ORAL
ACETAZOLAMIDE
@ WATSON LABS
250MG
A 088882
001 Oct 22, 1985
Jan DISC
ACETAZOLAMIDE SODIUM
INJECTABLE;INJECTION
ACETAZOLAMIDE SODIUM
SAGENT AGILA
EQ 500MG BASE/VIAL
A 200880
001 May 09, 2012
Jan CAHN
6GM/30ML (200MG/ML)
6GM/30ML (200MG/ML)
A 200644
A 200644
001 Nov 07, 2012
001 Nov 07, 2012
Dec CAHN
Dec CAHN
20%
20%
A 203853
A 203853
001 Jun 21, 2012
001 Jun 21, 2012
Dec CAHN
Dec CAHN
10MG
25MG
17.5MG
22.5MG
A 091455
A 091455
A 202897
A 202897
001
002
001
002
Mar
Mar
Mar
Mar
10MG
17.5MG
22.5MG
N 019821
N 019821
N 019821
001 Oct 28, 1996
003 Aug 06, 2009
004 Aug 06, 2009
ACETYLCYSTEINE
INJECTABLE;INTRAVENOUS
ACETYLCYSTEINE
INNOPHARMA INC
INNOPHARMA LICENSING
SOLUTION;INHALATION, ORAL
ACETYLCYSTEINE
INNOPHARMA INC
INNOPHARMA LICENSING
ACITRETIN
CAPSULE;ORAL
ACITRETIN
BARR LABS INC
TEVA PHARMS USA
SORIATANE
STIEFEL LABS INC
Apr
Apr
Apr
Apr
04,
04,
04,
04,
2013
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
Mar CFTG
Mar CFTG
Mar CFTG
AB
CAPSULE;ORAL
SORIATANE
+
25MG
AB
AB
AB
AB
AB
AB
AB
AB
AB
AP
December
1 -3
2013
002 Oct 28, 1996
Mar CFTG
N 019806
001 Mar 25, 1994
May CAHN
200MG
200MG
A 074977
A 075101
001 Apr 13, 1998
001 Apr 15, 1998
Aug DISC
Sep DISC
5%
N 021478
001 Dec 30, 2002
Jul CAHN
5%
A 202459
001 Apr 03, 2013
Mar NEWA
5%
5%
N 018604
N 018604
001 Mar 29, 1982
001 Mar 29, 1982
May CAHN
Mar CFTG
200MG/5ML
N 019909
001 Dec 22, 1989
Jun CAHN
50MG
50MG
N 203791
N 203791
001 Apr 12, 2013
001 Apr 12, 2013
Sep DISC
Apr NEWA
400MG
800MG
400MG
800MG
400MG
800MG
A 202168
A 202168
A 203834
A 203834
A 074976
A 074976
001
002
001
002
001
002
Oct
Oct
Oct
Oct
Aug
Aug
ACYCLOVIR SODIUM
ACYCLOVIR SODIUM
AUROBINDO PHARMA LTD
EQ 50MG BASE/ML
A 203701
001 Oct 11, 2013
Sep NEWA
ACYCLOVIR; HYDROCORTISONE
CREAM;TOPICAL
XERESE
+
VALEANT BERMUDA
5%;1%
N 022436
001 Jul 31, 2009
Apr CAHN
10MG
A 202051
001 Aug 29, 2013
Aug NEWA
10MG
N 021449
001 Sep 20, 2002
Aug CFTG
3MG/ML
N 020059
001 May 18, 1995
Aug CTEC
3MG/ML
3MG/ML
3MG/ML
A 076564
A 077425
A 078676
001 Jun 16, 2004
001 Aug 29, 2013
001 Jul 31, 2008
Apr CAHN
Aug NEWA
Apr CAHN
EQ 20MG BASE
EQ 30MG BASE
EQ 40MG BASE
N 201292
N 201292
N 201292
001 Jul 12, 2013
002 Jul 12, 2013
003 Jul 12, 2013
Jul NEWA
Jul NEWA
Jul NEWA
ACYCLOVIR
CAPSULE;ORAL
ACYCLOVIR
@ MYLAN
@ WATSON LABS
CREAM;TOPICAL
ZOVIRAX
+
VALEANT BERMUDA
OINTMENT;TOPICAL
ACYCLOVIR
MYLAN PHARMS INC
ZOVIRAX
+
VALEANT BERMUDA
+
VALEANT INTL
SUSPENSION;ORAL
ZOVIRAX
+
DELCOR ASSET
TABLET;BUCCAL
SITAVIG
@ BIOALLIANCE PHARMA
+
TABLET;ORAL
ACYCLOVIR
CADILA PHARMS LTD
HETERO LABS LTD V
@ MYLAN
@
AP
-
N 019821
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
CAPSULE;ORAL
SEMPREX-D
+
ACTIENT PHARMS
8MG;60MG
AB
12
ADEFOVIR DIPIVOXIL
TABLET;ORAL
ADEFOVIR DIPIVOXIL
SIGMAPHARM LABS LLC
HEPSERA
+
GILEAD
ADENOSINE
ADENOSCAN
+
ASTELLAS
ADENOSINE
@ TEVA PHARMS USA
AP
@
AFATINIB DIMALEATE
TABLET;ORAL
GILOTRIF
BOEHRINGER INGELHEIM
+
Nov
Nov
Oct
Oct
Apr
Apr
15,
15,
29,
29,
13,
13,
2013
2013
2013
2013
1998
1998
NEWA
NEWA
NEWA
NEWA
DISC
DISC
ALBENDAZOLE
TABLET;ORAL
ALBENZA
+
AMEDRA PHARMS
BX
BX
AN
AN
AA
AA
AB
AB
AB
AB
AB
AB
AB
ALOGLIPTIN BENZOATE
TABLET;ORAL
NESINA
TAKEDA PHARMS USA
+
1 -4
2013
Feb CAHN
0.09MG BASE/INH
N 021457
001 Oct 29, 2004
Apr CAHN
0.09MG BASE/INH
N 020983
001 Apr 19, 2001
May CAHN
0.021% BASE
0.042% BASE
0.083% BASE
0.5% BASE
0.083% BASE
0.083% BASE
A 078623
A 078623
A 075717
A 076391
A 072652
A 075394
001
002
001
001
001
001
Apr
Apr
Apr
Apr
Jan
Mar
A 077117
A 077559
001 Dec 31, 2007
001 Dec 31, 2007
Apr DISC
Aug CAHN
EQ 70MG BASE/75ML
A 090520
001 Feb 25, 2013
Feb NEWA
EQ 70MG BASE/75ML
N 021575
001 Sep 17, 2003
Feb CFTG
EQ
EQ
EQ
EQ
EQ
EQ
EQ
5MG BASE
10MG BASE
35MG BASE
40MG BASE
70MG BASE
35MG BASE
70MG BASE
A 076768
A 076768
A 076768
A 076768
A 076768
A 078638
A 078638
001
002
003
004
005
001
002
Aug
Aug
Aug
Aug
Aug
Aug
Aug
04,
04,
04,
04,
04,
04,
04,
2008
2008
2008
2008
2008
2008
2008
Jul
Jul
Jul
Jul
Jul
Aug
Aug
CAHN
CAHN
CAHN
CAHN
CAHN
DISC
DISC
EQ
EQ
EQ
EQ
5MG BASE
10MG BASE
35MG BASE
40MG BASE
N 020560
N 020560
N 020560
N 020560
003
001
004
002
Apr
Sep
Oct
Sep
25,
29,
20,
29,
1997
1995
2000
1995
Nov
Nov
Nov
Nov
DISC
DISC
DISC
DISC
N 021287
001 Jun 12, 2003
Apr CAHN
100MG
300MG
A 203154
A 203154
001 May 06, 2013
002 May 06, 2013
Apr NEWA
Apr NEWA
EQ 6.25MG BASE
EQ 12.5MG BASE
EQ 25MG BASE
N 022271
N 022271
N 022271
001 Jan 25, 2013
002 Jan 25, 2013
003 Jan 25, 2013
Jan NEWA
Jan NEWA
Jan NEWA
ALFUZOSIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE;ORAL
UROXATRAL
+
COVIS PHARMA SARL
10MG
ALLOPURINOL
TABLET;ORAL
ALLOPURINOL
ACCORD HLTHCARE
December
001 Jun 11, 1996
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
SOLUTION;INHALATION
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
@ APOTEX INC
EQ 0.083% BASE;0.017%
CIPLA LTD
EQ 0.083% BASE;0.017%
ALENDRONATE SODIUM
SOLUTION;ORAL
ALENDRONATE SODIUM
ROXANE
FOSAMAX
+
MERCK
TABLET;ORAL
ALENDRONATE SODIUM
CIPLA LTD
-
N 020666
ALBUTEROL SULFATE
AEROSOL, METERED;INHALATION
PROAIR HFA
+
TEVA BRANDED PHARM
EQ
VENTOLIN HFA
+
GLAXO GRP LTD
EQ
SOLUTION;INHALATION
ALBUTEROL SULFATE
@ APOTEX INC
EQ
@
EQ
@
EQ
@
EQ
+
MYLAN SPECLT
EQ
@ WOCKHARDT EU OPERATN EQ
@ MYLAN
@
FOSAMAX
@ MERCK AND CO INC
@
@
@
AB
200MG
12
Apr
Apr
Feb
Apr
Feb
Nov
05,
05,
02,
01,
21,
22,
2010
2010
2007
2003
1992
1999
DISC
DISC
DISC
DISC
CAHN
DISC
AP
>A> AP
December
1 -5
2013
N 203414
N 203414
002 Jan 25, 2013
001 Jan 25, 2013
Jan NEWA
Jan NEWA
ALOGLIPTIN BENZOATE; PIOGLITAZONE
TABLET;ORAL
OSENI
TAKEDA PHARMS USA
EQ 12.5MG BASE;15MG
EQ 12.5MG BASE;30MG
EQ 12.5MG BASE;45MG
EQ 25MG BASE;15MG
EQ 25MG BASE;30MG
+
EQ 25MG BASE;45MG
N 022426
N 022426
N 022426
N 022426
N 022426
N 022426
004
005
006
001
002
003
Jan
Jan
Jan
Jan
Jan
Jan
25,
25,
25,
25,
25,
25,
2013
2013
2013
2013
2013
2013
Jan
Jan
Jan
Jan
Jan
Jan
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
OSENI
TAKEDA PHARMS USA
EQ 12.5MG BASE;EQ 15MG BASE
EQ 25MG BASE;EQ 15MG BASE
+
N 022426
N 022426
N 022426
N 022426
N 022426
N 022426
004
005
006
001
002
003
Jan
Jan
Jan
Jan
Jan
Jan
25,
25,
25,
25,
25,
25,
2013
2013
2013
2013
2013
2013
Feb
Feb
Feb
Feb
Feb
Feb
CAIN
CAIN
CAIN
CAIN
CAIN
CAIN
ALPRAZOLAM
ALPRAZOLAM
@ TEVA PHARMS USA
0.5MG
@
1MG
@
2MG
@
3MG
A 077979
A 077979
A 077979
A 077979
001
002
003
004
Feb
Feb
Feb
Feb
28,
28,
28,
28,
2007
2007
2007
2007
Jun
Jun
Jun
Jun
DISC
DISC
DISC
DISC
ALPROSTADIL
ALPROSTADIL
TEVA PHARMS USA
0.5MG/ML
A 075196
001 Apr 30, 1999
Apr CAHN
EQ
EQ
EQ
EQ
A 204040
A 063264
A 064045
A 064045
001
001
001
002
Dec
Mar
Jun
Jun
8% (8GM/100ML)
A 020345
001 Apr 04, 1996
Nov CMS2
25MG/ML
25MG/ML
A 087209
A 087392
001 Feb 01, 1982
001 Dec 15, 1983
Jun DISC
Jun DISC
100MG
200MG
100MG
100MG
200MG
200MG
A 084540
A 085003
A 084540
A 084540
A 085003
A 085003
001
001
001
001
001
001
Dec
Dec
Dec
Jul
Dec
Jul
AMIKACIN SULFATE
AMIKACIN SULFATE
EMCURE PHARMS LTD
@ HOSPIRA
@ TEVA PHARMS USA
AMINO ACIDS
AMINOSYN-HF 8%
HOSPIRA
>D>
-
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
TABLET;ORAL
KAZANO
+
TAKEDA PHARMS USA
EQ 12.5MG BASE;1GM
EQ 12.5MG BASE;500MG
AP
>A>
>A>
>D>
12
AMINOPHYLLINE
AMINOPHYLLINE
@ INTL MEDICATION
@ PHARMA SERVE NY
TABLET;ORAL
AMINOPHYLLINE
@ HIKMA PHARMS LLC
@
@ WEST WARD
@
@
@
250MG BASE/ML
250MG BASE/ML
50MG BASE/ML
250MG BASE/ML
Dec
Nov
Sep
Sep
12,
30,
28,
28,
2013
1994
1993
1993
NEWA
DISC
CAHN
CAHN
CAHN
CAHN
CAHN
DISC
CAHN
DISC
>D>
AP
AP
AMIODARONE HYDROCHLORIDE
AMIODARONE HYDROCHLORIDE
@ AGILA SPECLTS
@
@ APOTEX INC
HOSPIRA INC
>A>
AP
+
@ JHP PHARMS LLC
MYLAN INSTITUTIONAL
@ TEVA PHARMS USA
AMLEXANOX
PASTE;DENTAL
APHTHASOL
@ ULURU
AB
AB
AB
AB
AB
AB
AB
AB
AB
CIPLA LTD
UNICHEM LABS LTD
-
December
1 -6
2013
50MG/ML
50MG/ML
50MG/ML
50MG/ML
50MG/ML
50MG/ML
50MG/ML
50MG/ML
A 076394
A 076394
A 076394
A 203884
A 203885
A 076394
A 076217
A 076163
001
001
001
001
001
001
001
001
5%
N 020511
001 Dec 17, 1996
Jun DISC
A 202553
A 202553
A 202553
A 077073
A 077073
A 077073
A 203245
A 203245
A 203245
001
002
003
001
002
003
001
002
003
Apr
Apr
Apr
Sep
Sep
Sep
Oct
Oct
Oct
29,
29,
29,
26,
26,
26,
21,
21,
21,
2013
2013
2013
2007
2007
2007
2013
2013
2013
Apr
Apr
Apr
Aug
Aug
Aug
Oct
Oct
Oct
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
A 200465
A 200465
A 200465
A 200465
A 200465
A 200465
A 200465
A 200465
A 200465
A 200465
A 200465
001
002
003
004
005
006
007
008
009
010
011
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
29,
29,
29,
29,
29,
29,
29,
29,
29,
29,
29,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
N 021540
N 021540
N 021540
N 021540
N 021540
N 021540
N 021540
N 021540
N 021540
N 021540
N 021540
009
010
011
001
002
003
004
005
006
007
008
Jul
Jul
Jul
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
29,
29,
29,
30,
30,
30,
30,
30,
30,
30,
30,
2004
2004
2004
2004
2004
2004
2004
2004
2004
2004
2004
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
A 091431
A 091431
A 091431
A 091431
A 091431
A 091431
001
002
003
004
005
006
Dec
Dec
Dec
Dec
Dec
Dec
30,
30,
30,
30,
30,
30,
2013
2013
2013
2013
2013
2013
Dec
Dec
Dec
Dec
Dec
Dec
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
2.5MG BASE
5MG BASE
10MG BASE
2.5MG BASE
5MG BASE
10MG BASE
2.5MG BASE
5MG BASE
10MG BASE
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
TABLET;ORAL
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
MYLAN PHARMS INC
CADUET
PFIZER
+
AB
AB
AB
AB
AB
AB
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
CAPSULE;ORAL
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
APOTEX INC
EQ 2.5MG BASE;10MG
EQ 5MG BASE;10MG
EQ 5MG BASE;20MG
EQ 5MG BASE;40MG
EQ 10MG BASE;20MG
EQ 10MG BASE;40MG
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
>A>
>A>
>A>
>A>
>A>
>A>
AMLODIPINE BESYLATE
TABLET;ORAL
AMLODIPINE BESYLATE
ACCORD HLTHCARE
12
Apr
Apr
Apr
Nov
Nov
Apr
Oct
Sep
25,
25,
25,
25,
25,
25,
15,
05,
2003
2003
2003
2013
2013
2003
2002
2003
Dec
Aug
Apr
Nov
Nov
Dec
Apr
Apr
CAHN
CAHN
DISC
NEWA
NEWA
CAHN
CAHN
CAHN
>A>
>A>
>A>
>A>
>A>
>A>
>A>
>A>
>A>
>D>
>A>
>D>
>A>
>D>
>A>
>D>
>A>
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
12
-
AMLODIPINE BESYLATE; TELMISARTAN
TABLET;ORAL
TELMISARTAN AND AMLODIPINE
LUPIN LTD
EQ 5MG BASE;40MG
EQ 5MG BASE;80MG
EQ 10MG BASE;40MG
EQ 10MG BASE;80MG
TORRENT PHARMS LTD
EQ 5MG BASE;40MG
EQ 5MG BASE;80MG
EQ 10MG BASE;40MG
EQ 10MG BASE;80MG
TWYNSTA
EQ 5MG BASE;40MG
EQ 5MG BASE;40MG
EQ 5MG BASE;80MG
EQ 5MG BASE;80MG
EQ 10MG BASE;40MG
EQ 10MG BASE;40MG
+
EQ 10MG BASE;80MG
+
EQ 10MG BASE;80MG
December
1 -7
2013
A 201586
A 201586
A 201586
A 201586
A 202517
A 202517
A 202517
A 202517
001
003
002
004
001
003
002
004
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
08,
08,
08,
08,
08,
08,
08,
08,
2014
2014
2014
2014
2014
2014
2014
2014
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
N 022401
N 022401
N 022401
N 022401
N 022401
N 022401
N 022401
N 022401
001
001
003
003
002
002
004
004
Oct
Oct
Oct
Oct
Oct
Oct
Oct
Oct
16,
16,
16,
16,
16,
16,
16,
16,
2009
2009
2009
2009
2009
2009
2009
2009
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
A 090011
A 090144
A 090011
A 090011
001
001
002
004
Mar
Mar
Mar
Mar
28,
28,
28,
28,
2013
2013
2013
2013
Mar
Mar
Mar
Mar
NEWA
NEWA
NEWA
NEWA
AB
AB
AB
AB
AMLODIPINE BESYLATE; VALSARTAN
TABLET;ORAL
AMLODIPINE BESYLATE AND VALSARTAN
PAR PHARM INC
EQ 5MG BASE;160MG
EQ 5MG BASE;320MG
EQ 10MG BASE;160MG
EQ 10MG BASE;320MG
EXFORGE
NOVARTIS
EQ 5MG BASE;160MG
EQ 5MG BASE;320MG
+
EQ 10MG BASE;160MG
+
EQ 10MG BASE;320MG
N 021990
N 021990
N 021990
N 021990
002
004
003
005
Jun
Jun
Jun
Jun
20,
20,
20,
20,
2007
2007
2007
2007
Mar
Mar
Mar
Mar
CFTG
CFTG
CFTG
CFTG
AP
AP
AP
AP
AP
AMMONIA N-13
AMMONIA N 13
CARDINAL HEALTH 414
+
FEINSTEIN
KREITCHMAN PET CTR
MCPRF
UCLA BIOMEDICAL
A 203700
N 022119
A 203938
A 203321
A 203812
001
001
001
001
001
Feb
Aug
Dec
Feb
Jun
25,
23,
09,
25,
27,
2013
2007
2013
2013
2013
Feb
Feb
Nov
Feb
Jun
NEWA
CFTG
NEWA
NEWA
NEWA
A 065113
A 065113
001 Nov 29, 2002
002 Nov 29, 2002
Feb DISC
Feb DISC
A 065344
001 Jan 15, 2009
Jun DISC
A 064139
A 064139
A 065060
A 065060
001
002
001
002
Mar
Mar
Feb
Feb
N 050761
N 050761
001 Apr 15, 1999
002 Apr 15, 1999
Feb DISC
Feb DISC
A 065324
A 065324
001 Jan 17, 2007
002 Jan 17, 2007
Jan DISC
Jan DISC
001 Aug 30, 2013
Aug NEWA
AB
AB
AB
AB
30MCI-300MCI/8ML
30MCI-300MCI/8ML
30MCI-300MCI/8ML
30MCI-300MCI/8ML
30MCI-300MCI/8ML
AMOXICILLIN
FOR SUSPENSION;ORAL
AMOXICILLIN
@ RANBAXY
200MG/5ML
@
400MG/5ML
TABLET;ORAL
AMOXICILLIN
@ DAVA PHARMS INC
875MG
TABLET, CHEWABLE;ORAL
AMOXICILLIN
@ DAVA PHARMS INC
125MG
@
250MG
@ RANBAXY
200MG
@
400MG
AMOXIL
@ DR REDDYS LABS INC
200MG
@
400MG
TABLET, FOR SUSPENSION;ORAL
AMOXICILLIN
@ AUROBINDO PHARMA LTD
200MG
@
400MG
AB
(3.75-37.5MCI/ML)
(3.75-37.5MCI/ML)
(3.75-37.5MCI/ML)
(3.75-37.5MCI/ML)
(3.75-37.5MCI/ML)
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN
TEVA PHARMS USA
500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/ A 200218
A,30MG
Jan
Jan
Nov
Nov
29,
29,
29,
29,
1996
1996
2000
2000
DISC
DISC
DISC
DISC
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
12
-
December
CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL
PREVPAC
+
TAKEDA PHARMS USA
500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/ N 050757
A,30MG
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
WOCKHARDT EU OPERATN
600MG/5ML;EQ 42.9MG BASE/5ML
TABLET;ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
@ APOTEX INC
250MG;EQ 125MG BASE
@
500MG;EQ 125MG BASE
@
875MG;EQ 125MG BASE
@ RANBAXY LABS
500MG;EQ 125MG BASE
TEVA PHARMS USA
875MG;EQ 125MG BASE
AUGMENTIN '250'
+
DR REDDYS LABS INC
250MG;EQ 125MG BASE
AUGMENTIN '500'
+
DR REDDYS LABS INC
500MG;EQ 125MG BASE
AUGMENTIN '875'
+
DR REDDYS LABS INC
875MG;EQ 125MG BASE
1 -8
2013
001 Dec 02, 1997
Aug CFTG
A 065420
001 Dec 02, 2013
Nov NEWA
A 065333
A 065333
A 065317
A 065109
A 065096
001
002
003
001
001
Apr
Apr
Apr
Apr
Apr
N 050564
001 Aug 06, 1984
Apr CRLD
N 050564
002 Aug 06, 1984
Apr CRLD
N 050720
001 Feb 13, 1996
Apr CRLD
Feb
Feb
Oct
Nov
Oct
24,
24,
20,
04,
29,
2009
2009
2008
2002
2002
DISC
DISC
DISC
DISC
CRLD
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
CAPSULE, EXTENDED RELEASE;ORAL
AMPHETAMINE ASP AMPHETAMINE SULF DEXTROAMPHET SACCHARATE & DEXTR SULF
TEVA
1.25MG;1.25MG;1.25MG;1.25MG
A 077488 001 Apr 29, 2013
Apr NEWA
2.5MG;2.5MG;2.5MG;2.5MG
A 077488 002 Apr 29, 2013
Apr NEWA
3.75MG;3.75MG;3.75MG;3.75MG
A 077488 003 Apr 29, 2013
Apr NEWA
5MG;5MG;5MG;5MG
A 077488 004 Apr 29, 2013
Apr NEWA
6.25MG;6.25MG;6.25MG;6.25MG
A 077488 005 Apr 29, 2013
Apr NEWA
7.5MG;7.5MG;7.5MG;7.5MG
A 077488 006 Apr 29, 2013
Apr NEWA
DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
BARR LABS INC
1.25MG;1.25MG;1.25MG;1.25MG
A 076536 001 Feb 12, 2013
Jan NEWA
2.5MG;2.5MG;2.5MG;2.5MG
A 076536 002 Feb 12, 2013
Jan NEWA
3.75MG;3.75MG;3.75MG;3.75MG
A 076536 003 Feb 12, 2013
Jan NEWA
5MG;5MG;5MG;5MG
A 076536 004 Feb 12, 2013
Jan NEWA
6.25MG;6.25MG;6.25MG;6.25MG
A 076536 005 Feb 12, 2013
Jan NEWA
7.5MG;7.5MG;7.5MG;7.5MG
A 076536 006 Feb 12, 2013
Jan NEWA
TABLET;ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
AUROLIFE PHARMA LLC
1.25MG;1.25MG;1.25MG;1.25MG
A 202424 001 Nov 27, 2013
Nov NEWA
1.875MG;1.875MG;1.875MG;1.875MG
A 202424 002 Nov 27, 2013
Nov NEWA
2.5MG;2.5MG;2.5MG;2.5MG
A 202424 003 Nov 27, 2013
Nov NEWA
3.125MG;3.125MG;3.125MG;3.125MG
A 202424 004 Nov 27, 2013
Nov NEWA
3.75MG;3.75MG;3.75MG;3.75MG
A 202424 005 Nov 27, 2013
Nov NEWA
5MG;5MG;5MG;5MG
A 202424 006 Nov 27, 2013
Nov NEWA
7.5MG;7.5MG;7.5MG;7.5MG
A 202424 007 Nov 27, 2013
Nov NEWA
MALLINCKRODT INC
1.25MG;1.25MG;1.25MG;1.25MG
A 040440 001 Oct 07, 2003
Sep CMFD
1.875MG;1.875MG;1.875MG;1.875MG
A 040440 002 Oct 07, 2003
Sep CMFD
2.5MG;2.5MG;2.5MG;2.5MG
A 040440 003 Oct 07, 2003
Sep CMFD
3.125MG;3.125MG;3.125MG;3.125MG
A 040440 004 Oct 07, 2003
Sep CMFD
3.75MG;3.75MG;3.75MG;3.75MG
A 040440 005 Oct 07, 2003
Sep CMFD
5MG;5MG;5MG;5MG
A 040440 006 Oct 07, 2003
Sep CMFD
7.5MG;7.5MG;7.5MG;7.5MG
A 040440 007 Oct 07, 2003
Sep CMFD
MUTUAL PHARM
1.25MG;1.25MG;1.25MG;1.25MG
A 040480 001 Sep 09, 2003
Oct CMFD
1.875MG;1.875MG;1.875MG;1.875MG
A 040480 002 Sep 09, 2003
Oct CMFD
2.5MG;2.5MG;2.5MG;2.5MG
A 040480 003 Sep 09, 2003
Oct CMFD
3.125MG;3.125MG;3.125MG;3.125MG
A 040480 004 Sep 09, 2003
Oct CMFD
3.75MG;3.75MG;3.75MG;3.75MG
A 040480 005 Sep 09, 2003
Oct CMFD
5MG;5MG;5MG;5MG
A 040480 006 Sep 09, 2003
Oct CMFD
7.5MG;7.5MG;7.5MG;7.5MG
A 040480 007 Sep 09, 2003
Oct CMFD
@ TEVA PHARMS
1.25MG;1.25MG;1.25MG;1.25MG
A 040472 001 Sep 30, 2003
Jan DISC
@
2.5MG;2.5MG;2.5MG;2.5MG
A 040472 002 Sep 30, 2003
Jan DISC
@
5MG;5MG;5MG;5MG
A 040472 003 Sep 30, 2003
Jan DISC
@
7.5MG;7.5MG;7.5MG;7.5MG
A 040472 004 Sep 30, 2003
Jan DISC
12
-
December
1 -9
2013
AMPHOTERICIN B
AMPHOTERICIN B
>D> AP
+
X GEN PHARMS
>A>
+
50MG/VIAL
50MG/VIAL
A 063206
A 063206
001 Apr 29, 1992
001 Apr 29, 1992
Dec CTEC
Dec CTEC
AMPICILLIN SODIUM
AMPICILLIN SODIUM
AP
ACS DOBFAR SPA
AP
AP
AP
@ ANTIBIOTICE
@
@
@
>A> AP
ISTITUTO BIO ITA SPA
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
A 090884
A 090884
A 090889
A 090884
A 090354
A 090354
A 090354
A 090354
A 201404
002
003
001
001
003
004
001
002
001
Mar
Mar
Mar
Mar
Jun
Jun
Jun
Jun
Dec
A 062901
A 062901
002 Feb 27, 1992
001 Nov 23, 1988
Jul NEWA
Jul CRLD
A 076417
A 076417
001 Apr 18, 2005
002 Apr 18, 2005
Sep DISC
Sep DISC
A 090568
A 091242
A 091331
001 Jun 28, 2010
001 May 31, 2012
001 Jan 05, 2011
Apr CAHN
Oct DISC
Feb DISC
N 202971
N 202971
001 Feb 28, 2013
002 Feb 28, 2013
Feb NEWA
Feb NEWA
N 022466
001 Feb 26, 2010
Oct CTNA
N 022466
002 Feb 26, 2010
Oct CTNA
1GM BASE/VIAL
2GM BASE/VIAL
10GM BASE/VIAL
500MG BASE/VIAL
1GM BASE/VIAL
2GM BASE/VIAL
250MG BASE/VIAL
500MG BASE/VIAL
10MG BASE/VIAL
AMPICILLIN SODIUM; SULBACTAM SODIUM
UNASYN
AP
+
PFIZER
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL
AP
+
EQ 1GM BASE/VIAL;EQ 500MG
BASE/VIAL
ANAGRELIDE HYDROCHLORIDE
CAPSULE;ORAL
ANAGRELIDE HYDROCHLORIDE
@ WATSON LABS
EQ 0.5MG BASE
@
EQ 1MG BASE
ANASTROZOLE
TABLET;ORAL
ANASTROZOLE
AB
ACCORD HLTHCARE
@ IMPAX LABS INC
@ KUDCO IRELAND
1MG
1MG
1MG
ARIPIPRAZOLE
FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
ABILIFY MAINTENA KIT
OTSUKA PHARM CO LTD
300MG/VIAL
+
400MG/VIAL
ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
ORABLOC
PIERREL
4%;EQ 0.009MG BASE/1.8ML (EQ
0.005MG BASE/ML)
+
4%;EQ 0.018MG BASE/1.8ML (EQ
0.01MG BASE/ML)
Apr
Apr
Apr
Apr
Dec
Dec
Dec
Dec
Dec
03,
03,
03,
03,
28,
28,
28,
28,
20,
2013
2013
2013
2013
2009
2009
2009
2009
2013
NEWA
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
NEWA
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM
SULFATE
FOR SOLUTION;ORAL
MOVIPREP
@ NOVEL LABS INC
4.7GM;100GM;1.015GM;5.9GM;2.691GM; A 090145 001 Jan 25, 2012
Aug DISC
7.5GM
+
SALIX PHARMS
4.7GM;100GM;1.015GM;5.9GM;2.691GM; N 021881 001 Aug 02, 2006
Aug CTEC
7.5GM
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
TABLET;ORAL
ORPHENGESIC
@ PRINSTON INC
385MG;30MG;25MG
ORPHENGESIC FORTE
@ PRINSTON INC
770MG;60MG;50MG
A 075141
001 May 29, 1998
Apr CAHN
A 075141
002 May 29, 1998
Apr CAHN
ATENOLOL
TABLET;ORAL
ATENOLOL
@ MYLAN
@
@
@ WATSON LABS
@
AB
AB
AB
AB
AP
AP
ATORVASTATIN CALCIUM
TABLET;ORAL
ATORVASTATIN CALCIUM
KUDCO IRELAND
25MG
50MG
100MG
50MG
100MG
>A> AT
>D>
>A> AT
-
December
1 -10
2013
A 074126
A 074126
A 074126
A 073352
A 073353
003
001
002
001
001
Aug
Mar
Mar
Dec
Dec
26,
23,
23,
27,
27,
1998
1994
1994
1991
1991
Aug
Aug
Aug
Mar
Mar
DISC
DISC
DISC
DISC
DISC
EQ
EQ
EQ
EQ
10MG
20MG
40MG
80MG
BASE
BASE
BASE
BASE
A 091624
A 091624
A 091624
A 091624
001
002
003
004
Apr
Apr
Apr
Apr
05,
05,
05,
05,
2013
2013
2013
2013
Mar
Mar
Mar
Mar
NEWA
NEWA
NEWA
NEWA
ATORVASTATIN CALCIUM; EZETIMIBE
TABLET;ORAL
LIPTRUZET
MERCK SHARP DOHME
EQ
EQ
EQ
+
EQ
10MG
20MG
40MG
80MG
BASE;10MG
BASE;10MG
BASE;10MG
BASE;10MG
N 200153
N 200153
N 200153
N 200153
001
002
003
004
May
May
May
May
03,
03,
03,
03,
2013
2013
2013
2013
May
May
May
May
NEWA
NEWA
NEWA
NEWA
100MG/VIAL
A 201537
001 Sep 16, 2013
Aug NEWA
100MG/VIAL
N 050794
001 May 19, 2004
Aug CFTG
AZELAIC ACID
GEL;TOPICAL
FINACEA
+
BAYER HLTHCARE
15%
N 021470
001 Dec 24, 2002
Jun CAHN
AZILSARTAN KAMEDOXOMIL
TABLET;ORAL
EDARBI
ARBOR PHARMS LLC
+
EQ 40MG MEDOXOMIL
EQ 80MG MEDOXOMIL
N 200796
N 200796
001 Feb 25, 2011
002 Feb 25, 2011
Sep CAHN
Sep CAHN
N 202331
N 202331
001 Dec 20, 2011
002 Dec 20, 2011
Sep CAHN
Sep CAHN
N 050797
001 Jun 10, 2005
Aug CAHN
A 090923
001 Apr 02, 2013
Mar NEWA
N 050810
001 Apr 27, 2007
Nov CAHN
A 203257
A 061212
A 061212
A 061212
001 Dec 13, 2013
001
001
001
Dec
Dec
Dec
Jun
A 061580
001
Mar DISC
AZACITIDINE
INJECTABLE;IV-SC
AZACITIDINE
DR REDDYS LABS LTD
VIDAZA
+
CELGENE
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
TABLET;ORAL
EDARBYCLOR
ARBOR PHARMS LLC
EQ 40MG MEDOXOMIL;12.5MG
+
EQ 40MG MEDOXOMIL;25MG
AP
12
AZITHROMYCIN
FOR SUSPENSION, EXTENDED RELEASE;ORAL
ZMAX
+
PF PRISM CV
EQ 2GM BASE/BOT
AZITHROMYCIN
SUN PHARM INDS LTD
EQ 500MG BASE/VIAL
SOLUTION/DROPS;OPHTHALMIC
AZASITE
+
OAK PHARMS AKORN
1%
BACITRACIN
OINTMENT;OPHTHALMIC
BACITRACIN
AKORN
+
PERRIGO CO TENNESSEE
+
+
POWDER;FOR RX COMPOUNDING
BACI-RX
@ X GEN PHARMS
500
500
500
500
UNITS/GM
UNITS/GM
UNITS/GM
UNITS/GM
5,000,000 UNITS/BOT
NEWA
CTEC
CTEC
CAHN
12
-
December
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
CORTISPORIN
@ CITRON PHARMA LLC
400 UNITS/GM;1%;EQ 3.5MG
N 050416
BASE/GM;10,000 UNITS/GM
AT
AT
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
400 UNITS/GM;EQ 3.5MG BASE;10,000
UNITS/GM
NEOSPORIN
@ CITRON PHARMA LLC
400 UNITS/GM;EQ 3.5MG
BASE/GM;10,000 UNITS/GM
BACITRACIN ZINC; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
BACITRACIN ZINC AND POLYMYXIN B SULFATE
500 UNITS/GM;10,000 UNITS/GM
1 -11
2013
002
Nov CAHN
A 060764
002
Jun CAHN
N 050417
001
Nov CAHN
A 065022
001 Feb 27, 2002
Jun CAHN
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
+
400 UNITS/GM;1%;EQ 3.5MG
A 062166 002
BASE;10,000 UNITS/GM
AP
AP
BACLOFEN
INJECTABLE;INTRATHECAL
GABLOFEN
MALLINCKRODT INC
0.05MG/ML
0.5MG/ML
1MG/ML
2MG/ML
N 022462
N 022462
N 022462
N 022462
001
002
004
003
0.05MG/ML
0.5MG/ML
2MG/ML
N 020075
N 020075
N 020075
003 Nov 07, 1996
001 Jun 17, 1992
002 Jun 17, 1992
Nov CAHN
Nov CAHN
Nov CAHN
BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED
TABLET;ORAL
DUAVEE
+
WYETH PHARMS PFIZER
EQ 20MG BASE;0.45MG
N 022247
001 Oct 03, 2013
Oct NEWA
BENDAMUSTINE HYDROCHLORIDE
SOLUTION;IV (INFUSION)
TREANDA
+
CEPHALON
+
+
+
45MG/0.5ML (90MG/ML)
180MG/2ML (90MG/ML)
180MG/2ML (90MG/ML)
N 022249
N 022249
N 022249
N 022249
003
003
004
004
Oct
Sep
Oct
Sep
100MG
200MG
A 040587
A 040587
001 Mar 19, 2008
002 Mar 19, 2008
May CAHN
May CAHN
AP
AP
AP
AP
AA
AA
AB
BT
Jun CAHN
+
+
+
LIORESAL
MEDTRONIC NEURO
BENZONATATE
CAPSULE;ORAL
BENZONATATE
CARACO
Nov
Nov
Jun
Nov
Sep
Oct
Sep
Oct
19,
19,
22,
19,
13,
13,
13,
13,
2010
2010
2012
2010
2013
2013
2013
2013
May
May
May
May
CAHN
CAHN
CAHN
CAHN
CMS2
NEWA
CMS2
NEWA
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
GEL;TOPICAL
ACANYA
+
DOW PHARM
2.5%;1.2%
BENZACLIN
VALEANT BERMUDA
5%;EQ 1% BASE
+
5%;EQ 1% BASE
N 050819
001 Oct 23, 2008
Apr CAHN
N 050756
N 050756
001 Dec 21, 2000
002 Apr 20, 2007
Apr CAHN
Apr CAHN
BENZOYL PEROXIDE; ERYTHROMYCIN
GEL;TOPICAL
BENZAMYCIN PAK
+
VALEANT LUXEMBOURG
5%;3%
N 050769
001 Nov 27, 2000
Jun CAHN
BENZPHETAMINE HYDROCHLORIDE
TABLET;ORAL
BENZPHETAMINE HYDROCHLORIDE
@ COREPHARMA
50MG
AP
AB
AB
AB
1 -12
2013
Feb DISC
1MG/ML
A 091525
001 Feb 05, 2013
Jan NEWA
0.5MG
1MG
2MG
A 040699
A 040705
A 040706
001 Feb 14, 2008
001 Feb 14, 2008
001 Feb 14, 2008
Mar DISC
Mar DISC
Mar DISC
0.6MG/5ML
N 014215
002
Apr CAHN
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
CELESTONE SOLUSPAN
+
MERCK SHARP DOHME
3MG/ML;EQ 3MG BASE/ML
N 014602
001
Apr CAHN
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE
SUSPENSION;TOPICAL
TACLONEX
+
LEO PHARMA AS
0.064%;0.005%
N 022185
001 May 09, 2008
Sep CAHN
0.12%
A 078337
001 Nov 26, 2012
Apr CPOT
0.12%
0.12%
N 020934
N 020934
001 Feb 28, 1999
001 Feb 28, 1999
Sep CAHN
Apr CPOT
A 075446
001 Sep 28, 2000
Apr DISC
5MG
10MG
25MG
50MG
5MG
50MG
A 040897
A 040897
A 040897
A 040897
A 040703
A 040677
001
002
003
004
001
001
Jun
Jun
Jun
Jun
Jun
Jun
75MG
N 021055
001 Dec 29, 1999
Jun CAHN
1%
1%
N 021056
N 021056
001 Jun 28, 2000
001 Jun 28, 2000
Jun CAHN
Feb CAHN
50MG
50MG
50MG
A 078917
A 077995
A 077973
001 Jul 06, 2009
001 Jul 06, 2009
001 Jul 06, 2009
Apr CAHN
Nov DISC
Sep DISC
BENZTROPINE MESYLATE
NAVINTA LLC
TABLET;ORAL
@ PROSAM LABS
@
@
BETAMETHASONE VALERATE
AEROSOL, FOAM;TOPICAL
BETAMETHASONE VALERATE
PERRIGO
LUXIQ
+
DELCOR ASSET
+
STIEFEL
BETHANECHOL CHLORIDE
TABLET;ORAL
BETHANECHOL CHLORIDE
CARACO
@ LANNETT HOLDINGS INC
@
BEXAROTENE
CAPSULE;ORAL
TARGRETIN
+
VALEANT LUXEMBOURG
GEL;TOPICAL
TARGRETIN
+
VALEANT LUXEMBOURG
+
VALEANT PHARMS INC
AB
December
001 Oct 29, 2007
BETAXOLOL HYDROCHLORIDE
BETAXOLOL HYDROCHLORIDE
@ APOTEX INC
EQ 0.5% BASE
AA
AA
AA
AA
-
A 040714
BETAMETHASONE
SYRUP;ORAL
CELESTONE
@ MERCK SHARP DOHME
AB
12
BICALUTAMIDE
TABLET;ORAL
BICALUTAMIDE
ACCORD HLTHCARE
@ KUDCO IRELAND
@ SYNTHON PHARMS
Apr
Apr
Apr
Apr
Mar
Mar
22,
22,
22,
22,
27,
27,
2009
2009
2009
2009
2008
2008
CAHN
CAHN
CAHN
CAHN
DISC
DISC
>D>
>D>
>A>
>A>
AP
AP
AP
AP
>D> AT
>A> AT
AT
AT
AT
AN
AN
AN
AN
AP
AP
AP
BLEOMYCIN SULFATE
BLEOMYCIN SULFATE
@ PHARMACHEMIE BV
TEVA PARENTERAL
UNITS
UNITS
UNITS
UNITS
UNITS
BASE/VIAL
BASE/VIAL
BASE/VIAL
BASE/VIAL
BASE/VIAL
December
1 -13
2013
001
001
002
001
002
EQ 0.33% BASE
0.33%
0.33%
N 204708
N 204708
N 204708
001 Aug 23, 2013
001 Aug 23, 2013
001 Aug 23, 2013
Oct CPOT
Sep CAHN
Aug NEWA
0.15%
N 021764
001 May 22, 2006
Dec CTNA
0.15%
N 021764
001 May 22, 2006
Dec CTNA
BRIMONIDINE TARTRATE; BRINZOLAMIDE
SUSPENSION/DROPS;OPHTHALMIC
SIMBRINZA
+
ALCON RES LTD
0.2%;1%
N 204251
001 Apr 19, 2013
Apr NEWA
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
COMBIGAN
+
ALLERGAN
0.2%;EQ 0.5% BASE
N 021398
001 Oct 30, 2007
Oct CPOT
N 021664
002 Oct 16, 2010
Apr CPOT
A 201211
A 202030
A 202030
001 May 11, 2011
001 Jan 09, 2013
001 Jan 09, 2013
Apr CPOT
Apr CPOT
Feb CAHN
N 203168
001 Apr 05, 2013
Apr NEWA
N 021664
001 Mar 24, 2005
Apr CPOT
A 078202
A 078202
A 201966
A 201966
A 201966
001
002
003
002
001
Apr
Apr
Sep
Sep
Sep
N 020929
003 Aug 08, 2000
Sep CTEC
N 203634
001 Jan 14, 2013
Jan NEWA
A 203895
A 203895
A 203895
A 076012
A 076012
A 076012
001
002
003
001
002
003
Oct
Oct
Oct
Jun
Jun
Jun
BRIMONIDINE TARTRATE
GEL;TOPICAL
MIRVASO
+
GALDERMA LABS LP
+
+
GALDERMA R AND D
BRIMONIDINE TARTRATE
ALCON PHARMS LTD
QOLIANA
ALCON PHARMS LTD
15
15
30
15
30
-
A 065201
A 065033
A 065033
A 065033
A 065033
TEVA PHARMS USA
EQ
EQ
EQ
EQ
EQ
12
BROMFENAC SODIUM
BROMDAY
+
ISTA PHARMS INC
EQ 0.09% ACID
BROMFENAC SODIUM
COASTAL PHARMS
EQ 0.09% ACID
LUITPOLD
EQ 0.09% ACID
0.09%
PROLENSA
+
BAUSCH AND LOMB
EQ 0.07% ACID
XIBROM
@ ISTA PHARMS INC
EQ 0.09% ACID
BUDESONIDE
SUSPENSION;INHALATION
BUDESONIDE
@ APOTEX INC
@
SANDOZ
0.25MG/2ML
0.5MG/2ML
0.25MG/2ML
0.5MG/2ML
1MG/2ML
PULMICORT RESPULES
+
ASTRAZENECA
1MG/2ML
UCERIS
+
SANTARUS
9MG
BUPIVACAINE HYDROCHLORIDE
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
AUROBINDO PHARMA LTD 0.25%
0.5%
0.75%
@ INTL MEDICATED
0.25%
@
0.5%
@
0.75%
Dec
Jun
Jun
Jun
Jun
Mar
Mar
Sep
Sep
Sep
Nov
Nov
Nov
Jan
Jan
Jan
13,
27,
27,
27,
27,
30,
30,
27,
27,
27,
05,
05,
05,
09,
09,
09,
2007
2000
2000
2000
2000
2009
2009
2013
2013
2013
2013
2013
2013
2002
2002
2002
Feb
Dec
Dec
Dec
Dec
DISC
CAHN
CAHN
CAHN
CAHN
DISC
DISC
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
DISC
DISC
DISC
BUPRENORPHINE
FILM, EXTENDED RELEASE;TRANSDERMAL
BUTRANS
PURDUE PHARMA LP
15MCG/HR
AB
AB
AB
AB
AB
AB
AB
AB
AB
-
BUPROPION HYDROCHLORIDE
TABLET;ORAL
@ TEVA
75MG
@
100MG
@ IMPAX LABS
300MG
JUBILANT LIFE
100MG
150MG
150MG
200MG
WATSON LABS
300MG
WATSON LABS INC
100MG
150MG
150MG
200MG
300MG
BUTOCONAZOLE NITRATE
CREAM;VAGINAL
BUTOCONAZOLE NITRATE
+
PERRIGO ISRAEL
GYNAZOLE-1
@ KV PHARM
1 -14
December 2013
N 021306
004 Jul 25, 2013
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
FILM;SUBLINGUAL
SUBOXONE
RECKITT BENCKISER
N 022410
+
N 022410
TABLET;SUBLINGUAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
ACTAVIS ELIZABETH
EQ 2MG BASE;EQ 0.5MG BASE
A 091422
+
A 091422
AMNEAL PHARMS
A 203136
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
AMNEAL PHARMS
A 203136
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE
ACTAVIS ELIZABETH
A 091422
+
A 091422
A 091422
AMNEAL PHARMS
A 203136
A 203136
ZUBSOLV
OREXO AB
EQ 1.4MG BASE;EQ 0.36MG BASE
N 204242
+
EQ 5.7MG BASE;EQ 1.4MG BASE
N 204242
BUPROPION HYDROBROMIDE
APLENZIN
VALEANT BERMUDA
174MG
348MG
+
348MG
+
522MG
522MG
AB1
AB1
AB2
AB1
BX
AB1
AB3
AB1
AB1
AB3
12
N 022108
N 022108
N 022108
N 022108
N 022108
Aug NEWA
002 Aug 30, 2010
004 Aug 10, 2012
Jul CRLD
Jul CRLD
001 Feb 22, 2013
002 Feb 22, 2013
002 Feb 22, 2013
Jul CTNA
Jul CTNA
Aug CTNA
001 Feb 22, 2013
Aug CTNA
001
002
002
001
002
Feb
Apr
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
22,
22,
22,
22,
22,
2013
2013
2013
2013
2013
NEWA
CRLD
NEWA
NEWA
NEWA
001 Jul 03, 2013
002 Jul 03, 2013
Jul NEWA
Jul NEWA
001
002
002
003
003
Apr
Nov
Apr
Nov
Apr
Apr
Apr
Apr
Apr
Apr
23,
23,
23,
23,
23,
2008
2008
2008
2008
2008
CAHN
CRLD
CAHN
CRLD
CAHN
A 075310
001 Nov 29, 1999
A 075310
002 Nov 29, 1999
Feb CDFR
Feb DISC
A 077415
A 202774
A 202774
A 202775
A 202774
A 077715
A 077455
A 077285
A 077455
A 077455
A 077285
Apr
Sep
Sep
Sep
Sep
Sep
Apr
Apr
Apr
Apr
Apr
002
001
002
001
003
002
001
001
002
003
002
Dec
Oct
Oct
Oct
Oct
Jun
Jul
Nov
Mar
Jul
Aug
15,
11,
11,
11,
11,
13,
19,
26,
12,
19,
15,
2006
2013
2013
2013
2013
2007
2010
2008
2008
2010
2008
DISC
NEWA
NEWA
NEWA
NEWA
CTEC
CAHN
CAHN
CAHN
CAHN
CAHN
2%
A 200923
001 May 18, 2012
Mar CRLD
2%
N 019881
001 Feb 07, 1997
Mar DISC
A 075697
001 Oct 23, 2001
Apr DISC
A 075695
A 075695
Apr DISC
Apr DISC
BUTORPHANOL TARTRATE
BUTORPHANOL TARTRATE
@ APOTEX INC
2MG/ML
BUTORPHANOL TARTRATE PRESERVATIVE FREE
@ APOTEX INC
1MG/ML
@
2MG/ML
001 Oct 23, 2001
002 Oct 23, 2001
STADOL
@ APOTHECON
2MG/ML
STADOL PRESERVATIVE FREE
@ APOTHECON
1MG/ML
@
2MG/ML
AB
AB
>A>
>D>
AA
CABERGOLINE
TABLET;ORAL
CABERGOLINE
APOTEX CORP
MYLAN PHARMS INC
AB
AB
AB
AB
CALCITRIOL
CAPSULE;ORAL
CALCITRIOL
BANNER PHARMACAPS
CALCIUM ACETATE
CAPSULE;ORAL
CALCIUM ACETATE
INVAGEN PHARMS
TABLET;ORAL
CALCIUM ACETATE
INVAGEN PHARMS
-
December
1 -15
2013
N 017857
004
Jun DISC
N 017857
N 017857
001
002
Jun DISC
Jun DISC
A 201503
A 202947
001 Mar 08, 2013
001 Dec 02, 2013
Feb NEWA
Nov NEWA
A 086557
A 086557
001 Oct 04, 1983
001 Oct 04, 1983
Dec CAHN
Dec CAHN
A 040590
A 040590
001 Sep 16, 2005
001 Sep 16, 2005
Mar CMFD
Jan DISC
0.005%
N 020273
001 Dec 29, 1993
Sep CAHN
0.25MCG
0.5MCG
A 091174
A 091174
001 May 24, 2013
002 May 24, 2013
May NEWA
May NEWA
EQ 169MG CALCIUM
A 203135
001 Feb 07, 2013
Jan NEWA
EQ 169MG CALCIUM
A 202420
001 Feb 05, 2013
Jan NEWA
0.5MG
0.5MG
CAFFEINE; ERGOTAMINE TARTRATE
SUPPOSITORY;RECTAL
MIGERGOT
+
CREALTA PHARMS LLC
100MG;2MG
+
G AND W LABS
100MG;2MG
TABLET;ORAL
ERGOTAMINE TARTRATE AND CAFFEINE
MIKART
100MG;1MG
@
100MG;1MG
CALCIPOTRIENE
OINTMENT;TOPICAL
DOVONEX
@ LEO PHARMA AS
12
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE;
SODIUM CITRATE
ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER
@ B BRAUN
35MG/100ML;5GM/100ML;30MG/100ML;74 N 019867 001 Dec 20, 1993
Mar DISC
MG/100ML;640MG/100ML;500MG/100ML;7
4MG/100ML
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
SOLUTION;INTRAPERITONEAL
INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
@ FRESENIUS
18.4MG/100ML;1.5GM/100ML;5.08MG/10 A 020374 001 Jun
0ML;538MG/100ML;448MG/100ML
@
18.4MG/100ML;1.5GM/100ML;5.08MG/10 A 020374 001 Jun
0ML;538MG/100ML;448MG/100ML
@ FRESENIUS
18.4MG/100ML;2.5GM/100ML;5.08MG/10 A 020374 002 Jun
0ML;538MG/100ML;448MG/100ML
@
18.4MG/100ML;2.5GM/100ML;5.08MG/10 A 020374 002 Jun
0ML;538MG/100ML;448MG/100ML
@ FRESENIUS
18.4MG/100ML;3.5GM/100ML;5.08MG/10 A 020374 003 Jun
0ML;538MG/100ML;448MG/100ML
@
18.4MG/100ML;3.5GM/100ML;5.08MG/10 A 020374 003 Jun
0ML;538MG/100ML;448MG/100ML
@ FRESENIUS
18.4MG/100ML;4.25GM/100ML;5.08MG/1 A 020374 004 Jun
00ML;538MG/100ML;448MG/100ML
@
18.4MG/100ML;4.25GM/100ML;5.08MG/1 A 020374 004 Jun
00ML;538MG/100ML;448MG/100ML
13, 1994
Nov CMS2
13, 1994
Feb DISC
13, 1994
Nov CMS2
13, 1994
Feb DISC
13, 1994
Nov CMS2
13, 1994
Feb DISC
13, 1994
Nov CMS2
13, 1994
Feb DISC
12
-
December
1 -16
2013
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE;INTRATHECAL
ELLIOTTS B SOLUTION
+
LUKARE MEDICAL LLC
0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/M N 020577 001 Sep 27, 1996
Jun CAHN
L;1.9MG/ML;7.3MG/ML;0.2MG/ML
CANAGLIFLOZIN
TABLET;ORAL
INVOKANA
JANSSEN PHARMS
+
JANSSEN RES AND DEV
+
AB
AB
AB
AB
>A>
>A>
>A>
>A>
100MG
300MG
100MG
300MG
N 204042
N 204042
N 204042
N 204042
001
002
001
002
Mar
Mar
Mar
Mar
29,
29,
29,
29,
2013
2013
2013
2013
Apr
Apr
Mar
Mar
CAHN
CAHN
NEWA
NEWA
4MG
8MG
16MG
32MG
N 020838
N 020838
N 020838
N 020838
001
002
003
004
Jun
Jun
Jun
Jun
04,
04,
04,
04,
1998
1998
1998
1998
Apr
Apr
Apr
Apr
CFTG
CFTG
CFTG
CFTG
4MG
8MG
16MG
32MG
4MG
8MG
16MG
32MG
A 202079
A 202079
A 202079
A 202079
A 078702
A 078702
A 078702
A 078702
001
002
003
004
001
002
003
004
Jan
Jan
Jan
Jan
May
May
May
May
10,
10,
10,
10,
03,
03,
03,
03,
2014
2014
2014
2014
2013
2013
2013
2013
Dec
Dec
Dec
Dec
Apr
Apr
Apr
Apr
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
A 202884
A 202965
A 202965
A 202965
003
001
002
003
Jun
Jun
Jun
Jun
03,
03,
03,
03,
2013
2013
2013
2013
May
May
May
May
NEWA
NEWA
NEWA
NEWA
150MG
500MG
A 091649
A 091649
001 Sep 16, 2013
002 Sep 16, 2013
Aug NEWA
Aug NEWA
150MG
500MG
N 020896
N 020896
001 Apr 30, 1998
002 Apr 30, 1998
Aug CFTG
Aug CFTG
CAPSAICIN
PATCH;TOPICAL
QUTENZA
+
ACORDA
8%
N 022395
001 Nov 16, 2009
Jul CAHN
CAPTOPRIL
TABLET;ORAL
CAPTOPRIL
@ PRINSTON INC
@
@
@
@ TEVA
@
@
@
12.5MG
25MG
50MG
100MG
12.5MG
25MG
50MG
100MG
A 074477
A 074477
A 074477
A 074477
A 074483
A 074483
A 074483
A 074483
001
002
003
004
001
002
003
004
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
CANDESARTAN CILEXETIL
TABLET;ORAL
ATACAND
ASTRAZENECA
+
CANDESARTAN CILEXETIL
APOTEX INC
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
SANDOZ
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
TABLET;ORAL
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
APOTEX INC
32MG;25MG
DR REDDYS LABS LTD
16MG;12.5MG
32MG;12.5MG
32MG;25MG
CAPECITABINE
TABLET;ORAL
CAPECITABINE
TEVA PHARMS USA
XELODA
HOFFMANN LA ROCHE
+
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
13,
13,
13,
13,
13,
13,
13,
13,
1996
1996
1996
1996
1996
1996
1996
1996
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
>D>
>D>
>D>
>D>
>A>
>A>
>A>
>A>
12
-
December
1 -17
2013
AB
AB
AB
CARBAMAZEPINE
CARBAMAZEPINE
TARO
100MG
200MG
300MG
A 201106
A 201106
A 201106
001 Jun 21, 2013
002 Jun 21, 2013
003 Jun 21, 2013
Jun NEWA
Jun NEWA
Jun NEWA
AB
AB
CARBIDOPA; LEVODOPA
CARBIDOPA AND LEVODOPA
ACCORD HLTHCARE
25MG;100MG
50MG;200MG
A 202323
A 202323
001 Feb 08, 2013
002 Feb 08, 2013
Jan NEWA
Jan NEWA
CARBINOXAMINE MALEATE
SUSPENSION, EXTENDED RELEASE;ORAL
KARBINAL ER
+
TRIS PHARMA INC
4MG/5ML
N 022556
001 Mar 28, 2013
Mar NEWA
50MG/VIAL
150MG/VIAL
450MG/VIAL
A 076602
A 076602
A 076602
001 Nov 16, 2004
002 Nov 16, 2004
003 Nov 16, 2004
Feb DISC
Feb DISC
Feb DISC
50MG/5ML (10MG/ML)
150MG/15ML (10MG/ML)
50MG/5ML (10MG/ML)
50MG/5ML (10MG/ML)
50MG/5ML (10MG/ML)
50MG/5ML (10MG/ML)
A 077266
A 077266
A 077679
A 077679
A 077679
A 077096
A 077096
A 077096
A 077096
A 077139
A 077139
A 077139
A 077139
A 077139
A 077139
A 077139
A 077139
001
002
001
002
003
001
002
003
004
001
002
003
004
001
002
003
004
Feb
Feb
Feb
Feb
Feb
Jun
Jun
Jun
Jun
Sep
Sep
Sep
Sep
Sep
Sep
Sep
Sep
15,
15,
25,
25,
25,
14,
14,
14,
03,
21,
21,
21,
21,
21,
21,
21,
21,
2006
2006
2009
2009
2009
2005
2005
2005
2013
2005
2005
2005
2005
2005
2005
2005
2005
Mar
Mar
Apr
Apr
Apr
Oct
Oct
Oct
Oct
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
DISC
DISC
DISC
DISC
DISC
CMFD
CMFD
CMFD
NEWA
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
50MG/5ML (10MG/ML)
N 020452
N 020452
N 020452
N 020452
001
002
003
004
Jul
Jul
Jul
Jan
14,
14,
14,
15,
2003
2003
2003
2004
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
350MG
350MG
350MG
350MG
350MG
A 040576
A 040397
A 040188
A 040124
A 040124
001
001
001
001
001
Jun
Sep
Mar
Jan
Jan
07,
21,
07,
24,
24,
2005
2000
1997
1996
1996
May
Feb
Jun
Dec
Dec
CAHN
DISC
DISC
DISC
DISC
7.7MG
N 020637
001 Sep 23, 1996
Mar CAHN
100MG/VIAL
N 017422
001
Jan CAHN
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
CARBOPLATIN
CARBOPLATIN
@ PLIVA
@
@
INJECTABLE;IV (INFUSION)
CARBOPLATIN
@ FRESENIUS KABI USA
@
@ PHARMACHEMIE BV
@
@
SAGENT PHARMS
+
+
+
+
+
+
+
+
TEVA PARENTERAL
TEVA PHARMS USA
PARAPLATIN
@ CORDENPHARMA
@
@
@
AA
>D> AA
>A>
CARISOPRODOL
TABLET;ORAL
CARISOPRODOL
ACCELRX LABS
@ COREPHARMA
@ PROSAM LABS
WEST WARD
@
CARMUSTINE
IMPLANT;INTRACRANIAL
GLIADEL
+
ARBOR PHARMS LLC
BICNU
+
EMCURE PHARMS LTD
CARTEOLOL HYDROCHLORIDE
CARTEOLOL HYDROCHLORIDE
@ APOTEX INC
1%
AB
AB
AB
AB
CARVEDILOL
TABLET;ORAL
CARVEDILOL
CIPLA LTD
@ WOCKHARDT LTD
@
@
@
AB
AB
AP
AP
AP
AP
AP
CEFADROXIL/CEFADROXIL HEMIHYDRATE
FOR SUSPENSION;ORAL
CEFADROXIL
AUROBINDO
EQ 250MG
EQ 500MG
@ TEVA PHARMS USA
EQ 250MG
@
EQ 500MG
BASE/5ML
BASE/5ML
BASE/5ML
BASE/5ML
-
December
1 -18
2013
A 076097
001 Feb 06, 2002
Apr DISC
A 077474
A 077474
A 077474
A 077474
A 078786
A 078786
A 078786
A 078786
001
002
003
004
001
002
003
004
Sep
Sep
Sep
Sep
Dec
Dec
Dec
Dec
05,
05,
05,
05,
22,
22,
22,
22,
2007
2007
2007
2007
2009
2009
2009
2009
Aug
Aug
Aug
Aug
Feb
Feb
Feb
Feb
CAHN
CAHN
CAHN
CAHN
DISC
DISC
DISC
DISC
A 065349
A 065349
A 065278
A 065278
001
002
001
002
Apr
Apr
Jan
Jan
25,
25,
20,
20,
2013
2013
2006
2006
Apr
Apr
Mar
Mar
NEWA
NEWA
DISC
DISC
Aug
Aug
Apr
Aug
Aug
Apr
Apr
08,
08,
21,
12,
12,
21,
30,
2008
2008
2005
2005
2005
2005
1999
Aug
Aug
Feb
Feb
Feb
Feb
Jul
DISC
DISC
CRLD
CRLD
CRLD
CRLD
CRLD
CEFAZOLIN SODIUM
CEFAZOLIN SODIUM
@ AUROBINDO PHARMA
@
+
HOSPIRA INC
+
+
+
+
STERI PHARMA
EQ
EQ
EQ
EQ
EQ
EQ
EQ
1GM BASE/VIAL
500MG BASE/VIAL
1GM BASE/VIAL
1GM BASE/VIAL
10GM BASE/VIAL
500MG BASE/VIAL
20GM BASE/VIAL
A 065395
A 065395
A 065226
A 065244
A 065247
A 065226
A 063209
002
001
002
001
001
001
002
CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE
@ SANDOZ
@
@
EQ 1GM BASE/VIAL
EQ 2GM BASE/VIAL
EQ 500MG BASE/VIAL
A 090291
A 090291
A 090291
002 Dec 21, 2010
003 Dec 21, 2010
001 Dec 21, 2010
Mar DISC
Mar DISC
Mar DISC
500MG/5ML
100MG/5ML
200MG/5ML
N 202091
A 065129
A 065355
001 Feb 20, 2013
001 Feb 23, 2004
001 Apr 10, 2007
Feb CDFR
Feb CDFR
Feb CDFR
CEFOTAXIME SODIUM
CEFOTAXIME SODIUM
@ AUROBINDO PHARMA
@
@
EQ
EQ
EQ
EQ
A 065517
A 065517
A 065517
A 065516
002
003
001
001
Aug
Aug
Aug
Jun
CEFOXITIN SODIUM
CEFOXITIN
+
ACS DOBFAR
+
+
EQ 1GM BASE/VIAL
EQ 2GM BASE/VIAL
EQ 10GM BASE/VIAL
A 065414
A 065414
A 065415
001 Jun 12, 2009
002 Jun 12, 2009
001 May 19, 2010
Oct CRLD
Oct CRLD
Oct CRLD
CEFTAZIDIME
CEFTAZIDIME
@
@
1GM/VIAL
2GM/VIAL
6GM/VIAL
A 065481
A 065481
A 065482
002 May 28, 2010
003 May 28, 2010
001 May 28, 2010
Jun DISC
Jun DISC
Jun DISC
CEFIXIME
FOR SUSPENSION;ORAL
SUPRAX
+
LUPIN LTD
LUPIN PHARMS
AP
AP
AP
3.125MG
6.25MG
12.5MG
25MG
3.125MG
6.25MG
12.5MG
25MG
12
1GM BASE/VIAL
2GM BASE/VIAL
500MG BASE/VIAL
10GM BASE/VIAL
Nov
Nov
Nov
Nov
06,
06,
06,
06,
2009
2009
2009
2009
DISC
DISC
DISC
DISC
CEFTAZIDIME
@
AP
AP
AP
AP
Jun DISC
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
A 065505
A 065505
A 065505
A 065505
A 065268
A 065268
A 065262
A 065262
A 065227
A 065227
A 065227
A 065227
003
004
001
002
001
002
001
002
003
004
001
002
May
May
May
May
Sep
Sep
Jul
Jul
May
May
May
May
A 065504
A 065274
001 Jul 31, 2008
001 May 01, 2006
May DISC
Oct DISC
A 064192
A 064192
001 Apr 16, 1998
002 Apr 16, 1998
Jul DISC
Jul DISC
A 065251
A 065251
001 Dec 30, 2009
002 Dec 30, 2009
Aug DISC
Aug DISC
N 050643
001 Apr 28, 1989
Jun DISC
EQ 333MG BASE
EQ 750MG BASE
A 090836
A 090836
003 Mar 29, 2013
004 Mar 29, 2013
Mar NEWA
Mar NEWA
EQ 750MG BASE
N 050405
005 May 12, 2006
Mar CTEC
CETIRIZINE HYDROCHLORIDE
SYRUP;ORAL
@ APOTEX INC
BIO PHARM INC
BRECKENRIDGE PHARM
CARACO
5MG/5ML
5MG/5ML
5MG/5ML
5MG/5ML
5MG/5ML
A 078412
A 090751
A 078870
A 078488
A 090191
001
001
001
001
001
Apr
Feb
May
Sep
Jun
CETRORELIX
CETROTIDE
@ EMD SERONO INC
EQ 3MG BASE/ML
N 021197
002 Aug 11, 2000
Jun DISC
A 091591
001 Jul 08, 2013
Jun NEWA
N 020989
002 Jan 11, 2000
Sep CAHN
N 012301
N 012301
001
001
Dec CAHN
Dec CAHN
CEFTRIAXONE SODIUM
INJECTABLE;IM-IV
CEFTRIAXONE
@
@
@
@ STERI PHARMA
@
@ TEVA
@
TEVA PHARMS USA
AB
AB
>D>
>A>
1 -19
2013
001 May 28, 2010
CEPHALEXIN
CAPSULE;ORAL
CEPHALEXIN
ALKEM LABS LTD
AB
December
A 065481
1GM BASE/VIAL
2GM BASE/VIAL
250MG BASE/VIAL
500MG BASE/VIAL
1GM BASE/VIAL
2GM BASE/VIAL
1GM BASE/VIAL
2GM BASE/VIAL
1GM BASE/VIAL
2GM BASE/VIAL
250MG BASE/VIAL
500MG BASE/VIAL
EQ 10GM BASE/VIAL
EQ 10GM BASE/VIAL
CEFUROXIME SODIUM
INJECTABLE;IM-IV
CEFUROXIME SODIUM
@ TEVA PHARMS
EQ 1.5GM BASE/VIAL
@
EQ 750MG BASE/VIAL
CEFUROXIME SODIUM IN PLASTIC CONTAINER
@ SAMSON MEDCL
EQ 75GM BASE/VIAL
@
EQ 225GM BASE/VIAL
ZINACEF IN PLASTIC CONTAINER
@ COVIS PHARMA SARL
EQ 15MG BASE/ML
AA
AA
AA
-
500MG/VIAL
CEFTRIAXONE
@ TEVA
AB
12
+
KEFLEX
SHIONOGI INC
CEVIMELINE HYDROCHLORIDE
CAPSULE;ORAL
CEVIMELINE HYDROCHLORIDE
ROXANE
30MG
EVOXAC
+
DAIICHI SANKYO
30MG
CHLORDIAZEPOXIDE HYDROCHLORIDE
LIBRIUM
@ VALEANT PHARM INTL
100MG/AMP
@ VALEANT PHARMS LLC
100MG/AMP
Jul
Jul
Jul
Jul
Feb
Feb
Jun
Jun
Mar
Mar
Mar
Mar
Jun
Dec
Apr
Oct
Nov
31,
31,
31,
31,
28,
28,
29,
29,
15,
15,
15,
15,
18,
16,
27,
06,
12,
2008
2008
2008
2008
2007
2007
2006
2006
2007
2007
2007
2007
2008
2009
2009
2008
2009
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
CAHN
CAHN
CAHN
CAHN
DISC
DISC
CAHN
CAHN
CAHN
AT
CHLORHEXIDINE GLUCONATE
SOLUTION;DENTAL
@ APOTEX INC
0.12%
PAROEX
SUNSTAR AMERICAS
0.12%
A 076434
001 Nov 29, 2005
Apr CTNA
250MG
500MG
250MG
500MG
A 084388
A 084217
A 086028
A 087736
001
001
001 Jul 14, 1982
001 Jul 14, 1982
Jul
Jul
Jul
Jul
250MG
500MG
N 011145
N 011145
004
002
Jan CAHN
Jan CAHN
EQ 500MG BASE/VIAL
EQ 500MG BASE/VIAL
A 202561
A 202561
001 Apr 22, 2013
001 Apr 22, 2013
Jun CAHN
Apr NEWA
EQ 500MG BASE/VIAL
N 011145
005
Jan CAHN
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
SOLUTION;ORAL
VITUZ
+
CYPRESS PHARM
4MG/5ML;5MG/5ML
N 204307
001 Feb 20, 2013
Feb NEWA
CHLORPROPAMIDE
TABLET;ORAL
CHLORPROPAMIDE
@ WATSON LABS INC
@
100MG
250MG
A 088852
A 088826
001 Sep 26, 1984
001 Sep 26, 1984
Jan DISC
Jan DISC
25MG
25MG
50MG
50MG
25MG
50MG
A 088902
A 088902
A 088903
A 088903
A 086831
A 086831
001
001
001
001
002
001
Sep
Sep
Sep
Sep
Sep
Sep
15MG
25MG
N 019574
N 019574
001 Dec 20, 1988
002 Feb 12, 1992
Nov CAHN
Nov CAHN
45MG FENOFIBRIC ACID
A 201573
A 201573
A 200750
A 200750
A 200913
A 200913
002
001
001
002
001
002
Jul
Jul
Nov
Nov
Mar
Mar
N 022224
N 022224
001 Dec 15, 2008
002 Dec 15, 2008
Mar CFTG
Mar CFTG
0.77%
N 018748
001 Dec 30, 1982
Sep CAHN
8%
8%
A 078172
A 078124
001 Sep 18, 2007
001 Sep 18, 2007
Apr DISC
Aug CAHN
CHLOROTHIAZIDE SODIUM
CHLOROTHIAZIDE SODIUM
LUITPOLD
PHARMAFORCE
DIURIL
+
OAK PHARMS AKORN
AB
@
AB
MYLAN
+
+
AB
AB
AB
AT
1 -20
2013
Apr DISC
CHLORTHALIDONE
TABLET;ORAL
CHLORTHALIDONE
@ BARR LABS INC
AB
AB
AB
AB
AB
AB
December
001 Nov 14, 2000
@ WEST WARD
@
DIURIL
@ OAK PHARMS AKORN
@
AP
-
A 075561
CHLOROTHIAZIDE
TABLET;ORAL
CHLOROTHIAZIDE
+
MYLAN
AP
AP
12
THALITONE
CITRON PHARMA LLC
@
CHOLINE FENOFIBRATE
CAPSULE, DELAYED RELEASE;ORAL
FENOFIBRIC ACID
ANCHEN PHARMS
EQ
EQ
LUPIN LTD
EQ
EQ
MYLAN PHARMS INC
EQ
EQ
TRILIPIX
ABBVIE
EQ
+
EQ
CICLOPIROX
CREAM;TOPICAL
LOPROX
+
MEDIMETRIKS PHARMS
SOLUTION;TOPICAL
CICLOPIROX
@ APOTEX INC
CIPLA LTD
Sep
Sep
Sep
Sep
Jul
Jul
Dec
Dec
Mar
Mar
19,
19,
19,
19,
18,
18,
04,
04,
25,
25,
1985
1985
1985
1985
2013
2013
2013
2013
2013
2013
CTEC
CTEC
DISC
DISC
DISC
CAHN
DISC
CAHN
CTEC
CTEC
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
>D> AT
>A>
AT
AT
AB
>D> AB
>A>
>D> AB
>A>
SOLUTION;TOPICAL
CICLOPIROX
MYLAN PHARMS INC
@
@ TEVA PHARMS
PENLAC
+
VALEANT BERMUDA
+
VALEANT INTL
SUSPENSION;TOPICAL
LOPROX
+
MEDIMETRIKS PHARMS
December
1 -21
2013
A 078567
A 078567
A 078079
001 Sep 18, 2007
001 Sep 18, 2007
001 Sep 18, 2007
Dec DISC
Dec DISC
Jan DISC
8%
8%
N 021022
N 021022
001 Dec 17, 1999
001 Dec 17, 1999
May CAHN
Feb CAHN
0.77%
N 019824
001 Dec 30, 1988
Oct CAHN
50MG
50MG
100MG
100MG
A 077150
A 077150
A 077022
A 077022
001
001
001
001
Mar
Mar
Nov
Nov
11,
11,
23,
23,
2005
2005
2004
2004
Dec
Dec
Dec
Dec
DISC
DISC
DISC
DISC
200MG
300MG
400MG
800MG
A 074349
A 074349
A 074349
A 074316
001
002
003
001
Aug
Aug
Aug
Feb
30,
30,
30,
28,
1996
1996
1996
1996
May
May
May
Jun
DISC
DISC
DISC
DISC
CIMETIDINE HYDROCHLORIDE
SOLUTION;ORAL
CIMETIDINE HYDROCHLORIDE
@ APOTEX INC
EQ 300MG BASE/5ML
A 075560
001 Mar 15, 2000
Apr DISC
CIPROFLOXACIN
CIPROFLOXACIN
@ TEVA PHARMS USA
@
A 077782
A 077782
001 Aug 28, 2006
002 Aug 28, 2006
Apr CAHN
Apr CAHN
A 075928
001 Jun 09, 2004
Apr DISC
BASE
BASE
N 021473
N 021473
001 Dec 13, 2002
002 Aug 28, 2003
May DISC
May DISC
BASE
BASE
BASE
A 077701
A 078183
A 078183
002 Oct 31, 2007
001 Mar 22, 2007
002 Mar 22, 2007
Jun DISC
May CRLD
May CRLD
1MG/ML
1MG/ML
N 018057
A 074814
004 Nov 08, 1988
001 May 16, 2000
Oct CMFD
Sep CAHN
10MG/VIAL
50MG/VIAL
N 018057
N 018057
001
002
Jan CAHN
Jan CAHN
0.5MG/ML
1MG/ML
N 018057
N 018057
003 Jul 18, 1984
004 Nov 08, 1988
Jan CAHN
Jan CAHN
CILOSTAZOL
TABLET;ORAL
CILOSTAZOL
COREPHARMA
@
@
CIPROFLOXACIN HYDROCHLORIDE
CIPROFLOXACIN HYDROCHLORIDE
@ APOTEX INC
EQ 0.3% BASE
AP
-
8%
8%
8%
CIMETIDINE
TABLET;ORAL
CIMETIDINE
@ WATSON LABS INC
@
@
@
AB
AB
12
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
CIPRO XR
@ BAYER HLTHCARE
212.6MG;EQ 287.5MG
@
425.2MG;EQ 574.9MG
CIPROFLOXACIN EXTENDED RELEASE
@ DR REDDYS LABS LTD
212.6MG;EQ 287.5MG
+
MYLAN PHARMS INC
212.6MG;EQ 287.5MG
+
425.2MG;EQ 574.9MG
CISPLATIN
CISPLATIN
HQ SPCLT PHARMA
@ TEVA PHARMS USA
PLATINOL
@ HQ SPCLT PHARMA
@
PLATINOL-AQ
@ HQ SPCLT PHARMA
@
>D>
>D> AA
>A>
>D> AA
>A> AA
AB
AB
AB
CITALOPRAM HYDROBROMIDE
SOLUTION;ORAL
CELEXA
+
FOREST LABS
@
@ APOTEX INC
ROXANE
+
TABLET;ORAL
CIPLA LTD
AB
AB
>A>
AA
AT
BT
AP
AP
AP
AT
-
December
1 -22
2013
EQ 10MG BASE/5ML
EQ 10MG BASE/5ML
N 021046
N 021046
001 Dec 22, 1999
001 Dec 22, 1999
Dec DISC
Dec DISC
EQ 10MG BASE/5ML
EQ 10MG BASE/5ML
EQ 10MG BASE/5ML
A 077601
A 077043
A 077043
001 Nov 15, 2005
001 Dec 13, 2004
001 Dec 13, 2004
Apr DISC
Dec CRLD
Dec CRLD
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
A 077044
A 077044
A 077044
A 077036
A 077036
A 077036
A 077141
A 077141
001
002
003
001
002
003
002
001
Aug
Aug
Aug
Feb
Feb
Feb
Jun
Jun
1MG/ML
1MG/ML
A 076571
A 076571
001 Apr 22, 2004
001 Apr 22, 2004
Dec CRLD
Dec CRLD
1MG/ML
1MG/ML
N 020229
N 020229
001 Feb 26, 1993
001 Feb 26, 1993
Dec DISC
Dec DISC
250MG
500MG
A 202710
A 202710
001 Jun 10, 2013
002 Jun 10, 2013
May NEWA
May NEWA
CLEMASTINE FUMARATE
SYRUP;ORAL
CLEMASTINE FUMARATE
@ APOTEX INC
@ SILARX
EQ 0.5MG BASE/5ML
EQ 0.5MG BASE/5ML
A 075703
A 074884
001 Nov 27, 2000
001 Dec 17, 1997
Apr DISC
Mar DISC
CLEVIDIPINE
EMULSION;INTRAVENOUS
CLEVIPREX
+
MEDICINES CO
+
+
25MG/50ML (0.5MG/ML)
50MG/100ML (0.5MG/ML)
125MG/250ML (0.5MG/ML)
N 022156
N 022156
N 022156
001 Aug 01, 2008
002 Aug 01, 2008
003 Nov 08, 2013
Feb CAIN
Feb CAIN
Dec NEWA
A 202409
001 Apr 30, 2013
Apr NEWA
N 050801
001 Oct 22, 2004
Sep CAHN
1% BASE
N 050782
001 Nov 27, 2000
Oct CAHN
DEXTROSE IN PLASTIC CONTAINER
6MG BASE/ML
12MG BASE/ML
18MG BASE/ML
A 203048
A 203048
A 203048
001 Apr 04, 2013
002 Apr 04, 2013
003 Apr 04, 2013
Mar NEWA
Mar NEWA
Mar NEWA
1% BASE
1% BASE
1% BASE
A 062811
A 064050
A 064050
001 Sep 01, 1988
001 Nov 30, 1995
001 Nov 30, 1995
May CAHN
Aug CMFD
Feb DISC
@ COREPHARMA
@
@
@ NATCO PHARMA LTD
@
>D> AP
>A> AP
>D>
>D> AP
>A>
12
CLADRIBINE
CLADRIBINE
FRESENIUS KABI USA
+
LEUSTATIN
+
JANSSEN PHARMS
@
CLARITHROMYCIN
TABLET;ORAL
CLARITHROMYCIN
ALLIED PHARMA INC
10MG
20MG
40MG
10MG
20MG
40MG
20MG
40MG
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
CLINDAMYCIN PALMITATE HYDROCHLORIDE
FOR SOLUTION;ORAL
CLINDAMYCIN PALMITATE HYDROCHLORIDE
EQ 75MG BASE/5ML
CLINDAMYCIN PHOSPHATE
EVOCLIN
+
DELCOR ASSET
1%
GEL;TOPICAL
CLINDAGEL
+
PRECISION DERMAT
EQ
CLINDAMYCIN PHOSPHATE IN 5%
AKORN INC
EQ
EQ
EQ
SOLUTION;TOPICAL
CLINDAMYCIN PHOSPHATE
@ ACTAVIS MID ATLANTIC
EQ
PERRIGO NEW YORK
EQ
@
EQ
Nov
Nov
Nov
Oct
Oct
Oct
Apr
Apr
05,
05,
05,
28,
28,
28,
10,
10,
2004
2004
2004
2004
2004
2004
2008
2008
CAHN
CAHN
CAHN
DISC
DISC
DISC
DISC
DISC
CLOBAZAM
TABLET;ORAL
ONFI
@ LUNDBECK LLC
CLOBETASOL PROPIONATE
OLUX E
AB2
+
DELCOR ASSET
CREAM;TOPICAL
CLOBETASOL PROPIONATE
@ TEVA PHARMS USA
SOLUTION;TOPICAL
EMBELINE
AT
+
HI TECH PHARMA
TEMOVATE
@ FOUGERA PHARMS
AB
AB
AB
CLONAZEPAM
TABLET;ORAL
CLONAZEPAM
ACCORD HLTHCARE
@ APOTEX INC
@
@
AP
AP
>D>
>A> AB
>D>
>A> AB
>D>
>A> AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
ACTAVIS TOTOWA
MUTUAL PHARM
-
December
1 -23
2013
5MG
N 202067
001 Oct 21, 2011
Jul DISC
0.05%
N 022013
001 Jan 12, 2007
Jun CAHN
0.05%
A 074087
001 Feb 16, 1994
Jun DISC
0.05%
A 074222
001 Dec 06, 1995
Jul CRLD
0.05%
N 019966
001 Feb 22, 1990
Jul DISC
0.5MG
1MG
2MG
0.5MG
1MG
2MG
A 077147
A 077147
A 077147
A 075468
A 075468
A 075468
001
002
003
001
002
003
Apr
Apr
Apr
Feb
Feb
Feb
A 203167
A 203167
001 Oct 29, 2013
002 Oct 29, 2013
Oct NEWA
Oct NEWA
A 091368
A 091368
A 091368
A 091368
A 091368
A 091368
A 091368
A 091368
A 091368
A 202297
A 202297
A 202297
001
001
001
002
002
002
003
003
003
001
002
003
Dec
Dec
Nov
Dec
Dec
Nov
Dec
Dec
Nov
May
May
May
A 202984
A 202984
001 Sep 30, 2013
002 Sep 30, 2013
Sep NEWA
Sep NEWA
N 022331
N 022331
001 Sep 30, 2009
002 May 25, 2010
May CAHN
May CAHN
N 022331
N 022331
N 022331
N 022331
003
003
004
004
Sep
Sep
Sep
Sep
28,
28,
28,
28,
2010
2010
2010
2010
Sep
May
Sep
May
CFTG
CAHN
CFTG
CAHN
A 202925
A 202925
A 090307
A 078133
001
002
001
001
Mar
Mar
May
Jun
27,
27,
28,
10,
2013
2013
2013
2013
Mar
Mar
May
May
NEWA
NEWA
NEWA
NEWA
CLONIDINE HYDROCHLORIDE
EXELA PHARMA SCS LLC 1MG/10ML (0.1MG/ML)
5MG/10ML (0.5MG/ML)
TABLET;ORAL
@ ALEMBIC PHARMS LTD
0.1MG
0.1MG
@
0.1MG
@
0.2MG
0.2MG
@
0.2MG
@
0.3MG
0.3MG
@
0.3MG
CARLSBAD
0.1MG
0.2MG
0.3MG
ANCHEN PHARMS
0.1MG
0.2MG
JENLOGA
@ CONCORDIA PHARMS INC 0.1MG
@
0.2MG
KAPVAY
+
CONCORDIA PHARMS INC 0.1MG
+
0.1MG
0.2MG
0.2MG
CLOPIDOGREL BISULFATE
TABLET;ORAL
CLOPIDOGREL BISULFATE
ACCORD HLTHCARE
12
EQ
EQ
EQ
EQ
75MG BASE
300MG BASE
75MG BASE
75MG BASE
May
May
May
Oct
Oct
Oct
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Jun
Jun
Jun
02,
02,
02,
06,
06,
06,
06,
06,
06,
06,
06,
06,
06,
06,
06,
13,
13,
13,
2005
2005
2005
2000
2000
2000
2011
2011
2011
2011
2011
2011
2011
2011
2011
2013
2013
2013
CAHN
CAHN
CAHN
DISC
DISC
DISC
CMFD
CMFD
DISC
CMFD
CMFD
DISC
CMFD
CMFD
DISC
NEWA
NEWA
NEWA
AB
AB
AB
CLORAZEPATE DIPOTASSIUM
CAPSULE;ORAL
TRANXENE
@ RECORDATI RARE
@
@
TABLET;ORAL
TRANXENE
RECORDATI RARE
>D> AT
>A>
AA
AB
AB
AB
AB
AB
December
2013
1 -24
N 017105
N 017105
N 017105
001
002
003
May CAHN
May CAHN
May CAHN
3.75MG
7.5MG
15MG
N 017105
N 017105
N 017105
006
007
008
May CAHN
May CAHN
May CAHN
11.25MG
22.5MG
N 017105
N 017105
005
004
May CAHN
May CAHN
1%
N 018183
001
Sep CAHN
1%
1%
A 074580
A 074580
001 Jul 29, 1996
001 Jul 29, 1996
Dec CTEC
Dec CTEC
1%
1%
N 018181
N 018181
001
001
Dec DISC
Dec DISC
50MG/ML
50MG/ML
N 203479
N 203479
001 Feb 06, 2013
001 Feb 06, 2013
Feb NEWA
Mar CAHN
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
SYRUP;ORAL
PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
AMNEAL PHARMS
10MG/5ML;6.25MG/5ML
CARACO
10MG/5ML;6.25MG/5ML
@ PHARM ASSOC
10MG/5ML;6.25MG/5ML
A 200894
A 090180
A 089647
001 Apr 24, 2013
001 Mar 17, 2010
001 Dec 22, 1988
Apr NEWA
May CAHN
Aug DISC
CRIZOTINIB
CAPSULE;ORAL
XALKORI
PF PRISM CV
+
N 202570
N 202570
001 Aug 26, 2011
002 Aug 26, 2011
Sep CAHN
Sep CAHN
A 202745
001 Apr 04, 2013
Mar NEWA
A 075333
001 Apr 30, 2002
Apr DISC
A 075615
001 Jan 26, 2001
Apr DISC
N 021777
N 021777
001 Feb 01, 2007
002 Feb 01, 2007
Jan CAHN
Jan CAHN
A 091281
A 091281
001 Jan 31, 2013
002 Jan 31, 2013
Jan NEWA
Jan NEWA
A 073144
A 077291
A 072854
003 Mar 25, 2013
001 Feb 03, 2006
002 Feb 03, 2006
Mar NEWA
Mar DISC
Apr DISC
+
CLOTRIMAZOLE
CREAM;TOPICAL
MYCELEX
@ BAYER
SOLUTION;TOPICAL
CLOTRIMAZOLE
TARO
+
MYCELEX
+
BAYER HLTHCARE
@
CLOZAPINE
SUSPENSION;ORAL
VERSACLOZ
+
DOUGLAS PHARMS
+
JAZZ PHARMS III
AA
AA
-
3.75MG
7.5MG
15MG
TRANXENE SD
@ RECORDATI RARE
@
>D> AT
>A> AT
12
200MG
250MG
CROMOLYN SODIUM
CONCENTRATE;ORAL
CROMOLYN SODIUM
MICRO LABS LTD INDIA 100MG/5ML
SOLUTION;INHALATION
CROMOLYN SODIUM
@ APOTEX INC
10MG/ML
CROMOLYN SODIUM
@ APOTEX INC
4%
CYCLOBENZAPRINE HYDROCHLORIDE
AMRIX
IVAX INTL
15MG
+
30MG
TWI PHARMS INC
15MG
30MG
TABLET;ORAL
MYLAN PHARMS INC
7.5MG
@ PROSAM LABS
5MG
@ SANDOZ
5MG
TABLET;ORAL
@
10MG
AP
AP
AP
1 -25
2013
Apr DISC
A 040165
001 Jan 13, 1997
Mar DISC
A 084108
001
Mar CTEC
25MG
50MG
N 203856
N 203856
001 Sep 16, 2013
002 Sep 16, 2013
Sep NEWA
Sep NEWA
1GM/VIAL
1GM/VIAL
2GM/VIAL
2GM/VIAL
500MG/VIAL
500MG/VIAL
N 012142
N 012142
N 012142
N 012142
N 012142
N 012142
004
010
005
009
003
008
Mar
Jan
Mar
Jan
Mar
Jan
100MG/ML
A 065167
001 Jan 05, 2005
Apr DISC
CYPROHEPTADINE HYDROCHLORIDE
SYRUP;ORAL
CYPROHEPTADINE HYDROCHLORIDE
PHARM ASSOC
2MG/5ML
A 091295
001 Mar 28, 2013
Mar NEWA
CYSTEAMINE BITARTRATE
PROCYSBI
RAPTOR PHARMS
EQ 25MG BASE
+
EQ 75MG BASE
N 203389
N 203389
001 Apr 30, 2013
002 Apr 30, 2013
Apr NEWA
Apr NEWA
1GM/VIAL
2GM/VIAL
100MG/VIAL
500MG/VIAL
A 075206
A 075206
A 075206
A 075206
004
003
001
002
Jun
Jun
Jun
Jun
DABRAFENIB MESYLATE
CAPSULE;ORAL
TAFINLAR
GLAXOSMITHKLINE
+
EQ 50MG BASE
EQ 75MG BASE
N 202806
N 202806
001 May 29, 2013
002 May 29, 2013
May NEWA
May NEWA
DACARBAZINE
DACARBAZINE
TEVA PHARMS USA
+
200MG/VIAL
500MG/VIAL
A 075259
A 075259
002 Aug 27, 1998
001 Sep 22, 2000
Apr CAHN
Apr CAHN
0.5MG/VIAL
N 050682
001
May CAHN
0.5MG/VIAL
0.5MG/VIAL
A 202562
A 202562
001 Aug 23, 2013
001 Aug 23, 2013
Nov CAHN
Aug NEWA
CYCLOSPORINE
SOLUTION;ORAL
CYCLOSPORINE
@ APOTEX INC
AP
AP
December
001 Nov 19, 1991
CYCLOPHOSPHAMIDE
CAPSULE;ORAL
CYCLOPHOSPHAMIDE
ROXANE
+
CYTOXAN (LYOPHILIZED)
AP
+
BAXTER HLTHCARE
@
AP
+
@
AP
+
@
AP
AP
AP
AP
-
A 072854
CYCLOPENTOLATE HYDROCHLORIDE
AKPENTOLATE
@ AKORN
2%
CYCLOGYL
+
ALCON LABS INC
2%
AA
12
CYTARABINE
CYTOSAR-U
+
TEVA PHARMS USA
+
+
DACTINOMYCIN
COSMEGEN
+
RECORDATI RARE
DACTINOMYCIN
LUITPOLD
PHARMAFORCE
Aug
Sep
Aug
Dec
30,
24,
30,
10,
1982
1985
1982
1985
Jan 04, 1984
Dec
Dec
Dec
Dec
30,
30,
30,
30,
1998
1998
1998
1998
CTNA
CTNA
CTNA
CTNA
CTNA
CTNA
CAHN
CAHN
CAHN
CAHN
DALTEPARIN SODIUM
INJECTABLE;SUBCUTANEOUS
FRAGMIN
@ EISAI INC
@
12
-
December
2013
1 -26
10,000IU/0.4ML (25,000IU/ML)
95,000IU/9.5ML (10,000IU/ML)
N 020287
N 020287
002 May 01, 2007
007 Apr 04, 2002
Jun DISC
Jun DISC
25MG
50MG
100MG
A 076686
A 076686
A 076686
001 Oct 24, 2005
002 Oct 24, 2005
003 Oct 24, 2005
Jul CMFD
Jul CMFD
Jul CMFD
EQ 400MG BASE
EQ 400MG BASE
N 021976
N 021976
003 Oct 21, 2008
003 Oct 21, 2008
Dec DISC
Dec DISC
A 065035
001 Jan 24, 2000
Apr CAHN
50MG/VIAL
N 021790
001 May 02, 2006
Jul CFTG
50MG/VIAL
A 203131
001 Jul 11, 2013
Jul NEWA
DESIPRAMINE HYDROCHLORIDE
TABLET;ORAL
DESIPRAMINE HYDROCHLORIDE
@ BARR LABS INC
150MG
A 071804
001 May 29, 1997
Nov CAHN
>D>
>A>
DESIRUDIN RECOMBINANT
IPRIVASK
+
CANYON
+
MARATHON PHARMS LLC
15MG/VIAL
15MG/VIAL
N 021271
N 021271
001 Apr 04, 2003
001 Apr 04, 2003
Dec CAHN
Dec CAHN
0.004MG/ML
0.004MG/ML
A 091280
A 074888
001 Jan 25, 2013
001 Oct 15, 1997
Jan NEWA
Apr CAHN
>A> AB
DESMOPRESSIN ACETATE
SUN PHARM INDS LTD
TEVA PHARMS USA
SOLUTION;NASAL
SUN PHARMA GLOBAL
0.01%
A 078271
001 Dec 23, 2013
Dec NEWA
A 202296
A 091234
001 Aug 30, 2013
001 Jul 12, 2013
Aug NEWA
Jul NEWA
A 201887
001 Mar 07, 2013
Feb NEWA
A 091247
001 Aug 01, 2013
Jul NEWA
N 021844
001 Oct 20, 2006
Jun CAHN
AB
AB
AB
DANTROLENE SODIUM
CAPSULE;ORAL
DANTROLENE SODIUM
MIKAH PHARMA
DARUNAVIR ETHANOLATE
TABLET;ORAL
PREZISTA
JANSSEN PRODS
@
>D>
>A>
AP
AP
AP
AP
AP
AB
AB
AB
AB
DAUNORUBICIN HYDROCHLORIDE
DAUNORUBICIN HYDROCHLORIDE
TEVA PHARMS USA
EQ 5MG BASE/ML
DECITABINE
DACOGEN
+
EISAI INC
DECITABINE
DR REDDYS LABS LTD
DESOGESTREL; ETHINYL ESTRADIOL
TABLET;ORAL-28
DESOGESTREL AND ETHINYL ESTRADIOL
FAMY CARE LTD
0.15MG,N/A;0.02MG,0.01MG
NOVAST LABS LTD
0.15MG;0.03MG
ENSKYCE
LUPIN LTD
0.15MG;0.03MG
PIMTREA
NOVAST LABS LTD
0.15MG,N/A;0.02MG,0.01MG
DESONIDE
GEL;TOPICAL
DESONATE
+
BAYER HLTHCARE
0.05%
AB
DESOXIMETASONE
OINTMENT;TOPICAL
DESOXIMETASONE
GLENMARK GENERICS
SPRAY;TOPICAL
TOPICORT
+
TARO
12
-
December
1 -27
2013
0.25%
A 202838
001 Sep 20, 2013
Sep NEWA
0.25%
N 204141
001 Apr 11, 2013
Apr NEWA
DESVENLAFAXINE
DESVENLAFAXINE
+
ALEMBIC PHARMS LTD
50MG
+
50MG
50MG
+
100MG
+
100MG
KHEDEZLA
OSMOTICA PHARM CORP
50MG
100MG
N 204150
N 204150
N 204150
N 204150
N 204150
001
001
001
002
002
Jul
Apr
Mar
Jul
Mar
N 204683
N 204683
001 Jul 10, 2013
002 Jul 10, 2013
Jul NEWA
Jul NEWA
DESVENLAFAXINE FUMARATE
DESVENLAFAXINE FUMARATE
+
TEVA PHARMS USA
EQ 50MG BASE
+
EQ 100MG BASE
N 205208
N 205208
001 Oct 11, 2013
002 Oct 11, 2013
Oct NEWA
Oct NEWA
AA
DEXAMETHASONE
ELIXIR;ORAL
DEXAMETHASONE
A 088254
001 Jul 27, 1983
May CRLD
AP
AP
DEXAMETHASONE SODIUM PHOSPHATE
DEXAMETHASONE SODIUM PHOSPHATE
AGILA SPECLTS
EQ 4MG PHOSPHATE/ML
EQ 10MG PHOSPHATE/ML
A 040803
A 040802
001 Aug 29, 2008
001 Aug 29, 2008
Nov CAHN
Nov CAHN
A 062938
001 Jul 31, 1989
Jun CAHN
A 062721
001 Nov 17, 1986
Jan DISC
N 021038
002 Mar 13, 2013
Mar NEWA
N 021038
003 Mar 13, 2013
Mar NEWA
A 078992
A 078992
A 202580
A 078908
A 078908
A 078908
A 202731
A 079108
003
004
001
001
002
003
002
005
Nov
Nov
Aug
Nov
Nov
Nov
Nov
Nov
18,
18,
28,
19,
19,
19,
19,
21,
2013
2013
2013
2013
2013
2013
2013
2013
Nov
Nov
Aug
Nov
Nov
Nov
Nov
Nov
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
N 021802
N 021802
N 021802
N 021802
N 021802
001
002
004
003
005
May
May
Aug
May
Oct
26,
26,
01,
26,
23,
2005
2005
2006
2005
2009
Nov
Nov
Nov
Nov
Aug
CTEC
CTEC
CTEC
CTEC
CFTG
BC
BC
BC
BC
AT
0.5MG/5ML
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT;OPHTHALMIC
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
0.1%;EQ 3.5MG BASE/GM;10,000
UNITS/GM
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
@ ALCON PHARMS LTD
0.1%;EQ 3.5MG BASE/ML;10,000
UNITS/ML
DEXMEDETOMIDINE HYDROCHLORIDE
PRECEDEX
+
HOSPIRA
EQ 200MCG BASE/50ML (EQ 4MCG
BASE/ML)
+
EQ 400MCG BASE/100ML (EQ 4MCG
BASE/ML)
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
DEXMETHYLPHENIDATE HYDROCHLORIDE
DEXMETHYLPHENIDATE HYDROCHLORIDE
INTELLIPHARMACEUTICS 15MG
30MG
MYLAN PHARMS INC
30MG
TEVA PHARMS USA
5MG
10MG
20MG
40MG
WATSON LABS INC
30MG
FOCALIN XR
NOVARTIS
5MG
10MG
15MG
20MG
30MG
Mar
Mar
Mar
Mar
Mar
04,
04,
04,
04,
04,
2013
2013
2013
2013
2013
CTEC
CRLD
NEWA
CTEC
NEWA
AB
FOCALIN XR
+
40MG
AA
AA
AB
AB
AB
AB
>D> AB
>A>
-
December
2013
1 -28
N 021802
006 Aug 11, 2010
Nov CTEC
N 022025
001 Sep 06, 2007
May CAHN
A 040776
A 203644
001 Jan 29, 2008
001 May 29, 2013
May CFTG
May NEWA
A 202893
A 202893
001 Jul 31, 2013
002 Jul 31, 2013
Jul NEWA
Jul NEWA
DEXTROSE; POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER
@ B BRAUN
5GM/100ML;220MG/100ML
N 018744
003 Nov 09, 1982
Jan DISC
DIAZEPAM
DIAZEPAM
@ WATSON LABS
5MG/ML
A 070296
001 Feb 12, 1986
Jun DISC
DIAZOXIDE
SUSPENSION;ORAL
PROGLYCEM
+
TEVA BRANDED PHARM
50MG/ML
N 017453
001
Apr CAHN
DICLOFENAC
CAPSULE;ORAL
ZORVOLEX
IROKO PHARMS LLC
+
18MG
35MG
N 204592
N 204592
001 Oct 18, 2013
002 Oct 18, 2013
Oct NEWA
Oct NEWA
A 200936
001 Oct 28, 2013
Oct NEWA
N 021005
001 Oct 16, 2000
Oct CFTG
A 077600
001 Nov 13, 2008
Apr DISC
A 200158
A 200158
001 May 09, 2013
002 May 09, 2013
Apr NEWA
Apr NEWA
A 040204
001 Feb 28, 1997
Jul DISC
A 040161
A 040161
001 Oct 01, 1996
001 Oct 01, 1996
Dec DISC
Dec DISC
A 077275
A 077275
A 077275
001 Aug 14, 2012
002 Aug 14, 2012
003 Aug 14, 2012
Apr CDFR
Apr CDFR
Apr CDFR
DEXRAZOXANE HYDROCHLORIDE
TOTECT
+
BIOCODEX INC
AA
AA
12
EQ 500MG BASE/VIAL
DEXTROAMPHETAMINE SULFATE
SOLUTION;ORAL
+
OUTLOOK PHARMS
5MG/5ML
TRIS PHARMA INC
5MG/5ML
TABLET;ORAL
AUROLIFE PHARMA LLC
5MG
10MG
DICLOFENAC SODIUM
GEL;TOPICAL
DICLOFENAC SODIUM
TOLMAR
3%
SOLARAZE
+
FOUGERA PHARMS
3%
DICLOFENAC SODIUM
@ APOTEX INC
0.1%
DICLOFENAC SODIUM; MISOPROSTOL
DICLOFENAC SODIUM AND MISOPROSTOL
SANDOZ
50MG;0.2MG
75MG;0.2MG
DICYCLOMINE HYDROCHLORIDE
CAPSULE;ORAL
@ WEST WARD
10MG
TABLET;ORAL
WEST WARD
20MG
@
20MG
DIDANOSINE
DIDANOSINE
AUROBINDO
100MG
150MG
+
200MG
BX
AB
AB
AB3
AB3
AB3
AB3
AB4
AB4
AB4
AB4
AB4
AB4
AP
DIFLORASONE DIACETATE
CREAM;TOPICAL
DIFLORASONE DIACETATE
@ FOUGERA PHARMS
+
TARO
PSORCON
@ TARO PHARMS NORTH
DIGOXIN
TABLET;ORAL
DIGOXIN
@ CARACO
@
HIKMA PHARMS
1 -29
2013
001 Mar 30, 1998
001 Apr 24, 2000
May DISC
May CRLD
0.05%
N 020205
001 Nov 20, 1992
Jun CAHN
0.125MG
0.25MG
0.125MG
0.25MG
A 076363
A 076363
A 077002
A 077002
001
002
002
001
Jan
Jan
Oct
Oct
31,
31,
30,
30,
2003
2003
2007
2007
Jun
Jun
Oct
Oct
DISC
DISC
CAHN
CAHN
A 074984
A 074984
A 074984
A 074984
A 091022
A 091022
A 091022
A 091022
A 091022
A 091022
001
002
003
004
001
002
003
004
005
006
Dec
Dec
Dec
Dec
Sep
Sep
Sep
Sep
Sep
Sep
20,
20,
20,
20,
28,
28,
28,
28,
28,
28,
1999
1999
1999
1999
2012
2012
2012
2012
2012
2012
Jan
Jan
Jan
Jan
Feb
Feb
Feb
Feb
Feb
Feb
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
A 075086
A 075375
A 074894
A 074894
001
001
001
002
Apr
Sep
Aug
Apr
09,
30,
26,
19,
1998
1999
1997
2002
Jul
Apr
Apr
Apr
CAHN
DISC
CAHN
CAHN
A 074093
A 074093
A 074093
A 074093
001
002
003
004
Nov
Nov
Nov
Nov
05,
05,
05,
05,
1992
1992
1992
1992
Jan
Jan
Jan
Jan
DISC
DISC
DISC
DISC
A 040519
A 080615
001 Jun 23, 2004
001
Apr CRLD
Apr DISC
N 204063
N 204063
001 Mar 27, 2013
002 Mar 27, 2013
Mar NEWA
Mar NEWA
A 080873
A 080873
001
002
Mar DISC
Mar DISC
A 091526
A 080873
001 Mar 26, 2013
003
Mar NEWA
Mar DISC
A 075769
A 075769
A 074952
001 Nov 27, 2002
001 Nov 27, 2002
001 Nov 26, 1997
Aug CAHN
Apr DISC
May CAHN
50MG/ML
50MG/ML
DIPHENHYDRAMINE HYDROCHLORIDE
DIPHENHYDRAMINE HYDROCHLORIDE
@ WATSON LABS INC
10MG/ML
@
50MG/ML
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
BD RX
50MG/ML
@ WATSON LABS INC
50MG/ML
DIPYRIDAMOLE
DIPYRIDAMOLE
@ AGILA SPECLTS
@ APOTEX INC
@ TEVA PHARMS USA
December
A 075187
A 075508
DIMETHYL FUMARATE
TECFIDERA
BIOGEN IDEC INC
120MG
+
240MG
AP
-
0.05%
0.05%
DILTIAZEM HYDROCHLORIDE
PAR PHARM
120MG
180MG
240MG
300MG
SANDOZ
120MG
180MG
240MG
300MG
360MG
420MG
AKORN INC
5MG/ML
@ APOTEX INC
5MG/ML
@ TEVA PHARMS USA
5MG/ML
+
10MG/ML
TABLET;ORAL
@ DAVA PHARMS INC
30MG
@
60MG
@
90MG
@
120MG
DIMENHYDRINATE
DIMENHYDRINATE
+
FRESENIUS KABI USA
@ WATSON LABS
12
5MG/ML
5MG/ML
5MG/ML
TABLET;ORAL
DIPYRIDAMOLE
@ PROSAM LABS
@
@
AB
AP
>D> AB
AB
>D> AB
AB
AB
AB
AB
AB
>A> AB
>A> AB
1 -30
2013
001 Apr 21, 2006
002 Apr 21, 2006
003 Apr 21, 2006
Jun DISC
Jun DISC
Jun DISC
250MG
A 091681
001 Aug 08, 2013
Jul NEWA
125MG VALPROIC ACID
250MG VALPROIC ACID
500MG VALPROIC ACID
A 077254
A 077254
A 077254
001 Jul 29, 2008
002 Jul 29, 2008
003 Jul 29, 2008
Aug DISC
Aug DISC
Aug DISC
500MG VALPROIC ACID
A 078700
001 Aug 03, 2009
Mar DISC
160MG/8ML (20MG/ML)
20MG/ML (20MG/ML)
80MG/4ML (20MG/ML)
140MG/7ML (20MG/ML)
80MG/2ML (40MG/ML)
N 201195
N 203551
N 203551
N 203551
N 022312
N 022312
005
001
002
003
001
002
Aug
Apr
Apr
Apr
May
May
160MG/8ML (20MG/ML)
N 020449
005 Apr 13, 2012
Aug NEWA
EQ 50MG BASE
N 204790
001 Aug 12, 2013
Aug NEWA
23MG
N 022568
001 Jul 23, 2010
Jul CTEC
5MG
10MG
5MG
5MG
10MG
10MG
5MG
10MG
23MG
23MG
5MG
10MG
A 201335
A 201335
A 090551
A 090551
A 090551
A 090551
A 201724
A 201724
A 202723
A 202542
A 090551
A 090551
001
002
001
001
002
002
001
002
001
001
001
002
Jan
Jan
Dec
Apr
Dec
Apr
Feb
Feb
Jul
Jul
Dec
Dec
250MG/VIAL
500MG/VIAL
N 022106
N 022106
002 Oct 05, 2010
001 Oct 12, 2007
Oct CAHN
Oct CAHN
DORZOLAMIDE HYDROCHLORIDE
DORZOLAMIDE HYDROCHLORIDE
@ APOTEX INC
EQ 2% BASE
ZACH SYSTEMS
EQ 2% BASE
A 078395
A 091034
001 Oct 28, 2008
001 Dec 04, 2013
Apr DISC
Nov NEWA
DISULFIRAM
TABLET;ORAL
DISULFIRAM
ALVOGEN PINE BROOK
DOCETAXEL
DOCETAXEL
ACCORD HLTHCARE
ACTAVIS INC
@ APOTEX INC
@
TAXOTERE
+
SANOFI AVENTIS US
DONEPEZIL HYDROCHLORIDE
TABLET;ORAL
ARICEPT
+
EISAI INC
DONEPEZIL HYDROCHLORIDE
@ ACCORD HLTHCARE
@
ACTAVIS GRP PTC
ALEMBIC PHARMS LTD
DR REDDYS LABS LTD
PAR PHARM
VIVIMED LABS
DORIPENEM
DORIBAX
SHIONOGI INC
+
AT
December
A 040542
A 040542
A 040542
DOLUTEGRAVIR SODIUM
TABLET;ORAL
TIVICAY
+
VIIV HLTHCARE
AB
-
25MG
50MG
75MG
DIVALPROEX SODIUM
DIVALPROEX SODIUM
@ MYLAN
EQ
@
EQ
@
EQ
DIVALPROEX SODIUM
@ TEVA PHARMS USA
EQ
AP
AP
AP
12
Apr
Apr
Apr
Apr
Jan
Jan
Aug
Aug
May
May
May
May
Feb
Feb
Jul
Jul
May
May
20,
12,
12,
12,
11,
11,
29,
29,
31,
31,
31,
31,
25,
25,
24,
24,
31,
31,
2012
2013
2013
2013
2012
2012
2011
2011
2011
2011
2011
2011
2013
2013
2013
2013
2011
2011
CTEC
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
AT
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
COSOPT
+
OAK PHARMS AKORN
EQ 2% BASE;EQ 0.5% BASE
COSOPT PF
+
OAK PHARMS AKORN
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
@ APOTEX INC
ZACH SYSTEMS
AP
DOXAPRAM HYDROCHLORIDE
DOPRAM
+
HIKMA MAPLE
DOXAZOSIN MESYLATE
TABLET;ORAL
DOXAZOSIN MESYLATE
@ WATSON LABS INC
@
@
@
AT
AB
AB
AB
AB
AB
DOXEPIN HYDROCHLORIDE
CAPSULE;ORAL
MYLAN PHARMS INC
+
@ PAR PHARM
@
@
@
@
@ WATSON LABS
@
@
@
@
CONCENTRATE;ORAL
@ PHARM ASSOC
TABLET;ORAL
ACTAVIS ELIZABETH
SILENOR
PERNIX THERAPS LLC
AB
AB
>A> AB
>A> AB
>D>
>A> AB
>D>
>A> AB
AP
AP
AP
+
+
DOXERCALCIFEROL
CAPSULE;ORAL
DOXERCALCIFEROL
ROXANE
HECTOROL
GENZYME CORP
+
+
DOXERCALCIFEROL
HIKMA PHARMS LLC
INNOPHARMA INC
HECTOROL
+
GENZYME CORP
12
-
December
1 -31
2013
N 020869
001 Apr 07, 1998
Nov CAHN
N 202667
001 Feb 01, 2012
Nov CAHN
A 078201
A 091180
001 Oct 28, 2008
001 Dec 04, 2013
Apr DISC
Nov NEWA
20MG/ML
N 014879
001
Jul CAHN
EQ
EQ
EQ
EQ
1MG
2MG
4MG
8MG
A 075426
A 075426
A 075426
A 075426
001
002
003
004
Oct
Oct
Oct
Oct
18,
18,
18,
18,
2000
2000
2000
2000
Jan
Jan
Jan
Jan
DISC
DISC
DISC
DISC
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
10MG BASE
10MG BASE
25MG BASE
10MG BASE
25MG BASE
50MG BASE
75MG BASE
100MG BASE
10MG BASE
25MG BASE
50MG BASE
75MG BASE
100MG BASE
A 070791
A 070791
A 070791
A 071697
A 071437
A 071595
A 071608
A 071422
A 071485
A 071486
A 071238
A 071326
A 071239
002
002
003
001
001
001
001
001
001
001
001
001
001
May
May
May
Nov
Nov
Nov
Nov
Nov
Apr
Apr
Apr
Apr
Apr
13,
13,
13,
09,
09,
09,
09,
09,
30,
30,
30,
30,
30,
1986
1986
1986
1987
1987
1987
1987
1987
1987
1987
1987
1987
1987
Jun
May
Jun
May
May
May
May
May
May
May
May
May
May
CRLD
CRLD
CRLD
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
EQ 10MG BASE/ML
A 075924
001 Jan 15, 2004
Mar DISC
EQ 3MG BASE
EQ 6MG BASE
A 201951
A 201951
001 Jul 26, 2013
002 Jul 26, 2013
Jul NEWA
Jul NEWA
EQ
EQ
EQ
EQ
N 022036
N 022036
N 022036
N 022036
001
001
002
002
Jul
Apr
Jul
Apr
1MCG
2.5MCG
A 091433
A 091433
002 Jan 14, 2014
003 Jan 14, 2014
Dec NEWA
Dec NEWA
1MCG
1MCG
2.5MCG
2.5MCG
N 020862
N 020862
N 020862
N 020862
003
003
001
001
Dec
Dec
Dec
Dec
4MCG/2ML (2MCG/ML)
4MCG/2ML (2MCG/ML)
A 091101
A 091101
001 Aug 30, 2013
001 Aug 30, 2013
Oct CAHN
Aug NEWA
4MCG/2ML (2MCG/ML)
N 021027
001 Apr 06, 2000
Aug CFTG
3MG
3MG
6MG
6MG
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
Mar
Mar
Mar
Mar
Jul
Jul
Jun
Jun
17,
17,
17,
17,
13,
13,
09,
09,
2010
2010
2010
2010
2009
2009
1999
1999
CFTG
CAHN
CFTG
CAHN
CTEC
CTEC
CTEC
CTEC
AB
AB
AB
AB
DOXORUBICIN HYDROCHLORIDE
SAGENT PHARMS
2MG/ML
TEVA PHARMS USA
2MG/ML
200MG/100ML
INJECTABLE, LIPOSOMAL;INJECTION
DOXIL
+
JANSSEN RES AND DEV
20MG/10ML (2MG/ML)
+
50MG/25ML (2MG/ML)
DOXIL (LIPOSOMAL)
JANSSEN RES AND DEV
20MG/10ML (2MG/ML)
+
20MG/10ML (2MG/ML)
50MG/25ML (2MG/ML)
+
50MG/25ML (2MG/ML)
SUN PHARMA GLOBAL
20MG/10ML (2MG/ML)
50MG/25ML (2MG/ML)
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
+
SUN PHARMA GLOBAL
20MG/10ML (2MG/ML)
+
20MG/10ML (2MG/ML)
+
50MG/25ML (2MG/ML)
+
50MG/25ML (2MG/ML)
AB
AB
DOXYCYCLINE
FOR SUSPENSION;ORAL
DOXYCYCLINE
CHARTWELL LIFE SCI
LUPIN LTD
AP
AP
AP
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AP
AB
AB
AB
AB
AB
AB
DOXYCYCLINE HYCLATE
CAPSULE;ORAL
DOXYCYCLINE HYCLATE
CHARTWELL LIFE SCI
HIKMA PHARMS
DOXYCYCLINE
AGILA SPECLTS
TABLET;ORAL
DOXYCYCLINE HYCLATE
@ BLU CARIBE INC
>A> AB
>A> AB
>A> AB
-
December
1 -32
2013
A 091495
A 064140
A 064140
001 Mar 18, 2013
001 Jul 28, 1995
002 Jul 28, 1995
Mar NEWA
Jun CAHN
Jun CAHN
N 050718
N 050718
001 Nov 17, 1995
002 Jun 13, 2000
Jan CFTG
Jan CFTG
N 050718
N 050718
N 050718
N 050718
001
001
002
002
Jun
Apr
Jun
Apr
A 203263
A 203263
001 Feb 04, 2013
002 Feb 04, 2013
Jan NEWA
Jan NEWA
A 203263
A 203263
A 203263
A 203263
001
001
002
002
Jun
Apr
Jun
Apr
EQ 25MG BASE/5ML
EQ 25MG BASE/5ML
A 065454
A 201678
001 Jul 16, 2008
001 Mar 18, 2013
Sep CAHN
Mar NEWA
EQ
EQ
EQ
EQ
A 062500
A 062500
A 062396
A 062396
001
002
002
001
Sep
Sep
May
May
A 091406
001 Aug 21, 2012
Nov CAHN
50MG BASE
100MG BASE
100MG BASE
100MG BASE
100MG BASE
A 062269
A 062269
A 062269
A 062505
A 065095
003
002
002
001
001
Mar
Nov
Mar
Jul
May
80MG BASE
200MG BASE
N 050795
N 050795
004 Apr 11, 2013
005 Apr 11, 2013
Apr NEWA
Apr NEWA
75MG BASE
100MG BASE
150MG BASE
A 200856
A 200856
A 200856
001 Apr 30, 2013
002 Apr 30, 2013
003 Apr 30, 2013
Apr NEWA
Apr NEWA
Apr NEWA
N 021876
001 Apr 08, 2013
Apr NEWA
BASE
BASE
BASE
N 021427
N 021427
N 021427
001 Aug 03, 2004
002 Aug 03, 2004
004 Aug 03, 2004
Nov CFTG
Nov CFTG
Nov CFTG
BASE
BASE
BASE
A 090776
A 090776
A 090776
001 Dec 17, 2013
002 Dec 17, 2013
003 Dec 17, 2013
Dec NEWA
Dec NEWA
Dec NEWA
50MG BASE
100MG BASE
50MG BASE
100MG BASE
EQ 100MG BASE/VIAL
EQ
EQ
@
EQ
CHARTWELL LIFE SCI
EQ
+
HIKMA PHARMS
EQ
DORYX
MAYNE PHARMA
EQ
EQ
DOXYCYCLINE HYCLATE
HERITAGE PHARMS INC
EQ
EQ
EQ
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
DICLEGIS
+
DUCHESNAY
10MG;10MG
AB
AB
AB
12
DULOXETINE HYDROCHLORIDE
CAPSULE, DELAYED REL PELLETS;ORAL
CYMBALTA
LILLY
EQ 20MG
EQ 30MG
+
EQ 60MG
ACTAVIS ELIZABETH
EQ 20MG
EQ 30MG
EQ 60MG
Nov
Nov
Jun
Jun
Feb
Feb
Feb
Feb
Sep
Sep
Nov
May
Nov
Nov
Sep
Jul
17,
17,
13,
13,
04,
04,
04,
04,
11,
11,
07,
07,
08,
08,
11,
02,
1995
1995
2000
2000
2013
2013
2013
2013
1984
1984
1984
1984
1982
1982
1984
2003
CRLD
CTNA
CRLD
CTNA
CRLD
CTNA
CRLD
CTNA
CAHN
CAHN
CAHN
CAHN
CAHN
CMFD
CAHN
CAHN
CAHN
AB
AB
AB
AB
AB
AB
AB
AB
>A>
>A>
>A>
>A>
>A>
>A>
AUROBINDO PHARMA LTD EQ 20MG
EQ 30MG
EQ 60MG
DR REDDYS LABS LTD
EQ 20MG
EQ 30MG
EQ 60MG
LUPIN LTD
EQ 20MG
EQ 30MG
EQ 40MG
EQ 60MG
SUN PHARMA GLOBAL
EQ 20MG
EQ 30MG
EQ 60MG
TEVA PHARMS USA
EQ 20MG
EQ 30MG
EQ 60MG
TORRENT PHARMS LTD
EQ 20MG
EQ 30MG
EQ 60MG
ZYDUS PHARMS USA INC EQ 20MG
EQ 20MG
EQ 30MG
EQ 30MG
EQ 60MG
EQ 60MG
-
December
1 -33
2013
A 090778
A 090778
A 090778
A 090723
A 090723
A 090723
A 090694
A 090694
A 090694
A 090694
A 090745
A 090745
A 090745
A 090783
A 090783
A 090783
A 090774
A 090774
A 090774
A 090728
A 090739
A 090728
A 090739
A 090728
A 090739
001
002
003
001
002
003
001
002
003
004
001
002
003
001
002
003
001
002
003
001
001
002
002
003
003
0.5MG
A 200899
001 May 30, 2013
May NEWA
1%
N 205175
001 Oct 24, 2013
Oct NEWA
1%
A 076574
001 Dec 17, 2004
Mar CAHN
N 007959
001
Jul CAHN
N 007959
002
Jul CAHN
1MG/ML
N 204308
001 Aug 13, 2013
Aug NEWA
2.5MG
5MG
10MG
20MG
A 075472
A 075472
A 075472
A 075472
001
002
003
004
Aug
Aug
Aug
Aug
AP
ENALAPRILAT
ENALAPRILAT
TEVA PHARMS USA
1.25MG/ML
A 075578
001 Aug 22, 2000
May CAHN
AB
ENTACAPONE
TABLET;ORAL
ENTACAPONE
MYLAN PHARMS INC
200MG
A 202394
001 May 13, 2013
Apr NEWA
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
DUTASTERIDE
CAPSULE;ORAL
DUTASTERIDE
BANNER PHARMACAPS
AB
ECONAZOLE NITRATE
ECOZA
+
AMDERMA PHARMS
CREAM;TOPICAL
ECONAZOLE NITRATE
IGI LABS INC
AP
AP
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
12
EDROPHONIUM CHLORIDE
TENSILON
+
VALEANT PHARMS
10MG/ML
TENSILON PRESERVATIVE FREE
+
VALEANT PHARMS
10MG/ML
ENALAPRIL MALEATE
FOR SOLUTION;ORAL
EPANED KIT
+
SILVERGATE PHARMS
TABLET;ORAL
ENALAPRIL MALEATE
@ MYLAN
@
@
@
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Jan
Jan
Jan
Jan
Jan
Jan
Aug
Aug
Aug
Aug
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
11,
08,
08,
08,
08,
08,
08,
22,
22,
22,
22,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2014
2014
2014
2014
2014
2014
2000
2000
2000
2000
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Nov
Dec
Dec
Dec
Dec
Dec
Dec
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
AT
>A>
>A>
>A>
BX
BX
BX
BX
AP
AP
AP
AP
EPINASTINE HYDROCHLORIDE
EPINASTINE HYDROCHLORIDE
BRECKENRIDGE PHARM
0.05%
EPINEPHRINE
INJECTABLE;IM-SC
ADRENALIN
+
JHP PHARMS LLC
EPIPEN
+
MERIDIAN MEDCL TECHN
+
MYLAN SPECLT
EPIPEN JR.
+
MERIDIAN MEDCL TECHN
+
MYLAN SPECLT
INJECTABLE;INTRAMUSCULAR
EPI E Z PEN JR
@ MYLAN SPECLT
EPIPEN E Z PEN
@ MYLAN SPECLT
AT
AT
AA
ESLICARBAZEPINE ACETATE
TABLET;ORAL
APTIOM
SUNOVION PHARMS INC
+
1 -34
2013
Nov CAHN
30MG/30ML (1MG/ML)
N 204640
001 Dec 18, 2013
Dec NEWA
0.3MG/DELIVERY
0.3MG/DELIVERY
N 019430
N 019430
001 Dec 22, 1987
001 Dec 22, 1987
Jul CDFR
Sep CAHN
0.15MG/DELIVERY
0.15MG/DELIVERY
N 019430
N 019430
002 Dec 22, 1987
002 Dec 22, 1987
Jul CDFR
Sep CAHN
0.15MG/DELIVERY
N 019430
004 Aug 03, 1995
Sep CAHN
0.3MG/DELIVERY
N 019430
003 Aug 03, 1995
Sep CAHN
A 065331
A 065331
001 Aug 09, 2007
002 Aug 09, 2007
Apr CAHN
Apr CAHN
A 078396
A 078396
001 Apr 23, 2008
002 Apr 23, 2008
Apr CAHN
Apr CAHN
N 021337
001 Nov 21, 2001
Jun CAHN
N 050536
A 062338
001
001
Mar CAHN
Apr DISC
N 050617
001 Oct 21, 1987
Jul CAHN
A 062447
001 Sep 26, 1983
Jun CAHN
A 062522
001 Jan 24, 1985
Apr CAHN
EQ 5MG BASE/5ML
A 090477
001 Jun 12, 2013
May NEWA
200MG
400MG
600MG
800MG
N 022416
N 022416
N 022416
N 022416
001
002
003
004
Nov
Nov
Nov
Nov
EQ 0.5MG BASE/VIAL
EQ 1.5MG BASE/VIAL
ERYTHROMYCIN
ERYC
+
MAYNE PHARMA
250MG
@ WARNER CHILCOTT LLC
250MG
GEL;TOPICAL
ERYGEL
+
DELCOR ASSET CORP
2%
OINTMENT;OPHTHALMIC
ERYTHROMYCIN
+
PERRIGO CO TENNESSEE 0.5%
SOLUTION;TOPICAL
SANSAC
@ DOW PHARM
2%
ESCITALOPRAM OXALATE
SOLUTION;ORAL
ESCITALOPRAM OXALATE
SILARX PHARMS INC
December
001 Mar 14, 2011
ERTAPENEM SODIUM
INJECTABLE;INTRAMUSCULAR, IV (INFUSION)
INVANZ
+
MERCK SHARP DOHME
EQ 1GM BASE/VIAL
AB
-
A 090870
EPIRUBICIN HYDROCHLORIDE
EPIRUBICIN HYDROCHLORIDE
TEVA PHARMS USA
50MG/25ML (2MG/ML)
EPOPROSTENOL SODIUM
EPOPROSTENOL SODIUM
TEVA PHARMS USA
12
Nov
Nov
Nov
Nov
08,
08,
08,
08,
2013
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
AB
AB
>D> AB
AB
>D> AB
AB
>A> AB
>A> AB
AP
AP
AP
AP
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
DR REDDYS LABS LTD
EQ 20MG BASE;375MG
EQ 20MG BASE;500MG
VIMOVO
ASTRAZENECA LP
EQ 20MG BASE;375MG
EQ 20MG BASE;375MG
+
EQ 20MG BASE;500MG
+
EQ 20MG BASE;500MG
HORIZON PHARMA
EQ 20MG BASE;375MG
+
EQ 20MG BASE;500MG
December
1 -35
2013
001 Sep 27, 2013
002 Sep 27, 2013
Sep NEWA
Sep NEWA
N 022511
N 022511
N 022511
N 022511
N 022511
N 022511
002
002
001
001
002
001
Dec
Sep
Dec
Sep
Dec
Dec
EQ 20MG BASE/VIAL
EQ 40MG BASE/VIAL
A 200882
A 200882
001 Mar 18, 2013
002 Mar 18, 2013
Mar NEWA
Mar NEWA
EQ 20MG BASE/VIAL
EQ 40MG BASE/VIAL
N 021689
N 021689
001 Mar 31, 2005
002 Mar 31, 2005
Mar CFTG
Mar CFTG
N 202342
N 202342
N 202342
N 202342
001
002
001
002
Sep
Sep
Aug
Aug
A 083714
A 083547
001
001
Jun DISC
Jun DISC
ESTROGENS, CONJUGATED SYNTHETIC A
CREAM;VAGINAL
SYNTHETIC CONJUGATED ESTROGENS A
@ TEVA WOMENS
0.625MG/GM
N 021788
001 Nov 28, 2008
Sep DISC
ESTRONE
ESTRONE
@ WATSON LABS
5MG/ML
A 085239
001
Jun DISC
ESTROPIPATE
TABLET;ORAL
ORTHO-EST
@ CARACO
@
0.75MG
1.5MG
A 089567
A 089582
001 Feb 27, 1991
001 Jul 17, 1991
Apr DISC
Apr DISC
1MG
2MG
3MG
1MG
2MG
3MG
A 091151
A 091151
A 091151
A 091103
A 091103
A 091103
001
002
003
001
002
003
Mar
Mar
Mar
Mar
Mar
Mar
1MG
2MG
3MG
N 021476
N 021476
N 021476
001 Dec 15, 2004
002 Dec 15, 2004
003 Dec 15, 2004
ESOMEPRAZOLE SODIUM
ESOMEPRAZOLE SODIUM
SUN PHARMA GLOBAL
+
+
NEXIUM IV
ASTRAZENECA
ESTRADIOL VALERATE
ESTRADIOL VALERATE
@ WATSON LABS
@ WATSON LABS INC
AB
AB
AB
-
A 202461
A 202461
ESOMEPRAZOLE STRONTIUM
ESOMEPRAZOLE STRONTIUM
HANMI PHARM CO LTD
EQ
+
EQ
HANMI USA
EQ
+
EQ
AB
AB
AB
AB
AB
AB
12
ESZOPICLONE
TABLET;ORAL
ESZOPICLONE
MYLAN PHARMS INC
SUN PHARMA GLOBAL
LUNESTA
SUNOVION PHARMS INC
+
20MG
40MG
20MG
40MG
BASE
BASE
BASE
BASE
40MG/ML
20MG/ML
Apr
Apr
Apr
Apr
Apr
Apr
Aug
Aug
Aug
Aug
Mar
Mar
Mar
Apr
Apr
Apr
30,
30,
30,
30,
30,
30,
06,
06,
06,
06,
26,
26,
26,
03,
03,
03,
2010
2010
2010
2010
2010
2010
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
CAHN
CFTG
CAHN
CFTG
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
Mar CTEC
Mar CTEC
Mar CTEC
AB
12
-
ETHAMBUTOL HYDROCHLORIDE
TABLET;ORAL
ETHAMBUTOL HYDROCHLORIDE
@ WEST WARD
100MG
@
400MG
MYAMBUTOL
+
STI PHARMA LLC
400MG
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET;ORAL
DAYSEE
AB
LUPIN LTD
0.03MG,0.01MG;0.15MG,N/A
QUARTETTE
+
TEVA BRANDED PHARM
0.02MG,0.15MG;0.025MG,0.15MG;0.03M
G,0.15MG;0.01MG,N/A
TABLET;ORAL-28
LEVONORGESTREL AND ETHINYL ESTRADIOL
AB1
FAMY CARE LTD
0.02MG;0.1MG
AB1
LUPIN LTD
0.02MG;0.1MG
AB
AB
AB
AB
AB
AB
AB
>A>
>D>
AB
AB
AB
AB
AB
AB
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET;ORAL-28
NORETHINDRONE AND ETHINYL ESTRADIOL
+
FAMY CARE LTD
0.05MG;1MG
0.05MG;1MG
OVCON-50
@ WARNER CHILCOTT LLC
0.05MG;1MG
+
0.05MG;1MG
PIRMELLA 1/35
LUPIN LTD
0.035MG;1MG
PIRMELLA 7/7/7
LUPIN LTD
0.035MG,0.035MG,0.035MG;0.5MG,0.75
MG,1MG
VYFEMLA
LUPIN LTD
0.035MG;0.4MG
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
AMNEAL PHARMS
0.035MG;0.4MG
+
WARNER CHILCOTT
0.025MG;0.8MG
+
WATSON LABS INC
0.025MG;0.8MG
December
2013
1 -36
A 075095
A 075095
001 Nov 30, 1999
002 Nov 30, 1999
Jul DISC
Jul DISC
N 016320
003
Jul CRLD
A 091467
001 Apr 10, 2013
Mar NEWA
N 204061
001 Mar 28, 2013
Mar NEWA
A 200245
A 091425
001 Oct 09, 2013
001 Jan 18, 2013
Sep NEWA
Jan NEWA
A 203006
A 203006
001 Aug 05, 2013
001 Aug 05, 2013
Oct CRLD
Jul NEWA
N 017576
N 017576
001
001
Oct DISC
Jul CFTG
A 201512
001 Apr 24, 2013
Apr NEWA
A 201510
001 Apr 24, 2013
Apr NEWA
A 201886
001 Sep 26, 2013
Sep NEWA
A 078892
N 022573
N 022573
001 Sep 26, 2011
001 Dec 22, 2010
001 Dec 22, 2010
Sep CAHN
Dec CAHN
Dec CAHN
001 Apr 19, 2013
Apr NEWA
001 Apr 19, 2013
May DISC
001 Nov 06, 2009
Jan CRLD
001 Sep 01, 2009
Sep CAHN
001 Dec 04, 2013
Nov NEWA
001 Nov 06, 2013
Oct NEWA
001 Aug 23, 2013
Aug NEWA
001 Aug 26, 2013
Aug NEWA
001 Nov 14, 2013
Oct NEWA
001 May 08, 2013
Oct CTNA
001 May 08, 2003
May NEWA
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
CAPSULE;ORAL
MINASTRIN 24 FE
+
WARNER CHILCOTT
0.02MG;1MG
N 204426
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
@ WARNER CHILCOTT
0.02MG;1MG
N 204426
TABLET;ORAL
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
+
BARR LABS INC
0.005MG;1MG
A 076221
AMNEAL PHARMS
0.02MG;1MG
A 078267
TABLET;ORAL-21
LARIN 1/20
NOVAST LABS LTD
0.02MG;1MG
A 202995
FAMY CARE LTD
0.02MG;1MG
A 202771
TABLET;ORAL-28
LARIN FE 1.5/30
NOVAST LABS LTD
0.03MG;1.5MG
A 091453
LARIN FE 1/20
NOVAST LABS LTD
0.02MG;1MG
A 091454
FAMY CARE LTD
0.02MG;1MG
A 202772
MINASTRIN 24 FE
+
WARNER CHILCOTT LLC
0.02MG;1MG
N 203667
+
WARNER CHILCOTT LLC
0.02MG;1MG
N 203667
12
TABLET, CHEWABLE, TABLET;ORAL
LO MINASTRIN FE
+
WARNER CHILCOTT
0.01MG,0.01MG,N/A;1MG,N/A,N/A
1 -37
-
December 2013
N 204654
001 Jul 24, 2013
ETHINYL ESTRADIOL; NORGESTIMATE
TABLET;ORAL-28
ESTARYLLA
AB
SANDOZ
0.035MG;0.25MG
A 090794
001 Jan 30, 2013
TRI LO SPRINTEC
@ BARR LABS INC
0.025MG,0.025MG,0.025MG;0.18MG,0.2
A 076784
001 Jun 29, 2009
15MG,0.25MG
TRI-ESTARYLLA
AB
SANDOZ
0.035MG,0.035MG,0.035MG;0.18MG,0.2
A 090793
001 Jan 30, 2013
15MG,0.25MG
Jul NEWA
Jan NEWA
Apr DISC
Jan NEWA
ETHOTOIN
TABLET;ORAL
PEGANONE
+
RECORDATI RARE
250MG
N 010841
001
May CAHN
ETODOLAC
TABLET;ORAL
ETODOLAC
@ PROSAM LABS
@
400MG
500MG
A 074819
001 Feb 28, 1997
A 074819
002 Apr 28, 1998
Mar DISC
Mar DISC
2MG/ML
2MG/ML
A 091297
001 Jun 20, 2012
A 091297
001 Jun 20, 2012
Dec CAHN
Dec CAHN
ETOPOSIDE
ETOPOSIDE
AP
ACCORD HLTHCARE
@ PHARMACHEMIE
AP
TEVA PHARMS USA
AP
20MG/ML
20MG/ML
20MG/ML
20MG/ML
A 074513
A 074227
A 074284
A 074529
Apr
Apr
May
Apr
FAMCICLOVIR
TABLET;ORAL
FAMCICLOVIR
AB
CIPLA LTD
AB
AB
125MG
250MG
500MG
A 078278
001 Mar 21, 2011
A 078278
002 Mar 21, 2011
A 078278
003 Mar 21, 2011
Jul CAHN
Jul CAHN
Jul CAHN
A 078641
001 Jun 25, 2008
A 075942
001 Aug 02, 2002
A 075799
001 Apr 30, 2002
Nov CAHN
Apr DISC
Oct DISC
A 078642
A 076324
A 076324
A 075789
Nov
Mar
Apr
Oct
ETOMIDATE
ETOMIDATE
>A> AP
JHP PHARMS LLC
>D> AP
MYLAN INSTITUTIONAL
AP
AP
AP
AP
FAMOTIDINE
FAMOTIDINE
AGILA SPECLTS
@ APOTEX INC
@ HIKMA MAPLE
FAMOTIDINE PRESERVATIVE
AGILA SPECLTS
AKORN INC
@ APOTEX INC
@ HIKMA MAPLE
FAMOTIDINE PRESERVATIVE
AKORN INC
@ APOTEX INC
TABLET;ORAL
FAMOTIDINE
@ WATSON LABS
@
10MG/ML
10MG/ML
10MG/ML
FREE
10MG/ML
10MG/ML
10MG/ML
10MG/ML
FREE (PHARMACY BULK)
10MG/ML
10MG/ML
20MG
40MG
FELODIPINE
FELODIPINE
AB
HERITAGE PHARMS INC
2.5MG
AB
5MG
AB
10MG
001
001
001
001
001
001
001
001
Mar
Feb
Feb
Jul
Jun
Nov
Nov
Apr
14,
22,
10,
24,
25,
27,
27,
30,
1996
1996
1994
1996
2008
2002
2002
2002
CAHN
DISC
CAHN
CAHN
CAHN
CAHN
DISC
DISC
A 076322
001 Nov 27, 2002
A 076322
001 Nov 27, 2002
Mar CAHN
Apr DISC
A 075062
002 Apr 16, 2001
A 075062
001 Apr 16, 2001
Sep DISC
Sep DISC
A 201964
001 Nov 08, 2013
A 201964
002 Nov 08, 2013
A 201964
003 Nov 08, 2013
Oct NEWA
Oct NEWA
Oct NEWA
>A> AB
>A> AB
>A> AB
FELODIPINE
RANBAXY LABS LTD
2.5MG
5MG
10MG
FENOFIBRATE
CAPSULE;ORAL
ANTARA (MICRONIZED)
LUPIN ATLANTIS
AB
AB
>A>
>A>
>D>
>D>
FENOFIBRATE (MICRONIZED)
APOTEX INC
43MG
130MG
TABLET;ORAL
FENOGLIDE
SALIX PHARMS INC
40MG
+
120MG
SANTARUS
40MG
+
120MG
AB
AB
AB
AB
AB
-
December
1 -38
2013
A 091200
A 091200
A 091200
001 Dec 13, 2013
002 Dec 13, 2013
003 Dec 13, 2013
Dec NEWA
Dec NEWA
Dec NEWA
N 021695
N 021695
004 Oct 18, 2013
005 Oct 18, 2013
Oct NEWA
Oct NEWA
A 202252
A 202252
001 Jul 26, 2013
002 Jul 26, 2013
Jul NEWA
Jul NEWA
N 022118
N 022118
N 022118
N 022118
001
002
001
002
Dec
Dec
Dec
Dec
Aug
Aug
Aug
Aug
10,
10,
10,
10,
2007
2007
2007
2007
CAHN
CAHN
CAHN
CAHN
FENOFIBRIC ACID
TABLET;ORAL
FIBRICOR
MUTUAL PHARM CO INC
+
35MG
105MG
N 022418
N 022418
001 Aug 14, 2009
002 Aug 14, 2009
Feb CAHN
Feb CAHN
FENOPROFEN CALCIUM
TABLET;ORAL
FENOPROFEN CALCIUM
@ IVAX SUB TEVA PHARMS
+
MYLAN PHARMS INC
EQ 600MG BASE
EQ 600MG BASE
A 072557
A 072267
001 Aug 29, 1988
001 Aug 17, 1988
Mar DISC
Mar CTEC
1.2MG
1.6MG
N 202788
N 202788
006 Aug 30, 2012
007 Aug 30, 2012
Aug NEWA
Aug NEWA
N 022266
N 022266
N 022266
N 022266
N 022266
001
002
003
004
005
May
May
May
May
May
N 019101
001 Jul 11, 1984
Jul CAHN
N 022569
N 022569
001 Jun 30, 2011
002 Jun 30, 2011
Sep CAHN
Sep CAHN
N 021947
N 021947
N 021947
N 021947
N 021947
N 021947
001
002
006
003
004
005
Sep
Sep
Mar
Sep
Sep
Sep
25,
25,
02,
25,
25,
25,
2006
2006
2007
2006
2006
2006
Feb
Feb
Feb
Feb
Feb
Feb
CDFR
CDFR
CDFR
CDFR
CDFR
CDFR
N 022510
N 022510
N 022510
N 022510
N 022510
N 022510
001
002
003
004
005
006
Jan
Jan
Jan
Jan
Jan
Jan
07,
07,
07,
07,
07,
07,
2011
2011
2011
2011
2011
2011
May
May
May
May
May
May
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
FENTANYL
SPRAY;SUBLINGUAL
SUBSYS
INSYS THERAP
AP
30MG
90MG
12
FENTANYL CITRATE
FILM;BUCCAL
ONSOLIS
@ MEDA PHARMS
EQ 0.2MG BASE
@
EQ 0.4MG BASE
@
EQ 0.6MG BASE
@
EQ 0.8MG BASE
@
EQ 1.2MG BASE
FENTANYL CITRATE PRESERVATIVE FREE
+
HIKMA MAPLE
EQ 0.05MG BASE/ML
SPRAY, METERED;NASAL
LAZANDA
DEPOMED INC
EQ 0.1MG BASE
+
EQ 0.4MG BASE
TABLET;BUCCAL, SUBLINGUAL
FENTORA
CEPHALON
EQ 0.1MG BASE
EQ 0.2MG BASE
@
EQ 0.3MG BASE
+
EQ 0.4MG BASE
EQ 0.6MG BASE
EQ 0.8MG BASE
TABLET;SUBLINGUAL
ABSTRAL
GALENA BIOPHARMA
EQ 0.1MG BASE
EQ 0.2MG BASE
EQ 0.3MG BASE
+
EQ 0.4MG BASE
EQ 0.6MG BASE
EQ 0.8MG BASE
Jul
Jul
Jul
Jul
Jul
16,
16,
16,
16,
16,
2009
2009
2009
2009
2009
DISC
DISC
DISC
DISC
DISC
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AP
AP
AP
AP
AP
AP
>A> AP
>D>
12
-
December
1 -39
2013
FERRIC CARBOXYMALTOSE
INJECTABLE;IV
INJECTAFER
+
LUITPOLD
750MG IRON/15ML (50MG IRON/ML)
N 203565
001 Jul 25, 2013
Jul NEWA
FERUMOXSIL
SUSPENSION;ORAL
GASTROMARK
@ AMAG PHARMS INC
EQ 0.175MG IRON/ML
N 020410
001 Dec 06, 1996
Feb DISC
5MG
1MG
1MG
1MG
1MG
5MG
1MG
1MG
1MG
A 090121
A 091643
A 078371
A 203687
A 090060
A 090061
A 078161
A 090508
A 076905
001
001
001
001
001
001
001
001
001
Feb
Nov
Nov
Nov
Jul
Jun
Nov
Jul
Nov
23,
05,
05,
05,
01,
07,
05,
01,
05,
2010
2013
2013
2013
2013
2010
2013
2013
2013
Apr
Oct
Oct
Oct
Jun
Apr
Oct
Jun
Oct
CAHN
NEWA
NEWA
NEWA
NEWA
CAHN
NEWA
NEWA
NEWA
50MG
100MG
150MG
150MG
A 079164
A 079164
A 079164
A 076278
001
002
003
003
Jul
Jul
Jul
Jan
09,
09,
09,
14,
2009
2009
2009
2003
Apr
Apr
Apr
May
DISC
DISC
DISC
CRLD
A 076918
A 076918
001 Dec 18, 2006
002 Dec 18, 2006
Mar DISC
Mar DISC
A 076888
A 076888
A 076888
A 076888
001
002
001
002
Aug
Aug
Apr
Apr
A 076653
A 076653
001 Jul 29, 2004
002 Jul 29, 2004
May CAHN
May CAHN
A 076889
A 076889
A 076889
A 076889
001
002
001
002
Mar
Mar
Mar
Mar
25,
25,
25,
25,
2005
2005
2005
2005
Aug
Aug
Apr
Apr
CAHN
CAHN
DISC
DISC
A 078423
A 078423
A 078423
A 078423
001
002
003
004
Mar
Mar
Mar
Mar
07,
07,
07,
07,
2011
2011
2011
2011
Sep
Sep
Sep
Sep
DISC
DISC
DISC
DISC
50MG/2ML (25MG/ML)
50MG/2ML (25MG/ML)
50MG/VIAL
50MG/2ML (25MG/ML)
A 078393
A 076661
A 076349
A 076661
001
001
001
001
Oct
Apr
Aug
Apr
15,
28,
28,
28,
2007
2004
2003
2004
Jan
Jan
Apr
Apr
CRLD
CRLD
CAHN
CAHN
20-500mCi/ML
A 203709
001 Oct 23, 2013
Dec NEWA
20-300mCi/ML
N 021870
002 Nov 21, 2008
Dec CTEC
FINASTERIDE
TABLET;ORAL
FINASTERIDE
ACCORD HLTHCARE
ACCORD HLTHCARE INC
ACTAVIS TOTOWA
HETERO LABS LTD III
MYLAN PHARMS INC
SUN PHARMA GLOBAL
TEVA
FLECAINIDE ACETATE
TABLET;ORAL
FLECAINIDE ACETATE
@ APOTEX INC
@
@
+
ROXANE
FLUCONAZOLE
FOR SUSPENSION;ORAL
FLUCONAZOLE
@ TARO PHARM INDS
50MG/5ML
@
200MG/5ML
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
@ AGILA SPECLTS
@
@ APOTEX INC
@
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
TEVA PHARMS USA
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
@ AGILA SPECLTS
@
@ APOTEX INC
@
TABLET;ORAL
FLUCONAZOLE
@ HARRIS PHARM
50MG
@
100MG
@
150MG
@
200MG
FLUDARABINE PHOSPHATE
FLUDARABINE PHOSPHATE
+
FRESENIUS KABI USA
TEVA PARENTERAL
TEVA PHARMS USA
FLUDEOXYGLUCOSE F-18
FLUDEOXYGLUCOSE F-18
WI MEDCL CYCLOTRON
FLUDEOXYGLUCOSE F18
+
FEINSTEIN
Mar
Mar
Mar
Mar
25,
25,
25,
25,
2005
2005
2005
2005
CAHN
CAHN
DISC
DISC
>A> AP
>D>
>A> AP
>A>
>A> AP
FLUDEOXYGLUCOSE F18
+
+
HOUSTON CYCLOTRON
+
+
+
MCPRF
+
UCLA BIOMEDICAL
UNIV TX MD ANDERSON
FLUDROCORTISONE ACETATE
TABLET;ORAL
FLORINEF
@ CITRON PHARMA LLC
AP
AP
AP
FLUMAZENIL
FLUMAZENIL
AGILA SPECLTS
+
@ APOTEX INC
@
+
PFIZER
@ TEVA PHARMS USA
@
ROMAZICON
@ HOFFMANN LA ROCHE
@
AT
AT
>A> AB
>D>
>A> AB
AB
AB
AT
AT
FLUOCINONIDE
CREAM;TOPICAL
FLUOCINONIDE
PERRIGO ISRAEL
VANOS
+
MEDICIS
+
GEL;TOPICAL
FLUOCINONIDE
+
TARO
LIDEX
@ CNTY LINE PHARMS
OINTMENT;TOPICAL
FLUOCINONIDE
+
TARO
LIDEX
@ CNTY LINE PHARMS
SOLUTION;TOPICAL
FLUOCINONIDE
ACTAVIS MID ATLANTIC
+
TARO
LIDEX
@ CNTY LINE PHARMS
@ MEDICIS
-
December
1 -40
2013
20-300mCi/ML
20-500mCi/ML
20-500mCi/ML
20-500mCi/ML
20-500mCi/ML
20-240mCi/ML
4-40mCi/ML
20-150mCi/ML
20-300mCi/ML
N 021870
A 203665
A 203665
A 203665
A 203665
A 203612
A 203811
A 203246
A 203246
002
001
001
001
001
001
001
001
002
0.1MG
N 010060
001
0.5MG/5ML (0.1MG/ML)
1MG/10ML (0.1MG/ML)
1MG/10ML (0.1MG/ML)
1MG/10ML (0.1MG/ML)
1MG/10ML (0.1MG/ML)
A 078595
A 078595
A 076755
A 076755
A 078595
A 076589
A 076589
001
002
002
001
002
002
001
1MG/10ML (0.1MG/ML)
N 020073
N 020073
001 Dec 20, 1991
002 Dec 20, 1991
Sep DISC
Sep DISC
N 018340
001 Aug 17, 1984
Sep DISC
0.01%
0.01%
A 202847
A 202848
001 Aug 09, 2013
001 Aug 09, 2013
Jul NEWA
Jul NEWA
0.1%
A 090256
001 Jan 14, 2014
Dec NEWA
0.1%
0.1%
N 021758
N 021758
001 Feb 11, 2005
001 Feb 11, 2005
Dec CTEC
Dec CTEC
0.05%
A 074935
001 Jul 29, 1997
Jan CRLD
0.05%
N 017373
001
Jan CAHN
0.05%
A 075008
001 Jun 30, 1999
Jan CRLD
0.05%
N 016909
002
Jan CAHN
0.05%
0.05%
A 071535
A 074799
001 Dec 02, 1988
001 Dec 31, 1996
May CAHN
Jan CRLD
0.05%
0.05%
N 018849
N 018849
001 Apr 06, 1984
001 Apr 06, 1984
May CAHN
Jan DISC
FLUNISOLIDE
AEROBID
@ ROCHE PALO
0.25MG/INH
FLUOCINOLONE ACETONIDE
OIL;TOPICAL
FLUOCINOLONE ACETONIDE
PERRIGO ISRAEL
12
Nov
Feb
Feb
Feb
Feb
Aug
Jun
Jan
Jan
21,
14,
14,
14,
14,
05,
27,
13,
13,
2008
2013
2013
2013
2013
2013
2013
2014
2014
Dec
Dec
Dec
Jun
Jan
Jul
Jun
Dec
Dec
CTEC
CTEC
CTEC
CRLD
NEWA
NEWA
NEWA
NEWA
NEWA
Nov CAHN
May
May
Oct
Oct
May
Oct
Oct
13,
13,
12,
12,
13,
12,
12,
2008
2008
2004
2004
2008
2004
2004
Nov
Nov
Apr
Apr
Oct
Apr
Apr
CAHN
CAHN
DISC
DISC
CRLD
CAHN
CAHN
FLUORESCEIN SODIUM
AK-FLUOR 25%
+
AKORN
>A>
>A>
>A>
>A>
>D>
>D>
>D>
>D>
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AB1
AB1
AB1
AB1
AB
AB1
AB1
AB
12
-
December
1 -41
2013
EQ 500MG BASE/2ML (EQ 250MG
BASE/ML)
N 022186
002 Aug 08, 2008
Oct CRLD
1GM/20ML (50MG/ML)
2.5GM/50ML (50MG/ML)
5GM/100ML (50MG/ML)
1GM/20ML (50MG/ML)
5GM/100ML (50MG/ML)
1GM/20ML (50MG/ML)
5GM/100ML (50MG/ML)
A 040743
A 040798
A 040798
A 040743
A 040743
A 040798
A 040798
A 040743
A 040743
A 040743
A 040334
A 040334
A 040333
001
002
001
002
001
002
001
002
001
002
001
002
001
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Feb
Feb
Jan
26,
26,
26,
26,
26,
26,
26,
26,
26,
26,
25,
25,
27,
2007
2007
2007
2007
2007
2007
2007
2007
2007
2007
2000
2000
2000
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Feb
Feb
May
May
May
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
A 076022
A 076022
A 076165
A 076165
A 076165
A 076165
A 075465
A 075465
A 075465
A 076001
A 076001
A 078143
A 078143
A 078143
001
002
001
001
002
002
001
002
003
001
002
001
002
003
Jan
Jan
Feb
Feb
Feb
Feb
Jan
Jan
Aug
Jan
Jan
Jan
Jan
Jan
30,
30,
01,
01,
01,
01,
29,
29,
02,
29,
29,
16,
16,
16,
2002
2002
2002
2002
2002
2002
2002
2002
2001
2002
2002
2008
2008
2008
Mar
Mar
Apr
Mar
Apr
Mar
Sep
Sep
Sep
Jul
Jul
Feb
Feb
Feb
DISC
DISC
DISC
CAHN
DISC
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
DISC
DISC
DISC
A 075292
001 Feb 07, 2002
Apr DISC
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
CAPSULE;ORAL
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
TEVA PHARMS
A 202074
001 Mar 25, 2013
Mar NEWA
FLUPHENAZINE DECANOATE
FLUPHENAZINE DECANOATE
@ AGILA SPECLTS
@ APOTEX INC
A 075918
A 075918
001 Aug 17, 2001
001 Aug 17, 2001
Aug CAHN
Apr DISC
FLURAZEPAM HYDROCHLORIDE
CAPSULE;ORAL
FLURAZEPAM HYDROCHLORIDE
@ WEST WARD
15MG
@
30MG
A 071107
A 071108
001 Dec 08, 1986
001 Dec 08, 1986
Jul DISC
Jul DISC
FLUTEMETAMOL F-18
VIZAMYL
+
GE HEALTHCARE
+
N 203137
N 203137
001 Oct 25, 2013
002 Oct 25, 2013
Oct NEWA
Oct NEWA
FLUOROURACIL
FLUOROURACIL
+
ACCORD HLTHCARE
+
+
+
+
MYLAN INSTITUTIONAL
+
+
+
+
MYLAN LLC
+
+
TEVA PHARMS USA
+
+
FLUOXETINE HYDROCHLORIDE
CAPSULE;ORAL
@ CARLSBAD
EQ 10MG BASE
@
EQ 20MG BASE
@ CR DOUBLE CRANE
EQ 10MG BASE
EQ 10MG BASE
@
EQ 20MG BASE
EQ 20MG BASE
DR REDDYS LABS LTD
EQ 10MG BASE
EQ 20MG BASE
EQ 40MG BASE
TEVA PHARMS USA
EQ 10MG BASE
EQ 20MG BASE
@ WOCKHARDT LTD
EQ 10MG BASE
@
EQ 20MG BASE
@
EQ 40MG BASE
SOLUTION;ORAL
@ APOTEX INC
EQ 20MG BASE/5ML
25MG/ML
25MG/ML
40.5mCi/10ML (4.05mCi/ML)
121.5mCi/30ML (4.05mCi/ML)
12
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
POWDER;INHALATION
BREO ELLIPTA
+
GLAXO GRP LTD
0.1MG/INH;EQ 0.025MG BASE/INH
AB
FLUTICASONE PROPIONATE
CREAM;TOPICAL
CUTIVATE
@ FOUGERA PHARMS
LOTION;TOPICAL
FLUTICASONE PROPIONATE
PERRIGO ISRAEL
POWDER;INHALATION
FLOVENT DISKUS 100
+
GLAXO GRP LTD
FLOVENT DISKUS 250
+
GLAXO GRP LTD
FLOVENT DISKUS 50
+
GLAXO GRP LTD
AB
AB
AA
December
1 -42
2013
N 204275
001 May 10, 2013
May NEWA
0.05%
N 019958
001 Dec 18, 1990
Aug DISC
0.05%
A 091553
001 Jul 30, 2013
Jul NEWA
0.1MG/INH
N 020833
002 Sep 29, 2000
May CAHN
0.25MG/INH
N 020833
003 Sep 29, 2000
May CAHN
0.05MG/INH
N 020833
001 Sep 29, 2000
May CAHN
N 021254
N 021254
N 021254
001 Jun 08, 2006
002 Jun 08, 2006
003 Jun 08, 2006
May CAHN
May CAHN
May CAHN
N 021077
001 Aug 24, 2000
May CAHN
N 021077
002 Aug 24, 2000
May CAHN
N 021077
003 Aug 24, 2000
May CAHN
A 091482
A 091482
A 091476
A 091476
001
002
001
002
Apr
Nov
Mar
Mar
N 022033
N 022033
001 Feb 28, 2008
002 Feb 28, 2008
Mar CFTG
Mar CFTG
A 075900
A 075900
A 075900
001 Feb 23, 2006
002 Feb 23, 2006
003 Feb 23, 2006
Jun DISC
Jun DISC
Jun DISC
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
ADVAIR HFA
+
GLAXO GRP LTD
+
+
POWDER;INHALATION
ADVAIR DISKUS 100/50
+
GLAXO GRP LTD
+
GLAXO GRP LTD
+
GLAXO GRP LTD
AB
AB
AB
AB
-
FLUVOXAMINE MALEATE
FLUVOXAMINE MALEATE
ACTAVIS ELIZABETH
100MG
150MG
ANCHEN PHARMS
100MG
150MG
LUVOX CR
JAZZ PHARMS
100MG
+
150MG
TABLET;ORAL
FLUVOXAMINE MALEATE
@ CARACO
25MG
@
50MG
@
100MG
Apr
Nov
Mar
Mar
23,
18,
13,
13,
2013
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
FOLIC ACID
TABLET;ORAL
FOLIC ACID
BICON PHARM
1MG
A 091145
001 Jul 12, 2013
Jul NEWA
FOSAPREPITANT DIMEGLUMINE
POWDER;INTRAVENOUS
EMEND
@ MERCK AND CO INC
EQ 115MG BASE/VIAL
N 022023
001 Jan 25, 2008
Sep DISC
FOSINOPRIL SODIUM
TABLET;ORAL
FOSINOPRIL SODIUM
@ WATSON LABS
@
@
10MG
20MG
40MG
A 076987
A 076987
A 076987
001 Dec 23, 2004
002 Dec 23, 2004
003 Dec 23, 2004
Mar DISC
Mar DISC
Mar DISC
AP
AA
AB
AB
>A>
-
December
1 -43
2013
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
TABLET;ORAL
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
@ MYLAN
10MG;12.5MG
@
20MG;12.5MG
A 077705
A 077705
001 Aug 14, 2006
002 Aug 14, 2006
Aug DISC
Aug DISC
FOSPHENYTOIN SODIUM
FOSPHENYTOIN SODIUM
AMNEAL PHARMS
@ APOTEX INC
@ TEVA PHARMS USA
EQ 50MG PNENYTOIN NA/ML
EQ 50MG PHENYTOIN NA/ML
EQ 50MG PHENYTOIN NA/ML
A 078476
A 078126
A 076886
001 Mar 18, 2008
001 Aug 06, 2007
001 Aug 06, 2007
May CAHN
Apr DISC
May CAHN
10MG/ML
N 018025
001
Jan DISC
20MG
40MG
80MG
N 018415
N 018415
N 018415
001 Jul 27, 1982
002 Jul 27, 1982
003 Nov 26, 1984
Feb DISC
Feb DISC
Feb DISC
100MG
300MG
400MG
A 077261
A 077261
A 077261
001 Aug 02, 2013
002 Aug 02, 2013
003 Aug 02, 2013
Jul NEWA
Jul NEWA
Jul NEWA
250MG/5ML
A 076672
001 Jul 03, 2013
Jun NEWA
600MG
800MG
A 203244
A 203244
002 Jul 12, 2013
001 Jul 12, 2013
Jul NEWA
Jul NEWA
GABAPENTIN ENACARBIL
HORIZANT
XENOPORT INC
300MG
+
600MG
N 022399
N 022399
002 Dec 13, 2011
001 Apr 06, 2011
May CAHN
May CAHN
GADOBUTROL
SOLUTION;INTRAVENOUS
GADAVIST
+
BAYER HLTHCARE
1.20944GM/2ML (604.72MG/ML)
N 201277
006 Dec 18, 2013
Dec NEWA
GADOTERATE MEGLUMINE
DOTAREM
+
GUERBET
+
+
+
3.769GM/10ML (376.9MG/ML)
5.6535GM/15ML (376.9MG/ML)
7.538GM/20ML (376.9MG/ML)
37.69GM/100ML (376.9MG/ML)
N 204781
N 204781
N 204781
N 204781
002
003
004
001
Mar
Mar
Mar
Mar
GADOXETATE DISODIUM
EOVIST
BAYER HLTHCARE
2.72145GM/15ML (181.43MG/ML)
N 022090
002 Feb 04, 2013
Feb NEWA
GALLIUM NITRATE
GANITE
@ CHAPTER 7 TRUSTEE
@ GENTA
25MG/ML
25MG/ML
N 019961
N 019961
002 Jan 17, 1991
002 Jan 17, 1991
Jul CAHN
Jul DISC
FUROSEMIDE
FUROSEMIDE
@ INTL MEDICATION
TABLET;ORAL
FUROSEMIDE
@ DAVA PHARMS INC
@
@
AB
AB
AB
12
GABAPENTIN
CAPSULE;ORAL
GABAPENTIN
TARO
SOLUTION;ORAL
GABAPENTIN
TARO
TABLET;ORAL
GABAPENTIN
ALLIED PHARMA INC
Mar
Mar
Mar
Mar
20,
20,
20,
20,
2013
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
AP
AP
12
-
December
1 -44
2013
GANCICLOVIR
IMPLANT;IMPLANTATION
VITRASERT
@ BAUSCH AND LOMB
4.5MG
N 020569
001 Mar 04, 1996
May DISC
GANCICLOVIR SODIUM
GANCICLOVIR
LUITPOLD
PHARMAFORCE
EQ 500MG BASE/VIAL
EQ 500MG BASE/VIAL
A 202624
A 202624
001 Sep 18, 2013
001 Sep 18, 2013
Oct CAHN
Aug NEWA
GANIRELIX ACETATE
GANIRELIX ACETATE
+
ORGANON USA INC
EQ 250MCG BASE/0.5ML
N 021057
001 Jul 29, 1999
Aug CTNA
A 079084
A 202653
001 Aug 19, 2011
001 Aug 28, 2013
Apr DISC
Aug NEWA
N 022548
001 May 18, 2010
Aug CFTG
A 078759
A 078759
A 202997
A 202485
A 202485
A 202031
A 202031
A 202031
A 202031
A 091597
A 091597
002
001
001
002
001
002
001
002
001
002
001
Jul
Jul
Apr
Apr
Apr
Aug
Aug
Apr
Apr
Apr
Apr
AT
GATIFLOXACIN
GATIFLOXACIN
@ APOTEX INC
0.3%
LUPIN LTD
0.5%
ZYMAXID
+
ALLERGAN
0.5%
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
GEMCITABINE HYDROCHLORIDE
GEMCITABINE HYDROCHLORIDE
CIPLA LTD
EQ
EQ
DR REDDYS LABS LTD
EQ
JIANGSU HANSOH PHARM EQ
EQ
LUITPOLD
EQ
EQ
PHARMAFORCE
EQ
EQ
SAGENT PHARMS
EQ
EQ
AB
GEMFIBROZIL
TABLET;ORAL
GEMFIBROZIL
CARACO
600MG
A 079239
001 Dec 29, 2008
Jun CAHN
GEMIFLOXACIN MESYLATE
TABLET;ORAL
FACTIVE
+
LG LIFE SCIENCES
EQ 320MG BASE
N 021158
001 Apr 04, 2003
Nov CAHN
EQ
EQ
EQ
EQ
A 062356
A 062366
A 062356
A 062366
001
002
002
001
Aug
Aug
Aug
Aug
A 065024
001 Jul 30, 2004
Jun CAHN
A 065121
001 Jan 30, 2004
Jun CAHN
N 020622
001 Dec 20, 1996
Apr CAHN
N 020622
002 Feb 12, 2002
Apr CAHN
AT
GENTAMICIN SULFATE
GENTAMICIN SULFATE
@ FRESENIUS KABI USA
AP
AP
AT
AT
1GM BASE/VIAL
200MG BASE/VIAL
2GM BASE/VIAL
1GM BASE/VIAL
200MG BASE/VIAL
1GM BASE/VIAL
200MG BASE/VIAL
1GM BASE/VIAL
200MG BASE/VIAL
1GM BASE/VIAL
200MG BASE/VIAL
10MG
10MG
40MG
40MG
BASE/ML
BASE/ML
BASE/ML
BASE/ML
@
+
OINTMENT;OPHTHALMIC
GENTAMICIN SULFATE
PERRIGO CO TENNESSEE EQ 0.3% BASE
GENTAMICIN SULFATE
PERRIGO CO TENNESSEE EQ 0.3% BASE
GLATIRAMER ACETATE
FOR SOLUTION;SUBCUTANEOUS
COPAXONE
@ TEVA PHARMS USA
20MG/VIAL
COPAXONE
+
TEVA PHARMS USA
20MG/ML
Jul
Jul
May
May
May
May
May
May
May
May
May
Mar
Feb
Mar
Aug
25,
25,
07,
07,
07,
07,
07,
07,
07,
07,
07,
04,
06,
04,
04,
2011
2011
2013
2013
2013
2013
2013
2013
2013
2013
2013
1982
1986
1982
1983
CAHN
CAHN
NEWA
NEWA
NEWA
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
DISC
NEWA
DISC
CRLD
AB
AB
AB
AB
AB
AB
AB
AB
GLIMEPIRIDE
TABLET;ORAL
GLIMEPIRIDE
@ COREPHARMA
@
@
HIKMA PHARMS
INDOCO REMEDIES
MICRO LABS LTD INDIA
AB
AB
@ MYLAN
@
@
AB
AB
AB
AB
AA
AP
AP
AP
AP
AP
AP
1MG
2MG
4MG
1MG
2MG
4MG
1MG
2MG
4MG
1MG
2MG
3MG
4MG
6MG
8MG
1MG
2MG
4MG
December
1 -45
2013
001
002
003
001
002
003
001
002
003
001
002
003
004
005
006
001
002
003
Oct
Oct
Oct
Aug
Aug
Aug
Apr
Apr
Apr
Jun
Jun
Jun
Jun
Jun
Jun
Feb
Feb
Feb
06,
06,
06,
01,
01,
01,
17,
17,
17,
29,
29,
29,
29,
29,
29,
10,
10,
10,
2005
2005
2005
2013
2013
2013
2013
2013
2013
2012
2012
2012
2012
2012
2012
2006
2006
2006
Feb
Feb
Feb
Jul
Jul
Jul
Apr
Apr
Apr
Jul
Jul
Jul
Jul
Jul
Jul
Aug
Aug
Aug
DISC
DISC
DISC
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
DISC
DISC
DISC
A 074550
A 074550
A 074619
A 074619
001
002
001
002
Sep
Sep
Apr
Apr
11,
11,
04,
04,
1997
1997
1997
1997
Apr
Apr
May
May
CAHN
CAHN
CAHN
CAHN
A 076159
A 076159
002 Sep 20, 2013
001 Sep 20, 2013
Sep NEWA
Sep NEWA
1.1GM/ML
N 203284
001 Feb 01, 2013
Feb NEWA
0.2MG/ML
N 017558
001
Apr CAHN
1MG
1MG
2MG
1MG
2MG
A 202675
A 040568
A 040568
A 040836
A 040836
001
001
002
001
002
A 078197
001 Dec 31, 2007
Apr DISC
A 078198
A 078198
A 078863
001 Jun 30, 2008
002 Jun 30, 2008
001 Jun 30, 2008
Apr DISC
Apr DISC
Nov CAHN
A 078880
A 078808
001 Jun 30, 2008
001 Apr 29, 2008
Nov CAHN
Feb DISC
A 078392
001 Dec 31, 2007
May CAHN
A 077963
A 077297
001 Jan 03, 2008
001 Jun 30, 2008
May CAHN
May CAHN
A 078863
A 077165
002 Jun 30, 2008
001 Dec 31, 2007
Nov CAHN
May CAHN
5MG
10MG
@ BARR LABS INC
5MG
@
10MG
GLIPIZIDE
PAR PHARM
5MG
10MG
GLYCOPYRROLATE
ROBINUL
+
HIKMA MAPLE
TABLET;ORAL
GLYCOPYRROLATE
AUROLIFE PHARMA LLC
@ COREPHARMA
@
@ WEST WARD
@
-
A 077274
A 077274
A 077274
A 078952
A 078952
A 078952
A 202112
A 202112
A 202112
A 091220
A 091220
A 091220
A 091220
A 091220
A 091220
A 077486
A 077486
A 077486
GLIPIZIDE
TABLET;ORAL
GLIPIZIDE
ACCORD HLTHCARE
GLYCEROL PHENYLBUTYRATE
LIQUID;ORAL
RAVICTI
+
HYPERION THERAP INC
AP
12
GRANISETRON HYDROCHLORIDE
GRANISETRON HYDROCHLORIDE
@ APOTEX INC
EQ 0.1MG BASE/ML (EQ 0.1MG
BASE/ML)
@
EQ 1MG BASE/ML (EQ 1MG BASE/ML)
@
EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
DSM PHARMS INC
BASE/ML)
@ EBEWE PHARMA
BASE/ML)
+
TEVA PHARMS USA
BASE/ML)
+
+
GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
DSM PHARMS INC
@ TEVA PHARMS USA
Apr
Dec
Dec
Mar
Mar
15,
22,
22,
05,
05,
2013
2004
2004
2009
2009
Apr
Mar
Mar
Jul
Jul
NEWA
DISC
DISC
DISC
DISC
AB
GRISEOFULVIN, MICROSIZE
SUSPENSION;ORAL
GRIFULVIN V
+
VALEANT LUXEMBOURG
TABLET;ORAL
GRISEOFULVIN
SANDOZ
12
-
December
1 -46
2013
125MG/5ML
A 062483
001 Jan 26, 1984
Apr CAHN
AB
250MG
500MG
A 091592
A 091592
001 Aug 07, 2013
002 Aug 07, 2013
Jul NEWA
Jul NEWA
>A> AB
>A> AB
GRISEOFULVIN, ULTRAMICROSIZE
TABLET;ORAL
GRISEOFULVIN, ULTRAMICROSIZE
RICONPHARMA LLC
125MG
250MG
A 204371
A 204371
001 Jan 09, 2014
002 Jan 09, 2014
Dec NEWA
Dec NEWA
A 074673
A 074673
A 074673
A 074673
A 074673
A 074673
001
001
001
002
002
002
Dec
Dec
Jun
Dec
Dec
Jun
0.05%
0.05%
0.05%
A 076903
A 077109
A 076994
001 Dec 16, 2004
001 Jun 14, 2005
001 Dec 16, 2004
Apr DISC
Jun CAHN
Mar DISC
EQ
EQ
EQ
EQ
EQ
EQ
50MG BASE/ML
100MG BASE/ML
50MG BASE/ML
100MG BASE/ML
50MG BASE/ML
100MG BASE/ML
A 075440
A 075440
A 075440
A 075440
A 075393
A 075393
001
002
001
002
001
002
Feb
Feb
Feb
Feb
May
May
28,
28,
28,
28,
11,
11,
2000
2000
2000
2000
1999
1999
Aug
Aug
Apr
Apr
Jun
Jun
CAHN
CAHN
DISC
DISC
CAHN
CAHN
HALOPERIDOL LACTATE
HALOPERIDOL
AGILA SPECLTS
@ APOTEX INC
@
TEVA PHARMS USA
EQ
EQ
EQ
EQ
5MG
5MG
5MG
5MG
A 078347
A 076791
A 076828
A 076035
001
001
001
001
Sep
Aug
Aug
Aug
14,
25,
25,
29,
2009
2004
2004
2001
Nov
Apr
Apr
Jun
CAHN
DISC
DISC
CAHN
HEPARIN SODIUM
HEPARIN SODIUM
+
HIKMA MAPLE
+
@
+
1,000 UNITS/ML
5,000 UNITS/ML
5,000 UNITS/0.5ML
10,000 UNITS/ML
N 017037
N 017037
N 017037
N 017037
001
002
013 Apr 07, 1986
003
Aug
Aug
Aug
Aug
CAHN
CAHN
CAHN
CAHN
A 091528
001 Apr 20, 2011
Sep CTEC
A 088508
001 Jul 30, 1985
Sep CTEC
N 021640
N 021640
002 Dec 02, 2004
001 May 05, 2004
May CAHN
May CAHN
>D>
>A> AB
>D>
>A> AB
GUANFACINE HYDROCHLORIDE
TABLET;ORAL
GUANFACINE HYDROCHLORIDE
@ EPIC PHARMA LLC
EQ
EQ
@
EQ
@
EQ
EQ
@
EQ
HALOBETASOL PROPIONATE
OINTMENT;TOPICAL
HALOBETASOL PROPIONATE
@ FOUGERA PHARMS
@ G AND W LABS INC
@ TARO
AO
AO
AP
AP
AP
AP
AP
AA
AA
HALOPERIDOL DECANOATE
HALOPERIDOL DECANOATE
@ AGILA SPECLTS
@
@ APOTEX INC
@
TEVA PHARMS USA
1MG
1MG
1MG
2MG
2MG
2MG
BASE
BASE
BASE
BASE
BASE
BASE
BASE/ML
BASE/ML
BASE/ML
BASE/ML
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
TABLET;ORAL
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
NOVEL LABS INC
1.5MG;5MG
TUSSIGON
+
KING PHARMS
1.5MG;5MG
HYALURONIDASE
VITRASE
+
BAUSCH AND LOMB
@
200 UNITS/VIAL
6,200 UNITS/VIAL
Feb
Feb
Feb
Feb
Feb
Feb
28,
28,
28,
28,
28,
28,
1997
1997
1997
1997
1997
1997
CMFD
CMFD
DISC
CMFD
CMFD
DISC
AP
HYDRALAZINE HYDROCHLORIDE
NAVINTA LLC
20MG/ML
TABLET;ORAL
ACTAVIS GRP PTC
10MG
25MG
50MG
100MG
ACTAVIS PHARMA
10MG
25MG
50MG
100MG
ALKEM LABS LTD
10MG
25MG
50MG
100MG
HETERO LABS LTD III
10MG
25MG
50MG
100MG
STRIDES ARCOLAB LTD
25MG
50MG
100MG
@ ZYDUS PHARMS USA
10MG
@
25MG
@
50MG
@
100MG
12
-
December
1 -47
2013
A 202938
001 Mar 28, 2013
Mar NEWA
A 091679
A 091679
A 091679
A 091679
A 091679
A 091679
A 091679
A 091679
A 200737
A 200737
A 200737
A 200737
A 040901
A 040901
A 040901
A 040901
A 200770
A 200770
A 200770
A 040858
A 040858
A 040858
A 040858
001
002
003
004
001
002
003
004
001
002
003
004
001
002
003
004
001
002
003
001
002
003
004
Apr
Apr
Apr
Apr
Feb
Feb
Feb
Feb
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Jun
Jun
Jun
Jun
12.5MG
12.5MG
A 077885
A 077885
001 Nov 26, 2007
001 Nov 26, 2007
Dec DISC
Dec DISC
25MG
25MG
25MG
A 081189
A 084878
A 084878
001 Jan 24, 1992
002 Jul 12, 2006
002 Jul 12, 2006
Mar DISC
Dec DISC
Dec DISC
AB
AB
AB
AB
HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET;ORAL
IRBESARTAN AND HYDROCHLOROTHIAZIDE
12.5MG;150MG
12.5MG;300MG
LUPIN LTD
12.5MG;150MG
12.5MG;300MG
A 203630
A 203630
A 201524
A 201524
001
002
001
002
Feb
Feb
Feb
Feb
AB
AB
AB
HYDROCHLOROTHIAZIDE; LISINOPRIL
TABLET;ORAL
LISINOPRIL AND HYDROCHLOROTHIAZIDE
HIKMA PHARMS LLC
12.5MG;10MG
12.5MG;20MG
25MG;20MG
A 076265
A 076265
A 076265
001 Jul 08, 2002
002 Jul 08, 2002
003 Jul 08, 2002
Oct CAHN
Oct CAHN
Oct CAHN
N 020387
N 020387
N 020387
001 Apr 28, 1995
003 Oct 20, 2005
002 Nov 10, 1998
Oct CAHN
Oct CAHN
Oct CAHN
A 201682
A 201682
A 201682
001 Mar 01, 2013
002 Mar 01, 2013
003 Mar 01, 2013
Feb NEWA
Feb NEWA
Feb NEWA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
AA
>D> AB
>A>
>D> AB
>A>
AB
AB
AB
AB
AB
AB
HYDROCHLOROTHIAZIDE
CAPSULE;ORAL
HYDROCHLOROTHIAZIDE
WEST WARD
@
TABLET;ORAL
HYDROCHLOROTHIAZIDE
@ WATSON LABS
WEST WARD
@
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
TABLET;ORAL
HYZAAR
MERCK SHARP DOHME
12.5MG;50MG
12.5MG;100MG
+
25MG;100MG
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
IPCA LABS LTD
12.5MG;50MG
12.5MG;100MG
25MG;100MG
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Dec
Dec
Dec
Dec
Sep
Sep
Sep
Sep
May
May
May
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
04,
04,
04,
04,
04,
04,
04,
04,
07,
07,
07,
07,
12,
12,
12,
12,
03,
03,
03,
26,
26,
26,
26,
22,
22,
27,
27,
2013
2013
2013
2013
2013
2013
2013
2013
2012
2012
2012
2012
2008
2008
2008
2008
2013
2013
2013
2010
2010
2010
2010
2013
2013
2013
2013
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
CTEC
CTEC
CTEC
CTEC
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
NEWA
NEWA
NEWA
NEWA
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
TABLET;ORAL
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
ALEMBIC PHARMS LTD
25MG;50MG
25MG;100MG
50MG;100MG
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
TABLET;ORAL
INDERIDE-40/25
+
WYETH PHARMS INC
25MG;40MG
INDERIDE-80/25
@ WYETH PHARMS INC
25MG;80MG
PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
@ WATSON LABS
25MG;40MG
@
25MG;80MG
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
TABLET;ORAL
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
APOTEX CORP
12.5MG;EQ 10MG BASE
12.5MG;EQ 20MG BASE
25MG;EQ 20MG BASE
HYDROCHLOROTHIAZIDE; TRIAMTERENE
TABLET;ORAL
MAXZIDE
+
MYLAN PHARMS INC
50MG;75MG
MAXZIDE-25
MYLAN PHARMS INC
25MG;37.5MG
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
@ WATSON LABS
50MG;75MG
HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET;ORAL
VALSARTAN AND HYDROCHLOROTHIAZIDE
ALEMBIC LTD
12.5MG;80MG
12.5MG;160MG
12.5MG;320MG
25MG;160MG
25MG;320MG
APOTEX INC
12.5MG;80MG
12.5MG;160MG
12.5MG;320MG
25MG;160MG
25MG;320MG
AUROBINDO PHARMA LTD 12.5MG;80MG
12.5MG;160MG
12.5MG;320MG
25MG;160MG
25MG;320MG
LUPIN LTD
12.5MG;80MG
12.5MG;160MG
12.5MG;320MG
25MG;160MG
25MG;320MG
MACLEODS PHARMS LTD
12.5MG;80MG
12.5MG;160MG
12.5MG;320MG
25MG;160MG
25MG;320MG
WATSON LABS INC
12.5MG;80MG
12.5MG;160MG
12.5MG;320MG
25MG;160MG
25MG;320MG
12
-
December
1 -48
2013
A 202870
A 202870
A 202870
001 Nov 06, 2013
002 Nov 06, 2013
003 Nov 06, 2013
Oct NEWA
Oct NEWA
Oct NEWA
N 018031
001
Jul CAHN
N 018031
002
Jul CAHN
A 070301
A 070305
001 Apr 18, 1986
001 Apr 18, 1986
Sep DISC
Sep DISC
A 091524
A 091524
A 091524
001 Mar 12, 2013
002 Mar 12, 2013
003 Mar 12, 2013
Mar NEWA
Mar NEWA
Mar NEWA
N 019129
001 Oct 22, 1984
May CAHN
N 019129
003 May 13, 1988
May CAHN
A 071969
001 Apr 17, 1988
Jan DISC
A 201662
A 201662
A 201662
A 201662
A 201662
A 203026
A 203026
A 203026
A 203026
A 203026
A 202519
A 202519
A 202519
A 202519
A 202519
A 078946
A 078946
A 078946
A 078946
A 078946
A 203145
A 203145
A 203145
A 203145
A 203145
A 091519
A 091519
A 091519
A 091519
A 091519
001
002
003
004
005
001
002
003
004
005
001
002
003
004
005
003
004
001
005
002
001
002
003
004
005
001
002
003
004
005
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Apr
Apr
Apr
Apr
Apr
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Apr
Apr
Apr
Apr
Apr
Mar
Mar
Mar
Mar
Mar
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
21,
19,
19,
19,
19,
19,
21,
21,
21,
21,
21,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
HYDROCODONE BITARTRATE
ZOHYDRO ER
+
ZOGENIX INC
10MG
15MG
20MG
30MG
40MG
50MG
AB
AB
AB
AB
AB
AB
>D> BP
>A>
HYDROCORTISONE ACETATE
CREAM;TOPICAL
MICORT-HC
+
SEBELA IRELAND LTD
PASTE;TOPICAL
ORABASE HCA
@ COLGATE
1 -49
2013
Oct
Oct
Oct
Oct
Oct
Oct
25,
25,
25,
25,
25,
25,
2013
2013
2013
2013
2013
2013
Oct
Oct
Oct
Oct
Oct
Oct
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
A 091633
A 091633
A 091633
A 091633
001
002
003
004
May
May
May
May
28,
28,
28,
28,
2013
2013
2013
2013
May
May
May
May
NEWA
NEWA
NEWA
NEWA
A 076642
A 076642
003 Oct 19, 2007
004 Oct 19, 2007
May CFTG
May CFTG
1%
A 089066
001 Nov 25, 1985
Feb DISC
2.5%
A 040310
001 Dec 29, 2000
Mar DISC
20MG
20MG
A 083365
A 083365
001
001
Dec DISC
Dec DISC
2%
2.5%
A 040398
A 040396
001 Mar 29, 2002
001 Feb 27, 2001
Nov CAHN
Nov CAHN
0.5%
A 083205
001
Mar DISC
A 083778
A 085368
001
001
Nov CAHN
Nov CAHN
A 085980
A 085979
001
001
Nov CAHN
Nov CAHN
A 080505
001
Aug DISC
A 089472
001 Jun 13, 1988
Aug CTEC
A 202145
001 Sep 27, 2013
Sep NEWA
N 020769
001 Sep 08, 1997
Sep CTEC
HYDROCORTISONE ACETATE; UREA
CREAM;TOPICAL
CARMOL HC
@ FOUGERA PHARMS
1%;10%
U-CORT
TARO
1%;10%
AB
December
001
002
003
004
005
006
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
CREAM;TOPICAL
PRAMOSONE
SEBELA IRELAND LTD
0.5%;1%
1%;1%
LOTION;TOPICAL
PRAMOSONE
SEBELA IRELAND LTD
1%;1%
2.5%;1%
AB
-
N 202880
N 202880
N 202880
N 202880
N 202880
N 202880
HYDROCODONE BITARTRATE; IBUPROFEN
TABLET;ORAL
HYDROCODONE BITARTRATE AND IBUPROFEN
SUN PHARM INDS INC
2.5MG;200MG
5MG;200MG
7.5MG;200MG
10MG;200MG
REPREXAIN
AMNEAL PHARMS NY
2.5MG;200MG
10MG;200MG
HYDROCORTISONE
LOTION;TOPICAL
STIE-CORT
@ PERRIGO CO
OINTMENT;TOPICAL
HYDROCORTISONE
@ TARO
TABLET;ORAL
HYDROCORTISONE
WEST WARD
@
12
HYDROCORTISONE BUTYRATE
CREAM;TOPICAL
HYDROCORTISONE BUTYRATE
GLENMARK GENERICS
0.1%
LOCOID LIPOCREAM
+
PRECISION DERMAT
0.1%
HYDROCORTISONE VALERATE
OINTMENT;TOPICAL
HYDROCORTISONE VALERATE
@ FOUGERA PHARMS
0.2%
+
TARO
0.2%
AT
AA
AB
AB
AB
AB
AB
AB
AB
AB
AP
12
-
December
1 -50
2013
A 075085
A 075043
001 Jul 31, 2001
001 Aug 25, 1998
Feb DISC
Feb CRLD
A 060613
001
Nov CAHN
HYDROMORPHONE HYDROCHLORIDE
EXALGO
MALLINCKRODT INC
16MG
+
32MG
N 021217
N 021217
003 Mar 01, 2010
004 Aug 24, 2012
Jan CRLD
Jan CRLD
HYDROXYUREA
CAPSULE;ORAL
HYDROXYUREA
@ BARR LABS INC
@
A 075020
A 075020
002 Jun 26, 2000
001 Jul 30, 1998
Jun CAHN
Jun CAHN
A 201674
001 Aug 21, 2013
Jul NEWA
A 040899
A 040899
A 040899
A 040805
A 040805
A 040805
001
002
003
001
002
003
Jun
Jun
Jun
Apr
Apr
Apr
25MG
50MG
A 201507
A 201507
001 Jun 03, 2013
002 Jun 03, 2013
May NEWA
May NEWA
IBRUTINIB
CAPSULE;ORAL
IMBRUVICA
+
PHARMACYCLICS INC
140MG
N 205552
001 Nov 13, 2013
Nov NEWA
IBUPROFEN
CALDOLOR
@ CUMBERLAND PHARMS
N 022348
001 Jun 11, 2009
May DISC
IBUPROFEN LYSINE
NEOPROFEN
+
RECORDATI RARE
EQ 20MG BASE/2ML (EQ 10MG BASE/ML) N 021903
001 Apr 13, 2006
May CAHN
ICOSAPENT ETHYL
CAPSULE;ORAL
VASCEPA
+
AMARIN PHARMS
1GM
N 202057
001 Jul 26, 2012
Jun NEWA
A 065036
001 May 01, 2002
Apr CAHN
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SUSPENSION/DROPS;OTIC
CORTISPORIN
+
CITRON PHARMA LLC
1%;EQ 3.5MG BASE/ML;10,000
UNITS/ML
250MG
500MG
HYDROXYZINE HYDROCHLORIDE
SYRUP;ORAL
SILARX PHARMS INC
10MG/5ML
TABLET;ORAL
CARACO
10MG
25MG
50MG
HETERO LABS LTD III
10MG
25MG
50MG
HYDROXYZINE PAMOATE
CAPSULE;ORAL
HYDROXYZINE PAMOATE
EMCURE PHARMS USA
IDARUBICIN HYDROCHLORIDE
IDARUBICIN HYDROCHLORIDE PFS
TEVA PHARMS USA
1MG/ML
Jun
Jun
Jun
May
May
May
10,
10,
10,
29,
29,
29,
2008
2008
2008
2008
2008
2008
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
AP
AP
IFOSFAMIDE
IFOSFAMIDE
+
TEVA PHARMS USA
+
May CAHN
May CAHN
1GM/20ML;1GM/10ML
(50MG/ML;100MG/ML)
3GM/60ML;1GM/10ML
(50MG/ML;100MG/ML)
A 075874
001 Feb 26, 2002
May CAHN
A 075874
002 Feb 26, 2002
May CAHN
A 040753
A 040752
A 040751
001 Feb 28, 2008
001 Feb 28, 2008
001 Feb 28, 2008
Mar DISC
Mar DISC
Mar DISC
A 202338
A 202338
A 202338
A 202338
001
002
003
004
Jun
Jun
Jun
Jun
EQ 100MG BASE
N 020685
006 Apr 19, 2000
Jun DISC
25MG
50MG
N 016059
N 016059
001
002
Mar CAHN
Mar CAHN
25MG
50MG
HETERO LABS LTD III
25MG
50MG
SUN PHARM INDS INC
25MG
50MG
INDOMETHACIN
WATSON LABS INC
75MG
A 091401
A 091401
A 091240
A 091240
A 091401
A 091401
001
002
001
002
001
002
A 202572
001 Dec 09, 2013
Nov NEWA
N 018878
001 Jan 30, 1985
May CAHN
N 021081
002 Apr 27, 2007
Aug NEWA
0.02%
0.02%
A 075441
A 075313
001 Mar 28, 2001
001 Feb 07, 2000
Apr DISC
Mar DISC
0.021MG/SPRAY
0.042MG/SPRAY
A 076156
A 076155
001 Apr 18, 2003
001 Apr 18, 2003
Apr DISC
Apr DISC
IMIPRAMINE PAMOATE
CAPSULE;ORAL
IMIPRAMINE PAMOATE
MYLAN PHARMS INC
INDINAVIR SULFATE
CAPSULE;ORAL
CRIXIVAN
@ MERCK SHARP DOHME
AP
1 -51
2013
001 Apr 04, 2007
002 Apr 04, 2007
IMIPRAMINE HYDROCHLORIDE
TABLET;ORAL
IMIPRAMINE HYDROCHLORIDE
@ PROSAM LABS
10MG
@
25MG
@
50MG
AB
December
A 076657
A 076657
+
AB
AB
AB
AB
AB
AB
-
1GM/20ML (50MG/ML)
3GM/60ML (50MG/ML)
IFOSFAMIDE; MESNA
IFOSFAMIDE/MESNA KIT
+
TEVA PHARMS USA
AB
AB
AB
AB
12
INDOMETHACIN
CAPSULE;ORAL
INDOCIN
@ ICEUTICA OPERATIONS
@
INDOMETHACIN
CARACO
INDOMETHACIN SODIUM
INDOCIN
+
RECORDATI RARE
EQ
EQ
EQ
EQ
75MG HCL
100MG HCL
125MG HCL
150MG HCL
EQ 1MG BASE/VIAL
INSULIN GLARGINE RECOMBINANT
LANTUS SOLOSTAR
+
SANOFI AVENTIS US
300 UNITS/3ML (100 UNITS/ML)
IPRATROPIUM BROMIDE
SOLUTION;INHALATION
IPRATROPIUM BROMIDE
@ APOTEX INC
@ TEVA PHARMS USA
IPRATROPIUM BROMIDE
@ APOTEX INC
@
Jun
Jun
Jun
Jun
Mar
Mar
Apr
Apr
Mar
Mar
28,
28,
28,
28,
28,
28,
12,
12,
28,
28,
2013
2013
2013
2013
2013
2013
2011
2011
2013
2013
Jun
Jun
Apr
Apr
Mar
Mar
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
AP
AP
AP
>D> AA
>A>
>D> AA
>A>
AA
AB
AB
December
1 -52
2013
A 090101
A 090101
A 090101
002 Feb 27, 2008
003 Feb 27, 2008
001 Nov 26, 2008
Sep CAHN
Sep CAHN
Sep CAHN
IRON SUCROSE
VENOFER
@ LUITPOLD
EQ 65MG BASE/3.25ML (EQ 20MG
BASE/ML)
BASE/ML)
N 021135
005 Mar 29, 2013
Sep DISC
N 021135
005 Mar 29, 2013
Mar NEWA
100MG
300MG
300MG
100MG
100MG
300MG
300MG
A 040090
A 040090
A 080521
A 080212
A 080212
A 087425
A 087425
001 Jun 26, 1997
002 Jun 26, 1997
001
001
001
001
001
Aug
Aug
Jun
Dec
Dec
Dec
Dec
300MG
A 089776
001 Jun 13, 1988
Nov CMFD
150MG;300MG
A 061884
001
Apr CTEC
150MG;300MG
A 065221
001 Jul 29, 2005
Apr DISC
A 083724
001
Mar DISC
N 010515
001
Mar CTEC
N 019790
001 Sep 02, 1988
May CAHN
N 012093
N 012093
N 012093
N 012093
N 012093
N 012093
N 012093
N 012093
N 012093
N 012093
007
002
006
005
001
007
002
006
005
001
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
29,
29,
29,
29,
29,
29,
29,
29,
29,
29,
1988
1988
1988
1988
1988
1988
1988
1988
1988
1988
Apr
Apr
Apr
Apr
Apr
Mar
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
A 086923
A 086923
A 086034
A 086032
001
001
001
001
Mar
Mar
Jan
Jan
12,
12,
06,
07,
1987
1987
1988
1988
Apr
Feb
Apr
Apr
CMFD
DISC
DISC
DISC
A 086054
A 086055
A 086055
001 Oct 29, 1987
001 Nov 02, 1987
001 Nov 02, 1987
ISONIAZID
TABLET;ORAL
ISONIAZID
@ MIKART
@
@ WATSON LABS
WEST WARD
@
@
LANIAZID
LANNETT
ISOPROTERENOL HYDROCHLORIDE
ISOPROTERENOL HYDROCHLORIDE
@ INTL MEDICATION
0.2MG/ML
ISUPREL
+
HOSPIRA
0.2MG/ML
AB
AB
AB
AB
-
IRINOTECAN HYDROCHLORIDE
IRINOTECAN HYDROCHLORIDE
TEVA PHARMS USA
40MG/2ML (20MG/ML)
100MG/5ML (20MG/ML)
ISONIAZID; RIFAMPIN
CAPSULE;ORAL
RIFAMATE
+
SANOFI AVENTIS US
RIFAMPIN AND ISONIAZID
@ WEST WARD PHARM CORP
AB
AB
AB
AB
12
ISOSORBIDE DINITRATE
DILATRATE-SR
+
ACTIENT PHARMS
40MG
TABLET;ORAL
ISORDIL
VALEANT BERMUDA
5MG
10MG
20MG
+
30MG
+
40MG
VALEANT PHARM NORTH
5MG
10MG
20MG
+
30MG
+
40MG
PAR PHARM
5MG
@
5MG
@ WATSON LABS
5MG
@
10MG
TABLET;SUBLINGUAL
@ WEST WARD
2.5MG
@ WEST WARD PHARM CORP 5MG
+
5MG
DISC
DISC
DISC
DISC
DISC
DISC
DISC
Aug DISC
Aug DISC
Jun CRLD
AB
AB
BX
BX
BX
BX
BX
ISOSORBIDE MONONITRATE
ISOSORBIDE MONONITRATE
HIKMA PHARMS
30MG
60MG
ISOTRETINOIN
CAPSULE;ORAL
ABSORICA
RANBAXY
+
AMNESTEEM
MYLAN PHARMS INC
CLARAVIS
TEVA PHARMS USA
AB
AB
AB
AB
AB
AB
AB
AP
AP
AP
AP
+
ZENATANE
DR REDDYS LABS LTD
KETOROLAC TROMETHAMINE
KETOROLAC TROMETHAMINE
AGILA SPECLTS
@ APOTEX INC
@
@
@
@ LUITPOLD
@
SAGENT PHARMS
AB
>D>
>A> AB
>A> AB
>A> AB
-
December
1 -53
2013
A 076813
A 076813
002 Mar 30, 2006
001 Jan 07, 2005
Oct CAHN
Oct CAHN
10MG
20MG
30MG
40MG
40MG
N 021951
N 021951
N 021951
N 021951
N 021951
001
002
003
004
004
Feb
Feb
Feb
Aug
Feb
20MG
A 075945
002 Nov 08, 2002
Apr CRLD
10MG
30MG
40MG
A 076356
A 076135
A 076135
001 Apr 11, 2003
003 May 11, 2006
001 Apr 11, 2003
May CAHN
Apr CRLD
Apr CRLD
10MG
20MG
40MG
A 202099
A 202099
A 202099
001 Mar 25, 2013
002 Mar 25, 2013
003 Mar 25, 2013
Mar NEWA
Mar NEWA
Mar NEWA
15MG/ML
30MG/ML
15MG/ML
30MG/ML
30MG/ML
30MG/ML
15MG/ML
30MG/ML
15MG/ML
30MG/ML
A 078299
A 078299
A 075631
A 075626
A 075631
A 077201
A 078145
A 078145
A 091065
A 091065
001
002
002
001
001
001
001
002
001
002
Nov
Nov
Apr
Apr
Apr
Apr
Jun
Jun
Nov
Nov
N 020811
001 Nov 03, 1997
May DISC
A 075431
A 075524
A 076051
001 Nov 29, 1999
001 Nov 29, 1999
001 Jul 05, 2002
Jul CAHN
Jul CAHN
Apr DISC
A 075113
002 Aug 04, 1998
Jan CRLD
N 018716
N 018716
001 May 24, 1985
002 Aug 01, 1984
Jan DISC
Jan DISC
ACULAR PRESERVATIVE FREE
@ ALLERGAN
0.5%
AP
AP
12
LABETALOL HYDROCHLORIDE
AKORN INC
5MG/ML
5MG/ML
@ APOTEX INC
5MG/ML
TABLET;ORAL
+
SANDOZ
200MG
TRANDATE
@ PROMETHEUS LABS
100MG
@
200MG
May
May
May
May
May
Jul
Jul
Jun
Jul
Jun
Oct
Jan
Jan
Nov
Nov
25,
25,
25,
25,
25,
16,
16,
29,
24,
29,
14,
14,
14,
27,
27,
2012
2012
2012
2012
2012
2007
2007
2001
2001
2001
2005
2008
2008
2013
2013
CAHN
CAHN
CAHN
CRLD
CAHN
CAHN
CAHN
DISC
DISC
DISC
DISC
DISC
DISC
NEWA
NEWA
LACTULOSE
SOLUTION;ORAL
LACTULOSE
@ APOTEX INC
SOLUTION;ORAL, RECTAL
LACTULOSE
@ APOTEX INC
10GM/15ML
A 075911
001 Feb 21, 2002
Apr DISC
10GM/15ML
A 076645
001 Jul 28, 2003
Apr DISC
LAMIVUDINE
TABLET;ORAL
EPIVIR-HBV
+
GLAXOSMITHKLINE
+
LAMIVUDINE
APOTEX INC
HETERO LABS LTD V
100MG
100MG
N 021003
N 021003
001 Dec 08, 1998
001 Dec 08, 1998
Dec CFTG
Dec CFTG
100MG
100MG
A 202941
A 203260
001 Jan 02, 2014
001 Jan 02, 2014
Dec NEWA
Dec NEWA
12
-
December
1 -54
2013
TABLET;ORAL
LAMIVUDINE
>A> AB
>A> AB
AB
150MG
300MG
A 203277
A 203277
001 Jan 06, 2014
002 Jan 06, 2014
Dec NEWA
Dec NEWA
25MG
50MG
100MG
150MG
200MG
250MG
N 020241
N 020241
N 020241
N 020241
N 020241
N 020241
005
006
001
002
003
004
Dec
Dec
Dec
Dec
Dec
Dec
27,
27,
27,
27,
27,
27,
1994
1994
1994
1994
1994
1994
Mar
Mar
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
25MG
100MG
150MG
200MG
25MG
100MG
150MG
200MG
25MG
25MG
100MG
100MG
150MG
150MG
200MG
200MG
A 200694
A 200694
A 200694
A 200694
A 077783
A 077783
A 077783
A 077783
A 078645
A 078645
A 078645
A 078645
A 078645
A 078645
A 078645
A 078645
001
002
003
004
001
002
003
004
001
001
002
002
003
003
004
004
Jun
Jun
Jun
Jun
Nov
Nov
Nov
Nov
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
14,
14,
14,
14,
01,
01,
01,
01,
27,
27,
27,
27,
27,
27,
27,
27,
2013
2013
2013
2013
2010
2010
2010
2010
2009
2009
2009
2009
2009
2009
2009
2009
Jun
Jun
Jun
Jun
Aug
Aug
Aug
Aug
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
CAHN
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
2MG
5MG
+
25MG
@
100MG
LAMICTAL XR
GLAXOSMITHKLINE LLC
25MG
+
50MG
100MG
200MG
250MG
300MG
LAMOTRIGINE
ACTAVIS ELIZABETH
100MG
200MG
25MG
50MG
250MG
300MG
DR REDDYS LABS LTD
25MG
50MG
100MG
200MG
300MG
PAR PHARM
25MG
50MG
100MG
200MG
250MG
300MG
TORRENT PHARMS LTD
25MG
50MG
100MG
200MG
WILSHIRE PHARMS INC
25MG
50MG
100MG
200MG
N 020764
N 020764
N 020764
N 020764
004
001
002
003
Sep
Aug
Aug
Aug
08,
24,
24,
24,
2000
1998
1998
1998
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
N 022115
N 022115
N 022115
N 022115
N 022115
N 022115
001
002
003
004
006
005
May
May
May
May
Jun
Apr
29,
29,
29,
29,
21,
14,
2009
2009
2009
2009
2011
2010
Mar
Mar
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
A 200672
A 200672
A 200672
A 200672
A 203733
A 200672
A 202383
A 202383
A 202383
A 202383
A 202383
A 201791
A 201791
A 201791
A 201791
A 201791
A 201791
A 203370
A 203370
A 203370
A 203370
A 202887
A 202887
A 202887
A 202887
003
004
001
002
001
005
001
002
003
004
005
001
002
003
004
005
006
001
002
003
004
001
002
003
004
Oct
Oct
Oct
Oct
Nov
Oct
Jun
Jun
Jun
Jun
Jun
Jan
Jan
Jan
Jan
Jan
Jan
Dec
Dec
Dec
Dec
Jun
Jun
Jun
Jun
17,
17,
17,
17,
13,
17,
19,
19,
19,
19,
19,
18,
18,
18,
18,
18,
18,
23,
23,
23,
23,
17,
17,
17,
17,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
Sep
Sep
Sep
Sep
Oct
Sep
Jun
Jun
Jun
Jun
Jun
Jan
Jan
Jan
Jan
Jan
Jan
Dec
Dec
Dec
Dec
Jun
Jun
Jun
Jun
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
LAMOTRIGINE
TABLET;ORAL
LAMICTAL
+
GLAXOSMITHKLINE LLC
@
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
>D> AB
>A>
>D> AB
>A>
>D> AB
>A>
>D> AB
>A>
AB
AB
AB
AB
AB
AB
AB
AB
AB
>A>
>A>
>A>
>A>
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
@
LAMOTRIGINE
ALKEM LABS LTD
CIPLA LTD
SANDOZ
@
@
@
@
LAMICTAL CD
GLAXOSMITHKLINE LLC
AB
AB
AB
AB
AB
AB
AB
AB
TABLET, ORALLY DISINTEGRATING;ORAL
LAMICTAL ODT
GLAXOSMITHKLINE LLC
25MG
25MG
+
50MG
+
50MG
100MG
100MG
200MG
200MG
LAMOTRIGINE
WATSON LABS INC
25MG
50MG
100MG
200MG
12
-
December
1 -55
2013
N 022251
N 022251
N 022251
N 022251
N 022251
N 022251
N 022251
N 022251
001
001
002
002
003
003
004
004
May
May
May
May
May
May
May
May
08,
08,
08,
08,
08,
08,
08,
08,
2009
2009
2009
2009
2009
2009
2009
2009
Jul
Mar
Jul
Mar
Jul
Mar
Jul
Mar
CFTG
CAHN
CFTG
CAHN
CFTG
CAHN
CFTG
CAHN
A 200828
A 200828
A 200828
A 200828
001
002
003
004
Jul
Jul
Jul
Jul
15,
15,
15,
15,
2013
2013
2013
2013
Jul
Jul
Jul
Jul
NEWA
NEWA
NEWA
NEWA
A 202637
A 091509
A 202366
A 202366
001
001
001
002
Sep
Sep
Aug
Aug
13,
13,
19,
19,
2013
2013
2013
2013
Aug
Aug
Jul
Jul
NEWA
NEWA
NEWA
NEWA
A 091212
A 091212
001 Sep 16, 2013
002 Sep 16, 2013
Aug NEWA
Aug NEWA
AB
AB
LANSOPRAZOLE
LANSOPRAZOLE
SUN PHARMA GLOBAL
15MG
30MG
ZYDUS HLTHCARE
15MG
30MG
LANSOPRAZOLE
KRKA TOVARNA ZDRAVIL
15MG
30MG
AT
LATANOPROST
LATANOPROST
@ APOTEX INC
0.005%
DR REDDYS LABS LTD
0.005%
A 077697
A 202077
001 Mar 22, 2011
001 Feb 11, 2013
Apr DISC
Jan NEWA
LENALIDOMIDE
CAPSULE;ORAL
REVLIMID
CELGENE
20MG
N 021880
006 Jun 05, 2013
Jun NEWA
LEPIRUDIN RECOMBINANT
REFLUDAN
@ BAYER HLTHCARE
50MG/VIAL
N 020807
001 Mar 06, 1998
Jun DISC
LETROZOLE
TABLET;ORAL
LETROZOLE
JIANGSU HENGRUI MED
2.5MG
A 202716
001 May 16, 2013
Apr NEWA
A 081277
A 040174
001 Sep 28, 1993
001 Jun 12, 1997
Mar CAHN
Mar CAHN
A 040338
001 Jan 31, 2001
Jun DISC
1MG/0.2ML
A 075471
001 Oct 25, 2000
Mar CAHN
1MG/0.2ML
N 019010
001 Apr 09, 1985
Jul CAHN
3.75MG/VIAL
7.5MG/VIAL
11.25MG/VIAL
22.5MG/VIAL
30MG/VIAL
45MG/VIAL
N 020011
N 019732
N 020708
N 020517
N 020517
N 020517
001
001
001
001
002
003
Apr
Jul
Jul
Jul
Jul
Jul
3.75MG/VIAL,7.5MG/VIAL
7.5MG/VIAL,7.5MG/VIAL
N 020263
N 020263
003 Apr 16, 1993
004 Apr 16, 1993
AB
AB
AB
AB
AB
AP
AP
AP
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
TEVA PHARMS USA
EQ 100MG BASE/VIAL
EQ 350MG BASE/VIAL
LEUCOVORIN CALCIUM PRESERVATIVE FREE
@ LUITPOLD
EQ 50MG BASE/VIAL
LEUPROLIDE ACETATE
LEUPROLIDE ACETATE
TEVA PHARMS USA
LUPRON
@ ABBVIE ENDOCRINE INC
LUPRON DEPOT
+
ABBVIE ENDOCRINE INC
+
+
+
+
LUPRON DEPOT-PED
@ ABBVIE ENDOCRINE INC
@
Oct
Jan
Mar
Dec
May
Jun
22,
26,
07,
22,
30,
17,
1990
1989
1997
1995
1997
2011
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
Jul CAHN
Jul CAHN
LUPRON DEPOT-PED
+
+
+
+
+
>A> AN
>A> AN
>A> AN
AN
AN
AN
>D> AN
>A> AN
AN
AN
AN
AP
AA
AA
AA
AA
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AP
AA
AB
AB
7.5MG/VIAL
11.25MG/VIAL
11.25MG/VIAL
15MG/VIAL
30MG/VIAL
12
-
December
1 -56
2013
N 020263
N 020263
N 020263
N 020263
N 020263
002
005
007
006
008
Apr
Jan
Aug
Jan
Aug
16,
21,
15,
21,
15,
1993
1994
2011
1994
2011
Jul
Jul
Jul
Jul
Jul
CAHN
CAHN
CAHN
CAHN
CAHN
A 078171
A 078171
A 078171
A 077800
A 077800
A 077800
A 078309
A 078309
A 090297
A 090297
A 090297
002
003
001
001
002
003
001
001
001
002
003
Dec
Dec
Dec
Mar
Mar
Mar
Mar
Mar
Apr
Apr
Apr
13,
13,
13,
15,
15,
15,
20,
20,
26,
26,
26,
2013
2013
2013
2013
2013
2013
2009
2009
2013
2013
2013
Dec
Dec
Dec
Mar
Mar
Mar
Dec
Dec
Apr
Apr
Apr
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
NEWA
NEWA
NEWA
A 091627
001 Jun 26, 2013
Jun NEWA
100MG/ML
100MG/ML
100MG/ML
100MG/ML
100MG/ML
A 090187
A 079120
A 203052
A 203052
A 203067
001
001
001
001
001
Aug
Jan
Feb
Feb
May
05,
16,
28,
28,
09,
2011
2009
2013
2013
2013
Apr
Sep
Feb
Apr
Apr
DISC
CAHN
NEWA
CAHN
NEWA
A 090515
A 090515
A 090515
A 090515
A 078106
A 078106
A 078106
A 078106
004
001
002
003
004
001
002
003
Oct
Oct
Oct
Oct
Feb
Feb
Feb
Feb
08,
08,
08,
08,
10,
10,
10,
10,
2010
2010
2010
2010
2009
2009
2009
2009
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
A 091668
A 091668
A 203059
A 203059
A 202533
A 202533
001
002
001
002
001
002
Nov
Nov
Sep
Sep
Jul
Jul
01,
01,
09,
09,
20,
20,
2012
2012
2013
2013
2012
2012
Mar
Mar
Aug
Aug
Jan
Jan
DISC
DISC
NEWA
NEWA
NEWA
NEWA
LEVOBUNOLOL HYDROCHLORIDE
LEVOBUNOLOL HYDROCHLORIDE
@ APOTEX INC
0.25%
@
0.5%
A 075473
A 075475
001 Aug 03, 2000
001 Aug 03, 2000
Apr DISC
Apr DISC
LEVOCARNITINE
LEVOCARNITINE
TEVA PHARMS USA
A 075881
001 Mar 29, 2001
May CAHN
A 202673
001 Jul 26, 2013
Jul NEWA
A 202046
A 090486
001 Sep 17, 2013
001 Mar 26, 2013
Aug NEWA
Mar NEWA
LEVALBUTEROL HYDROCHLORIDE
SOLUTION;INHALATION
LEVALBUTEROL HYDROCHLORIDE
CIPLA LTD
EQ
EQ
EQ
DEY
EQ
EQ
EQ
EQ
MYLAN SPECLT
EQ
TEVA PHARMS USA
EQ
EQ
EQ
LEVETIRACETAM
LEVETIRACETAM
SAGENT PHARMS
SOLUTION;ORAL
LEVETIRACETAM
@ APOTEX INC
BRECKENRIDGE PHARM
HETERO DRUGS LTD
HETERO LABS LTD III
ORIT LABS LLC
TABLET;ORAL
LEVETIRACETAM
HETERO LABS LTD III
0.021% BASE
0.042% BASE
0.0103% BASE
0.0103% BASE
0.021% BASE
0.042% BASE
0.25% BASE
0.25% BASE
0.0103% BASE
0.021% BASE
0.042% BASE
1GM
250MG
500MG
750MG
PRINSTON INC
1GM
250MG
500MG
750MG
LEVETIRACETAM
@ SANDOZ
500MG
@
750MG
SUN PHARMA GLOBAL
500MG
750MG
VINTAGE PHARMS LLC
500MG
750MG
200MG/ML
LEVOCETIRIZINE DIHYDROCHLORIDE
SOLUTION;ORAL
TARO PHARM INDS
2.5MG/5ML
TABLET;ORAL
MICRO LABS LTD INDIA 5MG
SANDOZ
5MG
AB
>D>
>D> AP
>A>
>D> AP
>A>
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AB
AB
AB
TABLET;ORAL
SUN PHARMA GLOBAL
5MG
LEVOFLOXACIN
LEVOFLOXACIN
AKORN
@
EQ 500MG/20ML (EQ 25MG/ML)
@
CLARIS LIFESCIENCES
EMCURE PHARMS LTD
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
CLARIS LIFESCIENCES
FRESENIUS KABI USA
LEVOFLOXACIN
@ APOTEX INC
0.5%
TABLET;ORAL
LEVOFLOXACIN
WATSON LABS INC
250MG
500MG
750MG
LEVOMILNACIPRAN HYDROCHLORIDE
FETZIMA
FOREST LABS INC
EQ 20MG BASE
EQ 40MG BASE
EQ 80MG BASE
+
EQ 120MG BASE
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN
@ NOVOCOL
0.05MG/ML;2%
SCANDONEST L
+
DEPROCO
0.05MG/ML;2%
AB
AB
LEVONORGESTREL
INTRAUTERINE DEVICE;INTRAUTERINE
SKYLA
+
BAYER HLTHCARE
13.5MG
TABLET;ORAL
LEVONORGESTREL
LUPIN LTD
0.75MG
NOVEL LABS INC
1.5MG
12
-
December
1 -57
2013
A 090362
001 Jan 31, 2013
Jan NEWA
A 091644
A 091644
A 091644
A 091644
A 202328
A 202328
A 091436
A 202590
A 202590
001
001
002
002
001
002
001
001
002
Jun
Jun
Jun
Jun
Jan
Jan
Jun
Jan
Jan
20,
20,
20,
20,
24,
24,
05,
24,
24,
2011
2011
2011
2011
2013
2013
2013
2013
2013
Dec
Dec
Dec
Dec
Jan
Jan
May
Jan
Jan
DISC
DISC
DISC
DISC
NEWA
NEWA
NEWA
NEWA
NEWA
A 091397
A 091397
A 091397
A 200674
A 200674
A 200674
001
002
003
001
002
003
Aug
Aug
Aug
Jun
Jun
Jun
08,
08,
08,
19,
19,
19,
2013
2013
2013
2013
2013
2013
Jul
Jul
Jul
Jun
Jun
Jun
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
A 078282
001 Dec 20, 2010
Apr DISC
A 201484
A 201484
A 201484
001 Nov 22, 2013
002 Nov 22, 2013
003 Nov 22, 2013
Nov NEWA
Nov NEWA
Nov NEWA
N 204168
N 204168
N 204168
N 204168
001
002
003
004
Jul
Jul
Jul
Jul
A 084697
001
Jun DISC
A 088388
001 Oct 10, 1984
Jun CRLD
N 203159
001 Jan 09, 2013
Jan NEWA
A 091328
A 202508
001 Jan 23, 2013
001 Feb 22, 2013
Jan NEWA
Feb NEWA
Jul
Jul
Jul
Jul
25,
25,
25,
25,
2013
2013
2013
2013
LEVOTHYROXINE SODIUM **
**See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
TABLET;ORAL
LEVOTHYROXINE SODIUM
@ MERCK KGAA
0.025MG
A 076752 001 Jun 16, 2005
@
0.05MG
A 076752 002 Jun 16, 2005
@
0.075MG
A 076752 003 Jun 16, 2005
@
0.088MG
A 076752 004 Jun 16, 2005
@
0.1MG
A 076752 005 Jun 16, 2005
@
0.112MG
A 076752 006 Jun 16, 2005
@
0.125MG
A 076752 007 Jun 16, 2005
@
0.15MG
A 076752 008 Jun 16, 2005
@
0.175MG
A 076752 009 Jun 16, 2005
@
0.2MG
A 076752 010 Jun 16, 2005
@
0.3MG
A 076752 011 Jun 16, 2005
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
NEWA
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
TABLET;ORAL
LEVOXYL
KING PHARMS R AND D
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1,
AB3
AB1, +
AB3
@
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
LIOTHYRONINE SODIUM
TABLET;ORAL
CYTOMEL
KING PHARMS R AND D
+
LISINOPRIL
TABLET;ORAL
LISINOPRIL
ACCORD HLTHCARE
HIKMA PHARMS
-
December
1 -58
2013
0.025MG
N 021301
001 May 25, 2001
Mar CAHN
0.05MG
N 021301
002 May 25, 2001
Mar CAHN
0.075MG
N 021301
003 May 25, 2001
Mar CAHN
0.088MG
N 021301
004 May 25, 2001
Mar CAHN
0.1MG
N 021301
005 May 25, 2001
Mar CAHN
0.112MG
N 021301
006 May 25, 2001
Mar CAHN
0.125MG
N 021301
007 May 25, 2001
Mar CAHN
0.137MG
N 021301
008 May 25, 2001
Mar CAHN
0.15MG
N 021301
009 May 25, 2001
Mar CAHN
0.175MG
N 021301
010 May 25, 2001
Mar CAHN
0.2MG
N 021301
011 May 25, 2001
Mar CAHN
0.3MG
N 021301
012 May 25, 2001
Mar CAHN
A 091056
A 091058
A 091056
A 091058
A 083173
A 083173
A 083198
001
001
002
002
001
002
001
Dec
Sep
Dec
Sep
08,
30,
08,
30,
2010
2010
2010
2010
Nov
Nov
Nov
Nov
Sep
Sep
Mar
CAHN
CAHN
CAHN
CAHN
CMFD
CMFD
DISC
A 090665
A 203040
A 203082
A 203040
A 203082
001
001
001
002
002
Sep
Mar
Mar
Mar
Mar
27,
14,
14,
14,
14,
2010
2013
2013
2013
2013
Nov
Mar
Mar
Mar
Mar
CAHN
NEWA
NEWA
NEWA
NEWA
A 080429
001
May DISC
A 081318
001 Apr 29, 1993
Jun DISC
70MG;70MG
N 021623
001 Jun 23, 2005
Aug CAHN
EQ 0.005MG BASE
EQ 0.025MG BASE
EQ 0.05MG BASE
N 010379
N 010379
N 010379
001
002
003
Mar CAHN
Mar CAHN
Mar CAHN
2.5MG
5MG
10MG
20MG
30MG
40MG
2.5MG
5MG
10MG
20MG
30MG
40MG
A 202554
A 202554
A 202554
A 202554
A 202554
A 202554
A 076063
A 076063
A 076063
A 076063
A 076063
A 076063
001
002
003
004
005
006
001
002
003
004
006
005
LIDOCAINE HYDROCHLORIDE
AGILA SPECLTS
0.5%
0.5%
1%
1%
INTL MEDICATION
1%
2%
@ LUITPOLD
2%
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
AGILA SPECLTS
2%
AUROBINDO PHARMA LTD 1%
1%
2%
2%
JELLY;TOPICAL
ANESTACON
@ POLYMEDICA
2%
@ TEVA PHARMS USA
2%
LIDOCAINE; TETRACAINE
PATCH;TOPICAL
SYNERA
+
GALEN SPECIALTY
12
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jun
Jul
30,
30,
30,
30,
30,
30,
01,
01,
01,
01,
27,
01,
2013
2013
2013
2013
2013
2013
2002
2002
2002
2002
2003
2002
Jul
Jul
Jul
Jul
Jul
Jul
Oct
Oct
Oct
Oct
Oct
Oct
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
AB
AB
AB
AB
AB
AB
TABLET;ORAL
LISINOPRIL
INVAGEN PHARMS
@ SANDOZ
@
@
@
@
@
@
@
@
@
@
@
AB
AB
AB
>D> AB
>A>
LITHIUM CARBONATE
CAPSULE;ORAL
LITHIUM CARBONATE
@ APOTEX INC
HETERO LABS LTD III
WEST WARD
@
TABLET;ORAL
LITHIUM CARBONATE
@ WEST WARD
LOMUSTINE
CAPSULE;ORAL
CEENU
CORDEN PHARMA
+
LOPERAMIDE HYDROCHLORIDE
SOLUTION;ORAL
IMODIUM
@ JANSSEN PHARMA
@ JANSSEN PHARMS
>D>
>A>
AA
AP
AB
AB
AB
>D> AB
AB
>D> AB
LORAZEPAM
CONCENTRATE;ORAL
LORAZEPAM
LUPIN LTD
LORAZEPAM
AKORN
@ WATSON LABS
@
TABLET;ORAL
LORAZEPAM
@ SANDOZ
@
@
LOSARTAN POTASSIUM
TABLET;ORAL
COZAAR
MERCK SHARP DOHME
+
LOSARTAN POTASSIUM
ACTAVIS GRP PTC
12
-
December
1 -59
2013
2.5MG
5MG
10MG
20MG
30MG
40MG
2.5MG
2.5MG
5MG
5MG
10MG
10MG
20MG
20MG
30MG
30MG
40MG
40MG
A 203508
A 203508
A 203508
A 203508
A 203508
A 203508
A 075903
A 075999
A 075903
A 075999
A 075903
A 075999
A 075903
A 075999
A 075903
A 075999
A 075903
A 075999
001
002
003
004
005
006
001
001
002
002
003
003
004
004
005
005
006
006
Oct
Oct
Oct
Oct
Oct
Oct
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
29,
29,
29,
29,
29,
29,
01,
01,
01,
01,
01,
01,
01,
01,
01,
01,
01,
01,
2013
2013
2013
2013
2013
2013
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
Oct
Oct
Oct
Oct
Oct
Oct
Aug
Jan
Aug
Jan
Aug
Jan
Aug
Jan
Aug
Jan
Aug
Jan
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
DISC
CAHN
DISC
CAHN
DISC
CAHN
DISC
CAHN
DISC
CAHN
DISC
CAHN
300MG
150MG
300MG
600MG
600MG
600MG
A 076795
A 090702
A 090702
A 090702
A 078763
A 078763
001
001
002
003
001
001
Nov
Sep
Sep
Sep
Apr
Apr
22,
25,
25,
25,
15,
15,
2004
2009
2009
2009
2008
2008
Feb
Apr
Apr
Apr
Dec
Dec
DISC
CAHN
CAHN
CAHN
DISC
DISC
300MG
A 078715
001 Dec 28, 2010
Aug DISC
10MG
40MG
100MG
N 017588
N 017588
N 017588
001
002
003
Apr CAHN
Apr CAHN
Apr CAHN
1MG/5ML
1MG/5ML
N 019037
N 019037
001 Jul 31, 1984
001 Jul 31, 1984
Dec CAHN
Dec CAHN
2MG/ML
A 091407
001 Feb 19, 2013
Feb NEWA
2MG/ML
2MG/ML
4MG/ML
A 075025
A 074276
A 074276
001 Jul 23, 1998
001 Apr 15, 1994
002 Apr 15, 1994
Jul CAHN
Sep DISC
Sep DISC
0.5MG
1MG
2MG
A 071193
A 071194
A 071195
001 Apr 15, 1988
001 Apr 15, 1988
001 Apr 15, 1988
Apr DISC
Apr DISC
Apr DISC
25MG
50MG
100MG
N 020386
N 020386
N 020386
001 Apr 14, 1995
002 Apr 14, 1995
003 Oct 13, 1998
Oct CAHN
Oct CAHN
Oct CAHN
25MG
25MG
50MG
A 090382
A 090382
A 090382
001 Oct 06, 2010
001 Oct 06, 2010
002 Oct 06, 2010
Dec CAHN
Mar CAHN
Dec CAHN
12
-
December
1 -60
2013
TABLET;ORAL
LOSARTAN POTASSIUM
AB
>D> AB
AB
AB
AB
AB
>A> AB
>A> AB
>A> AB
AB
AB
AB
AB
AB
AB
AB
AB
IPCA LABS LTD
VIVIMED LABS
50MG
100MG
100MG
25MG
50MG
100MG
25MG
50MG
100MG
A 090382
A 090382
A 090382
A 200290
A 200290
A 200290
A 090382
A 090382
A 090382
002
003
003
001
002
003
001
002
003
Oct
Oct
Oct
Aug
Aug
Aug
Oct
Oct
Oct
06,
06,
06,
30,
30,
30,
06,
06,
06,
2010
2010
2010
2013
2013
2013
2010
2010
2010
Mar
Dec
Mar
Aug
Aug
Aug
Dec
Dec
Dec
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
LOVASTATIN
TABLET;ORAL
LOVASTATIN
+
CARLSBAD
MEVACOR
@ MERCK
@
40MG
A 075991
003 Jun 05, 2002
Feb CRLD
20MG
40MG
N 019643
N 019643
003 Aug 31, 1987
004 Dec 14, 1988
Feb DISC
Feb DISC
LOXAPINE
POWDER;INHALATION
ADASUVE
+
TEVA PHARMS USA INC
10MG
N 022549
001 Dec 21, 2012
Jul CAHN
EQ
EQ
EQ
EQ
A 076868
A 076868
A 076868
A 076868
001
002
003
004
May
May
May
May
LOXAPINE SUCCINATE
CAPSULE;ORAL
LOXAPINE SUCCINATE
MIKAH PHARMA
5MG BASE
10MG BASE
25MG BASE
50MG BASE
Aug
Aug
Aug
Aug
04,
04,
04,
04,
2005
2005
2005
2005
CMFD
CMFD
CMFD
CMFD
LULICONAZOLE
CREAM;TOPICAL
LUZU
MEDICIS
1%
N 204153
001 Nov 14, 2013
Nov NEWA
LURASIDONE HYDROCHLORIDE
TABLET;ORAL
LATUDA
SUNOVION PHARMS INC
60MG
N 200603
005 Jul 12, 2013
Jul NEWA
MACITENTAN
TABLET;ORAL
OPSUMIT
+
ACTELION PHARMS LTD
10MG
N 204410
001 Oct 18, 2013
Oct NEWA
EQ 85MG BASE/GM
N 016763
001
May CAHN
5%
A 201511
001 Feb 12, 2013
Jan NEWA
5%
5%
N 019832
N 019832
003 Jun 05, 1998
003 Jun 05, 1998
May CAHN
Jan CFTG
MAFENIDE ACETATE
CREAM;TOPICAL
SULFAMYLON
+
MYLAN INSTITUTIONAL
FOR SOLUTION;TOPICAL
MAFENIDE ACETATE
PAR FORM
SULFAMYLON
+
MYLAN INSTITUTIONAL
+
MYLAN LLC
MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM
BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
SOLUTION;ORAL
SUCLEAR
+
BRAINTREE LABS
1.6GM/BOT,3.13GM/BOT,17.5GM/BOT,N/ N 203595 001 Jan 18, 2013
A,N/A,N/A,N/A;N/A,N/A,N/A,210GM,0.
74GM,2.86GM,5.6GM
Jan NEWA
MANNITOL
MANNITOL 20%
@ B BRAUN
20GM/100ML
12
-
December
1 -61
2013
N 014738
001
Jan DISC
A 204054
001 Mar 19, 2013
Mar NEWA
MECHLORETHAMINE HYDROCHLORIDE
GEL;TOPICAL
VALCHLOR
+
ACTELION PHARMS LTD
0.02%
+
CEPTARIS THERAP
0.02%
MUSTARGEN
+
RECORDATI RARE
10MG/VIAL
N 202317
N 202317
001 Aug 23, 2013
001 Aug 23, 2013
Sep CAHN
Aug NEWA
N 006695
001
May CAHN
MECLIZINE HYDROCHLORIDE
TABLET;ORAL
ANTIVERT
+
CITRON PHARMA LLC
+
+
ANTIVERT
@ CITRON PHARMA LLC
12.5MG
25MG
50MG
N 010721
N 010721
N 010721
006
004
001 Jan 20, 1982
Nov CAHN
Nov CAHN
Nov CAHN
25MG
N 010721
005
Nov CAHN
EQ
EQ
EQ
EQ
A 071081
A 071081
A 071468
A 071469
002
001
001
001
AB
MEDROXYPROGESTERONE ACETATE
MEDROXYPROGESTERONE ACETATE
@ TEVA PHARMS USA
150MG/ML
150MG/ML
A 076552
A 076553
001 Oct 27, 2004
001 Jul 28, 2004
May CAHN
May CAHN
AB
AB
MEFENAMIC ACID
CAPSULE;ORAL
MEFENAMIC ACID
BRECKENRIDGE PHARM
CYPRESS PHARM
250MG
250MG
A 090359
A 090359
001 Feb 05, 2013
001 Feb 05, 2013
Sep CAHN
Jan NEWA
MEFLOQUINE HYDROCHLORIDE
TABLET;ORAL
MEFLOQUINE HYDROCHLORIDE
@ WEST WARD PHARM CORP 250MG
A 077699
001 Apr 21, 2010
Jun DISC
MEGESTROL ACETATE
SUSPENSION;ORAL
MEGESTROL ACETATE
@ APOTEX INC
40MG/ML
A 077404
001 Feb 16, 2006
Apr DISC
7.5MG
15MG
7.5MG
15MG
7.5MG
7.5MG
15MG
15MG
7.5MG
A 077929
A 077929
A 077930
A 077930
A 078039
A 078039
A 078039
A 078039
A 077934
001
002
001
002
001
001
002
002
001
Aug
Aug
Feb
Feb
Apr
Mar
Apr
Mar
Aug
MECAMYLAMINE HYDROCHLORIDE
TABLET;ORAL
MECAMYLAMINE HYDROCHLORIDE
NEXGEN PHARMA
2.5MG
AA
AA
AA
MECLOFENAMATE SODIUM
CAPSULE;ORAL
MECLOFENAMATE SODIUM
MYLAN
+
@ WATSON LABS
@
AB
AB
MELOXICAM
TABLET;ORAL
MELOXICAM
CIPLA LTD
@ COREPHARMA
@
@ CR DOUBLE CRANE
AB
@
AB
@ MYLAN
50MG BASE
100MG BASE
50MG BASE
100MG BASE
Sep
Sep
Apr
Apr
Jul
Jul
Jul
Jul
Dec
Dec
Dec
Dec
Jul
03,
03,
15,
15,
19,
19,
19,
19,
14,
14,
14,
14,
20,
1986
1986
1987
1987
2006
2006
2006
2006
2006
2006
2006
2006
2006
Sep
Sep
Sep
Sep
CTEC
CTEC
DISC
DISC
CAHN
CAHN
DISC
DISC
DISC
CAHN
DISC
CAHN
DISC
TABLET;ORAL
MELOXICAM
@
>D> AP
>A> AP
AP
AB
AB
AB
AB
AB
AB
AB
AB
AB
December
1 -62
2013
002 Jul 20, 2006
Aug DISC
MELPHALAN HYDROCHLORIDE
MELPHALAN HYDROCHLORIDE
@ MYLAN INSTITUTIONAL
EQ 50MG BASE/VIAL
A 090299
001 Oct 27, 2009
Nov DISC
MEPROBAMATE
TABLET;ORAL
MEPROBAMATE
@ TARO
@
200MG
400MG
A 200998
A 200998
001 May 23, 2011
002 May 23, 2011
Jan DISC
Jan DISC
MESALAMINE
DELZICOL
+
WARNER CHILCOTT LLC
400MG
SUPPOSITORY;RECTAL
CANASA
+
APTALIS PHARMA US
1GM
N 204412
001 Feb 01, 2013
Feb NEWA
N 021252
002 Nov 05, 2004
Feb CRLD
100MG/ML
100MG/ML
100MG/ML
A 090913
A 090913
A 075764
001 Apr 13, 2010
001 Apr 13, 2010
001 Apr 27, 2001
Dec CAHN
Dec CAHN
May CAHN
0.4%
0.6%
A 075402
A 075403
001 Feb 28, 2001
001 Feb 28, 2001
Apr DISC
Apr DISC
10MG/5ML
10MG/5ML
10MG/5ML
A 075235
A 075235
A 073632
001 Jan 27, 2000
001 Jan 27, 2000
001 Jul 22, 1992
Apr DISC
Feb DISC
Feb CTEC
10MG
20MG
10MG
20MG
A 072024
A 072025
A 073013
A 072795
001
001
001
001
Mar
Mar
Mar
Mar
800MG
A 203399
001 Jun 21, 2013
Jun NEWA
METFORMIN HYDROCHLORIDE
TABLET;ORAL
CHARTWELL LIFE SCI
1GM
500MG
625MG
750MG
850MG
SANDOZ
1GM
@
1GM
500MG
@
500MG
850MG
@
850MG
SCIEGEN PHARMS INC
500MG
850MG
1GM
A 075972
A 075972
A 075972
A 075972
A 075972
A 075965
A 075965
A 075965
A 075965
A 075965
A 075965
A 203769
A 203769
A 203769
003
001
005
004
002
003
003
001
001
002
002
001
002
003
Aug
Aug
Aug
Aug
Aug
May
Mar
May
Mar
May
Mar
Aug
Aug
Aug
METAPROTERENOL SULFATE
SOLUTION;INHALATION
@ APOTEX INC
@
SYRUP;ORAL
@ APOTEX INC
@ NOVEX
+
SILARX
TABLET;ORAL
PAR PHARM
+
@ WATSON LABS
@
AB
-
A 077934
MESNA
MESNA
SAGENT AGILA
SAGENT PHARMS
TEVA PHARMS USA
METAXALONE
TABLET;ORAL
METAXALONE
AMNEAL PHARMS
15MG
12
Jun
Jun
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Sep
Sep
Sep
28,
28,
31,
31,
24,
24,
24,
24,
24,
25,
25,
25,
25,
25,
25,
11,
11,
11,
1988
1988
1991
1991
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2002
2013
2013
2013
CTEC
CTEC
DISC
DISC
CAHN
CAHN
CAHN
CAHN
CAHN
CMFD
DISC
CMFD
DISC
CMFD
DISC
NEWA
NEWA
NEWA
AB2
>A>
>A>
>A>
>A>
>A>
>A>
>A>
>D>
>D>
>D>
>D>
>D>
AB3
AB3
AB3
AB3
AB3
AB3
AB3
AB3
AB3
AB3
AB3
AB3
AB3
>D> AB3
>D> AB3
AB3
AB1
AB
AB2
AB3
AB3
AB2
AB
AB
AB
AB
AB
AB
FORTAMET
+
ANDRX LABS LLC
1GM
GLUMETZA
+
SALIX PHARMS INC
1GM
+
1GM
+
1GM
+
1GM
+
1GM
500MG
500MG
+
SANTARUS
1GM
+
1GM
+
1GM
+
1GM
+
1GM
+
1GM
500MG
500MG
500MG
CSPC OUYI PHARM CO
500MG
750MG
LUPIN LTD
1GM
1GM
500MG
MYLAN PHARMS INC
1GM
@ TORRENT PHARMS LTD
750MG
@ WATSON LABS INC
500MG
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
N 021748
002
002
002
002
002
001
001
002
002
002
002
002
002
001
001
001
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
03,
03,
03,
03,
03,
03,
03,
03,
03,
03,
03,
03,
03,
03,
03,
03,
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Jul
Dec
Dec
Jul
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CTEC
CAHN
CAHN
CTEC
A 078321
A 078321
A 090692
A 091664
A 091664
A 200690
A 079226
A 076818
001
002
002
002
001
002
001
001
Apr
Apr
Jun
Jul
Jul
Aug
Feb
Dec
17,
17,
29,
19,
19,
01,
18,
14,
2008
2008
2011
2013
2013
2012
2010
2004
Sep
Sep
Jul
Jul
Jul
Jul
Jun
Mar
CAHN
CAHN
CTEC
NEWA
NEWA
CTEC
DISC
DISC
A 200823
A 200823
A 091273
A 091273
A 202001
A 202001
001
002
001
002
001
002
Feb
Feb
Apr
Apr
Feb
Feb
13,
13,
16,
16,
13,
13,
2013
2013
2013
2013
2013
2013
Jan
Jan
Apr
Apr
Jan
Jan
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
A 077142
N 017058
A 075082
001 Jul 12, 2005
001
001 Mar 25, 1998
Mar CDFR
Mar CDFR
Mar CDFR
A 074184
001 Apr 29, 1993
Mar CDFR
N 005378
002
May CAHN
100MG/ML
A 086459
001
Jul DISC
100MG/ML
100MG/ML
N 011790
N 011790
001
001
Jul CTEC
Sep CAHN
500MG
500MG
750MG
500MG
750MG
750MG
500MG
750MG
500MG
A 200958
A 200958
A 200958
A 090200
A 090200
A 085123
A 086989
A 086988
A 086989
001
001
002
001
002
001
001
001
001
AA
METHAMPHETAMINE HYDROCHLORIDE
TABLET;ORAL
DESOXYN
+
RECORDATI RARE
5MG
AA
AA
AA
AA
AA
AA
HETERO LABS LTD III
HIKMA PHARMS
PRINSTON INC
@ SOLCO HLTHCARE
1 -63
2013
Jul CTEC
AA
AA
December
002 Apr 27, 2004
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
AUROBINDO PHARMA LTD 500MG;EQ 15MG BASE
850MG;EQ 15MG BASE
SANDOZ
500MG;EQ 15MG BASE
850MG;EQ 15MG BASE
TORRENT PHARMS LTD
500MG;EQ 15MG BASE
850MG;EQ 15MG BASE
METHOCARBAMOL
METHOCARBAMOL
@ WATSON LABS
ROBAXIN
+
BAXTER HLTHCARE CORP
+
HIKMA MAPLE
TABLET;ORAL
METHOCARBAMOL
AUSTARPHARMA LLC
@
-
N 021574
METHADONE HYDROCHLORIDE
METHADONE HYDROCHLORIDE
MALLINCKRODT INC
40MG
+
ROXANE
40MG
SANDOZ
40MG
METHADOSE
MALLINCKRODT
40MG
AA
AA
AA
12
Oct
Oct
Oct
Nov
Nov
21,
21,
21,
06,
06,
2011
2011
2011
2009
2009
May
Jan
May
Apr
Apr
Oct
Feb
Feb
Jan
CMFD
DISC
CMFD
CAHN
CAHN
CAHN
CMFD
CAHN
DISC
METHOTREXATE
SOLUTION;SUBCUTANEOUS
OTREXUP
ANTARES PHARMA INC
+
>A> AP
>A> AP
>A> AP
>D> AP
>D> AP
>D> AP
METHOTREXATE SODIUM
METHOTREXATE SODIUM PRESERVATIVE FREE
+
ACCORD HLTHCARE
EQ 1GM BASE/40ML (EQ 25MG BASE/ML)
+
+
BASE/ML)
+
MYLAN INSTITUTIONAL
EQ 1GM BASE/40ML (EQ 25MG BASE/ML)
+
+
BASE/ML)
AB2
AB2
AB2
AB1
AB1
AB1
AA
AA
AB
AB
AB
AB
December
1 -64
2013
N 204824
N 204824
N 204824
N 204824
001
002
003
004
Oct
Oct
Oct
Oct
11,
11,
11,
11,
2013
2013
2013
2013
Oct
Oct
Oct
Oct
NEWA
NEWA
NEWA
NEWA
A 040716
A 040767
A 040768
001 Apr 30, 2007
001 Apr 30, 2007
001 Apr 30, 2007
Dec CAHN
Dec CAHN
Dec CAHN
A 040716
A 040767
A 040768
001 Apr 30, 2007
001 Apr 30, 2007
001 Apr 30, 2007
Dec CAHN
Dec CAHN
Dec CAHN
METHOXSALEN
CAPSULE;ORAL
OXSORALEN-ULTRA
+
DOW PHARM
10MG
N 019600
001 Oct 30, 1986
Apr CAHN
METHYCLOTHIAZIDE
TABLET;ORAL
METHYCLOTHIAZIDE
+
MYLAN PHARMS INC
@ WATSON LABS
5MG
5MG
A 087672
A 088724
001 Aug 17, 1982
001 Sep 06, 1984
Jan CTEC
Jan DISC
N 021415
001 Jul 27, 2004
Jun DISC
A 070070
A 070084
A 070085
003 Oct 15, 1985
001 Oct 15, 1985
001 Oct 15, 1985
Apr CAHN
Apr CAHN
Apr CAHN
N 021259
N 021259
N 021259
003 May 27, 2003
005 Feb 19, 2006
006 Feb 19, 2006
Sep CTEC
Sep CTEC
Sep CTEC
A 077707
A 078873
A 078873
A 078458
A 078458
A 078458
001
002
003
001
002
003
Sep
Sep
Sep
Apr
Apr
Apr
A 201466
A 201466
001 Nov 12, 2013
002 Nov 12, 2013
Oct NEWA
Oct NEWA
A 090710
A 090710
A 090710
001 Mar 15, 2012
002 Mar 15, 2012
003 Mar 15, 2012
May CAHN
May CAHN
May CAHN
N 021121
001 Aug 01, 2000
Jun CTEC
A 075629
001 May 09, 2000
Feb CTEC
METHYLDOPA
TABLET;ORAL
METHYLDOPA
@ ACCORD HLTHCARE
AB2
AB2
AB2
-
10MG/0.4ML
15MG/0.4ML
20MG/0.4ML
25MG/0.4ML
METHYL AMINOLEVULINATE HYDROCHLORIDE
CREAM;TOPICAL
METVIXIA
@ GALDERMA LABS LP
EQ 16.8% BASE
AB
AB
12
125MG
250MG
500MG
METHYLPHENIDATE HYDROCHLORIDE
METADATE CD
UCB INC
10MG
50MG
+
60MG
TEVA PHARMS
10MG
50MG
60MG
WATSON LABS INC
20MG
30MG
40MG
SOLUTION;ORAL
CARACO
5MG/5ML
10MG/5ML
TABLET;ORAL
CARACO
5MG
10MG
20MG
CONCERTA
JANSSEN PHARMS
18MG
METHYLIN ER
MALLINCKRODT INC
10MG
Jul
Jul
Jul
Dec
Dec
Dec
19,
19,
19,
01,
01,
01,
2012
2012
2012
2011
2011
2011
CTEC
CTEC
CTEC
CAHN
CAHN
CAHN
AB
AB
AB
AB
KUDCO IRELAND
18MG
27MG
36MG
54MG
002
A 040557
A 040620
A 040557
A 040620
001
001
002
002
A 204756
001 Dec 20, 2013
Dec NEWA
A 091392
A 073135
A 073135
A 073135
A 073135
001
001
001
001
001
Apr
Feb
Dec
Dec
May
N 022246
N 022246
001 Sep 04, 2009
002 Sep 04, 2009
Jul CRLD
Jul DISC
A 076600
A 076833
A 075543
001 Jan 06, 2004
001 Mar 01, 2004
003 Dec 24, 2003
Mar DISC
Jun DISC
May DISC
A 077779
A 077176
001 Mar 20, 2008
001 May 14, 2008
Feb DISC
May DISC
1MG/ML
1MG/ML
A 078950
A 074032
001 Apr 29, 2013
001 Dec 21, 1993
Apr NEWA
Mar DISC
@ PRINSTON INC
@
25MG
50MG
100MG
50MG
100MG
A 202871
A 202871
A 202871
A 074453
A 074453
001
002
003
001
002
May
May
May
Mar
Mar
METRONIDAZOLE
TABLET;ORAL
METRONIDAZOLE
TEVA PHARMS USA
250MG
A 070027
001 Nov 06, 1984
AB
AB
AB
AB
2MG
METOCLOPRAMIDE HYDROCHLORIDE
METOCLOPRAMIDE
EMCURE PHARMS LTD
EQ 5MG BASE/ML
METOCLOPRAMIDE HYDROCHLORIDE
BD RX
EQ 5MG BASE/ML
@ TEVA PARENTERAL
EQ 5MG BASE/ML
@ TEVA PHARMS USA
EQ 5MG BASE/ML
EQ 5MG BASE/ML
@
EQ 5MG BASE/ML
METOZOLV ODT
+
SALIX PHARMS
EQ 5MG BASE
@
EQ 10MG BASE
METOLAZONE
TABLET;ORAL
METOLAZONE
@ TEVA
@
@
2.5MG
5MG
10MG
METOPROLOL SUCCINATE
METOPROLOL SUCCINATE
@ NESHER PHARMS
EQ 25MG TARTRATE
@
EQ 50MG TARTRATE
AP
AB
AB
AB
AB
1 -65
2013
N 011153
METHYLPREDNISOLONE ACETATE
METHYLPREDNISOLONE ACETATE
TEVA PHARMS USA
40MG/ML
40MG/ML
80MG/ML
80MG/ML
>D>
>A> AP
December
001
002
003
004
AB
AP
-
A 091695
A 091695
A 091695
A 091695
METHYLPREDNISOLONE
TABLET;ORAL
MEDROL
PHARMACIA AND UPJOHN
>A> AP
12
METOPROLOL TARTRATE
METOPROLOL TARTRATE
CLARIS LIFESCIENCES
@ WATSON LABS
TABLET;ORAL
METOPROLOL TARTRATE
ALEMBIC PHARMS LTD
Jul
Jul
Sep
Sep
09,
09,
23,
23,
2013
2013
2013
2013
Jun
Jun
Sep
Sep
NEWA
NEWA
NEWA
NEWA
Oct CMFD
Feb
Oct
Feb
Oct
Apr
Nov
Nov
Nov
Nov
May
May
May
Apr
Apr
23,
27,
23,
27,
19,
27,
27,
27,
27,
28,
28,
28,
27,
27,
2005
2006
2005
2006
2013
1991
1991
1991
1991
2013
2013
2013
1995
1995
May
May
May
May
CAHN
CAHN
CAHN
CAHN
NEWA
DISC
CMFD
CMFD
CAHN
NEWA
NEWA
NEWA
CAHN
CAHN
Mar CAHN
METYROSINE
CAPSULE;ORAL
DEMSER
+
ATON PHARMA VPNA
AP
AP
AP
12
December
1 -66
2013
250MG
N 017871
001
MEXILETINE HYDROCHLORIDE
CAPSULE;ORAL
MEXILETINE HYDROCHLORIDE
TEVA
150MG
200MG
+
250MG
@ WATSON LABS
150MG
@
150MG
@
200MG
@
200MG
@
250MG
@
250MG
A 074377
A 074377
A 074377
A 074711
A 074865
A 074711
A 074865
A 074711
A 074865
001
002
003
001
001
002
002
003
003
May
May
May
Feb
Apr
Feb
Apr
Feb
Apr
16,
16,
16,
26,
13,
26,
13,
26,
13,
1995
1995
1995
1997
1998
1997
1998
1997
1998
Sep
Sep
Sep
Sep
Sep
Sep
Sep
Sep
Sep
CTEC
CTEC
CTEC
DISC
DISC
DISC
DISC
DISC
DISC
BASE/ML
BASE/ML
BASE/ML
BASE/ML
BASE/ML
BASE/ML
BASE/ML
BASE/ML
BASE/ML
BASE/ML
BASE/ML
A 075494
A 075481
A 075494
A 075637
A 075637
A 075637
A 075637
A 076144
A 076144
A 076020
A 076020
001
001
002
001
002
001
002
001
002
001
002
Jun
Jun
Jun
Oct
Oct
Oct
Oct
Jan
Jan
Jul
Jul
30,
30,
30,
31,
31,
31,
31,
26,
26,
16,
16,
2000
2000
2000
2000
2000
2000
2000
2005
2005
2004
2004
Jul
Jul
Jul
Apr
Apr
Jan
Jan
Jun
Jun
May
May
CAHN
CAHN
CAHN
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
2MG BASE/ML
A 077115
001 Sep 09, 2005
Apr DISC
A 076427
001 Sep 21, 2004
Apr DISC
A 077151
001 Jul 20, 2005
Apr DISC
A 090867
A 090867
A 090867
001 May 13, 2013
002 May 13, 2013
003 May 13, 2013
Apr NEWA
Apr NEWA
Apr NEWA
N 201922
N 201922
N 201922
N 201922
N 201922
001
002
003
004
005
May
May
May
May
May
N 050808
N 050808
008 Aug 27, 2010
007 Aug 27, 2010
Apr CRLD
Apr CRLD
N 203568
001 Jan 29, 2013
Jan NEWA
MIDAZOLAM HYDROCHLORIDE
AKORN INC
EQ
EQ
EQ
@ APOTEX INC
EQ
@
EQ
@ CLARIS LIFESCIENCES
EQ
@
EQ
@ INTL MEDICATED
EQ
@
EQ
@ INTL MEDICATION
EQ
@
EQ
SYRUP;ORAL
@ APOTEX INC
EQ
1MG
5MG
5MG
1MG
5MG
1MG
5MG
1MG
5MG
1MG
5MG
MILRINONE LACTATE
MILRINONE LACTATE
@ APOTEX INC
EQ 1MG BASE/ML
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
@ APOTEX INC
EQ 20MG BASE/100ML (EQ 0.2MG
BASE/ML)
AB
AB
AB
-
MINOCYCLINE HYDROCHLORIDE
CAPSULE;ORAL
MINOCYCLINE HYDROCHLORIDE
CARACO
EQ 50MG BASE
EQ 75MG BASE
EQ 100MG BASE
XIMINO
@ RANBAXY LABS LTD
EQ 45MG BASE
@
EQ 67.5MG BASE
@
EQ 90MG BASE
@
EQ 112.5MG BASE
@
EQ 135MG BASE
SOLODYN
+
MEDICIS
EQ 55MG BASE
+
EQ 80MG BASE
MIPOMERSEN SODIUM
SOLUTION;SUBCUTANEOUS
KYNAMRO
+
GENZYME CORP
200MG/ML (200MG/ML)
Jun CAHN
Jul
Jul
Jul
Jul
Jul
11,
11,
11,
11,
11,
2012
2012
2012
2012
2012
DISC
DISC
DISC
DISC
DISC
12
-
MIRTAZAPINE
MIRTAZAPINE
@ ACTAVIS ELIZABETH
15MG
@
30MG
@
45MG
AP
AP
AP
AP
AB
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
AB1
1 -67
2013
A 077959
A 077959
A 077959
001 Feb 14, 2011
002 Feb 14, 2011
003 Feb 14, 2011
Jun DISC
Jun DISC
Jun DISC
A 201014
A 077356
A 077356
001 Dec 11, 2012
001 Apr 11, 2006
002 Apr 11, 2006
Mar CAIN
May CAHN
May CAHN
A 077356
003 Apr 11, 2006
May CAHN
0.1%
N 019625
002 Apr 19, 2013
Apr NEWA
0.1%
A 076624
001 Dec 03, 2004
May DISC
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
N 020616
008
008
001
004
009
002
005
010
006
003
011
012
007
007
Apr
Apr
Jul
Mar
Jul
Jul
Mar
Jul
Oct
Jul
Jul
Jul
Feb
Feb
20,
20,
03,
09,
09,
03,
09,
09,
27,
03,
09,
09,
27,
27,
2007
2007
1996
2001
2012
1996
2001
2012
2006
1996
2012
2012
2007
2007
May
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
May
Apr
CTEC
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CTEC
CAHN
A 200812
A 200812
A 200812
A 200812
A 200812
A 200812
A 202104
A 202104
A 202104
A 202104
A 202104
A 202104
A 202104
001
002
003
004
005
006
001
002
003
004
005
006
007
Nov
Nov
Nov
Nov
Nov
Nov
Jun
Jun
Jun
Jun
Jun
Jun
Jun
10,
10,
10,
10,
10,
10,
03,
03,
03,
03,
03,
03,
03,
2011
2011
2011
2011
2011
2011
2013
2013
2013
2013
2013
2013
2013
Apr
Apr
Apr
Apr
Apr
Apr
May
May
May
May
May
May
May
CTEC
CTEC
CTEC
CTEC
CTEC
CTEC
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
N 204223
N 204223
N 204223
N 204223
N 204223
001
002
003
004
005
Oct
Oct
Oct
Oct
Oct
30,
30,
30,
30,
30,
2013
2013
2013
2013
2013
Oct
Oct
Oct
Oct
Oct
NEWA
NEWA
NEWA
NEWA
NEWA
N 201517
001 Jun 23, 2011
MITOXANTRONE HYDROCHLORIDE
MITOXANTRONE HYDROCHLORIDE
ONCO THERAPIES LTD
TEVA PHARMS USA
BASE/ML)
MOMETASONE FUROATE
CREAM;TOPICAL
ELOCON
MERCK SHARP DOHME
OINTMENT;TOPICAL
MOMETASONE FUROATE
@ TARO
December
MORPHINE SULFATE
KADIAN
+
WATSON LABS INC
10MG
+
10MG
20MG
30MG
40MG
50MG
60MG
70MG
80MG
+
100MG
130MG
150MG
+
200MG
+
200MG
MORPHINE SULFATE
PAR PHARM INC
20MG
30MG
50MG
60MG
80MG
100MG
UPSHER SMITH
10MG
20MG
30MG
50MG
60MG
80MG
100MG
SOLUTION;IM-IV
MORPHINE SULFATE
+
BD RX
2MG/ML (2MG/ML)
+
4MG/ML (4MG/ML)
+
5MG/ML (5MG/ML)
+
8MG/ML (8MG/ML)
+
10MG/ML (10MG/ML)
SOLUTION;ORAL
MORPHINE SULFATE
LANNETT HOLDINGS INC
100MG/5ML
Jul CPOT
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
EMBEDA
+
ALPHARMA KING
60MG;2.4MG
100MG;4MG
12
-
December
1 -68
2013
N 022321
N 022321
004 Aug 13, 2009
006 Aug 13, 2009
Jul CRLD
Jul CRLD
EQ 2% BASE
N 050746
001 Dec 11, 1997
Jan CFTG
AB
MUPIROCIN CALCIUM
CREAM;TOPICAL
BACTROBAN
+
GLAXOSMITHKLINE
MUPIROCIN
GLENMARK GENERICS
EQ 2% BASE
A 201587
001 Jan 24, 2013
Jan NEWA
AB
AB
MYCOPHENOLATE MOFETIL
CAPSULE;ORAL
MYCOPHENOLATE MOFETIL
ACCORD HLTHCARE
ALKEM LABS LTD
250MG
250MG
A 090253
A 200197
001 May 04, 2009
001 Jun 13, 2013
Apr CAHN
Jun NEWA
MYCOPHENOLIC ACID
MYCOPHENOLIC ACID
MYLAN PHARMS INC
180MG
360MG
MYFORTIC
+
NOVARTIS
360MG
+
360MG
A 091248
A 091248
002 Jan 08, 2014
001 Jan 08, 2014
Dec NEWA
Dec NEWA
N 050791
N 050791
002 Feb 27, 2004
002 Feb 27, 2004
Dec CTEC
Dec CTEC
NABUMETONE
TABLET;ORAL
NABUMETONE
@
@ PROSAM LABS
@
500MG
750MG
500MG
750MG
A 078420
A 078420
A 079093
A 079093
001
002
001
002
Apr
Apr
Mar
Mar
NAFTIFINE HYDROCHLORIDE
GEL;TOPICAL
NAFTIN
+
MERZ PHARMS
2%
N 204286
001 Jun 27, 2013
Jun NEWA
A 075735
A 075523
A 074736
001 Jul 11, 2001
001 Mar 17, 2000
001 Jan 21, 1997
Aug CTNA
Aug CTNA
Aug CTNA
A 075434
001 Mar 08, 2000
Apr DISC
N 018932
001 Nov 20, 1984
Jul CAHN
A 083590
001
Jul CAHN
A 076494
A 076494
A 076494
001 Jan 14, 2004
002 Jan 14, 2004
003 Jan 14, 2004
Apr CAHN
Apr CAHN
Apr CAHN
AB
>A> AB
>A> AB
>D>
>A> AB
AB
AB
AB
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE
TABLET;ORAL
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
GAVIS PHARMS
RANBAXY
+
WATSON LABS
AB
NALTREXONE HYDROCHLORIDE
TABLET;ORAL
NALTREXONE HYDROCHLORIDE
@ SANDOZ
50MG
REVIA
+
TEVA WOMENS
50MG
AT
NAPHAZOLINE HYDROCHLORIDE
NAPHAZOLINE HYDROCHLORIDE
AKORN INC
0.1%
AB
AB
AB
NAPROXEN
TABLET;ORAL
NAPROXEN
WEST WARD PHARM CORP
250MG
375MG
500MG
Sep
Sep
Feb
Feb
24,
24,
27,
27,
2008
2008
2009
2009
DISC
DISC
DISC
DISC
AB
AB
AB
AB
AB
AB
AB
AB
-
1 -69
December 2013
NAPROXEN SODIUM
NAPRELAN
ALMATICA PHARMA INC
EQ 375MG BASE
EQ 500MG BASE
+
EQ 750MG BASE
N 020353
001 Jan 05, 1996
N 020353
002 Jan 05, 1996
N 020353
003 Jan 05, 1996
Nov CAHN
Nov CAHN
Nov CAHN
NARATRIPTAN HYDROCHLORIDE
TABLET;ORAL
AMERGE
GLAXOSMITHKLINE LLC
+
EQ 1MG BASE
EQ 2.5MG BASE
N 020763
002 Feb 10, 1998
N 020763
001 Feb 10, 1998
Mar CAHN
Mar CAHN
NELFINAVIR MESYLATE
POWDER;ORAL
VIRACEPT
@ AGOURON
EQ 50MG BASE/SCOOPFUL
N 020778
001 Mar 14, 1997
Jun DISC
A 061579
001
Mar DISC
NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
POLY-PRED
@ ALLERGAN
EQ 0.35% BASE;10,000 UNITS/ML;0.5% N 050081
002
May DISC
NEOSTIGMINE METHYLSULFATE
BLOXIVERZ
+
ECLAT PHARMS LLC
+
N 204078
001 May 31, 2013
N 204078
002 May 31, 2013
May NEWA
May NEWA
NEPAFENAC
ILEVRO
+
ALCON RES LTD
0.3%
N 203491
001 Oct 16, 2012
Aug CTNA
NESIRITIDE RECOMBINANT
FOR SOLUTION;INTRAVENOUS
NATRECOR
+
SCIOS LLC
N 020920
001 Aug 10, 2001
Nov CAHN
A 076250
001 Apr 14, 2005
A 076378
001 Apr 26, 2005
A 076378
002 Apr 26, 2005
Aug CMFD
Aug CMFD
Aug CMFD
N 020381
004 Jul 28, 1997
N 020381
002 Jul 28, 1997
N 020381
003 Jul 28, 1997
Oct CTEC
Oct CTEC
Oct CTEC
20MG
10MG
10MG
20MG
A 072556
A 073250
A 202644
A 202644
Apr
Apr
Apr
Apr
50MG
150MG
N 020169
001 Sep 19, 1996
N 020169
002 Apr 30, 1999
NEOMYCIN SULFATE
NEO-RX
@ X GEN PHARMS
100%
AB
AB
AB
12
5MG/10ML (0.5MG/ML)
10MG/10ML (1MG/ML)
1.5MG/VIAL
NIACIN
NIACIN
BARR
1GM
500MG
750MG
NIASPAN
+
ABBVIE
1GM
500MG
+
750MG
NIFEDIPINE
CAPSULE;ORAL
NIFEDIPINE
ACTAVIS ELIZABETH
@ CATALENT
EMCURE PHARMS USA
NILUTAMIDE
TABLET;ORAL
NILANDRON
@ COVIS PHARMA SARL
+
001
001
001
002
Sep
Oct
Apr
Apr
20,
08,
25,
25,
1990
1991
2013
2013
CTEC
DISC
NEWA
NEWA
Apr CAHN
Apr CAHN
AB
AB
NIMODIPINE
CAPSULE;ORAL
NIMODIPINE
+
BANNER PHARMACAPS
SUN PHARM INDS INC
SOLUTION;ORAL
NYMALIZE
+
ARBOR PHARMS INC
+
AB
AB
AB
AB
AB
>A>
>D>
AB1
AB1
AB1
AB1
AB
AB
NITROFURANTOIN
SUSPENSION;ORAL
NITROFURANTOIN
CARACO
-
December
1 -70
2013
30MG
30MG
A 076740
A 077067
001 Jan 17, 2008
001 Apr 17, 2007
Jul CRLD
Jul CRLD
60MG/20ML
N 203340
001 May 10, 2013
May NEWA
A 079051
A 091001
001 Jul 25, 2008
003 Jan 26, 2011
Jul CRLD
Oct CTEC
N 020356
006 Jan 02, 2008
Oct DISC
2MG
5MG
10MG
N 021232
N 021232
N 021232
001 Jan 18, 2002
002 Jan 18, 2002
003 Jan 18, 2002
May CAHN
May CAHN
May CAHN
25MG/5ML
A 201355
001 Aug 14, 2013
Jul NEWA
N 016620
N 016620
N 016620
N 016620
003
003
001
002
Mar
Feb
Feb
Feb
A 073696
A 073696
A 073696
001 Dec 31, 1992
002 Dec 31, 1992
003 Dec 31, 1992
Mar DISC
Mar DISC
Mar DISC
N 020064
001 Dec 24, 1991
Mar CAHN
N 021780
N 021780
001 Nov 02, 2006
001 Nov 02, 2006
Dec CAHN
Dec CAHN
N 020145
N 020145
N 020145
N 020145
N 020145
N 020145
001
002
003
004
005
006
Mar
Mar
Mar
Mar
Mar
Mar
A 072034
001 May 24, 1988
Jul CTEC
A 091496
001 Sep 20, 2013
Sep NEWA
N 018705
002 Jan 10, 1997
Sep CFTG
NISOLDIPINE
NISOLDIPINE
MYLAN
20MG
25.5MG
SULAR
@ SHIONOGI INC
25.5MG
NITISINONE
CAPSULE;ORAL
ORFADIN
SWEDISH ORPHAN
12
NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
MACRODANTIN
ALVOGEN INC
25MG
25MG
50MG
+
100MG
NITROFURANTOIN
@ WATSON LABS
25MG
@
50MG
@
100MG
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE;ORAL
MACROBID
+
ALVOGEN INC
75MG;25MG
NITROGLYCERIN
AEROSOL, METERED;SUBLINGUAL
NITROMIST
+
MIST PHARMS LLC
0.4MG/SPRAY
+
NOVADEL
0.4MG/SPRAY
NITRO-DUR
+
MERCK SHARP DOHME
0.1MG/HR
+
0.2MG/HR
+
0.3MG/HR
+
0.4MG/HR
+
0.6MG/HR
+
0.8MG/HR
NITROGLYCERIN
+
LUITPOLD
5MG/ML
SPRAY, METERED;SUBLINGUAL
NITROGLYCERIN
PERRIGO ISRAEL
0.4MG/SPRAY
NITROLINGUAL PUMPSPRAY
+
POHL BOSKAMP
0.4MG/SPRAY
Apr
Apr
Apr
Apr
Apr
Apr
04,
04,
04,
04,
04,
04,
1995
1995
1995
1995
1995
1995
CTEC
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
NIZATIDINE
CAPSULE;ORAL
NIZATIDINE
@ APOTEX INC
@
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AT
>A>
>A>
>D>
>D>
AB
AB
AB
AB
-
December
1 -71
2013
A 076383
A 076383
001 Jan 23, 2003
002 Jan 23, 2003
Feb DISC
Feb DISC
A 040455
001 Mar 03, 2003
May CAHN
0.35MG
A 202260
001 Aug 01, 2013
Jul NEWA
0.35MG
0.35MG
A 091323
A 091323
001 Mar 28, 2013
001 Mar 28, 2013
Apr CTEC
Mar NEWA
0.35MG
0.35MG
0.35MG
0.35MG
0.35MG
A 200980
A 201483
A 202260
A 200961
A 202014
001
001
001
001
001
May
Jun
Aug
Aug
Aug
NORETHINDRONE ACETATE
TABLET;ORAL
NORETHINDRONE ACETATE
AMNEAL PHARMS
5MG
A 200275
001 Jul 30, 2012
Sep CTNA
NYSTATIN
SUSPENSION;ORAL
NILSTAT
@ GLENMARK GENERICS
100,000 UNITS/ML
N 050299
001
Feb DISC
A 091041
A 091041
A 075957
A 075957
A 075959
A 075957
A 075959
001
002
001
002
001
003
002
A 090834
A 090834
A 090834
001 Nov 12, 2013
002 Nov 12, 2013
003 Nov 12, 2013
Oct NEWA
Oct NEWA
Oct NEWA
OFLOXACIN
OFLOXACIN
ALTAIRE PHARMS INC
0.3%
@ APOTEX INC
0.3%
A 202692
A 076513
001 Apr 29, 2013
001 May 14, 2004
Apr NEWA
Apr DISC
OLIVE OIL; SOYBEAN OIL
CLINOLIPID 20%
+
BAXTER HLTHCARE
N 204508
001 Oct 03, 2013
Oct NEWA
N 021849
N 021849
N 021849
N 021849
001
002
001
002
Dec
Dec
Dec
Dec
NOREPINEPHRINE BITARTRATE
NOREPINEPHRINE BITARTRATE
TEVA PHARMS USA
EQ 1MG BASE/ML
NORETHINDRONE
TABLET;ORAL
NORETHINDRONE
AB1
HAUPT PHARMA
TABLET;ORAL-28
JENCYCLA
AB2
LUPIN LTD
AB
NORETHINDRONE
AB2
FAMY CARE LTD
AB1
AB1
HAUPT PHARMA
AB2
NOVAST LABS
AB1
NOVAST LABS LTD
AB
150MG
300MG
12
OCTREOTIDE ACETATE
OCTREOTIDE ACETATE
SAGENT PHARMS
EQ 0.2MG BASE/ML
EQ 1MG BASE/ML
TEVA PHARMS USA
EQ 0.05MG BASE/ML
EQ 0.1MG BASE/ML
EQ 0.2MG BASE/ML
EQ 0.5MG BASE/ML
EQ 1MG BASE/ML
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
SAGENT PHARMS
EQ 0.05MG BASE/ML
EQ 0.1MG BASE/ML
EQ 0.5MG BASE/ML
16%(160GM/1000ML);4%
(40GM/1000ML)
OMEPRAZOLE; SODIUM BICARBONATE
CAPSULE;ORAL
ZEGERID
SALIX PHARMS INC
20MG;1.1GM
+
40MG;1.1GM
SANTARUS
20MG;1.1GM
+
40MG;1.1GM
Jun
Jun
Aug
Sep
Sep
Nov
Nov
Oct
Oct
Nov
Oct
Nov
Feb
Feb
Feb
Feb
12,
24,
01,
13,
13,
12,
12,
03,
03,
21,
03,
21,
27,
27,
27,
27,
2013
2013
2013
2013
2013
2013
2013
2005
2005
2005
2005
2005
2006
2006
2006
2006
Oct
Oct
May
May
May
May
May
NEWA
NEWA
CDFR
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
AB
AB
>A> AB
>A> AB
>D> AB
AB
>D> AB
AB
AP
AP
AP
>D> AP
>A>
AP
AP
AP
AP
AB
AP
AP
AP
AB
AB
AB
FOR SUSPENSION;ORAL
OMEPRAZOLE AND SODIUM BICARBONATE
PAR PHARM
20MG/PACKET;1.68GM/PACKET
ZEGERID
SALIX PHARMS INC
+
SANTARUS
+
+
12
-
December
1 -72
2013
A 079182
A 079182
001 Apr 19, 2013
002 Apr 19, 2013
Apr NEWA
Apr NEWA
N 021636
N 021636
N 021636
N 021636
N 021636
N 021636
001
002
001
001
002
002
Jun
Dec
Jun
Jun
Dec
Dec
15,
21,
15,
15,
21,
21,
2004
2004
2004
2004
2004
2004
Dec
Dec
Dec
Apr
Dec
Apr
CAHN
CAHN
CAHN
CFTG
CAHN
CFTG
001
001
001
001
001
001
Apr
Dec
Feb
Feb
Dec
Dec
23,
26,
22,
22,
26,
26,
2008
2006
2013
2013
2006
2006
Nov
Apr
Jul
Feb
Mar
Feb
CAHN
DISC
CPOT
NEWA
DISC
DISC
001
001
001
001
Apr
Apr
Mar
Feb
13,
13,
17,
01,
2009
2009
2008
2007
Dec
Dec
Jan
Jan
DISC
DISC
DISC
DISC
001
001
001
001
001
001
Apr
Dec
Jul
Feb
Feb
Dec
23,
26,
19,
22,
22,
26,
2008
2006
2013
2013
2013
2006
Nov
Apr
Jul
Jul
Feb
Mar
CAHN
DISC
NEWA
CPOT
NEWA
DISC
ONDANSETRON HYDROCHLORIDE
AGILA SPECLTS
EQ 2MG BASE/ML
A 078257
@ APOTEX INC
EQ 2MG BASE/ML
A 077368
CLARIS LIFESCIENCES
EQ 2MG BASE/ML
A 078288
2MG/ML
A 078288
@ LUITPOLD
EQ 2MG BASE/ML
A 077582
@ PLIVA HRVATSKA DOO
EQ 2MG BASE/ML
A 077544
ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
BEDFORD LABS
EQ 0.64MG BASE/ML
A 078291
@
EQ 0.64MG BASE/ML
A 078291
@ CLARIS LIFESCIENCES
EQ 0.64MG BASE/ML
A 078308
@ HOSPIRA
EQ 0.64MG BASE/ML
A 077348
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
AGILA SPECLTS
EQ 2MG BASE/ML
A 078244
@ APOTEX INC
EQ 2MG BASE/ML
A 077343
BD RX
EQ 2MG BASE/ML
A 202253
CLARIS LIFESCIENCES
EQ 2MG BASE/ML
A 078287
2MG/ML
A 078287
@ LUITPOLD
EQ 2MG BASE/ML
A 077387
TABLET;ORAL
@ TARO
EQ 4MG BASE
A 077729
@
EQ 8MG BASE
A 077729
@
EQ 24MG BASE
A 077729
001 Mar 28, 2011
002 Mar 28, 2011
003 Mar 28, 2011
Sep DISC
Sep DISC
Sep DISC
ORPHENADRINE CITRATE
ORPHENADRINE CITRATE
TEDOR PHARMA INC
100MG
A 040249
001 Jan 29, 1999
Oct CAHN
OSPEMIFENE
TABLET;ORAL
OSPHENA
+
SHIONOGI INC
60MG
N 203505
001 Feb 26, 2013
Feb NEWA
EQ 1GM BASE/VIAL
EQ 2GM BASE/VIAL
EQ 10GM BASE/VIAL
A 201539
A 201539
A 201538
001 Jan 18, 2013
002 Jan 18, 2013
001 Jan 18, 2013
Jan NEWA
Jan NEWA
Jan NEWA
OXAPROZIN
TABLET;ORAL
OXAPROZIN
CARACO
@
600MG
600MG
A 075844
A 075844
001 Jan 03, 2002
001 Jan 03, 2002
Nov CMFD
Jan DISC
OXAZEPAM
CAPSULE;ORAL
OXAZEPAM
+
ACTAVIS ELIZABETH
IVAX SUB TEVA PHARMS
30MG
30MG
A 072253
A 070945
001 Apr 14, 1988
001 Aug 03, 1987
Jul CRLD
Jul CRLD
OXACILLIN SODIUM
OXACILLIN SODIUM
AB
AA
AA
AA
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
12
-
December
1 -73
2013
OXCARBAZEPINE
TABLET;ORAL
OXCARBAZEPINE
@ TEVA PHARMS USA
@
@
150MG
300MG
600MG
A 078005
A 078005
A 078005
001 Dec 11, 2007
002 Dec 11, 2007
003 Dec 11, 2007
Mar DISC
Mar DISC
Mar DISC
OXYBUTYNIN
GEL, METERED;TRANSDERMAL
GELNIQUE 3%
+
WATSON LABS INC
3%
N 202513
001 Dec 07, 2011
Jun CTNA
5MG/5ML
5MG/5ML
A 074997
A 075039
001 Oct 15, 1997
001 Jan 29, 1999
Apr DISC
Jun DISC
5MG
A 071655
001 Nov 14, 1988
Mar CAHN
A 204037
A 203208
N 201194
001 Jul 15, 2013
001 Jul 12, 2013
001 Jan 12, 2012
Jul NEWA
Jul NEWA
Jul CTEC
A 077290
A 077290
A 077290
A 077290
A 077290
A 077290
A 077290
A 077290
A 077290
A 077290
001
001
002
002
003
003
004
004
005
005
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
Dec
08,
08,
08,
08,
08,
08,
08,
08,
08,
08,
2005
2005
2005
2005
2005
2005
2005
2005
2005
2005
Jun
Mar
Jun
Mar
Jun
Mar
Jun
Mar
Jun
Mar
CMFD
DISC
CMFD
DISC
CMFD
DISC
CMFD
DISC
CMFD
DISC
A 203601
A 203601
A 202321
A 202321
001
002
001
002
Jan
Jan
Apr
Apr
30,
30,
25,
25,
2013
2013
2013
2013
Jan
Jan
Apr
Apr
NEWA
NEWA
NEWA
NEWA
A 079046
A 079046
A 079046
A 079046
A 079046
A 079046
A 079046
A 079087
A 079087
A 079087
A 079087
A 079087
A 200822
A 200822
A 200822
A 200822
A 200822
A 200822
A 200822
003
001
004
002
005
006
007
001
003
005
006
007
002
003
004
005
006
007
001
Jul
Dec
Jul
Dec
Jul
Jul
Jul
Jun
Jun
Jun
Jul
Jun
Jul
Jul
Jul
Jul
Jul
Jul
Jul
11,
13,
11,
13,
11,
11,
11,
14,
14,
14,
22,
14,
15,
15,
15,
15,
15,
15,
15,
2013
2010
2013
2010
2013
2013
2013
2010
2010
2010
2010
2010
2013
2013
2013
2013
2013
2013
2013
Jul
Apr
Jul
Apr
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
Jul
NEWA
CAHN
NEWA
CAHN
NEWA
NEWA
NEWA
CTEC
CTEC
CTEC
CTEC
CTEC
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
OXYBUTYNIN CHLORIDE
SYRUP;ORAL
OXYBUTYNIN CHLORIDE
@ APOTEX INC
@ MIKART
TABLET;ORAL
OXYBUTYNIN CHLORIDE
TEVA PHARMS USA
OXYCODONE HYDROCHLORIDE
SOLUTION;ORAL
ROXANE
5MG/5ML
100MG/5ML
+
VISTAPHARM
5MG/5ML
TABLET;ORAL
NESHER PHARMS
5MG
@
5MG
10MG
@
10MG
15MG
@
15MG
20MG
@
20MG
30MG
@
30MG
OXYMORPHONE HYDROCHLORIDE
TABLET;ORAL
AVANTHI INC
5MG
10MG
MALLINCKRODT INC
5MG
10MG
ACTAVIS ELIZABETH
5MG
7.5MG
10MG
15MG
20MG
30MG
40MG
IMPAX LABS
5MG
10MG
20MG
30MG
40MG
ROXANE
5MG
7.5MG
10MG
15MG
20MG
30MG
40MG
AP
AP
AP
AP
AP
AP
OXYTOCIN
OXYTOCIN
HIKMA FARMACEUTICA
@ TEVA PHARMS USA
@
12
-
AB
AB
AB
AB
AB
AB
1 -74
2013
10USP UNITS/ML (10USP UNITS/ML)
A 200219
10USP UNITS/ML (10USP UNITS/ML)
A 077453
100USP UNITS/10ML (10USP UNITS/ML) A 077453
001 Feb 13, 2013
001 Jan 24, 2008
002 Jan 24, 2008
Jan NEWA
May CAHN
May CAHN
6MG/ML
6MG/ML
A 075436
A 075297
001 Nov 12, 2004
001 Jan 25, 2002
Apr DISC
May CAHN
6MG/ML
6MG/ML
N 020262
N 020262
001 Dec 29, 1992
001 Dec 29, 1992
Apr CMFD
Jan CAHN
A 078520
A 078520
A 076153
A 076153
001
002
001
002
Nov
Nov
Mar
Mar
N 020725
005 Mar 14, 2013
Mar NEWA
1MG/ML
2MG/ML
A 072759
A 072760
001 Jul 31, 1990
001 Jul 31, 1990
May CAHN
Mar CAHN
1MCG
2MCG
4MCG
A 090829
A 090829
A 090829
001 Sep 27, 2013
002 Sep 27, 2013
003 Sep 27, 2013
Sep NEWA
Sep NEWA
Sep NEWA
1MCG
2MCG
4MCG
N 021606
N 021606
N 021606
001 May 26, 2005
002 May 26, 2005
003 May 26, 2005
Sep CFTG
Sep CFTG
Sep CFTG
PAROXETINE HYDROCHLORIDE
SUSPENSION;ORAL
PAROXETINE HYDROCHLORIDE
@ APOTEX INC
EQ 10MG BASE/5ML
A 077395
001 Dec 05, 2006
Apr DISC
PAROXETINE MESYLATE
CAPSULE;ORAL
BRISDELLE
+
NOVEN THERAP
N 204516
001 Jun 28, 2013
Jun NEWA
N 202799
N 202799
N 202799
N 202799
007
007
008
008
May
Apr
May
Apr
N 202799
001 Mar 27, 2012
May DISC
N 202799
001 Mar 27, 2012
Apr CAHN
N 202799
002 Mar 27, 2012
May DISC
N 202799
002 Mar 27, 2012
Apr CAHN
PACLITAXEL
PACLITAXEL
@ ACCORD HLTHCARE
@ TEVA PHARMS USA
TAXOL
HQ SPCLT PHARMA
@
PAMIDRONATE DISODIUM
PAMIDRONATE DISODIUM
AGILA SPECLTS
TEVA PHARMS USA
30MG/10ML
90MG/10ML
30MG/10ML
90MG/10ML
(3MG/ML)
(9MG/ML)
(3MG/ML)
(9MG/ML)
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
CREON
ABBVIE
180,000USP UNITS;36,000USP
UNITS;114,000USP UNITS
AP
AP
December
PANCURONIUM BROMIDE
PANCURONIUM BROMIDE
+
TEVA PHARMS USA
+
PARICALCITOL
CAPSULE;ORAL
PARICALCITOL
TEVA PHARMS USA
ZEMPLAR
ABBVIE
+
EQ 7.5MG BASE
PEGINESATIDE ACETATE
SOLUTION;INTRAVENOUS, SUBCUTANEOUS
OMONTYS
@ TAKEDA PHARMS USA
+
@
+
OMONTYS PRESERVATIVE FREE
@ TAKEDA PHARMS USA
BASE/0.5ML)
+
BASE/0.5ML)
@
BASE/0.5ML)
+
EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.
Oct
Oct
Mar
Mar
Mar
Mar
Mar
Mar
31,
31,
27,
27,
27,
27,
27,
27,
2008
2008
2002
2002
2012
2012
2012
2012
CAHN
CAHN
CAHN
CAHN
DISC
CAHN
DISC
CAHN
SOLUTION;INTRAVENOUS, SUBCUTANEOUS
OMONTYS PRESERVATIVE FREE
5ML)
@
EQ 3MG BASE/0.5ML
BASE/0.5ML)
+
EQ 3MG BASE/0.5ML
BASE/0.5ML)
@
EQ 4MG BASE/0.5ML
BASE/0.5ML)
+
EQ 4MG BASE/0.5ML
BASE/0.5ML)
@
EQ 5MG BASE/0.5ML
BASE/0.5ML)
+
EQ 5MG BASE/0.5ML
BASE/0.5ML)
@
EQ 6MG BASE/0.5ML
BASE/0.5ML)
+
EQ 6MG BASE/0.5ML
BASE/0.5ML)
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
>A> AB
>A> AB
>A> AB
12
-
December
1 -75
2013
(EQ 3MG
N 202799
003 Mar 27, 2012
May DISC
(EQ 3MG
N 202799
003 Mar 27, 2012
Apr CAHN
(EQ 4MG
N 202799
004 Mar 27, 2012
May DISC
(EQ 4MG
N 202799
004 Mar 27, 2012
Apr CAHN
(EQ 5MG
N 202799
005 Mar 27, 2012
May DISC
(EQ 5MG
N 202799
005 Mar 27, 2012
Apr CAHN
(EQ 6MG
N 202799
006 Mar 27, 2012
May DISC
(EQ 6MG
N 202799
006 Mar 27, 2012
Apr CAHN
A 090549
A 090549
001 Oct 11, 2013
002 Oct 11, 2013
Sep NEWA
Sep NEWA
PHENYLEPHRINE HYDROCHLORIDE
PHENYLEPHRINE HYDROCHLORIDE
PARAGON BIOTECK
2.5%
+
10%
N 203510
N 203510
001 Mar 21, 2013
002 Mar 21, 2013
Mar NEWA
Mar NEWA
PHENYTOIN SODIUM
PHENYTOIN SODIUM
@ HOSPIRA
50MG/ML
A 089744
001 Dec 18, 1987
Mar DISC
PHYTONADIONE
TABLET;ORAL
MEPHYTON
+
VALEANT PHARMS
5MG
N 010104
003
Jun CAHN
PINDOLOL
TABLET;ORAL
PINDOLOL
MYLAN PHARMS INC
+
@ WATSON LABS
@
5MG
10MG
5MG
10MG
A 074019
A 074019
A 074437
A 074437
001
002
001
002
Sep
Sep
Feb
Feb
03,
03,
27,
27,
1992
1992
1995
1995
Jun
Jun
Jun
Jun
CTEC
CTEC
DISC
DISC
A 200044
A 200044
A 200044
A 200268
A 200268
A 200268
A 078383
A 078383
A 078383
A 202467
A 202467
A 202467
A 078670
A 078670
A 078670
A 078472
A 078472
A 078472
A 077210
A 077210
A 077210
001
002
003
001
002
003
001
002
003
001
002
003
001
002
003
001
002
003
001
002
003
Feb
Feb
Feb
Feb
Feb
Feb
Mar
Mar
Mar
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Jan
Jan
Jan
13,
13,
13,
13,
13,
13,
12,
12,
12,
06,
06,
06,
13,
13,
13,
13,
13,
13,
10,
10,
10,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2014
2014
2014
Jan
Jan
Jan
Jan
Jan
Jan
Mar
Mar
Mar
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Dec
Dec
Dec
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
PENICILLIN V POTASSIUM
TABLET;ORAL
PENICILLIN V POTASSIUM
HIKMA PHARMS
EQ 250MG BASE
EQ 500MG BASE
PIOGLITAZONE HYDROCHLORIDE
TABLET;ORAL
ACCORD HLTHCARE
EQ
EQ
EQ
AUROBINDO PHARMA LTD EQ
EQ
EQ
DR REDDYS LABS LTD
EQ
EQ
EQ
MACLEODS PHARMS LTD
EQ
EQ
EQ
SANDOZ
EQ
EQ
EQ
SYNTHON PHARMS
EQ
EQ
EQ
TEVA PHARMS USA
EQ
EQ
EQ
15MG
30MG
45MG
15MG
30MG
45MG
15MG
30MG
45MG
15MG
30MG
45MG
15MG
30MG
45MG
15MG
30MG
45MG
15MG
30MG
45MG
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
BASE
AB
AB
AB
AB
AB
AB
TABLET;ORAL
TORRENT PHARMS LTD
EQ
EQ
EQ
ZYDUS PHARMS USA INC
EQ
EQ
EQ
POLIDOCANOL
VARITHENA
+
PROVENSIS
15MG
30MG
45MG
15MG
30MG
45MG
12
-
December
BASE
BASE
BASE
BASE
BASE
BASE
A 091298
A 091298
A 091298
A 202456
A 202456
A 202456
001
002
003
001
002
003
N 205098
001 Nov 25, 2013
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
ANHYDROUS
FOR SOLUTION;ORAL
COLYTE
MEDA PHARMS
227.1GM/BOT;2.82GM/BOT;6.36GM/BOT; N 018983
5.53GM/BOT;21.5GM/BOT
@
240GM/BOT;2.98GM/BOT;6.72GM/BOT;5. N 018983
84GM/BOT;22.72GM/BOT
COLYTE WITH FLAVOR PACKS
MEDA PHARMS
COLYTE-FLAVORED
@ MEDA PHARMS
227.1GM/BOT;2.82GM/BOT;6.36GM/BOT; N 018983
5.53GM/BOT;21.5GM/BOT
@
>A> AP
AT
POLYMYXIN B SULFATE
POLYMYXIN B SULFATE
XELLIA PHARMS APS
EQ 500,000 U BASE/VIAL
POLY-RX
@ X GEN PHARMS
100,000,000 UNITS/BOT
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
AKORN INC
10,000 UNITS/ML;EQ 1MG BASE/ML
POMALIDOMIDE
CAPSULE;ORAL
POMALYST
CELGENE
+
1MG
2MG
3MG
4MG
POSACONAZOLE
NOXAFIL
+
MERCK SHARP DOHME
100MG
AB
>A> AB
>A> AB
BC
1 -76
2013
POTASSIUM CHLORIDE
POTASSIUM CHLORIDE
AMNEAL PHARMS
10MEQ
ANCHEN PHARMS
8MEQ
10MEQ
K-TAB
ABBVIE
20MEQ
KLOR-CON
UPSHER-SMITH LABS
8MEQ
POTASSIUM CHLORIDE
@ ABBVIE
8MEQ
Feb
Feb
Feb
Feb
Feb
Feb
13,
13,
13,
13,
13,
13,
2013
2013
2013
2013
2013
2013
Jan
Jan
Jan
Jan
Jan
Jan
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
Nov NEWA
CHLORIDE; SODIUM SULFATE
010 Jan 31, 1989
Jul CTEC
007 Jun 12, 1987
Jul DISC
012 Oct 08, 1998
Jul CTEC
008 Nov 14, 1991
Jul DISC
009 Nov 14, 1991
Jul DISC
A 202766
001 Jan 15, 2014
Dec NEWA
A 061578
001
Mar DISC
A 065006
001 Dec 17, 1998
Jul CAHN
N 204026
N 204026
N 204026
N 204026
001
002
003
004
Feb
Feb
Feb
Feb
N 205053
001 Nov 25, 2013
Nov NEWA
A 202128
A 202886
A 202886
001 Feb 22, 2013
001 Dec 26, 2013
002 Dec 26, 2013
Feb NEWA
Dec NEWA
Dec NEWA
N 018279
003 Nov 25, 2013
Nov NEWA
N 019123
001 Apr 17, 1986
Nov CTEC
N 018279
002 Aug 01, 1988
Nov DISC
Feb
Feb
Feb
Feb
08,
08,
08,
08,
2013
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET;ORAL
PRAMIPEXOLE DIHYDROCHLORIDE
ACTAVIS GRP PTC
0.125MG
0.25MG
0.5MG
0.75MG
1MG
1.5MG
SUN PHARM INDS INC
0.125MG
0.25MG
0.5MG
0.75MG
1MG
1.5MG
N 021332
003 Sep 25, 2007
Jan CAHN
600MCG
N 021332
001 Mar 16, 2005
Jan CAHN
(EQ 1MG
N 021332
003 Sep 25, 2007
Jun CRLD
600MCG
N 021332
001 Mar 16, 2005
Jun DISC
10MG
20MG
40MG
A 077904
A 077904
A 077904
001 Oct 23, 2006
002 Oct 23, 2006
003 Oct 23, 2006
Aug CAHN
Aug CAHN
Aug CAHN
PRAZIQUANTEL
TABLET;ORAL
BILTRICIDE
+
BAYER HLTHCARE
600MG
N 018714
001 Dec 29, 1982
Jun CAHN
PREDNISOLONE
SYRUP;ORAL
PREDNISOLONE
@ APOTEX INC
@
5MG/5ML
15MG/5ML
A 040570
A 040571
001 Aug 25, 2005
001 Aug 25, 2005
Apr DISC
Apr DISC
A 075117
001 Dec 14, 2000
May CAHN
A 076988
A 076123
A 075250
001 May 24, 2005
001 Dec 23, 2002
001 Jul 12, 2002
May DISC
Mar DISC
Mar DISC
N 021959
N 021959
N 021959
N 021959
N 021959
N 021959
001
002
003
001
002
003
May
May
May
Mar
Mar
Mar
A 202179
A 202179
A 202179
001 Apr 10, 2013
002 Apr 10, 2013
003 Apr 10, 2013
AMYLIN PHARMS LLC
@
AB
AB
AB
1 -77
2013
(EQ 1MG
+
AB
AB
AB
AB
AB
AB
December
001
002
003
004
005
006
001
002
003
004
005
006
+
AA
-
A 091254
A 091254
A 091254
A 091254
A 091254
A 091254
A 091683
A 091683
A 091683
A 091683
A 091683
A 091683
PRAMLINTIDE ACETATE
SYMLIN
AMYLIN PHARMS
AB
AB
AB
12
PRAVASTATIN SODIUM
TABLET;ORAL
PRAVASTATIN SODIUM
CIPLA LTD
EQ 2.7MG BASE/2.7ML
BASE/ML)
EQ 3MG BASE/5ML (EQ
BASE/ML)
EQ 2.7MG BASE/2.7ML
BASE/ML)
EQ 3MG BASE/5ML (EQ
BASE/ML)
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION;ORAL
ORAPRED
+
CONCORDIA PHARMS INC
EQ 15MG BASE/5ML
@ NESHER PHARMS
EQ 15MG BASE/5ML
@ PHARM ASSOC
EQ 5MG BASE/5ML
@ WE PHARMS
EQ 15MG BASE/5ML
ORAPRED ODT
CONCORDIA PHARMS INC
EQ 10MG BASE
EQ 15MG BASE
+
EQ 30MG BASE
SHIONOGI INC
EQ 10MG BASE
EQ 15MG BASE
+
EQ 30MG BASE
MYLAN PHARMS INC
EQ 10MG BASE
EQ 15MG BASE
EQ 30MG BASE
Nov
Nov
Nov
Nov
Nov
Nov
Mar
Mar
Mar
Mar
Mar
Mar
Jun
Jun
Jun
Jun
Jun
Jun
30,
30,
30,
30,
30,
30,
27,
27,
27,
27,
27,
27,
01,
01,
01,
01,
01,
01,
2010
2010
2010
2010
2010
2010
2013
2013
2013
2013
2013
2013
2006
2006
2006
2006
2006
2006
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
CAHN
CFTG
CFTG
CFTG
Mar NEWA
Mar NEWA
Mar NEWA
AB
AB
AB
AB
AB
AB
AP
AB
AB
AB
AB
PREDNISONE
TABLET;ORAL
PREDNISONE
HIKMA PHARMS
12
-
December
1 -78
2013
1MG
2.5MG
5MG
10MG
20MG
50MG
A 040890
A 040538
A 080292
A 088832
A 083677
A 088465
001
001
001
001
001
001
PRIMIDONE
TABLET;ORAL
PRIMIDONE
@
@ WEST WARD
50MG
250MG
50MG
A 040862
A 040862
A 040667
001 Oct 03, 2008
002 Oct 03, 2008
001 Jul 27, 2006
Apr DISC
Apr DISC
Jul DISC
PROBENECID
TABLET;ORAL
PROBENECID
@ IVAX SUB TEVA PHARMS
500MG
A 083740
001 May 09, 1984
May DISC
A 204147
001 Oct 15, 2013
Sep NEWA
100MG
200MG
A 200900
A 200900
001 Aug 16, 2013
002 Aug 16, 2013
Jul NEWA
Jul NEWA
100MG
200MG
300MG
N 019781
N 019781
N 019781
001 May 14, 1998
002 Oct 15, 1999
003 Oct 15, 1999
May CAHN
May CAHN
May CAHN
A 040454
A 040454
001 Aug 22, 2002
002 Aug 22, 2002
Mar CAHN
Mar CAHN
A 040891
001 Mar 13, 2009
May CAHN
A 040863
A 040863
A 040863
001 Dec 30, 2008
002 Dec 30, 2008
003 Dec 30, 2008
May CAHN
May CAHN
May CAHN
PROCHLORPERAZINE EDISYLATE
PROCHLORPERAZINE EDISYLATE
EMCURE PHARMS LTD
EQ 5MG BASE/ML
PROGESTERONE
CAPSULE;ORAL
PROGESTERONE
BANNER PHARMACAPS
PROMETRIUM
ABBVIE INC
+
@
Nov 01, 2010
Jan 08, 2004
Dec 04, 1985
Jun 01, 1984
May
May
May
May
May
May
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
AB
AB
AB
PROMETHAZINE HYDROCHLORIDE
+
TEVA PHARMS USA
25MG/ML
+
50MG/ML
SYRUP;ORAL
CARACO
6.25MG/5ML
TABLET;ORAL
CARACO
12.5MG
25MG
50MG
AT
PROPARACAINE HYDROCHLORIDE
PROPARACAINE HYDROCHLORIDE
AKORN INC
0.5%
A 040277
001 Mar 16, 2000
Jul CAHN
PROPIOMAZINE HYDROCHLORIDE
LARGON
@ HIKMA MAPLE
20MG/ML
N 012382
002
Nov CAHN
PROPOFOL
PROPOFOL
TEVA PHARMS USA
10MG/ML
A 075102
001 Jan 04, 1999
Mar CAHN
AP
AP
AA
AB
AB
AB
AB
AB
AB
AB
AB
>D> BD
>A>
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
PROPRANOLOL HYDROCHLORIDE
PROPRANOLOL HYDROCHLORIDE
GLATT AIR
60MG
80MG
120MG
160MG
TABLET;ORAL
INDERAL
@ WYETH PHARMS INC
10MG
@
20MG
40MG
60MG
+
80MG
@
90MG
12
-
December
1 -79
2013
A 078065
A 078065
A 078065
A 078065
001
002
003
004
Jan
Jan
Jan
Jan
26,
26,
26,
26,
2007
2007
2007
2007
Feb
Feb
Feb
Feb
CAHN
CAHN
CAHN
CAHN
N 016418
N 016418
N 016418
N 016418
N 016418
N 016418
001
003
002
009 Oct 18, 1982
004
010 Oct 18, 1982
Jul
Jul
Jul
Jul
Jul
Jul
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
PROPYLTHIOURACIL
TABLET;ORAL
PROPYLTHIOURACIL
WEST WARD
@
50MG
50MG
A 080154
A 080154
001
001
Dec DISC
Dec DISC
PROTRIPTYLINE HYDROCHLORIDE
TABLET;ORAL
VIVACTIL
@ TEVA WOMENS
@
5MG
10MG
N 016012
N 016012
001
002
Mar CAHN
Mar CAHN
PYRIDOSTIGMINE BROMIDE
TABLET;ORAL
PYRIDOSTIGMINE BROMIDE
@ COREPHARMA
60MG
A 040457
001 Dec 26, 2002
Nov DISC
PYRIMETHAMINE
TABLET;ORAL
DARAPRIM
+
AMEDRA PHARMS
25MG
N 008578
001
Apr CAHN
QUAZEPAM
TABLET;ORAL
DORAL
@ SCIECURE PHARMA INC
+
7.5MG
15MG
N 018708
N 018708
003 Feb 26, 1987
001 Dec 27, 1985
Jun CAHN
Jun CAHN
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
A 202152
A 202152
A 202152
A 202152
A 202152
A 202152
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201762
A 201504
A 201504
A 201504
A 201504
001
002
003
004
005
006
001
002
003
004
005
006
007
001
002
003
004
005
006
007
001
002
003
004
Apr
Apr
Apr
Apr
Apr
Apr
May
May
May
May
May
May
May
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Jan
Jan
Jan
Jan
QUETIAPINE FUMARATE
TABLET;ORAL
QUETIAPINE FUMARATE
ACCORD HLTHCARE
ACTAVIS GRP PTC
ACTAVIS PHARMA
ALKEM LABS LTD
25MG BASE
50MG BASE
100MG BASE
200MG BASE
300MG BASE
400MG BASE
25MG BASE
50MG BASE
100MG BASE
150MG BASE
200MG BASE
300MG BASE
400MG BASE
25MG BASE
50MG BASE
100MG BASE
150MG BASE
200MG BASE
300MG BASE
400MG BASE
25MG BASE
50MG BASE
100MG BASE
150MG BASE
Mar
Mar
Mar
Mar
Mar
Mar
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
27,
12,
12,
12,
12,
2012
2012
2012
2012
2012
2012
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
12
-
December
1 -80
2013
TABLET;ORAL
QUETIAPINE FUMARATE
AB
AB
AB
AB
AB
AB
AB
AB
JUBILANT LIFE
QUINAPRIL HYDROCHLORIDE
TABLET;ORAL
QUINAPRIL HYDROCHLORIDE
@ APOTEX INC
@
@
@
@ MYLAN
@
@
@
AB
AB
AB
AB
AB
AB
AB
RALTEGRAVIR POTASSIUM
POWDER;ORAL
ISENTRESS
+
MERCK SHARP DOHME
SOLUTION;ORAL
ISENTRESS
+
MERCK SHARP DOHME
AB
AB
200MG BASE
300MG BASE
400MG BASE
25MG BASE
A 201504
A 201504
A 201504
A 203150
005
006
007
001
Feb
Feb
Feb
Nov
12,
12,
12,
26,
2013
2013
2013
2013
Jan
Jan
Jan
Nov
NEWA
NEWA
NEWA
NEWA
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
5MG BASE
10MG BASE
20MG BASE
40MG BASE
5MG BASE
10MG BASE
20MG BASE
40MG BASE
5MG BASE
10MG BASE
20MG BASE
40MG BASE
A 076240
A 076240
A 076240
A 076240
A 202725
A 202725
A 202725
A 202725
A 076036
A 076036
A 076036
A 076036
001
002
003
004
001
002
003
004
001
002
003
004
Jan
Jan
Jan
Jan
Apr
Apr
Apr
Apr
Jan
Jan
Jan
Jan
26,
26,
26,
26,
29,
29,
29,
29,
28,
28,
28,
28,
2006
2006
2006
2006
2013
2013
2013
2013
2005
2005
2005
2005
Mar
Mar
Mar
Mar
Apr
Apr
Apr
Apr
Aug
Aug
Aug
Aug
DISC
DISC
DISC
DISC
NEWA
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
N 204736
N 204736
001 Mar 26, 2013
002 Mar 26, 2013
Mar NEWA
Mar NEWA
N 020973
002 Aug 19, 1999
Oct CFTG
A 076824
A 090678
A 078964
A 076885
A 076822
A 202376
001
001
001
001
001
001
Oct
Oct
Oct
Oct
Oct
Oct
162MCI/6ML (27MCI/ML)
N 203971
001 May 15, 2013
May NEWA
EQ 100MG BASE/PACKET
N 205786
001 Dec 20, 2013
Dec NEWA
100MG
N 205786
001 Dec 20, 2013
Dec NEWA
8MG
A 091693
001 Jul 26, 2013
Jul NEWA
8MG
N 021782
001 Jul 22, 2005
Jul CFTG
1.25MG
2.5MG
5MG
10MG
A 077004
A 077004
A 077004
A 077004
001
002
003
004
Jul
Jul
Jul
Jul
RABEPRAZOLE SODIUM
ACIPHEX SPRINKLE
EISAI INC
5MG
+
10MG
ACIPHEX
+
EISAI INC
20MG
RABEPRAZOLE SODIUM
DR REDDYS LABS LTD
20MG
KREMERS URBAN DEV
20MG
LUPIN LTD
20MG
MYLAN PHARMS INC
20MG
TEVA PHARMS USA
20MG
TORRENT PHARMS LTD
20MG
RADIUM RA-223 DICHLORIDE
XOFIGO
+
BAYER HLTHCARE
>A>
>A>
>A>
>A>
>A>
>A>
EQ
EQ
EQ
EQ
RAMELTEON
TABLET;ORAL
RAMELTEON
TEVA PHARMS USA
ROZEREM
+
TAKEDA PHARMS USA
RAMIPRIL
CAPSULE;ORAL
RAMIPRIL
@ CIPLA
@
@
@
Nov
Nov
Nov
Nov
Nov
Nov
Aug
Aug
Aug
Aug
08,
08,
08,
08,
08,
08,
07,
07,
07,
07,
2013
2013
2013
2013
2013
2013
2008
2008
2008
2008
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
AP
AA
AA
AA
AA
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
RANITIDINE HYDROCHLORIDE
GRANULE, EFFERVESCENT;ORAL
ZANTAC 150
@ GLAXO GRP LTD
EQ 150MG BASE/PACKET
25MG/ML
ZANTAC IN PLASTIC CONTAINER
@ COVIS PHARMA SARL
EQ 1MG BASE/ML
SYRUP;ORAL
@ APOTEX INC
EQ 15MG BASE/ML
BIO PHARM INC
EQ 15MG BASE/ML
BRECKENRIDGE PHARM
EQ 15MG BASE/ML
CARACO
EQ 15MG BASE/ML
ZANTAC
+
GLAXO GRP LTD
EQ 15MG BASE/ML
TABLET;ORAL
@ WATSON LABS
EQ 150MG BASE
@
EQ 300MG BASE
@ WATSON LABS INC
EQ 150MG BASE
@
EQ 300MG BASE
ZANTAC 150
GLAXO GRP LTD
EQ 150MG BASE
ZANTAC 300
+
GLAXO GRP LTD
EQ 300MG BASE
TABLET, EFFERVESCENT;ORAL
ZANTAC 150
@ GLAXO GRP LTD
EQ 150MG BASE
WATSON LABS INC
REPAGLINIDE
TABLET;ORAL
PRANDIN
NOVO NORDISK INC
+
REPAGLINIDE
CARACO
MYLAN PHARMS INC
PADDOCK LLC
SANDOZ
RESERPINE
TABLET;ORAL
SERPALAN
@ LANNETT
@
-
December
1 -81
2013
N 020251
002 Mar 31, 1994
Jun CAHN
A 091534
001 Feb 22, 2013
Feb NEWA
N 019593
002 Sep 27, 1991
Jun DISC
A 077602
A 090102
A 078684
A 091091
001
001
001
001
Apr
Apr
Sep
Apr
N 019675
001 Dec 30, 1988
Jun CAHN
A 074864
A 074864
A 077426
A 077426
001
002
001
002
Jan
Jan
Mar
Mar
N 018703
001 Jun 09, 1983
Jun CAHN
N 018703
002 Dec 09, 1985
Jun CAHN
N 020251
001 Mar 31, 1994
Jun CAHN
N 021526
N 021526
001 Feb 12, 2007
002 Jan 27, 2006
Jul CFTG
Jul CFTG
A 201046
A 201046
001 Jul 29, 2013
002 Jul 29, 2013
Jul NEWA
Jul NEWA
EQ 0.5MG BASE
EQ 1MG BASE
N 021641
N 021641
001 May 16, 2006
002 May 16, 2006
Jun CFTG
Jun CFTG
EQ
EQ
EQ
EQ
A 201950
A 201950
A 201823
A 201823
001
002
001
002
Aug
Aug
Jun
Jun
0.5MG
1MG
2MG
N 020741
N 020741
N 020741
001 Dec 22, 1997
002 Dec 22, 1997
003 Dec 22, 1997
Jul CTEC
Jul CFTG
Jul CFTG
1MG
2MG
0.5MG
0.5MG
0.5MG
A 077571
A 077571
A 090252
A 201189
A 078555
002
003
001
001
001
Jul
Jul
Aug
Jul
Nov
0.1MG
0.25MG
N 010124
N 010124
001
002
RANOLAZINE
RANEXA
+
GILEAD
1GM
500MG
RANOLAZINE
LUPIN LTD
500MG
1GM
RASAGILINE MESYLATE
TABLET;ORAL
AZILECT
TEVA
+
RASAGILINE MESYLATE
APOTEX INC
12
0.5MG BASE
1MG BASE
0.5MG BASE
1MG BASE
Sep
May
Aug
Sep
Oct
Oct
Dec
Dec
Sep
Sep
Jul
Jul
Jul
Jul
Aug
Jul
Nov
17,
26,
27,
20,
20,
20,
19,
19,
12,
12,
01,
01,
11,
11,
23,
17,
22,
2007
2009
2009
2011
1997
1997
2005
2005
2013
2013
2013
2013
2013
2013
2013
2013
2013
DISC
CAHN
CAHN
CAHN
DISC
DISC
DISC
DISC
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
May DISC
May DISC
AB
AB
AP
AB
AB
AB
AB
AB
RIFAMPIN
CAPSULE;ORAL
RIFAMPIN
LUPIN PHARMS
RIFAMPIN
AGILA SPECLTS
RILUZOLE
TABLET;ORAL
RILUTEK
+
COVIS PHARMA SARL
RILUZOLE
APOTEX CORP
GLENMARK GENERICS
MYLAN PHARMS INC
SUN PHARM INDS LTD
+
AA
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
RIZATRIPTAN BENZOATE
TABLET;ORAL
CIPLA LTD
December
1 -82
2013
A 090034
A 090034
001 Aug 21, 2013
002 Aug 21, 2013
Jul NEWA
Jul NEWA
600MG/VIAL
A 065421
001 May 22, 2008
Nov CAHN
50MG
N 020599
001 Dec 12, 1995
Apr CAHN
50MG
50MG
50MG
50MG
A 091300
A 091394
A 203042
A 091417
001
001
001
001
Jun
Jun
Jun
Jun
A 075916
001 Nov 02, 2001
Feb DISC
N 204819
N 204819
N 204819
N 204819
N 204819
001
002
003
004
005
Oct
Oct
Oct
Oct
Oct
A 078909
001 Jul 29, 2009
May CAHN
A 091537
A 077494
A 078464
A 078464
A 078464
A 078464
A 078464
006
001
001
002
003
004
005
Feb
Apr
Apr
Apr
Apr
Apr
Apr
12,
30,
08,
08,
08,
08,
08,
2013
2009
2013
2013
2013
2013
2013
Feb
Feb
Mar
Mar
Mar
Mar
Mar
NEWA
CTEC
NEWA
NEWA
NEWA
NEWA
NEWA
A 091072
A 091072
A 091072
A 091072
001
002
003
004
May
May
May
May
16,
16,
16,
16,
2013
2013
2013
2013
Apr
Apr
Apr
Apr
NEWA
NEWA
NEWA
NEWA
A 077526
A 077526
A 204090
A 204090
A 204339
A 204339
001
002
001
002
001
002
Mar
Mar
Nov
Nov
Jul
Jul
26,
26,
26,
26,
01,
01,
2013
2013
2013
2013
2013
2013
Mar
Mar
Nov
Nov
Jun
Jun
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
A 202477
A 202477
A 203062
A 203062
A 201914
001
002
001
002
001
Jul
Jul
Jul
Jul
Jul
01,
01,
01,
01,
01,
2013
2013
2013
2013
2013
Jun
Jun
Jun
Jun
Jun
NEWA
NEWA
NEWA
NEWA
NEWA
0.5MG
1MG
1.5MG
2MG
2.5MG
RISPERIDONE
SOLUTION;ORAL
RISPERIDONE
BIO PHARM INC
1MG/ML
RISPERIDONE
MYLAN PHARMS INC
0.25MG
PAR PHARM
0.25MG
SUN PHARM INDS LTD
0.5MG
1MG
2MG
3MG
4MG
RIVASTIGMINE TARTRATE
CAPSULE;ORAL
RIVASTIGMINE TARTRATE
APOTEX INC
-
150MG
300MG
RIMANTADINE HYDROCHLORIDE
TABLET;ORAL
RIMANTADINE HYDROCHLORIDE
@ COREPHARMA
100MG
RIOCIGUAT
TABLET;ORAL
ADEMPAS
BAYER HLTHCARE
12
EQ
EQ
EQ
EQ
1.5MG BASE
3MG BASE
4.5MG BASE
6MG BASE
EQ 5MG BASE
EQ 10MG BASE
EMCURE PHARMS LTD
EQ 5MG BASE
EQ 10MG BASE
INVAGEN PHARMS
EQ 5MG BASE
EQ 10MG BASE
APOTEX INC
EQ 5MG BASE
EQ 10MG BASE
AUROBINDO PHARMA LTD EQ 5MG BASE
EQ 10MG BASE
GLENMARK GENERICS
EQ 5MG BASE
Jun
Jun
Jul
Jun
Oct
Oct
Oct
Oct
Oct
18,
18,
01,
18,
08,
08,
08,
08,
08,
2013
2013
2013
2013
2013
2013
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
AB
AB
AB
AB
AB
AP
AP
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
EQ 10MG BASE
NATCO PHARMA LTD
EQ 5MG BASE
EQ 10MG BASE
SANDOZ
EQ 5MG BASE
EQ 10MG BASE
ROCURONIUM BROMIDE
ZEMURON
+
ORGANON USA INC
@
+
ROPINIROLE HYDROCHLORIDE
TABLET;ORAL
REQUIP
+
GLAXOSMITHKLINE LLC
+
ROSIGLITAZONE MALEATE
TEVA
-
December
1 -83
2013
A 201914
A 203478
A 203478
A 078739
A 078739
002
001
002
001
002
50MG/5ML (10MG/ML)
10MG/ML (10MG/ML)
N 020214
N 020214
N 020214
001 Mar 17, 1994
002 Mar 17, 1994
003 Mar 17, 1994
Jan CAHN
Jan CAHN
Jan CAHN
EQ
EQ
EQ
EQ
EQ
EQ
EQ
0.25MG BASE
0.5MG BASE
1MG BASE
2MG BASE
3MG BASE
4MG BASE
5MG BASE
N 020658
N 020658
N 020658
N 020658
N 020658
N 020658
N 020658
001
002
003
004
006
007
005
Sep
Sep
Sep
Sep
Jan
Jan
Sep
19,
19,
19,
19,
27,
27,
19,
1997
1997
1997
1997
1999
1999
1997
Mar
Mar
Mar
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
0.25MG BASE
0.5MG BASE
1MG BASE
2MG BASE
3MG BASE
4MG BASE
5MG BASE
A 078230
A 078230
A 078230
A 078230
A 078230
A 078230
A 078230
001
002
003
004
005
006
007
May
May
May
May
May
May
May
20,
20,
20,
20,
20,
20,
20,
2008
2008
2008
2008
2008
2008
2008
Jul
Jul
Jul
Jul
Jul
Jul
Jul
DISC
DISC
DISC
DISC
DISC
DISC
DISC
2MG BASE
3MG BASE
4MG BASE
6MG BASE
8MG BASE
12MG BASE
N 022008
N 022008
N 022008
N 022008
N 022008
N 022008
001
002
003
006
004
005
Jun
Jun
Jun
Apr
Jun
Oct
13,
13,
13,
10,
13,
31,
2008
2008
2008
2009
2008
2008
Mar
Mar
Mar
Mar
Mar
Mar
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
2MG BASE
4MG BASE
6MG BASE
8MG BASE
12MG BASE
2MG BASE
4MG BASE
6MG BASE
8MG BASE
12MG BASE
A 090869
A 090869
A 090869
A 090869
A 090869
A 202786
A 202786
A 202786
A 202786
A 202786
001
002
003
004
005
001
002
003
004
005
May
May
May
May
May
Apr
Apr
Apr
Apr
Apr
17,
17,
17,
17,
17,
22,
22,
22,
22,
22,
2012
2012
2012
2012
2012
2013
2013
2013
2013
2013
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
Apr
CAHN
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
NEWA
EQ 2MG BASE
EQ 4MG BASE
EQ 8MG BASE
N 021071
N 021071
N 021071
002 May 25, 1999
003 May 25, 1999
004 May 25, 1999
Jan CFTG
Jan CFTG
Jan CFTG
EQ 2MG BASE
EQ 4MG BASE
EQ 8MG BASE
A 076747
A 076747
A 076747
001 Jan 25, 2013
002 Jan 25, 2013
003 Jan 25, 2013
Jan NEWA
Jan NEWA
Jan NEWA
N 021829
N 021829
001 May 09, 2007
006 Apr 02, 2012
May CRLD
May CRLD
@ COREPHARMA
EQ
@
EQ
@
EQ
@
EQ
@
EQ
@
EQ
@
EQ
REQUIP XL
+
GLAXOSMITHKLINE LLC
EQ
@
EQ
EQ
EQ
EQ
EQ
ACTAVIS ELIZABETH
EQ
EQ
EQ
EQ
EQ
ALEMBIC LTD
EQ
EQ
EQ
EQ
EQ
ROSIGLITAZONE MALEATE
TABLET;ORAL
AVANDIA
SB PHARMCO
12
ROTIGOTINE
NEUPRO
+
UCB INC
2MG/24HR
8MG/24HR
Jul
Jul
Jul
Jul
Jul
01,
01,
01,
01,
01,
2013
2013
2013
2013
2013
Jun
Jun
Jun
Jun
Jun
NEWA
NEWA
NEWA
NEWA
NEWA
>D>
>A>
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
QUADRAMET
+
JAZZ EUSA PHARMA
50mCi/ML
+
LANTHEUS MEDICAL
50mCi/ML
>A>
>A>
>A>
>A>
>A>
>A>
SAPROPTERIN DIHYDROCHLORIDE
FOR SOLUTION;ORAL
KUVAN
+
BIOMARIN PHARM
POWDER;ORAL
KUVAN
+
BIOMARIN PHARM
December
1 -84
2013
001 Mar 28, 1997
001 Mar 28, 1997
Dec CAHN
Dec CAHN
100MG
N 205065
001 Dec 19, 2013
Dec NEWA
100MG/PACKET
N 205065
001 Dec 19, 2013
Dec NEWA
EQ 500MG BASE
N 021785
001 Dec 17, 2004
Feb CAHN
SELEGILINE HYDROCHLORIDE
TABLET;ORAL
SELEGILINE HYDROCHLORIDE
@ DAVA PHARMS INC
5MG
A 074641
001 Aug 02, 1996
Jan DISC
SERTACONAZOLE NITRATE
CREAM;TOPICAL
ERTACZO
+
VALEANT LUXEMBOURG
2%
N 021385
001 Dec 10, 2003
Jun CAHN
SERTRALINE HYDROCHLORIDE
TABLET;ORAL
SERTRALINE HYDROCHLORIDE
@ CIPLA LTD
@
@
@
@
EQ
EQ
EQ
EQ
EQ
EQ
25MG BASE
50MG BASE
100MG BASE
25MG BASE
50MG BASE
100MG BASE
A 077162
A 077162
A 077162
A 076442
A 076442
A 076442
001
002
003
001
002
003
Feb
Feb
Feb
Apr
Apr
Apr
06,
06,
06,
30,
30,
30,
2007
2007
2007
2007
2007
2007
Aug
Aug
Aug
Apr
Apr
Apr
CAHN
CAHN
CAHN
DISC
DISC
DISC
SILDENAFIL CITRATE
TABLET;ORAL
SILDENAFIL CITRATE
ACTAVIS GRP PTC
ACTAVIS PHARMA
AMNEAL PHARMS
MACLEODS PHARMS LTD
EQ
EQ
EQ
EQ
20MG
20MG
20MG
20MG
A 200149
A 200149
A 202025
A 203814
001
001
001
001
Feb
Feb
Feb
Dec
25,
25,
28,
17,
2013
2013
2013
2013
Apr
Feb
Feb
Dec
CAHN
NEWA
NEWA
NEWA
SIMEPREVIR
CAPSULE;ORAL
OLYSIO
+
JANSSEN RES AND DEV
150MG
N 205123
001 Nov 22, 2013
Nov NEWA
N 202343
N 202343
N 202343
N 202343
N 202343
N 202343
004
001
005
002
006
003
Sep
Sep
Sep
Sep
Sep
Sep
1MG/ML
N 021083
001 Sep 15, 1999
Sep CAHN
0.5MG
0.5MG
0.5MG
N 021110
N 021110
N 021110
004 Jan 25, 2010
004 Jan 25, 2010
004 Jan 25, 2010
Dec CFTG
Dec CFTG
Sep CAHN
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
TABLET;ORAL
JUVISYNC
@ MERCK SHARP DOHME
10MG;EQ
@
10MG;EQ
@
20MG;EQ
@
20MG;EQ
@
40MG;EQ
@
40MG;EQ
>D>
>A> AB
-
N 020570
N 020570
SAQUINAVIR MESYLATE
TABLET;ORAL
INVIRASE
+
HOFFMAN LA ROCHE
AB
AB
AB
>A> AB
12
SIROLIMUS
SOLUTION;ORAL
RAPAMUNE
+
PF PRISM CV
TABLET;ORAL
RAPAMUNE
PF PRISM CV
BASE
BASE
BASE
BASE
50MG BASE
100MG BASE
50MG BASE
100MG BASE
50MG BASE
100MG BASE
Sep
Oct
Sep
Oct
Sep
Oct
18,
07,
18,
07,
18,
07,
2012
2011
2012
2011
2012
2011
DISC
DISC
DISC
DISC
DISC
DISC
12
-
December
1 -85
2013
TABLET;ORAL
RAPAMUNE
+
>A>
>A> AB
@
SIROLIMUS
SODIUM CHLORIDE
SODIUM CHLORIDE 0.9%
MEDEFIL INC
1MG
2MG
5MG
N 021110
N 021110
N 021110
001 Aug 25, 2000
002 Aug 22, 2002
003 Feb 23, 2004
Sep CAHN
Sep CAHN
Sep CAHN
0.5MG
A 201676
003 Jan 08, 2014
Dec NEWA
18MG/2ML (9MG/ML)
22.5MG/2.5ML (9MG/ML)
27MG/3ML (9MG/ML)
45MG/5ML (9MG/ML)
90MG/10ML (9MG/ML)
N 202832
N 202832
N 202832
N 202832
N 202832
002
003
004
005
006
Mar
Mar
Mar
Mar
Mar
A 201833
001 Sep 24, 2013
Sep NEWA
N 202832
001 Jan 06, 2012
Mar CPOT
N 017864
001
Jan DISC
SODIUM CHLORIDE 0.9%
HIKMA MAPLE
9MG/ML
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
MEDEFIL INC
9MG/ML (9MG/ML)
SOLUTION;IRRIGATION
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
@ BAXTER HLTHCARE
450MG/100ML
>D>
>A> AP
>A> AP
>A> AB
>D> AB
AB
AB
>A> AB
>D> AB
Jan
Jan
Jan
Jan
Jan
06,
06,
06,
06,
06,
2012
2012
2012
2012
2012
NEWA
NEWA
NEWA
NEWA
NEWA
SODIUM FLUORIDE F-18
SODIUM FLUORIDE F-18
+
HOUSTON CYCLOTRON
+
+
MCPRF
UNIV TX MD ANDERSON
10-200mCi/ML
10-200mCi/ML
10-91.5MCI/ML
10-200mCi/ML
A 203544
A 203544
A 203605
A 203247
001
001
001
001
SODIUM IODIDE I-123
CAPSULE;ORAL
SODIUM IODIDE I 123
@ CARDINAL HLTH 414
400uCi
N 018671
003 May 27, 1982
Sep DISC
3GM/TEASPOONFUL
3GM/TEASPOONFUL
3GM/TEASPOONFUL
N 020573
N 020573
N 020573
001 Apr 30, 1996
001 Apr 30, 1996
001 Apr 30, 1996
Dec CAHN
Dec CAHN
Mar CFTG
3GM/TEASPOONFUL
A 202819
001 Mar 22, 2013
Mar NEWA
500MG
500MG
N 020572
N 020572
001 May 13, 1996
001 May 13, 1996
Dec CAHN
Dec CAHN
SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
TABLET;ORAL
VISICOL
@ SALIX PHARMS
0.398GM;1.102GM
N 021097 001 Sep 21, 2000
Jul DISC
SODIUM PHENYLBUTYRATE
POWDER;ORAL
BUPHENYL
+
HYPERION THERAPS INC
+
MEDICIS
+
SODIUM PHENYLBUTYRATE
SIGMAPHARM LABS LLC
TABLET;ORAL
BUPHENYL
+
HYPERION THERAPS INC
+
MEDICIS
Dec
Dec
Jun
Dec
26,
26,
28,
23,
2012
2012
2013
2013
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
TABLET;ORAL
MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE
@ NOVEL LABS INC
0.398GM;1.102GM
A 079247 001 Dec 30, 2011
OSMOPREP
+
SALIX PHARMS
0.398GM;1.102GM
N 021892 001 Mar 16, 2006
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
SODIUM PHOSPHATES IN PLASTIC CONTAINER
+
HOSPIRA
142MG/ML;276MG/ML
N 018892 001 May 10, 1983
Dec
Dec
Jun
Dec
CTEC
CTEC
NEWA
NEWA
Aug DISC
Aug CTEC
Jun CRLD
AA
AA
>A>
>A>
>A>
>A>
SODIUM POLYSTYRENE SULFONATE
POWDER;ORAL, RECTAL
KAYEXALATE
+
COVIS PHARMA SARL
453.6GM/BOT
SUSPENSION;ORAL, RECTAL
SODIUM POLYSTYRENE SULFONATE
ROXANE
15GM/60ML
@
15GM/60ML
AB
AT
AP
1 -86
2013
Apr CAHN
A 089049
A 089049
001 Nov 17, 1986
001 Nov 17, 1986
Oct CMFD
Mar DISC
400MG
N 204671
001 Dec 06, 2013
Dec NEWA
15MG
20MG
30MG
40MG
A 078957
A 078957
A 078957
A 078957
001
002
003
004
Apr
Apr
Apr
Apr
STREPTOZOCIN
ZANOSAR
+
TEVA PHARMS USA
1GM/VIAL
N 050577
001 May 07, 1982
Apr CAHN
SUCCIMER
CAPSULE;ORAL
CHEMET
+
RECORDATI RARE
100MG
N 019998
002 Jan 30, 1991
May CAHN
SUCROFERRIC OXYHYDROXIDE
VELPHORO
+
VIFOR FRESENIUS
500MG
N 205109
001 Nov 27, 2013
Nov NEWA
10%
N 019931
001 Dec 23, 1996
Feb CAHN
10%
A 080029
001
Jun CAHN
A 073303
001 Oct 31, 1991
Mar CAHN
A 070022
001 Feb 15, 1985
Mar DISC
A 070032
001 Feb 15, 1985
Mar DISC
N 018598
004 May 19, 1982
Jun DISC
150MG
200MG
A 073262
A 073262
002 Sep 06, 1991
001 Sep 06, 1991
Apr CMFD
Apr CMFD
BASE/ML)
BASE/ML)
A 202758
001 Apr 23, 2013
Apr NEWA
A 079240
002 Sep 18, 2009
Dec DISC
A 079240
002 Sep 18, 2009
Dec DISC
STAVUDINE
CAPSULE;ORAL
STAVUDINE
HETERO LABS LTD III
SULFACETAMIDE SODIUM
LOTION;TOPICAL
KLARON
+
VALEANT BERMUDA
OINTMENT;OPHTHALMIC
SULFACETAMIDE SODIUM
SULINDAC
TABLET;ORAL
SULINDAC
HERITAGE PHARMS INC
SUMATRIPTAN SUCCINATE
>D> AP
>A>
December
001
SULFAMETHOXAZOLE; TRIMETHOPRIM
SULFAMETHOXAZOLE AND TRIMETHOPRIM
+
TEVA PHARMS USA
80MG/ML;16MG/ML
TABLET;ORAL
SULFAMETHOPRIM
@ NOVEL LABS INC
400MG;80MG
SULFAMETHOPRIM-DS
@ NOVEL LABS INC
800MG;160MG
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
@ SANDOZ
800MG;160MG
AB
AB
-
N 011287
SOFOSBUVIR
TABLET;ORAL
SOLVADI
+
GILEAD SCIENCES INC
AB
AB
AB
AB
12
FRESENIUS KABI USA
@
Dec
Dec
Dec
Dec
29,
29,
29,
29,
2008
2008
2008
2008
CAHN
CAHN
CAHN
CAHN
12
-
December
1 -87
2013
>D> AP
>A>
AP
BASE/ML)
EQ 4MG BASE/0.5ML
EQ 4MG BASE/0.5ML
EQ 6MG BASE/0.5ML
BASE/ML)
EQ 6MG BASE/0.5ML
BASE/ML)
EQ 4MG BASE/0.5ML
EQ 4MG BASE/0.5ML
EQ 6MG BASE/0.5ML
BASE/ML)
EQ 6MG BASE/0.5ML
BASE/ML)
EQ 6MG BASE/0.5ML
BASE/ML)
(EQ 8MG BASE/ML) A 079240
(EQ 12MG
A 200183
001 Sep 18, 2009
001 Sep 18, 2009
001 Sep 16, 2013
Dec DISC
Dec DISC
Aug NEWA
(EQ 12MG
A 090641
001 Jul 28, 2010
Feb CAHN
(EQ 12MG
A 078067
002 Feb 06, 2009
002 Feb 06, 2009
001 Feb 06, 2009
Dec DISC
Dec DISC
Dec DISC
(EQ 12MG
A 078067
001 Feb 06, 2009
Dec DISC
(EQ 12MG
A 077907
001 Feb 06, 2009
Mar CAHN
EQ 6.5MG BASE/4HR
N 202278
001 Jan 17, 2013
Jan NEWA
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
25MG BASE
50MG BASE
100MG BASE
25MG BASE
50MG BASE
100MG BASE
25MG BASE
50MG BASE
100MG BASE
A 078298
A 078298
A 078298
A 077163
A 077163
A 077163
A 076840
A 076840
A 076840
001
002
003
001
002
003
001
002
003
May
May
May
Aug
Aug
Aug
Nov
Nov
Nov
TACROLIMUS
ASTAGRAF XL
ASTELLAS
EQ 0.5MG BASE
EQ 1MG BASE
+
EQ 5MG BASE
OINTMENT;TOPICAL
PROTOPIC
+
ASTELLAS
0.03%
N 204096
N 204096
N 204096
001 Jul 19, 2013
002 Jul 19, 2013
003 Jul 19, 2013
Jul NEWA
Jul NEWA
Jul NEWA
N 050777
001 Dec 08, 2000
Jun CRLD
TAMSULOSIN HYDROCHLORIDE
CAPSULE;ORAL
TAMSULOSIN HYDROCHLORIDE
0.4MG
A 202433
001 Apr 30, 2013
Apr NEWA
>A> BS
>D> BS
TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT
PULMOLITE
JUBILANT DRAXIMAGE
N/A
PHARMALUCENCE
N/A
N 017776
N 017776
001
001
Dec CAHN
Dec CAHN
>A> AP
>D> AP
TECHNETIUM TC-99M PENTETATE KIT
AN-DTPA
JUBILANT DRAXIMAGE
N/A
PHARMALUCENCE
N/A
N 017714
N 017714
001
001
Dec CAHN
Dec CAHN
TECHNETIUM TC-99M TILMANOCEPT
LYMPHOSEEK KIT
+
NAVIDEA BIOPHARMS
N/A
N 202207
001 Mar 13, 2013
Mar NEWA
N 020850
N 020850
N 020850
N 020850
N 020850
N 020850
003
003
001
001
002
002
Dec
Dec
Dec
Dec
Dec
Dec
@
HIKMA FARMACEUTICA
AP
SAGENT AGILA
>D> AP
>A>
>D> AP
@
SANDOZ
>A>
@
AP
AB
AB
AB
TEVA PHARMS USA
SYSTEM;IONTOPHORESIS
ZECUITY
+
NUPATHE
TABLET;ORAL
HIKMA PHARMS
@ MYLAN
@
@
@ TEVA
@
@
AB
>D>
>A> AB
>D>
>A> AB
>D>
>A> AB
TELMISARTAN
TABLET;ORAL
MICARDIS
+
+
20MG
20MG
40MG
40MG
80MG
80MG
May
May
May
Nov
Nov
Nov
Feb
Feb
Feb
Apr
Apr
Nov
Nov
Nov
Nov
21,
21,
21,
02,
02,
02,
09,
09,
09,
04,
04,
10,
10,
10,
10,
2013
2013
2013
2009
2009
2009
2009
2009
2009
2000
2000
1998
1998
1998
1998
NEWA
NEWA
NEWA
DISC
DISC
DISC
DISC
DISC
DISC
CFTG
CFTG
CFTG
CFTG
CFTG
CFTG
RX DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 12
>A>
>A> AB
>A> AB
>A> AB
>A>
>D>
AB
AP
>D> AB
>A>
>D> AB
>A>
TABLET;ORAL
TELMISARTAN
WATSON LABS
A 078710
001 Jan 08, 2014
A 078710
002 Jan 08, 2014
A 078710
003 Jan 08, 2014
Dec NEWA
Dec NEWA
Dec NEWA
TEMSIROLIMUS
TORISEL
+
PF PRISM CV
+
WYETH PHARMS INC
25MG/ML (25MG/ML)
25MG/ML (25MG/ML)
N 022088
001 May 30, 2007
N 022088
001 May 30, 2007
Dec CAHN
Dec CAHN
TENIPOSIDE
VUMON
+
CORDEN PHARMA
+
HQ SPECLT PHARMA
10MG/ML
10MG/ML
N 020119
001 Jul 14, 1992
N 020119
001 Jul 14, 1992
Apr CAHN
Jul CAHN
TERBINAFINE HYDROCHLORIDE
TABLET;ORAL
TERBINAFINE HYDROCHLORIDE
CIPLA LTD
EQ 250MG BASE
@ MYLAN
EQ 250MG BASE
A 077137
001 Jul 02, 2007
A 077136
001 Jul 02, 2007
Jul CAHN
Aug DISC
TERBUTALINE SULFATE
TERBUTALINE SULFATE
@ TEVA PHARMS USA
UNITED BIOMEDCL
1MG/ML
1MG/ML
A 076853
001 Jul 20, 2004
A 200122
001 Nov 08, 2013
Mar CAHN
Oct NEWA
TERCONAZOLE
SUPPOSITORY;VAGINAL
TERCONAZOLE
FOUGERA PHARMS
@
TARO
@
80MG
80MG
80MG
80MG
A 076850
A 076850
A 077553
A 077553
Dec
Dec
Dec
Dec
25MG/2.5GM PACKET
50MG/5GM PACKET
N 203098
002 Jan 31, 2013
N 203098
003 Jan 31, 2013
Jan NEWA
Jan NEWA
12.5MG/1.25GM ACTUATION
N 203098
001 Jan 31, 2013
Jan NEWA
100MG/ML
200MG/ML
A 201720
001 Jun 03, 2013
A 201720
002 Jun 03, 2013
May NEWA
May NEWA
200MG/ML
200MG/ML
N 009165
001
N 009165
003
Jan CAHN
Jan CAHN
250MG
250MG
500MG
500MG
N 050278
N 050278
N 050278
N 050278
Dec
Dec
Dec
Dec
GEL, METERED;TRANSDERMAL
TESTOSTERONE
PERRIGO ISRAEL
AO
>D>
>A> AB
>D>
>A> AB
1 -88
December 2013
20MG
40MG
80MG
TESTOSTERONE
GEL;TRANSDERMAL
TESTOSTERONE
PERRIGO ISRAEL
AO
AO
-
TESTOSTERONE CYPIONATE
TESTOSTERONE CYPIONATE
SUN PHARM INDS LTD
TESTOSTERONE ENANTHATE
DELATESTRYL
@ ENDO PHARMS
+
TETRACYCLINE HYDROCHLORIDE
CAPSULE;ORAL
ACHROMYCIN V
@ HERITAGE PHARMS INC
@
001
001
001
001
003
003
001
001
Jul
Jul
Mar
Mar
12,
12,
09,
09,
2006
2006
2007
2007
DISC
DISC
DISC
DISC
CMFD
CMFD
CMFD
CMFD
THALLOUS CHLORIDE TL-201
THALLOUS CHLORIDE TL 201
@ MALLINCKRODT
2mCi/ML
>A> AB
AB
>D>
>A> AB
>D>
BT
AB
AB
-
December
2013
1 -89
A 077698
001 Nov 09, 2006
Aug DISC
THEOPHYLLINE
THEOPHYLLINE
RHODES PHARMS
600MG
+
TEVA PHARMS
450MG
UNIPHYL
@ RHODES PHARMS
400MG
400MG
@
600MG
A 040086
A 081236
001 Apr 15, 1996
001 Nov 09, 1992
Dec CMFD
Mar CAHN
A 087571
A 087571
A 040086
001 Sep 01, 1982
001 Sep 01, 1982
001 Apr 15, 1996
Dec CMFD
Dec CMFD
Dec CMFD
THIABENDAZOLE
SUSPENSION;ORAL
MINTEZOL
@ MERCK SHARP DOHME
MINTEZOL
@ MERCK SHARP DOHME
500MG/5ML
N 016097
001
May CAHN
500MG
N 016096
001
May CAHN
40MG
N 012429
001
Mar CAHN
TICLOPIDINE HYDROCHLORIDE
TABLET;ORAL
TICLOPIDINE HYDROCHLORIDE
@ MYLAN
250MG
A 075161
001 Sep 13, 1999
Aug DISC
TIGECYCLINE
TYGACIL
+
PF PRISM CV
50MG/VIAL
N 021821
001 Jun 15, 2005
Aug CAHN
TILUDRONATE DISODIUM
TABLET;ORAL
SKELID
@ SANOFI AVENTIS US
EQ 200MG BASE
N 020707
001 Mar 07, 1997
Jun DISC
N 020330
N 020330
001 Nov 04, 1993
002 Nov 04, 1993
Jan CAHN
Jan CAHN
N 021516
001 Jun 04, 2004
May CAHN
A 074515
A 075411
A 075412
001 Mar 25, 1997
001 Sep 08, 2000
001 Sep 08, 2000
Jun DISC
Apr DISC
Apr DISC
250MG
500MG
A 202489
A 202489
001 Oct 09, 2013
002 Oct 09, 2013
Sep NEWA
Sep NEWA
100MG
N 019569
001 Aug 11, 1988
Aug CTNA
THIOGUANINE
TABLET;ORAL
THIOGUANINE
+
ASPEN GLOBAL INC
AB
AB
12
TIMOLOL MALEATE
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC
TIMOPTIC-XE
+
VALEANT PHARMS LLC
EQ 0.25% BASE
+
EQ 0.5% BASE
ISTALOL
+
BAUSCH AND LOMB
EQ 0.5% BASE
TIMOLOL MALEATE
@ AKORN
EQ 0.25% BASE
@ APOTEX INC
EQ 0.25% BASE
@
EQ 0.5% BASE
TINIDAZOLE
TABLET;ORAL
TINIDAZOLE
UNIQUE PHARM LABS
TIOPRONIN
TABLET;ORAL
THIOLA
+
MISSION PHARMA
AB
AB
AB
AN
AN
AP
AP
AB
AB
AB
AB
>D> AB
>A>
>D> AB
>A>
AB
AB
TIZANIDINE HYDROCHLORIDE
CAPSULE;ORAL
MYLAN PHARMS INC
EQ
EQ
EQ
TABLET;ORAL
@ MYLAN PHARMS INC
EQ
@
EQ
12
-
December
1 -90
2013
2MG BASE
4MG BASE
6MG BASE
A 091502
A 091502
A 091502
001 Nov 09, 2012
002 Nov 09, 2012
003 Nov 09, 2012
May CAHN
May CAHN
May CAHN
2MG BASE
4MG BASE
A 076282
A 076282
001 Dec 16, 2003
002 Dec 16, 2003
Feb DISC
Feb DISC
28MG
N 201688
001 Mar 22, 2013
Mar NEWA
300MG/5ML
N 050753
001 Dec 22, 1997
Sep CFTG
300MG/5ML
A 091589
001 Oct 10, 2013
Sep NEWA
0.3%
A 065087
001 Feb 25, 2002
Apr DISC
TOBRAMYCIN SULFATE
TOBRAMYCIN SULFATE
AGILA SPECLTS
TEVA PHARMS USA
EQ 40MG BASE/ML
EQ 40MG BASE/ML
A 065407
A 063100
001 Mar 11, 2008
001 Jan 30, 1992
Nov CAHN
Sep CAHN
TOFACITINIB CITRATE
TABLET;ORAL
XELJANZ
+
PF PRISM CV
EQ 5MG BASE
N 203214
001 Nov 06, 2012
Sep CAHN
TOLAZAMIDE
TABLET;ORAL
TOLAZAMIDE
MYLAN PHARMS INC
+
@ WATSON LABS
@
250MG
500MG
250MG
500MG
A 070259
A 070259
A 070514
A 070515
001
003
001
001
Mar
Mar
Mar
Mar
N 021228
N 021228
001 Dec 22, 2000
002 Dec 22, 2000
Oct CFTG
Oct CFTG
A 201486
A 201486
001 Oct 31, 2013
002 Oct 31, 2013
Oct NEWA
Oct NEWA
A 079206
A 079206
A 079206
A 079206
001
001
002
002
Oct
Oct
Oct
Oct
14,
14,
14,
14,
2009
2009
2009
2009
Dec
Dec
Dec
Dec
DISC
DISC
DISC
DISC
N 201635
N 201635
N 201635
N 201635
001
002
003
004
Aug
Aug
Aug
Aug
16,
16,
16,
16,
2013
2013
2013
2013
Aug
Aug
Aug
Aug
NEWA
NEWA
NEWA
NEWA
N 020505
N 020505
004 Dec 24, 1996
001 Dec 24, 1996
TOBRAMYCIN
POWDER;INHALATION
TOBI PODHALER
+
NOVARTIS
SOLUTION;INHALATION
TOBI
+
NOVARTIS PHARMS
TOBRAMYCIN
TEVA PHARMS USA
TOBRAMYCIN
@ APOTEX INC
TOLTERODINE TARTRATE
DETROL LA
PHARMACIA AND UPJOHN 2MG
+
4MG
TOLTERODINE TARTRATE
MYLAN PHARMS INC
2MG
4MG
TOPIRAMATE
CAPSULE;ORAL
TOPIRAMATE
SANDOZ
@
15MG
15MG
25MG
@
25MG
TROKENDI XR
SUPERNUS PHARMS
25MG
50MG
100MG
+
200MG
TABLET;ORAL
TOPAMAX
JANSSEN PHARMS
25MG
+
100MG
Jan
Mar
Jan
Jan
02,
17,
09,
09,
1986
1986
1986
1986
CTEC
CTEC
DISC
DISC
Apr CRLD
Apr CRLD
AB
AB
AB
AB
AB
AB
AB
AB
AB
>D>
>A> AB
>D>
>A> AB
>D>
>A> AB
>D>
>A> AB
AB
AB
AB
AB
AP
AP
TABLET;ORAL
TOPIRAMATE
ACTIVIS TOTOWA LLC
LUPIN
UNICHEM LABS LTD
@ UPSHER SMITH
@
@
@
@
@
@
@
TOPIRAMATE
HIKMA PHARMS
TOPOTECAN HYDROCHLORIDE
CAPSULE;ORAL
HYCAMTIN
GLAXO WELLCOME
+
TOPOTECAN HYDROCHLORIDE
ACCORD HLTHCARE
SUN PHARM INDS LTD
TOREMIFENE CITRATE
TABLET;ORAL
FARESTON
+
PROSTRAKAN INC
AB
AB
AB
AB
AB
AB
AB2
AB2
AB2
AB1
AB2
TORSEMIDE
TABLET;ORAL
TORSEMIDE
HETERO LABS LTD III
12
-
December
1 -91
2013
25MG
50MG
100MG
200MG
25MG
50MG
100MG
200MG
200MG
25MG
25MG
25MG
50MG
50MG
50MG
100MG
100MG
100MG
200MG
200MG
200MG
A 078637
A 078637
A 078637
A 078637
A 078410
A 078410
A 078410
A 078410
A 090162
A 078499
A 078499
A 078499
A 078499
A 078499
A 078499
A 078499
A 078499
A 078499
A 078499
A 078499
A 078499
001
002
003
004
001
002
003
004
004
001
001
001
002
002
002
003
003
003
004
004
004
Feb
Feb
Feb
Feb
Sep
Sep
Sep
Sep
Feb
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
Jan
27,
27,
27,
27,
11,
11,
11,
11,
19,
07,
07,
07,
07,
07,
07,
07,
07,
07,
07,
07,
07,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
Feb
Feb
Feb
Feb
Aug
Aug
Aug
Aug
Feb
Dec
Dec
Jun
Dec
Dec
Jun
Dec
Dec
Jun
Dec
Dec
Jun
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
CMFD
CMFD
DISC
CMFD
CMFD
DISC
CMFD
CMFD
DISC
CMFD
CMFD
DISC
25MG
50MG
100MG
200MG
A 091185
A 091185
A 091185
A 091185
001
002
003
004
Nov
Nov
Nov
Nov
25,
25,
25,
25,
2013
2013
2013
2013
Nov
Nov
Nov
Nov
NEWA
NEWA
NEWA
NEWA
EQ 0.25MG BASE
EQ 1MG BASE
N 020981
N 020981
001 Oct 11, 2007
002 Oct 11, 2007
Sep CAHN
Sep CAHN
EQ 4MG BASE/VIAL
EQ 4MG BASE/VIAL
A 202351
A 202203
001 Jun 26, 2013
001 Aug 29, 2013
Jun NEWA
Aug NEWA
EQ 60MG BASE
N 020497
001 May 29, 1997
May CAHN
5MG
10MG
20MG
100MG
A 079234
A 079234
A 079234
A 079234
001
002
003
004
Apr
Apr
Apr
Apr
A 202390
A 091498
001 May 16, 2013
001 Mar 29, 2013
Apr NEWA
Mar NEWA
A 091609
A 091609
A 091609
A 078783
A 091607
001
002
003
001
001
Apr
Apr
Apr
Feb
Feb
N 021693
001 May 05, 2005
TRAMADOL HYDROCHLORIDE
TABLET;ORAL
ACCORD HLTHCARE INC
50MG
CSPC OUYI PHARM CO
50MG
ACTAVIS ELIZABETH
100MG
200MG
300MG
PAR PHARM INC
100MG
+
SUN PHARMA GLOBAL
100MG
RYBIX ODT
@ SHIONOGI INC
50MG
Jan
Jan
Jan
Jan
Jun
Jun
Jun
Nov
Dec
27,
27,
27,
27,
27,
27,
27,
13,
30,
2009
2009
2009
2009
2012
2012
2012
2009
2011
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
CRLD
CRLD
Aug DISC
AP
AP
>A>
>A>
>A>
>A>
>A>
>A>
-
December
1 -92
2013
TRAMETINIB DIMETHYL SULFOXIDE
TABLET;ORAL
MEKINIST
GLAXOSMITHKLINE LLC
EQ 0.5MG NON-SOLVATED PARENT
EQ 1MG NON-SOLVATED PARENT
+
EQ 2MG NON-SOLVATED PARENT
N 204114
N 204114
N 204114
001 May 29, 2013
002 May 29, 2013
003 May 29, 2013
May NEWA
May NEWA
May NEWA
TRANDOLAPRIL
TABLET;ORAL
TRANDOLAPRIL
@ CIPLA
@
@
@
@
1MG
2MG
4MG
1MG
2MG
4MG
A 077307
A 077307
A 077307
A 078493
A 078493
A 078493
002
001
003
001
002
003
Jul
Jul
Jul
Apr
Apr
Apr
TRANEXAMIC ACID
TRANEXAMIC ACID
CUSTOPHARM INC
X-GEN PHARMS INC
100MG/ML
100MG/ML
A 201580
A 201580
001 Jun 14, 2013
001 Jun 14, 2013
Jun NEWA
Oct CAHN
A 091340
001 Mar 01, 2013
Feb NEWA
A 071523
A 071524
A 202180
A 202180
A 202180
A 202180
001
001
001
002
003
004
Dec
Dec
Nov
Nov
Nov
Nov
11,
11,
27,
27,
27,
27,
1987
1987
2013
2013
2013
2013
Mar
Mar
Nov
Nov
Nov
Nov
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
N 022411
N 022411
N 022411
N 022411
001
002
001
002
Feb
Feb
Feb
Feb
02,
02,
02,
02,
2010
2010
2010
2010
May
May
Jun
Jun
DISC
DISC
CMFD
CMFD
N 021272
N 021272
N 021272
N 021272
001
002
003
004
May
May
May
May
21,
21,
21,
21,
2002
2002
2002
2002
May
May
May
Jun
CAIN
CAIN
CAIN
CAIN
N 022387
001 Jul 30, 2009
May CAIN
N 203496
N 203496
N 203496
N 203496
001
002
003
004
Dec
Dec
Dec
Dec
0.025%
0.05%
0.1%
N 019049
N 017522
N 017340
001 Sep 16, 1988
001
001
Jun CAHN
Jun CAHN
Jun CAHN
0.05%
N 022070
001 Jul 26, 2007
Apr CAHN
TRAVOPROST
TRAVOPROST
PAR PHARM
0.004%
AB
AB
AB
AB
AB
AB
12
TRAZODONE HYDROCHLORIDE
TABLET;ORAL
TRAZODONE HYDROCHLORIDE
TEVA PHARMS USA
50MG
100MG
TORRENT PHARMS LTD
50MG
100MG
150MG
300MG
OLEPTRO
@ ANGELINI LLC
150MG
@
300MG
+
ANGELINI PHARMA
150MG
300MG
TREPROSTINIL
INJECTABLE;IV (INFUSION)-SC
REMODULIN
UNITED THERAP
1MG/ML
2.5MG/ML
5MG/ML
+
10MG/ML
SOLUTION;INHALATION
TYVASO
+
UNITED THERAP
EQ 0.6MG BASE/ML
ORENITRAM
UNITED THERAP
0.125MG
0.25MG
1MG
+
2.5MG
TRETINOIN
CREAM;TOPICAL
RETIN-A
AB
+
VALEANT BERMUDA
AB1
+
AB
+
GEL;TOPICAL
ATRALIN
+
DOW PHARM
Jun
Jun
Jun
Aug
Aug
Aug
Dec
Dec
Dec
Dec
12,
12,
12,
25,
25,
25,
20,
20,
20,
20,
2007
2007
2007
2008
2008
2008
2013
2013
2013
2013
DISC
DISC
DISC
DISC
DISC
DISC
NEWA
NEWA
NEWA
NEWA
AB
AB
AB
AB
AT
AT
AT
AT
AT
AB
AB
>A>
>A>
>A>
>A>
GEL;TOPICAL
RETIN-A MICRO
+
VALEANT INTL
+
TRETINOIN
SPEAR PHARMS INC
12
December
1 -93
2013
0.04%
0.1%
N 020475
N 020475
002 May 10, 2002
001 Feb 07, 1997
Jul CTEC
Jul CTEC
0.04%
0.1%
A 202567
A 202026
001 Jul 17, 2013
001 Jul 17, 2013
Jul NEWA
Jul NEWA
A 084908
A 084908
001
003
Apr DISC
Apr DISC
A 085692
A 085692
A 089797
A 086277
A 086276
A 086275
001
003
001 May 31, 1991
001
001
001
Apr
Apr
May
Apr
Apr
Apr
N 022220
001 Jun 16, 2008
May DISC
A 202374
A 202374
A 088450
001 May 08, 2013
002 May 08, 2013
001 Apr 01, 1985
Apr NEWA
Apr NEWA
Apr CAHN
N 011600
N 011600
003
001
Apr DISC
Apr DISC
A 040040
A 040374
A 087902
A 040386
001
001
001
001
A 078104
001 Jul 30, 2009
Oct CTEC
TRIHEXYPHENIDYL HYDROCHLORIDE
TABLET;ORAL
TRIHEXYPHENIDYL HYDROCHLORIDE
@ WEST WARD
2MG
@
5MG
A 040337
A 040337
002 Feb 16, 2000
001 Feb 16, 2000
Jul DISC
Jul DISC
TRIMETHOPRIM
TABLET;ORAL
TRIMETHOPRIM
+
TEVA
@
N 018679
A 071259
001 Jul 30, 1982
001 Jun 18, 1987
Jul CRLD
Jun DISC
A 201291
001 May 24, 2013
May NEWA
N 203975
001 Dec 18, 2013
Dec NEWA
A 202540
A 202540
A 079184
A 079184
001
002
001
002
Feb
Feb
Apr
Apr
TRIAMCINOLONE ACETONIDE
CREAM;TOPICAL
TRIACET
@ TEVA
0.025%
@
0.5%
+
FOUGERA PHARMS
0.025%
+
0.1%
@ G AND W LABS
0.025%
@ TARO
0.025%
@
0.1%
@
0.5%
INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
TRIVARIS
@ ALLERGAN
8MG/0.1ML (8MG/0.1ML)
LOTION;TOPICAL
VERSAPHARM INC
0.025%
0.1%
+
0.025%
OINTMENT;TOPICAL
KENALOG
@ APOTHECON
0.025%
@
0.1%
@ TARO
0.025%
@
0.025%
@
0.1%
@
0.5%
TEVA PHARMS
0.055MG/SPRAY
100MG
200MG
TROSPIUM CHLORIDE
TROSPIUM CHLORIDE
PADDOCK LLC
60MG
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
POWDER;INHALATION
ANORO ELLIPTA
+
GLAXO GRP LTD
EQ 0.0625MG BASE/INH;EQ 0.025MG
BASE/INH
AB
AB
-
URSODIOL
TABLET;ORAL
URSODIOL
PAR PHARM
@ TEVA PHARMS USA
@
250MG
500MG
250MG
500MG
Sep
Jun
Dec
Jun
Feb
Feb
May
May
30,
05,
27,
05,
14,
14,
13,
13,
1994
2001
1982
2001
2013
2013
2009
2009
May
May
May
May
CRLD
CRLD
DISC
DISC
DISC
DISC
DISC
DISC
DISC
DISC
NEWA
NEWA
DISC
DISC
AB
AB
AB
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
VALACYCLOVIR HYDROCHLORIDE
TABLET;ORAL
VALACYCLOVIR HYDROCHLORIDE
ACTAVIS GRP PTC
EQ 1GM BASE
EQ 500MG BASE
VALPROIC ACID
CAPSULE;ORAL
VALPROIC ACID
SUN PHARM INDS LTD
250MG
STAVZOR
@ BANNER PHARMACAPS
125MG
@
250MG
@
500MG
VANCOMYCIN HYDROCHLORIDE
VANCOMYCIN HYDROCHLORIDE
AGILA SPECLTS
EQ
EQ
EQ
EQ
EMCURE PHARMS LTD
EQ
EQ
EQ
EQ
VECURONIUM BROMIDE
VECURONIUM BROMIDE
AGILA SPECLTS
TEVA PHARMS USA
1GM BASE/VIAL
5GM BASE/VIAL
10GM BASE/VIAL
500MG BASE/VIAL
1GM BASE/VIAL
10GM BASE/VIAL
5GM BASE/VIAL
500MG BASE/VIAL
10MG/VIAL
20MG/VIAL
10MG/VIAL
20MG/VIAL
VENLAFAXINE HYDROCHLORIDE
VENLAFAXINE HYDROCHLORIDE
VALEANT BERMUDA
EQ 37.5MG BASE
EQ 75MG BASE
EQ 150MG BASE
VERAPAMIL HYDROCHLORIDE
VERELAN PM
ALKERMES GAINESVILLE 100MG
200MG
+
300MG
@ INTL MEDICATION
2.5MG/ML
TABLET;ORAL
HERITAGE PHARMS INC
80MG
120MG
CARACO
120MG
180MG
240MG
VERTEPORFIN
VISUDYNE
+
VALEANT PHARMS INC
15MG/VIAL
12
-
December
1 -94
2013
A 090370
A 090370
002 Mar 16, 2011
001 Mar 16, 2011
Mar CAHN
Mar CAHN
A 091037
001 Feb 22, 2013
Feb NEWA
N 022152
N 022152
N 022152
001 Jul 29, 2008
002 Jul 29, 2008
003 Jul 29, 2008
Jun DISC
Jun DISC
Jun DISC
A 065397
A 065432
A 091469
A 065397
A 202275
A 202464
A 202274
A 202275
002
001
001
001
002
001
001
001
Dec
Dec
Jul
Dec
Oct
Oct
Oct
Oct
30,
30,
01,
30,
31,
09,
31,
31,
2008
2008
2011
2008
2013
2013
2013
2013
Sep
Sep
Sep
Sep
Oct
Sep
Oct
Oct
CAHN
CAHN
CAHN
CAHN
NEWA
NEWA
NEWA
NEWA
A 090243
A 090243
A 074688
A 074688
001
002
001
002
May
May
Aug
Aug
11,
11,
25,
25,
2010
2010
1999
1999
Nov
Nov
Apr
Apr
CAHN
CAHN
CAHN
CAHN
A 090071
A 090071
A 090071
001 Apr 15, 2011
002 Apr 15, 2011
003 Apr 15, 2011
Jul CAHN
Jul CAHN
Jul CAHN
N 020943
N 020943
N 020943
001 Nov 25, 1998
002 Nov 25, 1998
003 Nov 25, 1998
Sep CAHN
Sep CAHN
Sep CAHN
A 070451
001 Dec 16, 1985
Mar DISC
A 071880
A 071881
001 Apr 05, 1988
001 Apr 05, 1988
Aug CMFD
Aug CMFD
A 090529
A 090529
A 090529
001 Dec 30, 2011
002 Dec 30, 2011
003 Dec 30, 2011
May CAHN
May CAHN
May CAHN
N 021119
001 Apr 12, 2000
Jan CAHN
12
-
December
1 -95
2013
AP
VINCRISTINE SULFATE
VINCRISTINE SULFATE PFS
TEVA PHARMS USA
1MG/ML
A 075493
001 Sep 01, 1999
Apr CAHN
AP
AP
VINORELBINE TARTRATE
VINORELBINE TARTRATE
DR REDDYS LABS LTD
TEVA PHARMS USA
EQ 10MG BASE/ML
EQ 10MG BASE/ML
A 202017
A 076028
001 Sep 12, 2013
001 Feb 03, 2003
Aug NEWA
Apr CAHN
200MG/5ML
N 021630
001 Dec 19, 2003
May CFTG
200MG/5ML
A 202361
001 May 28, 2013
May NEWA
EQ
EQ
EQ
EQ
N 204447
N 204447
N 204447
N 204447
001
002
003
004
Sep
Sep
Sep
Sep
30,
30,
30,
30,
2013
2013
2013
2013
Sep
Sep
Sep
Sep
NEWA
NEWA
NEWA
NEWA
1MG
2MG
2.5MG
3MG
4MG
5MG
6MG
7.5MG
10MG
1MG
2MG
2.5MG
3MG
4MG
5MG
6MG
7.5MG
10MG
A 202202
A 202202
A 202202
A 202202
A 202202
A 202202
A 202202
A 202202
A 202202
A 200104
A 200104
A 200104
A 200104
A 200104
A 200104
A 200104
A 200104
A 200104
001
002
003
004
005
006
007
008
009
001
002
003
004
005
006
007
008
009
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Mar
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
04,
04,
04,
04,
04,
04,
04,
04,
04,
27,
27,
27,
27,
27,
27,
27,
27,
27,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Feb
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
Jun
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
5MG
10MG
N 020859
N 020859
001 Aug 13, 1999
002 Aug 13, 1999
Apr CAHN
Apr CAHN
10MG/ML
A 204538
001 Nov 26, 2013
Nov NEWA
300MG
300MG
300MG
300MG
A 202058
A 202058
A 090092
A 202058
001
001
001
001
Feb
Jan
Apr
Oct
A 202395
A 202395
A 202395
001 Oct 10, 2013
002 Oct 10, 2013
003 Oct 10, 2013
AB
AB
VORICONAZOLE
FOR SUSPENSION;ORAL
VFEND
+
PFIZER
VORICONAZOLE
MYLAN PHARMS INC
VORTIOXETINE HYDROBROMIDE
TABLET;ORAL
BRINTELLIX
TAKEDA PHARMS USA
+
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
WARFARIN SODIUM
TABLET;ORAL
WARFARIN SODIUM
AMNEAL PHARMS
IPCA LABS LTD
ZALEPLON
CAPSULE;ORAL
SONATA
PFIZER
+
5MG BASE
10MG BASE
15MG BASE
20MG BASE
AB
AB
ZIDOVUDINE
ZIDOVUDINE
LIAONING CHENGDA
TABLET;ORAL
ZIDOVUDINE
HEC PHARM USA INC
@
+
HETERO LABS LTD III
SUNSHINE LAKE
AB
AB
AB
ZIPRASIDONE HYDROCHLORIDE
CAPSULE;ORAL
MYLAN PHARMS INC
EQ 20MG BASE
EQ 40MG BASE
EQ 60MG BASE
AP
AB
Oct
Oct
Apr
Oct
07,
07,
25,
07,
2011
2011
2008
2011
CMFD
DISC
CRLD
CAHN
Sep NEWA
Sep NEWA
Sep NEWA
AB
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
AP
CAPSULE;ORAL
EQ 80MG BASE
ZOLEDRONIC ACID
ZOLEDRONIC ACID
DR REDDYS LABS LTD
EMCURE PHARMS LTD
RECLAST
+
NOVARTIS
ZOLEDRONIC ACID
ACS DOBFAR INFO SA
ACTAVIS INC
AGILA SPECLTS
DR REDDYS LABS LTD
EMCURE PHARMS LTD
GLAND PHARMA LTD
HIKMA FARMACEUTICA
HOSPIRA INC
PHARMACEUTICS
+
PHARMS
SUN PHARMA GLOBAL
AP
AP
AP
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
AB
+
+
ZOMETA
NOVARTIS
ZOLMITRIPTAN
SPRAY;NASAL
ZOMIG
ASTRAZENECA
TABLET;ORAL
ZOLMITRIPTAN
APOTEX INC
GLENMARK GENERICS
MYLAN PHARMS INC
12
-
December
1 -96
2013
A 202395
004 Oct 10, 2013
Sep NEWA
EQ 5MG BASE/100ML
EQ 5MG BASE/100ML
A 091363
A 201801
001 Mar 29, 2013
001 Mar 29, 2013
Mar NEWA
Mar NEWA
EQ 5MG BASE/100ML
N 021817
001 Apr 16, 2007
Mar CTEC
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
EQ
BASE/100ML
BASE/100ML
BASE/5ML
BASE/5ML
BASE/5ML
BASE/100ML
BASE/5ML
BASE/100ML
BASE/5ML
BASE/5ML
BASE/100ML
BASE/5ML
BASE/100ML
BASE/5ML
BASE/VIAL
BASE/5ML
N 203231
A 202828
A 202472
A 202650
A 091186
A 091363
A 201783
A 201801
A 202930
A 202182
A 202837
A 091170
A 202163
A 202571
A 090018
A 202746
001
001
001
001
001
001
001
001
001
001
001
001
001
001
001
001
Aug
Sep
Feb
Feb
Feb
Jul
Mar
Jul
Jul
May
Mar
Feb
Jul
Apr
Feb
Feb
EQ 4MG BASE/5ML
EQ 4MG BASE/100ML
N 021223
N 021223
002 Mar 07, 2003
003 Jun 17, 2011
Feb CFTG
Aug CTEC
2.5MG/SPRAY
N 021450
003 Sep 16, 2013
Sep NEWA
2.5MG
5MG
2.5MG
5MG
2.5MG
5MG
A 202078
A 202078
A 201779
A 201779
A 203186
A 203186
001
002
001
002
001
002
Apr
Apr
Apr
Apr
Apr
Apr
N 020768
N 020768
001 Nov 25, 1997
002 Nov 25, 1997
Apr CFTG
Apr CFTG
A 202476
A 202476
A 202560
A 202560
A 202890
A 202890
001
002
001
002
001
002
Apr
Apr
Apr
Apr
Apr
Apr
N 021231
N 021231
001 Feb 13, 2001
002 Sep 17, 2001
Apr CFTG
Apr CFTG
A 077985
A 077985
001 Apr 23, 2007
002 Apr 23, 2007
Apr DISC
Apr DISC
A 078179
A 078179
A 200266
A 200266
A 078970
002
001
001
002
001
Apr
Apr
Aug
Aug
Aug
4MG
5MG
4MG
4MG
4MG
5MG
4MG
5MG
4MG
4MG
5MG
4MG
5MG
4MG
4MG
4MG
ZOMIG
IPR
2.5MG
+
5MG
ZOLMITRIPTAN
APOTEX INC
2.5MG
5MG
GLENMARK GENERICS
2.5MG
5MG
ZYDUS PHARMS USA INC 2.5MG
5MG
ZOMIG-ZMT
ASTRAZENECA
2.5MG
+
5MG
ZOLPIDEM TARTRATE
TABLET;ORAL
ZOLPIDEM TARTRATE
5MG
@
10MG
ZOLPIDEM TARTRATE
ACTAVIS ELIZABETH
6.25MG
12.5MG
APOTEX INC
6.25MG
12.5MG
LUPIN LTD
6.25MG
Aug
Sep
Mar
Mar
Mar
Mar
Mar
Mar
Aug
Jun
Apr
Mar
Aug
May
Mar
Mar
May
May
May
May
May
May
May
May
May
May
May
May
Oct
Jun
Sep
Sep
Sep
02,
23,
04,
04,
04,
29,
12,
29,
05,
03,
05,
04,
05,
07,
04,
04,
14,
14,
14,
14,
14,
14,
14,
14,
14,
14,
15,
15,
13,
06,
10,
10,
11,
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2010
2011
2013
2013
2013
NEWA
NEWA
NEWA
NEWA
NEWA
CDFR
NEWA
CDFR
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
NEWA
CAHN
CAHN
NEWA
NEWA
NEWA
AB
AB
AB
ZOLPIDEM TARTRATE
12.5MG
WATSON LABS INC FL
6.25MG
12.5MG
ZONISAMIDE
CAPSULE;ORAL
ZONISAMIDE
@ COREPHARMA
@
@
@
@
25MG
50MG
100MG
25MG
50MG
100MG
12
-
December
1 -97
2013
A 078970
A 090153
A 090153
002 Sep 11, 2013
001 Mar 25, 2013
002 Mar 25, 2013
Aug NEWA
Mar NEWA
Mar NEWA
A 077876
A 077876
A 077876
A 077645
A 077645
A 077645
001
002
003
002
003
001
Feb
Feb
Feb
Mar
Mar
Mar
Feb
Feb
Feb
Sep
Sep
Dec
21,
21,
21,
29,
29,
22,
2007
2007
2007
2006
2006
2005
DISC
DISC
DISC
DISC
DISC
DISC
OTC DRUG PRODUCT LIST
-
33RD
OTC DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT
>D>
>D>
>D>
>A>
>A>
>A>
>D>
>A>
ACETAMINOPHEN
SUPPOSITORY;RECTAL
ACETAMINOPHEN
+
TARO PHARMS NORTH
+
120MG
325MG
650MG
120MG
325MG
650MG
INFANTS' FEVERALL
80MG
TARO PHARMS NORTH
80MG
TYLENOL
+
MCNEIL CONS
650MG
+
650MG
ASPIRIN
CAPSULE;ORAL
ASPIRIN
+
PLX PHARMA
325MG
SYRUP;ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
@ APOTEX INC
5MG/5ML
BIO PHARM INC
5MG/5ML
CARACO
5MG/5ML
PERRIGO R AND D
5MG/5ML
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
@ APOTEX INC
5MG/5ML
BIO PHARM INC
5MG/5ML
CARACO
5MG/5ML
TABLET;ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
CIPLA LTD
5MG
10MG
CONTRACT PHARMACAL
5MG
10MG
CETIRIZINE HYDROCHLORIDE ALLERGY
+
SANDOZ
10MG
CHILDREN'S ZYRTEC ALLERGY
@ MCNEIL CONS
5MG
+
5MG
@
10MG
CHILDREN'S ZYRTEC HIVES RELIEF
@ MCNEIL CONS
5MG
+
5MG
@
10MG
SOLUTION;TOPICAL
DYNA-HEX
BAJAJ MEDICAL LLC
0.75%
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
SWAB;TOPICAL
PREVANTICS MAXI SWABSTICK
+
PROF DSPLS
3.15%;70% (5.1ML)
PREVANTICS SWAB
+
PROF DSPLS
3.15%;70% (1ML)
PREVANTICS SWABSTICK
+
PROF DSPLS
3.15%;70% (1.6ML)
12
EDITION
-
December
2 -1
2013
N 018337
N 018337
N 018337
N 018337
N 018337
N 018337
003 Sep 12, 1983
002
001
003 Sep 12, 1983
002
001
Dec
Dec
Dec
Dec
Dec
Dec
N 018337
N 018337
004 Aug 26, 1992
004 Aug 26, 1992
Dec CAHN
Dec CAHN
N 019872
N 019872
001 Jun 08, 1994
002 Jan 11, 2001
Jul CTNA
Jul CTNA
N 203697
001 Jan 14, 2013
Jan NEWA
A 090188
A 090474
A 091327
A 204226
002
002
001
001
Apr
May
May
Aug
A 090188
A 090474
A 091327
001 Apr 22, 2008
001 Mar 30, 2009
002 Oct 17, 2011
Apr DISC
May CAHN
May CAHN
A 077318
A 077318
A 076047
A 076047
001
002
001
002
Jul
Jul
Oct
Oct
A 078692
002 Feb 14, 2008
Apr CRLD
N 021621
N 021621
N 021621
003 Nov 16, 2007
003 Nov 16, 2007
004 Nov 16, 2007
Apr DISC
Feb CRLD
Feb DISC
N 021621
N 021621
N 021621
005 Nov 16, 2007
005 Nov 16, 2007
006 Nov 16, 2007
Apr DISC
Feb CRLD
Feb DISC
N 020111
001 Sep 11, 1997
Apr CAHN
N 021524
003 Jun 03, 2005
Mar CTNA
N 021524
001 Jun 03, 2005
Mar CTNA
N 021524
002 Jun 03, 2005
Mar CTNA
Apr
Mar
Oct
Sep
Jul
Jul
Dec
Dec
22,
30,
17,
09,
25,
25,
27,
27,
2008
2009
2011
2013
2013
2013
2007
2007
CAHN
CAHN
CAHN
CAHN
CAHN
CAHN
DISC
CAHN
CAHN
NEWA
NEWA
NEWA
CAHN
CAHN
CIMETIDINE
TABLET;ORAL
TAGAMET HB
@ MEDTECH PRODS
+
12 -
100MG
200MG
December 2013
2 -2
N 020238
001 Jun 19, 1995
N 020238
002 Aug 21, 1996
Aug CAHN
Aug CAHN
N 018230
002 Dec 26, 1991
Sep CAHN
N 020389
002 Jun 23, 1994
Sep CAHN
N 018182
002 Dec 26, 1991
Sep CAHN
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE
AVANTHI INC
6MG;120MG
A 078648
001 Feb 27, 2013
Feb NEWA
FAMOTIDINE
TABLET;ORAL
PEPCID AC
MCNEIL CONS
N 020902
001 Aug 05, 1999
Jul CTNA
A 202978
001 Jan 18, 2013
Jan NEWA
A 202978
002 Jan 18, 2013
Jan NEWA
KETOTIFEN FUMARATE
KETOTIFEN FUMARATE
@ APOTEX INC
EQ 0.025% BASE
A 077354
001 May 09, 2006
Apr DISC
LEVONORGESTREL
TABLET;ORAL
LEVONORGESTREL
LUPIN LTD
NOVEL LABS INC
0.75MG
1.5MG
A 091328
001 Jan 23, 2013
A 202508
001 Feb 22, 2013
Jan NEWA
Feb NEWA
LORATADINE
SYRUP;ORAL
LORATADINE
@ APOTEX INC
1MG/ML
A 075565
001 Oct 05, 2004
Apr DISC
LORATADINE; PSEUDOEPHEDRINE SULFATE
LORATADINE AND PSEUDOEPHEDRINE SULFATE
@ WATSON LABS INC FL
5MG;120MG
A 076208
001 Jan 28, 2004
Feb DISC
MICONAZOLE NITRATE
CREAM;VAGINAL
MICONAZOLE NITRATE
APHENA PHARMA MD
G AND W LABS INC
2%
2%
A 074366
001 Feb 22, 1996
A 074366
001 Feb 22, 1996
Jan CAHN
Sep CAHN
2%
A 074924
001 Apr 29, 1998
Apr DISC
2%
(FOR MEN)
5%
A 074924
002 Apr 29, 1998
Apr DISC
A 075839
001 Oct 01, 2001
Apr DISC
CLOTRIMAZOLE
CREAM;VAGINAL
MYCELEX-7
BAYER
1%
CREAM, TABLET;TOPICAL, VAGINAL
MYCELEX-7 COMBINATION PACK
BAYER
1%,100MG
TABLET;VAGINAL
MYCELEX-7
BAYER
100MG
10MG
FEXOFENADINE HYDROCHLORIDE
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
DR REDDYS LABS LTD
30MG
CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
DR REDDYS LABS LTD
30MG
MINOXIDIL
SOLUTION;TOPICAL
MINOXIDIL (FOR MEN)
@ APOTEX INC
MINOXIDIL (FOR WOMEN)
@ APOTEX INC
MINOXIDIL EXTRA STRENGTH
@ APOTEX INC
12
-
December
2013
2 -3
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
AKORN INC
0.025%;0.3%
A 202795
001 Jan 24, 2013
Jan NEWA
OMEPRAZOLE; SODIUM BICARBONATE
FOR SUSPENSION;ORAL
ZEGERID OTC
+
MSD CONSUMER
N 022283
001 Jun 17, 2013
Jun NEWA
OXYBUTYNIN
OXYTROL FOR WOMEN
+
MSD CONSUMER
3.9MG/24HR
N 202211
001 Jan 25, 2013
Jan NEWA
PIPERONYL BUTOXIDE; PYRETHRINS
AEROSOL;TOPICAL
RID MOUSSE
+
BAYER
4%;EQ 0.33% BASE
N 021043
001 Mar 07, 2000
Sep CAHN
POLYETHYLENE GLYCOL 3350
FOR SOLUTION;ORAL
POLYETHYLENE GLYCOL 3350
PAR PHARM
17GM/SCOOPFUL
A 079214
001 Jan 31, 2013
Jan NEWA
TABLET;ORAL
@ WATSON LABS
EQ 75MG BASE
A 075212
001 Jan 14, 2000
Mar DISC
NASACORT ALLERGY 24 HOUR
SANOFI AVENTIS US
0.055MG/SPRAY
N 020468
002 Oct 11, 2013
Oct NEWA
3-1
DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT
ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST
CUMULATIVE SUPPLEMENT NUMBER 12 DECEMBER 2013
NO DECEMBER 2013 APPROVALS
4-1
ORPHAN PRODUCT DESIGNATIONS AND APPROVALS LIST
The list of List of Orphan Designations and Approvals is available at:
http://www.fda.gov/orphan/designat/list.htm
5-1
DRUG PRODUCTS WHICH MUST DEMONSTRATE IN VIVO BIOAVAILABILITY
ONLY IF PRODUCT FAILS TO ACHIEVE ADEQUATE DISSOLUTION
NO DECEMBER 2013 ADDITIONS
35(6&5,37,21$1'27&'58*352'8&73$7(17$1'(;&/86,9,7</,675'(',7,21
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
6HH/LVWIRRWQRWHIRULQIRUPDWLRQUHJDUGLQJ/LVWFRQWHQW
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
$%$&$9,568/)$7(/$0,98',1(=,'298',1($%$&$9,568/)$7(/$0,98',1($1'=,'298',1(
$ !$! 3&
$%,5$7(521($&(7$7(=<7,*$
1 'HF
'HF
'6 '3 8
'6 '3 8
$&(7</&<67(,1($&(7$'27(
1 $XJ
8
$&<&/29,56,7$9,*
1 !$! 'HF
'3 8
$'$3$/(1(',))(5,1
1 6HS
'3 8
$'$3$/(1(%(1=2</3(52;,'((3,'82
1 -XO
8
$'()29,5',3,92;,/$'()29,5',3,92;,/
$ (;&/86,9,7<
(;3,5$7,21
'$7(
-XQ
13
$SU
133
)HE
3&
0DU
$)$7,1,%',0$/($7(*,/275,)
1 5(
-XO
2FW
'HF
-DQ
'6 '3 8
'6 '3
'3
'6 '3
1&(
2'(
-XO
-XO
$)$7,1,%',0$/($7(*,/275,)
1 5(
-XO
2FW
'HF
-DQ
'6 '3 8
'6 '3
'3
'6 '3
1&(
2'(
-XO
-XO
$)$7,1,%',0$/($7(*,/275,)
1 5(
-XO
2FW
'HF
-DQ
'6 '3 8
'6 '3
'3
'6 '3
1&(
2'(
-XO
-XO
$/%87(52/68/)$7(3529(17,/+)$
1 -XO
'HF
'3
'3
$/&$)7$',1(/$67$&$)7
1 $SU
'6 '3
$/,6.,5(1+(0,)80$5$7(9$/6$57$19$/7851$
1 -XO
'3
$/,6.,5(1+(0,)80$5$7(9$/6$57$19$/7851$
1 -XO
'3
1&(
-DQ
$/2*/,37,1%(1=2$7(1(6,1$
1 -XQ
-XQ
$XJ
$SU
-XQ
)HE
)HE
)HE
-XQ
0DU
0DU
8
8
8
8
'3 8
8
8
8
'6 '3 8
8
'6
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
$/2*/,37,1%(1=2$7(1(6,1$
1 -XQ
-XQ
$XJ
$SU
-XQ
)HE
)HE
)HE
-XQ
0DU
0DU
8
8
8
8
'3 8
8
8
8
'6 '3 8
8
'6
1&(
-DQ
$/2*/,37,1%(1=2$7(1(6,1$
1 -XQ
-XQ
$XJ
$SU
-XQ
)HE
)HE
)HE
-XQ
0DU
0DU
8
8
8
8
'3 8
8
8
8
'6 '3 8
8
'6
1&(
-DQ
1&
1&(
-DQ
-DQ
1&
1&(
-DQ
-DQ
$/2*/,37,1%(1=2$7(0(7)250,1+<'52&+/25,'(.$=$12
1 -XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
$/2*/,37,1%(1=2$7(0(7)250,1+<'52&+/25,'(.$=$12
1 -XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
$/2*/,37,1%(1=2$7(3,2*/,7$=21(+<'52&+/25,'(26(1,
1 -XQ
'3 8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
'3 8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
$/2*/,37,1%(1=2$7(3,2*/,7$=21(+<'52&+/25,'(26(1,
1 -XQ
'3 8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
'3 8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
$/2*/,37,1%(1=2$7(3,2*/,7$=21(+<'52&+/25,'(26(1,
1 -XQ
'3 8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
'3 8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
1&
1&(
-DQ
-DQ
1&
1&(
-DQ
-DQ
1&
1&(
-DQ
-DQ
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
$/2*/,37,1%(1=2$7(3,2*/,7$=21(+<'52&+/25,'(26(1,
-XQ
'3 8
1 -XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
'3 8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
$/2*/,37,1%(1=2$7(3,2*/,7$=21(+<'52&+/25,'(26(1,
-XQ
'3 8
1 -XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
'3 8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
$/2*/,37,1%(1=2$7(3,2*/,7$=21(+<'52&+/25,'(26(1,
-XQ
'3 8
1 -XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
-XQ
8
$XJ
8
$SU
8
-XQ
'3 8
)HE
8
)HE
8
)HE
8
-XQ
'6 '3 8
0DU
8
0DU
'6
$/9,023$1(17(5(*
1 -XO
$0%5,6(17$1/(7$,5,6
1 2FW
'6 '3
$0%5,6(17$1/(7$,5,6
1 2FW
'6 '3
'3 8
$0/2',3,1(%(6</$7(+<'52&+/2527+,$=,'(9$/6$57$1(;)25*(+&7
1 0D\
'3
3('
1RY
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
1&
1&(
-DQ
-DQ
1&
1&(
-DQ
-DQ
1&
1&(
-DQ
-DQ
0
2FW
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
$0/2',3,1(%(6</$7(+<'52&+/2527+,$=,'(9$/6$57$1(;)25*(+&7
1 0D\
'3
3('
1RY
$0/2',3,1(%(6</$7(+<'52&+/2527+,$=,'(9$/6$57$1(;)25*(+&7
1 0D\
'3
3('
1RY
$0/2',3,1(%(6</$7(+<'52&+/2527+,$=,'(9$/6$57$1(;)25*(+&7
1 0D\
'3
3('
1RY
$0/2',3,1(%(6</$7(+<'52&+/2527+,$=,'(9$/6$57$1(;)25*(+&7
1 0D\
'3
3('
1RY
$02;,&,//,102;$7$*
1 $3,;$%$1(/,48,6
1 $3,;$%$1(/,48,6
1 'HF
'3
'HF
)HE
)HE
'6 '3 8
'6 '3 8
'6 '3 8
'HF
)HE
)HE
'6 '3 8
'6 '3 8
'6 '3 8
$5)25027(52/7$575$7(%529$1$
1 $SU
-XQ
-XQ
-XQ
-XQ
-XQ
$5,3,35$=2/($%,/,)<
1 3('
3('
-DQ
-XQ
'HF
6HS
0DU
$5,3,35$=2/($%,/,)<
1 3('
3('
-DQ
-XQ
'HF
6HS
0DU
$5,3,35$=2/($%,/,)<
1 3('
3('
-DQ
-XQ
'HF
6HS
0DU
$5,3,35$=2/($%,/,)<
1 3('
3('
-DQ
-XQ
'HF
6HS
0DU
$5,3,35$=2/($%,/,)<
1 3('
3('
-DQ
-XQ
'HF
6HS
0DU
8
'3 8
8
'3
8
8
8
'3
'6
8
'3
'6
8
'3
'6
8
'3
'6
8
'3
'6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
$5,3,35$=2/($%,/,)<
1 3('
3('
-DQ
-XQ
'HF
6HS
0DU
$5,3,35$=2/($%,/,)<
1 !$! -DQ
$5,3,35$=2/($%,/,)<
1 3('
3('
3('
-DQ
-XQ
'HF
-DQ
-XO
6HS
0DU
$5,3,35$=2/($%,/,)<
1 3('
3('
3('
-DQ
-XQ
'HF
-DQ
-XO
6HS
0DU
$5,3,35$=2/($%,/,)<
1 3('
3('
3('
-DQ
-XQ
'HF
-DQ
-XO
6HS
0DU
$5,3,35$=2/($%,/,)<
1 3('
3('
3('
-DQ
-XQ
'HF
-DQ
-XO
6HS
0DU
$5,3,35$=2/($%,/,)<0$,17(1$.,7
1 $SU
2FW
2FW
0DU
$XJ
'HF
'6 '3 8
'3
8
'3 8
'3 8
'6
1')
)HE
$5,3,35$=2/($%,/,)<0$,17(1$.,7
1 $SU
2FW
2FW
0DU
$XJ
'HF
'6 '3 8
'3
8
'3 8
'3 8
'6
1')
)HE
$6(1$3,1(0$/($7(6$3+5,6
1 -XQ
'3 8
$6(1$3,1(0$/($7(6$3+5,6
1 -XQ
'3 8
1&
0D\
$7259$67$7,1&$/&,80(=(7,0,%(/,3758=(7
1 6HS
3('
0DU
5(
2FW
5(3('
$SU
8
'3
'6
8
8
'3
'3
'6
8
'3
'3
'6
8
'3
'3
'6
8
'3
'3
'6
'3 8
'6 '3 8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
$7259$67$7,1&$/&,80(=(7,0,%(/,3758=(7
1 6HS
3('
0DU
5(
2FW
5(3('
$SU
$7259$67$7,1&$/&,80(=(7,0,%(/,3758=(7
1 6HS
3('
0DU
5(
2FW
5(3('
$SU
$7259$67$7,1&$/&,80(=(7,0,%(/,3758=(7
1 6HS
3('
0DU
5(
2FW
5(3('
$SU
3$7(17
&2'(6
'3 8
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
1&
0D\
1&
0D\
1&
0D\
0
133
$XJ
$XJ
1&
1&(
'HF
)HE
2'(
'HF
2'(
3('
2FW
0D\
2'(
3('
2FW
0D\
'3 8
2'(
2'(
3('
3('
0DU
2FW
6HS
0D\
'3 8
2'(
2'(
3('
3('
2FW
0DU
0D\
6HS
'6 '3 8
'3 8
'6 '3 8
'3 8
'6 '3 8
$=(/$67,1(+<'52&+/25,'($67(352
1 1RY
8
$=(/$67,1(+<'52&+/25,'($67(352
1 1RY
8
$=,/6$57$1.$0('2;20,/&+/257+$/,'21(('$5%<&/25
1 $=75(21$0&$<6721
1 'HF
'3 8
%$/6$/$=,'(',62',80*,$=2
1 -XQ
8
%$=('2;,)(1($&(7$7((6752*(16&21-8*$7(''8$9((
1 $SU
0D\
0D\
$SU
0DU
0DU
'6 '3
'3
'3
'6 '3
'6 '3
'6 '3
%('$48,/,1()80$5$7(6,57852
1 2FW
'6 '3 8
%(1'$0867,1(+<'52&+/25,'(75($1'$
1 3('
3('
!$! !$! 3('
2FW
$SU
0DU
6HS
-DQ
-XO
%(1'$0867,1(+<'52&+/25,'(75($1'$
1 3('
3('
!$! !$! 3('
2FW
$SU
0DU
6HS
-DQ
-XO
%(1'$0867,1(+<'52&+/25,'(75($1'$
1 3('
3('
6HS
0DU
0DU
6HS
%(1'$0867,1(+<'52&+/25,'(75($1'$
1 3('
3('
6HS
0DU
0DU
6HS
%(327$67,1(%(6,/$7(%(35(9(
1 6HS
8
8
8
8
8
8
'3
'6 '3 8
'3
'3
'6 '3 8
'3
'6
'6
'6 '3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
%(6,)/2;$&,1+<'52&+/25,'(%(6,9$1&(
1 1RY
-DQ
!$! 0DU
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
8
'3
0DU
0DU
8
8
%,0$7235267/$7,66(
1 -DQ
8
%2&(35(9,59,&75(/,6
1 $XJ
-XQ
-XQ
0D\
0D\
0D\
0DU
0DU
8
'3 8
'3
'3
8
8
'3 8
'3 8
%5,021,',1(7$575$7(%5,1=2/$0,'(6,0%5,1=$
1 'HF
%5,021,',1(7$575$7(7,02/2/0$/($7(&20%,*$1
1 -DQ
$SU
8
'3
'3 8
%520)(1$&62',80352/(16$
1 6HS
%5202&5,37,1(0(6</$7(&<&/26(7
1 -XO
-XO
-XO
-XO
$SU
8
8
8
8
'3 8
%8'(621,'(8&(5,6
1 5(
-XQ
-XQ
-XQ
-XQ
'3 8
'3
'3
'3 8
%8'(621,'()25027(52/)80$5$7(',+<'5$7(6<0%,&257
1 1RY
2FW
-DQ
%8'(621,'()25027(52/)80$5$7(',+<'5$7(6<0%,&257
1 1RY
6HS
2FW
-DQ
(;&/86,9,7<
(;3,5$7,21
'$7(
'6
%,0$7235267/80,*$1
1 !$! %5,021,',1(7$575$7(0,59$62
1 (;&/86,9,7<
&2'(6
'6 '3
'3
'3
'3 8
'3
8
'3
'3 8
%835(1253+,1(+<'52&+/25,'(1$/2;21(+<'52&+/25,'(68%2;21(
1 0DU
'3 8
!$! $SU
'3 8
%835(1253+,1(+<'52&+/25,'(1$/2;21(+<'52&+/25,'(68%2;21(
1 0DU
'3 8
!$! $SU
'3
%835(1253+,1(+<'52&+/25,'(1$/2;21(+<'52&+/25,'(68%2;21(
1 0DU
'3 8
!$! $SU
'3
%835(1253+,1(+<'52&+/25,'(1$/2;21(+<'52&+/25,'(68%2;21(
1 0DU
'3 8
!$! $SU
'3
0
133
)HE
)HE
1')
$XJ
1&
$SU
13
$SU
1')
-DQ
<
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
%835(1253+,1(+<'52&+/25,'(1$/2;21(+<'52&+/25,'(=8%62/9
1 6HS
8
2FW
'3 8
%835(1253+,1(+<'52&+/25,'(1$/2;21(+<'52&+/25,'(=8%62/9
1 6HS
8
2FW
'3 8
&$%2=$17,1,%60$/$7(&20(75,4
1 2'(
1RY
&$%2=$17,1,%60$/$7(&20(75,4
1 2'(
1RY
&$/&,721,16$/0215(&20%,1$17)257,&$/
1 5(
)HE
'3 8
&$/&,80$&(7$7(3+26/<5$
1 !$! !$! )HE
-XO
'3 8
8
&$1$*/,)/2=,1,192.$1$
1 )HE
-XO
-XO
'HF
'6 '3 8
'6 '3
8
'6 '3 8
1&(
0DU
&$1$*/,)/2=,1,192.$1$
1 )HE
-XO
-XO
'HF
'6 '3 8
'6 '3
8
'6 '3 8
1&(
0DU
&$1'(6$57$1&,/(;(7,/&$1'(6$57$1&,/(;(7,/
$ 3&
-XO
&$1'(6$57$1&,/(;(7,/&$1'(6$57$1&,/(;(7,/
$ 3&
-XO
&$1'(6$57$1&,/(;(7,/&$1'(6$57$1&,/(;(7,/
$ 3&
-XO
&$1'(6$57$1&,/(;(7,/&$1'(6$57$1&,/(;(7,/
$ 3&
-XO
&$1'(6$57$1&,/(;(7,/+<'52&+/2527+,$=,'(&$1'(6$57$1&,/(;(7,/$1'+<'52&+/2527+,$=,'(
$ 3&
-XQ
&$3(&,7$%,1(;(/2'$
1 3('
'HF
-XQ
'6 '3 8
!$! 0
!$! 3('
'HF
-XQ
&$3(&,7$%,1(;(/2'$
1 3('
'HF
-XQ
'6 '3 8
!$! 0
!$! 3('
'HF
-XQ
&$5%,12;$0,1(0$/($7(.$5%,1$/(5
1 0DU
&(/(&2;,%&(/(%5(;
1 5(
5(
5(
5(
5(
5(
5(3('
-XQ
-XQ
-XQ
-XQ
-XQ
-XQ
'HF
8
8
8
8
8
8
&(/(&2;,%&(/(%5(;
1 5(
5(
5(
5(
5(
5(
5(3('
-XQ
-XQ
-XQ
-XQ
-XQ
-XQ
'HF
8
8
8
8
8
8
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
&(/(&2;,%&(/(%5(;
1 5(
5(
5(
5(
5(
5(
5(3('
-XQ
-XQ
-XQ
-XQ
-XQ
-XQ
'HF
8
8
8
8
8
8
&(/(&2;,%&(/(%5(;
1 5(
5(
5(
5(
5(
5(
5(3('
-XQ
-XQ
-XQ
-XQ
-XQ
-XQ
'HF
8
8
8
8
8
8
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
&+/25+(;,',1(*/8&21$7(,623523</$/&2+2/&+/25$35(3:,7+7,17
1 $SU
'3 8
&+/25+(;,',1(*/8&21$7(,623523</$/&2+2/&+/25$35(3:,7+7,17
1 $SU
'3 8
&+/25+(;,',1(*/8&21$7(,623523</$/&2+2/&+/25$35(3:,7+7,17
1 $SU
'3 8
&,&/(621,'($/9(6&2
1 $XJ
8
0
'HF
&,&/(621,'($/9(6&2
1 $XJ
8
0
'HF
&,&/(621,'(201$5,6
1 $XJ
2FW
&,&/(621,'(=(7211$
1 $XJ
&/2%$=$021),
1 2'(
2FW
&/2%(7$62/3523,21$7(&/2%(7$62/3523,21$7(
$ 3&
-XO
8
'3
8
&,352)/2;$&,1&,352)/2;$&,1+<'52&+/25,'(&,352;5
1 -XQ
3('
'HF
'3
&,352)/2;$&,1&,352)/2;$&,1+<'52&+/25,'(&,352;5
1 -XQ
3('
'HF
'3
&,75,&$&,'0$*1(6,802;,'(62',803,&268/)$7(35(323,.
1 2FW
'3
2FW
'3
&/2%(7$62/3523,21$7(2/8;(
1 1RY
'3 8
&2%,&,67$7(/9,7(*5$9,5(075,&,7$%,1(7(12)29,5',62352;,/)80$5$7(675,%,/'
1 2FW
'6 '3 8
!$! -DQ
'3 8
&2/&+,&,1(&2/&5<6
1 2FW
2FW
)HE
)HE
8
8
8
8
&52)(/(0(5)8/<=$4
1 -DQ
8
&<&/26325,1(5(67$6,6
1 !$! $XJ
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
&<67($0,1(%,7$575$7(352&<6%,
1 6HS
-DQ
'3
&<67($0,1(%,7$575$7(352&<6%,
1 6HS
-DQ
'3
'$%5$)(1,%0(6</$7(7$),1/$5
1 3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
8
1')
$SU
8
1')
$SU
-DQ
-DQ
'6 '3 8
'6 '3 8
1&(
2'(
0D\
0D\
'$%5$)(1,%0(6</$7(7$),1/$5
1 -DQ
-DQ
'6 '3 8
'6 '3 8
1&(
2'(
0D\
0D\
'$/)$035,',1($03<5$
1 -XO
'HF
$SU
8
8
8
'$581$9,5(7+$12/$7(35(=,67$
1 3('
!$! )HE
$XJ
-XQ
'6 '3
'
3('
)HE
$XJ
'$581$9,5(7+$12/$7(35(=,67$
1 3('
!$! )HE
$XJ
-XQ
'6 '3
'
3('
)HE
$XJ
'$581$9,5(7+$12/$7(35(=,67$
1 3('
!$! )HE
$XJ
-XQ
'6 '3
'
3('
)HE
$XJ
'$581$9,5(7+$12/$7(35(=,67$
1 3('
!$! )HE
$XJ
-XQ
'6 '3
'
3('
)HE
$XJ
'$581$9,5(7+$12/$7(35(=,67$
1 3('
!$! )HE
$XJ
-XQ
'6 '3
'
3('
)HE
$XJ
'$581$9,5(7+$12/$7(35(=,67$
1 3('
!$! )HE
$XJ
-XQ
'6 '3
'
3('
)HE
$XJ
'$581$9,5(7+$12/$7(35(=,67$
1 3('
!$! )HE
$XJ
-XQ
'6 '3
'
3('
)HE
$XJ
'()(5$6,52;(;-$'(
1 ,
-DQ
'()(5$6,52;(;-$'(
1 ,
-DQ
'()(5$6,52;(;-$'(
1 ,
-DQ
1')
$SU
,
)HE
'(621,'(9(5'(62
1 8
8
1RY
'3 8
'(62;,0(7$621(723,&257
1 0DU
$SU
'3 8
'3 8
'(69(1/$)$;,1(68&&,1$7(35,67,4
1 )HE
)HE
'6 '3 8
'6 '3 8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
'(69(1/$)$;,1(68&&,1$7(35,67,4
1 )HE
)HE
'6 '3 8
'6 '3 8
'(;$0(7+$621(2=85'(;
1 -DQ
8
'(;/$16235$=2/('(;,/$17
1 3('
-DQ
-XO
'3
'(;/$16235$=2/('(;,/$17
1 3('
-DQ
-XO
'3
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
,
)HE
'(;0(7+</3+(1,'$7(+<'52&+/25,'('(;0(7+</3+(1,'$7(+<'52&+/25,'(
$ 3&
0D\
',&/2)(1$&=2592/(;
1 13
2FW
',&/2)(1$&=2592/(;
1 13
2FW
,
0
2'(
3('
3('
3('
-XQ
0DU
-XQ
'HF
'HF
6HS
1&(
0DU
'(;0('(720,',1(+<'52&+/25,'(35(&('(;
1 -XO
3('
-DQ
0DU
3('
2FW
'(;0('(720,',1(+<'52&+/25,'(35(&('(;
1 -XO
3('
-DQ
0DU
3('
2FW
-DQ
3('
-XO
-DQ
3('
-XO
-DQ
3('
-XO
'(;0('(720,',1(+<'52&+/25,'(35(&('(;
1 -XO
3('
-DQ
0DU
3('
2FW
-DQ
3('
-XO
-DQ
3('
-XO
-DQ
3('
-XO
'6 '3 8
8
'6 '3 8
8
'3
'3
8
'6 '3 8
8
'3
'3
8
',&/2)(1$&62',803(116$,'
1 !$! $XJ
$XJ
-XO
',)/835('1$7('85(=2/
1 3('
0D\
1RY
'3
',0(7+</)80$5$7(7(&),'(5$
1 2FW
0D\
$SU
$SU
)HE
$SU
'3
8
8
8
8
8
8
8
8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
',0(7+</)80$5$7(7(&),'(5$
1 2FW
0D\
$SU
$SU
)HE
$SU
'3
'2/87(*5$9,562',807,9,&$<
1 2FW
'6 '3
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
1&(
0DU
8
8
8
8
8
1&(
$XJ
'21(3(=,/+<'52&+/25,'('21(3(=,/+<'52&+/25,'(
$ 3&
-DQ
'21(3(=,/+<'52&+/25,'('21(3(=,/+<'52&+/25,'(
$ 3&
-DQ
'
16
$SU
$SU
13
$SU
0
3('
2FW
$SU
0
3('
2FW
$SU
0
3('
2FW
$SU
1')
2FW
'21(3(=,/+<'52&+/25,'($5,&(37
1 2FW
'2;(3,1+<'52&+/25,'(6,/(125
1 $SU
8
'2;(3,1+<'52&+/25,'(6,/(125
1 $SU
8
'2;<&<&/,1(25$&($
1 !$! $SU
$SU
$SU
$SU
'3 8
'3 8
'3 8
8
'2;<&<&/,1(+<&/$7('25<;
1 'HF
'3 8
'2;<&<&/,1(+<&/$7('25<;
1 'HF
'3 8
'3
'2;</$0,1(68&&,1$7(3<5,'2;,1(+<'52&+/25,'(',&/(*,6
1 -XQ
'3 8
-DQ
'3
'521('$521(+<'52&+/25,'(08/7$4
1 !$! -XO
-XO
$SU
$SU
-XQ
'6 '3 8
'6 '3 8
8
8
8
'5263,5(121((7+,1</(675$',2/<$=
1 5(
-XQ
8
'5263,5(121((7+,1</(675$',2//(920()2/$7(&$/&,80%(<$=
1 5(
-XQ
8
'8/2;(7,1(+<'52&+/25,'(&<0%$/7$
1 '8/2;(7,1(+<'52&+/25,'(&<0%$/7$
1 '8/2;(7,1(+<'52&+/25,'(&<0%$/7$
1 (&21$=2/(1,75$7((&2=$
1 -DQ
'3 8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
()$9,5(1=6867,9$
1 3('
3('
3('
3('
3('
3('
0D\
1RY
6HS
0DU
$SU
2FW
$SU
2FW
)HE
$XJ
-DQ
-XO
'6 '3
()$9,5(1=6867,9$
1 3('
3('
3('
3('
3('
3('
0D\
1RY
6HS
0DU
$SU
2FW
$SU
2FW
)HE
$XJ
-DQ
-XO
'6 '3
()$9,5(1=6867,9$
1 3('
3('
3('
3('
3('
3('
0D\
1RY
6HS
0DU
$SU
2FW
$SU
2FW
)HE
$XJ
-DQ
-XO
'6 '3
()$9,5(1=6867,9$
1 3('
3('
3('
3('
0D\
1RY
6HS
0DU
)HE
$XJ
-DQ
-XO
()$9,5(1=6867,9$
1 3('
3('
3('
3('
0D\
1RY
6HS
0DU
)HE
$XJ
-DQ
-XO
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
133
3('
0D\
1RY
133
3('
0D\
1RY
133
3('
0D\
1RY
8
'3
8
'6
'6
8
'3
8
'6
'6
8
'3
8
'6
'6
'6
'6
'6 '3
8
'6
'6
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
()$9,5(1=(075,&,7$%,1(7(12)29,5',62352;,/)80$5$7($75,3/$
1 0D\
'6 '3
3('
1RY
6HS
8
6HS
8
3('
0DU
)HE
'6
3('
$XJ
-DQ
'6
3('
-XO
!$! -DQ
'3 8
!$! -DQ
'3 8
!$! 0D\
'3
(075,&,7$%,1(5,/3,9,5,1(+<'52&+/25,'(7(12)29,5',62352;,/)80$5$7(&203/(5$
1 !$! -DQ
'3 8
!$! 133
'HF
(075,&,7$%,1(7(12)29,5',62352;,/)80$5$7(7589$'$
1 !$! -DQ
!$! -DQ
!$! -DQ
'3 8
'3 8
'3 8
(1$/$35,/0$/($7((3$1('.,7
1 1RY
'3
(17(&$9,5%$5$&/8'(
1 3('
)HE
$XJ
'6
'
133
133
3('
3('
3('
2FW
2FW
2FW
$SU
$SU
$SU
(17(&$9,5%$5$&/8'(
1 3('
)HE
$XJ
'6
'
133
133
3('
3('
3('
2FW
2FW
2FW
$SU
$SU
$SU
(17(&$9,5%$5$&/8'(
1 3('
)HE
$XJ
'6
'
133
133
3('
3('
3('
2FW
2FW
2FW
$SU
$SU
$SU
(3,1(3+5,1($89,4
1 -XQ
-DQ
2FW
1RY
0DU
0DU
1RY
)HE
1RY
1RY
'3
'3
'3
'3
'3
'3
'3
'3
'3
'3
(3,1(3+5,1($89,4
1 -XQ
-DQ
2FW
1RY
0DU
0DU
1RY
)HE
1RY
1RY
'3
'3
'3
'3
'3
'3
'3
'3
'3
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
(3235267(12/62',809(/(75,
1 !$! 0DU
)HE
'3
(3235267(12/62',809(/(75,
1 !$! 0DU
)HE
'3
(5/27,1,%+<'52&+/25,'(7$5&(9$
1 1RY
1RY
1RY
1RY
1RY
1RY
1RY
'6
'6
'6
'6
'3
'3
'3
'3
8
8
8
8
8
8
8
,
0D\
(5/27,1,%+<'52&+/25,'(7$5&(9$
1 1RY
1RY
1RY
1RY
1RY
1RY
1RY
'6
'6
'6
'6
'3
'3
'3
'3
8
8
8
8
8
8
8
,
0D\
(5/27,1,%+<'52&+/25,'(7$5&(9$
1 1RY
1RY
1RY
1RY
1RY
1RY
1RY
'6
'6
'6
'6
'3
'3
'3
'3
8
8
8
8
8
8
8
,
0D\
(6/,&$5%$=(3,1($&(7$7($37,20
1 -XQ
$SU
'6 '3 8
'3
1&(
1RY
(6/,&$5%$=(3,1($&(7$7($37,20
1 -XQ
$SU
'6 '3 8
'3
1&(
1RY
(6/,&$5%$=(3,1($&(7$7($37,20
1 -XQ
$SU
'6 '3 8
'3
1&(
1RY
(6/,&$5%$=(3,1($&(7$7($37,20
1 -XQ
$SU
'6 '3 8
'3
1&(
1RY
(620(35$=2/(0$*1(6,801(;,80
1 3('
0D\
1RY
8
(620(35$=2/(0$*1(6,801(;,80
1 3('
0D\
1RY
8
(620(35$=2/(0$*1(6,801(;,80
1 3('
0D\
1RY
8
(620(35$=2/(0$*1(6,801(;,80
1 3('
0D\
1RY
8
(620(35$=2/(0$*1(6,801$352;(19,0292
1 0D\
'3
(620(35$=2/(0$*1(6,801$352;(19,0292
1 0D\
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
(675$',2/0,1,9(//(
1 $XJ
-DQ
-XO
'6 '3
'6 '3
'6 '3
(675$',2/0,1,9(//(
1 $XJ
-DQ
-XO
'6 '3
'6 '3
'6 '3
(675$',2/0,1,9(//(
1 $XJ
-DQ
-XO
'6 '3
'6 '3
'6 '3
(675$',2/0,1,9(//(
1 $XJ
-DQ
-XO
'6 '3
'6 '3
'6 '3
(6=23,&/21(/81(67$
1 (6=23,&/21(/81(67$
1 (6=23,&/21(/81(67$
1 (7+,1</(675$',2//(92125*(675(/48$57(77(
1 0DU
2FW
'3
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
0
3('
2FW
$SU
0
3('
2FW
$SU
0
3('
2FW
$SU
13
0DU
1')
0D\
8
(7+,1</(675$',2/125(7+,1'521($&(7$7(0,1$675,1)(
1 -XO
8
(7+,1</(675$',2/125(7+,1'521($&(7$7(125(7+,1'521($&(7$7($1'(7+,1</(675$',2/$1')(55286)80$5$7(
1 -XO
8
0DU
'3
(7+,1</(675$',2/125(7+,1'521($&(7$7(/20,1$675,1)(
1 -XO
8
$SU
'3 8
)HE
8
(9(52/,086=2575(66
1 3('
3('
3('
3('
6HS
6HS
0DU
-XO
-XO
-DQ
6HS
6HS
0DU
-XO
-XO
-DQ
'6 '3 8
'6 '3 8
'3 8
'3 8
'3 8
'3 8
8
8
,
)HE
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
(9(52/,086=2575(66
1 3('
3('
3('
3('
6HS
6HS
0DU
-XO
-XO
-DQ
6HS
6HS
0DU
-XO
-XO
-DQ
'6 '3 8
'6 '3 8
(9(52/,086=2575(66
1 3('
3('
3('
3('
6HS
6HS
0DU
-XO
-XO
-DQ
6HS
6HS
0DU
-XO
-XO
-DQ
'6 '3 8
'6 '3 8
(9(52/,086$),1,725
1 3('
3('
0D\
1RY
)HE
$XJ
'6 '3 8
(9(52/,086$),1,725
1 3('
3('
0D\
1RY
)HE
$XJ
'6 '3 8
(9(52/,086$),1,725
1 3('
3('
0D\
1RY
)HE
$XJ
'6 '3 8
(9(52/,086$),1,725
1 3('
3('
0D\
1RY
)HE
$XJ
'6 '3 8
(;(1$7,'(6<17+(7,&%<'85(21
1 $SU
$SU
'3 8
'3 8
)$027,',1(,%8352)(1'8(;,6
1 -XO
-XO
'3
)(%8;267$78/25,&
1 0DU
6HS
'6 '3 8
8
)(%8;267$78/25,&
1 0DU
6HS
'6 '3 8
8
)(12),%5$7($17$5$0,&521,=('
1 $SU
$SU
8
8
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
,
)HE
,
)HE
'3 8
'3 8
'3 8
'3 8
8
8
'3 8
'3 8
'3 8
'3 8
8
8
'6 '3 8
'6 '3 8
'6 '3 8
'6 '3 8
8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
)(12),%5$7($17$5$0,&521,=('
1 $SU
$SU
8
8
)(12),%5$7()(12*/,'(
1 2FW
'3 8
)(12),%5$7()(12*/,'(
1 2FW
'3 8
$SU
$SU
'3
$SU
$SU
'3
$SU
$SU
'3
$SU
$SU
'3
$SU
$SU
'3
$SU
$SU
'3
$SU
$SU
'3
)(17$1</68%6<6
1 )(17$1</68%6<6
1 )(17$1</68%6<6
1 )(17$1</68%6<6
1 )(17$1</68%6<6
1 )(17$1</68%6<6
1 )(17$1</68%6<6
1 (;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
8
8
8
8
8
13
-DQ
13
-DQ
13
-XO
0
$XJ
133
-XO
8
8
)(55,&&$5%2;<0$/726(,1-(&7$)(5
1 )HE
)HE
)(5802;<72/)(5$+(0(
1 !$! 0DU
0DU
)(627(52',1()80$5$7(729,$=
1 0D\
-XQ
'6 '3 8
'3
)(627(52',1()80$5$7(729,$=
1 0D\
-XQ
'6 '3 8
'3
'6 '3
'3 8
8
'3
)(;2)(1$',1(+<'52&+/25,'(&+,/'5(1
6$//(*5$$//(5*<
1 !$! 0DU
!$! 0DU
!$! 1RY
8
8
'3 8
)(;2)(1$',1(+<'52&+/25,'(&+,/'5(1
6$//(*5$+,9(6
1 !$! 0DU
!$! 1RY
'3
),'$;20,&,1',),&,'
1 $SU
'6 '3
)/25%(7$3,5)$0<9,'
1 $SU
'6 '3 8
)/25%(7$3,5)$0<9,'
1 $SU
'6 '3 8
)/25%(7$3,5)$0<9,'
1 $SU
'6 '3 8
)/81,62/,'($(5263$1+)$
1 'HF
)/82;(7,1(+<'52&+/25,'(352=$&
1 3$7(17
'(/,67
5(48(67('
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
)/82;(7,1(+<'52&+/25,'(352=$&
1 133
-XO
)/82;(7,1(+<'52&+/25,'(352=$&
1 133
-XO
)/82;(7,1(+<'52&+/25,'(352=$&
1 133
-XO
)/82;(7,1(+<'52&+/25,'(2/$1=$3,1(6<0%<$;
1 133
-XO
)/82;(7,1(+<'52&+/25,'(2/$1=$3,1(6<0%<$;
1 133
-XO
)/82;(7,1(+<'52&+/25,'(2/$1=$3,1(6<0%<$;
1 133
-XO
)/82;(7,1(+<'52&+/25,'(2/$1=$3,1(6<0%<$;
1 133
-XO
)/82;(7,1(+<'52&+/25,'(2/$1=$3,1(6<0%<$;
1 133
-XO
3&
6HS
)/87(0(7$02/)9,=$0</
1 0D\
'6 '3
)/87(0(7$02/)9,=$0</
1 0D\
'6 '3
)/87,&$621()852$7(9(5$0<67
1 $SU
'3
)/87,&$621()852$7(9,/$17(52/75,)(1$7$7(%5(2(//,37$
1 )HE
'3
$XJ
'3
$XJ
'3
$XJ
$XJ
'6 '3
0DU
'6 '3
6HS
'6 '3
$XJ
'3
6HS
'3
2FW
'3
)HE
'3
1RY
'3
$XJ
'3
)/87,&$621(3523,21$7()/29(17+)$
1 -XQ
3('
'HF
'3
)/87,&$621(3523,21$7()/29(17+)$
1 -XQ
3('
'HF
'3
)/87,&$621(3523,21$7()/29(17+)$
1 -XQ
3('
'HF
'3
8
8
8
8
8
8
8
)/892;$0,1(0$/($7()/892;$0,1(0$/($7(
$ )2//,7523,1$/)$%(7$)2//,67,0$4
1 -DQ
-DQ
$XJ
$XJ
$XJ
'3 8
'3 8
8
8
8
)2//,7523,1$/)$%(7$)2//,67,0$4
1 -DQ
-DQ
$XJ
$XJ
$XJ
'3 8
'3 8
8
8
8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
)2//,7523,1$/)$%(7$)2//,67,0$4
1 -DQ
-DQ
$XJ
$XJ
$XJ
'3 8
'3 8
8
8
8
)2//,7523,1$/)$%(7$)2//,67,0$4
1 -DQ
-DQ
$XJ
$XJ
$XJ
'3 8
'3 8
8
8
8
)2//,7523,1$/)$%(7$)2//,67,0$4
1 -XQ
-DQ
'6
)2//,7523,1$/)$%(7$)2//,67,0$4
1 -XQ
-DQ
'6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
'3 8
'3 8
)25027(52/)80$5$7(020(7$621()852$7('8/(5$
1 0D\
'3 8
)25027(52/)80$5$7(020(7$621()852$7('8/(5$
1 0D\
'3 8
)8/9(675$17)$6/2'(;
1 3('
-DQ
-XO
*$%$3(17,1*5$/,6(
1 2FW
'3 8
*$%$3(17,1*5$/,6(
1 2FW
'3 8
*$'2)269(6(775,62',80$%/$9$5
1 )HE
8
*$'2)269(6(775,62',80$%/$9$5
1 )HE
8
8
*$'27(5$7(0(*/80,1('27$5(0
1 1&(
0DU
*$'27(5$7(0(*/80,1('27$5(0
1 1&(
0DU
*$'27(5$7(0(*/80,1('27$5(0
1 1&(
0DU
*$'27(5$7(0(*/80,1('27$5(0
1 1&(
0DU
*$'2;(7$7(',62',80(29,67
1 1&(
-XO
3&
0DU
1(
2'(
)HE
)HE
*$1,5(/,;$&(7$7(*$1,5(/,;$&(7$7(
1 -XQ
8
*$7,)/2;$&,1*$7,)/2;$&,1
$ */$7,5$0(5$&(7$7(&23$;21(
1 0D\
*/,3,=,'(*/8&2752/;/
1 5(
0DU
8
*/,3,=,'(*/8&2752/;/
1 5(
0DU
8
*/,3,=,'(*/8&2752/;/
1 5(
0DU
8
*/<&(52/3+(1</%87<5$7(5$9,&7,
1 )HE
0DU
'6 '3 8
8
'6
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
*/<&23<552/$7(52%,18/
1 $SU
8
<
*/<&23<552/$7(52%,18/)257(
1 $SU
8
<
+<'52&2'21(%,7$575$7(=2+<'52(5
1 !$! 1RY
'3
13
2FW
+<'52&2'21(%,7$575$7(=2+<'52(5
1 !$! 1RY
'3
13
2FW
+<'52&2'21(%,7$575$7(=2+<'52(5
1 !$! 1RY
'3
13
2FW
+<'52&2'21(%,7$575$7(=2+<'52(5
1 !$! 1RY
'3
13
2FW
+<'52&2'21(%,7$575$7(=2+<'52(5
1 !$! 1RY
'3
13
2FW
+<'52&2'21(%,7$575$7(=2+<'52(5
1 !$! 1RY
'3
13
2FW
,%587,1,%,0%589,&$
1 'HF
'HF
'HF
'HF
'6 '3
'6 '3
1&(
2'(
1RY
1RY
,%8352)(1/<6,1(1(2352)(1
1 0DU
'6 '3
,&26$3(17(7+</9$6&(3$
1 !$! !$! !$! )HE
)HE
)HE
)HE
)HE
)HE
)HE
)HE
$SU
$SU
$SU
$SU
$SU
$SU
$SU
$SU
$SU
$SU
$SU
,0$7,1,%0(6</$7(*/((9(&
1 3('
5(
5(3('
-DQ
-XO
-DQ
-XO
'6 '3
<
,
2'(
-DQ
-DQ
,0$7,1,%0(6</$7(*/((9(&
1 3('
5(
5(3('
-DQ
-XO
-DQ
-XO
'6 '3
<
,
2'(
-DQ
-DQ
,0,48,02'=<&/$5$
1 $XJ
$XJ
,1'$&$7(52/0$/($7($5&$37$1(2+$/(5
1 -XQ
2FW
,1',80,13(17(75(27,'(.,72&75(26&$1
1 6HS
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
'6 '3
'6 '3
8
8
8
'3
8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
,1*(12/0(%87$7(3,&$72
1 'HF
'HF
'HF
'HF
'HF
'6
'6
'6
'6
'3 8
'3
'3
'3
8
,1*(12/0(%87$7(3,&$72
1 'HF
'HF
'HF
'HF
'HF
'6
'6
'6
'6
'3 8
'3
'3
'3
8
,168/,1*/$5*,1(5(&20%,1$17/$178662/267$5
1 6HS
0DU
!$! 0DU
'3
'3
'3
,168/,1*/8/,6,1(5(&20%,1$17$3,'5$62/267$5
1 6HS
0DU
!$! 0DU
'3
'3
'3
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
,168/,1/,63523527$0,1(5(&20%,1$17,168/,1/,63525(&20%,1$17+80$/2*0,;.:,.3(1
1 $XJ
'3
,168/,1/,63523527$0,1(5(&20%,1$17,168/,1/,63525(&20%,1$17+80$/2*0,;.:,.3(1
1 $XJ
'3
,168/,1/,63525(&20%,1$17+80$/2*.:,.3(1
1 $XJ
'3
,168/,15(&20%,1$17+80$1,168/,16863,623+$1(5(&20%,1$17+80$1+808/,1
1 $XJ
'3
,168/,15(&20%,1$17+80$1,168/,16863,623+$1(5(&20%,1$17+80$1+808/,13(1
1 $XJ
'3
,168/,16863,623+$1(5(&20%,1$17+80$1+808/,11
1 $XJ
'3
,2%(1*8$1(68/)$7(,$'5(9,(:
1 ,
0DU
,52168&526(9(12)(5
1 133
6HS
,6275(7,12,1$%625,&$
1 6HS
8
,6275(7,12,1$%625,&$
1 6HS
8
,6275(7,12,1$%625,&$
1 6HS
8
,6275(7,12,1$%625,&$
1 6HS
8
,75$&21$=2/(210(/
1 !$! 2FW
0D\
'3 8
'3 8
,9$&$)725.$/<'(&2
1 'HF
'3
.(7252/$&7520(7+$0,1($&8/$5/6
1 3('
3('
0D\
1RY
0D\
1RY
.(7252/$&7520(7+$0,1($&89$,/
1 0DU
8
8
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
/$3$7,1,%',726</$7(7<.(5%
1 -XO
-XO
6HS
6HS
-DQ
-DQ
-XO
-XO
1RY
-DQ
/(1$/,'20,'(5(9/,0,'
1 !$! -XO
-XO
2FW
$SU
0D\
$XJ
8
8
8
8
8
8
,
2'(
-XQ
-XQ
/(1$/,'20,'(5(9/,0,'
1 !$! -XO
-XO
2FW
$SU
0D\
$XJ
8
8
8
8
8
8
,
2'(
-XQ
-XQ
/(1$/,'20,'(5(9/,0,'
1 !$! -XO
-XO
2FW
$SU
0D\
$XJ
8
8
8
8
8
8
,
2'(
-XQ
-XQ
/(1$/,'20,'(5(9/,0,'
1 !$! -XO
-XO
2FW
$SU
0D\
$XJ
8
8
8
8
8
8
,
2'(
-XQ
-XQ
/(1$/,'20,'(5(9/,0,'
1 !$! -XO
-XO
2FW
$SU
0D\
$XJ
8
8
8
8
8
8
,
2'(
-XQ
-XQ
'6
'6
'6
'6
'6
'6
'3
'3
'3
'3
'3
'3
8
8
8
8
8
8
8
8
'6 '3
'6 '3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
/(1$/,'20,'(5(9/,0,'
1 !$! 3$7(17
(;3,5$7,21
'$7(
2FW
$XJ
-XO
-XO
2FW
-XO
$XJ
2FW
2FW
$XJ
-XO
$SU
$SU
2FW
1RY
2FW
$XJ
-XO
2FW
$SU
0D\
$XJ
3$7(17
&2'(6
'6 '3 8
8
8
8
8
'3 8
8
8
8
8
'3
8
'6 '3
8
'6 '3
8
8
'6 '3
8
8
8
8
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
,
16
2'(
-XQ
-XQ
-XQ
/(9$/%87(52/+<'52&+/25,'(/(9$/%87(52/+<'52&+/25,'(
$ 3&
)HE
/(9$/%87(52/+<'52&+/25,'(/(9$/%87(52/+<'52&+/25,'(
$ 3&
)HE
/(9$/%87(52/+<'52&+/25,'(/(9$/%87(52/+<'52&+/25,'(
$ 3&
)HE
/(92/(8&2925,1&$/&,80)86,/(9
1 0DU
'6 '3
/(92/(8&2925,1&$/&,80)86,/(9
1 0DU
'6 '3
/(92/(8&2925,1&$/&,80)86,/(9
1 0DU
'6 '3
/(920,/1$&,35$1+<'52&+/25,'()(7=,0$
1 0DU
5(
-XQ
8
8
1&(
-XO
/(920,/1$&,35$1+<'52&+/25,'()(7=,0$
1 0DU
5(
-XQ
8
8
1&(
-XO
/(920,/1$&,35$1+<'52&+/25,'()(7=,0$
1 0DU
5(
-XQ
8
8
1&(
-XO
/(920,/1$&,35$1+<'52&+/25,'()(7=,0$
1 0DU
5(
-XQ
8
8
1&(
-XO
572
572
$SU
$SU
13
-DQ
/(92125*(675(/3/$1%21(67(3
1 /(92125*(675(/6.</$
1 'HF
1RY
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
'3
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/(927+<52;,1(62',80/(92;</
1 2FW
8
/,'2&$,1(+<'52&+/25,'(=,1*2
1 2FW
8
/,5$*/87,'(5(&20%,1$179,&72=$
1 $XJ
'6 '3 8
/20,7$3,'(0(6</$7(-8;7$3,'
1 )HE
$XJ
'6
8
8
2'(
'HF
/20,7$3,'(0(6</$7(-8;7$3,'
1 )HE
$XJ
'6
8
8
2'(
'HF
/20,7$3,'(0(6</$7(-8;7$3,'
1 )HE
$XJ
'6
8
8
2'(
'HF
/23,1$9,55,721$9,5.$/(75$
1 1RY
'3
/23,1$9,55,721$9,5.$/(75$
1 3('
3('
3('
3('
'HF
-XQ
2FW
$SU
$XJ
)HE
6HS
0DU
'3
/23,1$9,55,721$9,5.$/(75$
1 3('
3('
3('
3('
'HF
-XQ
2FW
$SU
$XJ
)HE
6HS
0DU
'3
/25&$6(5,1+<'52&+/25,'(%(/9,4
1 $SU
$SU
$SU
$SU
$SU
$SU
$SU
$SU
$SU
8
'3
'3
8
'3
'3
'6
'6
'6
'6
'6
'6
'6
'6
'3
'3
'3
'3
'3
'3
'3
'3
8
8
8
8
8
8
8
8
8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
/27(35('12/(7$%21$7(/27(0$;
1 3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
-DQ
'3
0D\
0DU
2FW
2FW
$XJ
2FW
2FW
2FW
2FW
2FW
2FW
2FW
'3
'3
'3 8
'3
'3
'3
'3
'3
'3
'3
'3
'3
/8%,3526721($0,7,=$
1 6HS
6HS
'HF
$XJ
$XJ
2FW
6HS
6HS
1RY
1RY
1RY
1RY
/8&,1$&7$17685)$;,1
1 !$! 1RY
'6 '3 8
/8/,&21$=2/(/8=8
1 -XO
/85$6,'21(+<'52&+/25,'(/$78'$
1 /85$6,'21(+<'52&+/25,'(/$78'$
1 /85$6,'21(+<'52&+/25,'(/$78'$
1 /85$6,'21(+<'52&+/25,'(/$78'$
1 /2;$3,1($'$689(
1 8
8
8
8
8
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
,
$SU
'6 '3 8
1&(
1RY
-XO
'6
,
-XQ
-XO
'6
,
-XQ
-XO
'6
,
-XQ
-XO
'6
,
-XQ
'
,
1&(
$SU
-XQ
2FW
1&(
2'(
2FW
2FW
'3
8
8
8
8
'3 8
'3 8
/85$6,'21(+<'52&+/25,'(/$78'$
1 0$&,7(17$123680,7
1 3$7(17
'(/,67
5(48(67('
2FW
$SU
2FW
'6 '3
8
'3 8
0$*1(6,8068/)$7(32/<(7+</(1(*/<&2/327$66,80&+/25,'(327$66,8068/)$7(62',80%,&$5%21$7(62',80
&+/25,'(62',8068/)$7(68&/($5
1 1&
-DQ
0(&+/25(7+$0,1(+<'52&+/25,'(9$/&+/25
1 0DU
-XO
0DU
0DU
0DU
'3
8
'3
'3
8
1')
2'(
$XJ
$XJ
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
0(0$17,1(+<'52&+/25,'(1$0(1'$;5
1 1RY
1RY
1RY
1RY
1RY
'3
0(0$17,1(+<'52&+/25,'(1$0(1'$;5
1 1RY
1RY
1RY
1RY
1RY
'3
0(0$17,1(+<'52&+/25,'(1$0(1'$;5
1 1RY
1RY
1RY
1RY
1RY
'3
0(0$17,1(+<'52&+/25,'(1$0(1'$;5
1 !$! 1RY
1RY
1RY
1RY
1RY
1RY
'3
0(6$/$0,1(&$1$6$
1 -XQ
-XQ
'3
'3
0(6$/$0,1($6$&2/+'
1 1RY
'3
0(6$/$0,1($35,62
1 $SU
'3
0(6$/$0,1('(/=,&2/
1 -XO
-XO
$SU
'3 8
'3 8
'3
0(7)250,1+<'52&+/25,'()257$0(7
1 0DU
8
0(7)250,1+<'52&+/25,'()257$0(7
1 0DU
8
8
8
'3
8
8
8
'3
8
8
8
'3
8
8
8
'3
8
'3
0(7)250,1+<'52&+/25,'(3,2*/,7$=21(+<'52&+/25,'($&723/860(7;5
1 6HS
'3
0DU
8
0(7)250,1+<'52&+/25,'(3,2*/,7$=21(+<'52&+/25,'($&723/860(7;5
1 6HS
'3
0DU
8
0(7)250,1+<'52&+/25,'(6$;$*/,37,1+<'52&+/25,'(.20%,*/<=(;5
1 5(
-XO
'6 '3 8
0(7)250,1+<'52&+/25,'(6$;$*/,37,1+<'52&+/25,'(.20%,*/<=(;5
1 5(
-XO
'6 '3 8
0(7)250,1+<'52&+/25,'(6$;$*/,37,1+<'52&+/25,'(.20%,*/<=(;5
1 5(
-XO
'6 '3 8
0(7)250,1+<'52&+/25,'(6,7$*/,37,13+263+$7(-$180(7
1 )HE
8
-XO
'3 8
0(7)250,1+<'52&+/25,'(6,7$*/,37,13+263+$7(-$180(7
1 )HE
8
-XO
'3 8
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
0(7+275(;$7(275(;83
1 $SU
$XJ
$XJ
2FW
0DU
-DQ
0DU
'3
'3 8
'3
'3
'3 8
'3
'3 8
0(7+275(;$7(275(;83
1 $SU
$XJ
$XJ
2FW
0DU
-DQ
0DU
'3
'3 8
'3
'3
'3 8
'3
'3 8
0(7+275(;$7(275(;83
1 $SU
$XJ
$XJ
2FW
0DU
-DQ
0DU
'3
'3 8
'3
'3
'3 8
'3
'3 8
0(7+275(;$7(275(;83
1 $SU
$XJ
$XJ
2FW
0DU
-DQ
0DU
'3
'3 8
'3
'3
'3 8
'3
'3 8
0(7+</1$/75(;21(%520,'(5(/,6725
1 6HS
$SU
'3
0(7+</1$/75(;21(%520,'(5(/,6725
1 6HS
$SU
'3
0(7+</1$/75(;21(%520,'(5(/,6725
1 6HS
$SU
'3
0(7+</3+(1,'$7(+<'52&+/25,'(48,//,9$17;5
1 0DU
)HE
)HE
)HE
8
'3
'3
'3 8
'3 8
3&
6HS
)HE
$SU
$SU
-XQ
0DU
-XQ
-XQ
(;&/86,9,7<
(;3,5$7,21
'$7(
8
'3
0,&21$=2/(1,75$7(3(752/$780:+,7(=,1&2;,'(986,21
1 0DU
0,12&<&/,1(+<'52&+/25,'(;,0,12
1 (;&/86,9,7<
&2'(6
8
0(7521,'$=2/(0(7521,'$=2/(
$ 0,&21$=2/(25$9,*
1 3$7(17
'(/,67
5(48(67('
8
8
8
'3
8
8
8
8
'HF
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
0,12&<&/,1(+<'52&+/25,'(;,0,12
1 )HE
$SU
$SU
-XQ
0DU
-XQ
-XQ
0,12&<&/,1(+<'52&+/25,'(;,0,12
1 )HE
$SU
$SU
-XQ
0DU
-XQ
-XQ
0,320(56(162',80.<1$052
1 -XQ
'HF
0DU
)HE
0DU
6HS
$XJ
'HF
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
'3
8
8
8
8
8
8
'3
8
8
8
8
'6
'6
'6
'6
'6
'6
083,52&,1&$/&,80%$&752%$1
1 2FW
8
083,52&,1&$/&,80%$&752%$1
1 2FW
8
0<&23+(12/,&$&,'0<)257,&
1 )HE
'3
0<&23+(12/,&$&,'0<)257,&
1 )HE
'3
0DU
13
$SU
13
-XQ
'3
1$)7,),1(+<'52&+/25,'(1$)7,1
1 1(9,5$3,1(9,5$081(;5
1 -DQ
-DQ
8
0D\
-XQ
-XO
-XQ
1&(
2'(
'6
02;,)/2;$&,1+<'52&+/25,'(02;(=$
1 (;&/86,9,7<
(;3,5$7,21
'$7(
8
8
020(7$621()852$7((/2&21
1 1(3$)(1$&,/(952
1 (;&/86,9,7<
&2'(6
8
'3
'3
8
1,&$5',3,1(+<'52&+/25,'(&$5'(1(,1'(;7526(,13/$67,&&217$,1(5
1 $SU
8
1,&$5',3,1(+<'52&+/25,'(&$5'(1(,162',80&+/25,'(,13/$67,&&217$,1(5
1 $SU
8
1,&$5',3,1(+<'52&+/25,'(&$5'(1(,162',80&+/25,'(,13/$67,&&217$,1(5
1 $SU
8
1,&$5',3,1(+<'52&+/25,'(&$5'(1(,1'(;7526(,13/$67,&&217$,1(5
1 $SU
8
1,&27,1(32/$&5,/(;1,&25(77(
1 -XQ
'3
1,&27,1(32/$&5,/(;1,&25(77(
1 -XQ
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
1,/27,1,%+<'52&+/25,'(0212+<'5$7(7$6,*1$
1 -XO
-XO
-XO
'6 '3 8
'6 '3 8
'6 '3
1,/27,1,%+<'52&+/25,'(0212+<'5$7(7$6,*1$
1 -XO
-XO
-XO
'6 '3 8
'6 '3 8
'6 '3
3$7(17
'(/,67
5(48(67('
1,02',3,1(1<0$/,=(
1 (;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
2'(
0D\
2/$1=$3,1(=<35(;$
1 133
-XO
2/$1=$3,1(=<35(;$
1 133
-XO
2/$1=$3,1(=<35(;$
1 133
-XO
2/$1=$3,1(=<35(;$
1 133
-XO
2/$1=$3,1(=<35(;$
1 133
-XO
2/$1=$3,1(=<35(;$
1 133
-XO
2/$1=$3,1(=<35(;$=<',6
1 133
-XO
2/$1=$3,1(=<35(;$=<',6
1 133
-XO
2/$1=$3,1(=<35(;$=<',6
1 133
-XO
2/$1=$3,1(=<35(;$=<',6
1 133
-XO
1,75,&2;,'(,120$;
1 !$! 3('
3('
3('
0D\
-XQ
'HF
-DQ
-XO
-DQ
-XO
'3 8
8
1,75,&2;,'(,120$;
1 !$! 3('
3('
3('
0D\
-XQ
'HF
-DQ
-XO
-DQ
-XO
'3 8
8
2/23$7$',1(+<'52&+/25,'(3$7$1$6(
1 6HS
3('
0DU
'3
'3 8
'3
'3 8
8
20(35$=2/(62',80%,&$5%21$7(=(*(5,'
1 -XO
-XO
-XO
'6 '3 8
'6 '3
8
<
<
<
20(35$=2/(62',80%,&$5%21$7(=(*(5,'
1 -XO
-XO
-XO
-XO
-XO
'6 '3 8
'6 '3 8
'6 '3
8
8
<
<
<
<
<
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
20(35$=2/(62',80%,&$5%21$7(=(*(5,'27&
1 -XO
-XO
-XO
20(35$=2/(62',80%,&$5%21$7(=(*(5,'27&
1 -XO
-XO
-XO
3$7(17
&2'(6
'3 8
'3
'3
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
<
<
<
8
'3
8
21'$16(7521=83/(1=
1 1RY
'3
21'$16(7521=83/(1=
1 1RY
'3
26(/7$0,9,53+263+$7(7$0,)/8
1 133
'HF
26(/7$0,9,53+263+$7(7$0,)/8
1 133
'HF
26(/7$0,9,53+263+$7(7$0,)/8
1 133
'HF
26(/7$0,9,53+263+$7(7$0,)/8
1 133
'HF
26(/7$0,9,53+263+$7(7$0,)/8
1 133
'HF
8
8
8
8
8
1&(
)HE
8
8
8
8
8
8
8
8
13
-DQ
3&
-XO
263(0,)(1(263+(1$
1 -XO
$XJ
$XJ
)HE
)HE
2;&$5%$=(3,1(2;7(//$5;5
1 !$! $SU
'3
2;&$5%$=(3,1(2;7(//$5;5
1 !$! $SU
'3
2;&$5%$=(3,1(2;7(//$5;5
1 !$! $SU
'3
2;<%87<1,12;<752/)25:20(1
1 $SU
$SU
$SU
$SU
$SU
$SU
$SU
$SU
'3
'3
'3
'3
'3
'3
'3
2;<&2'21(+<'52&+/25,'(2;(&7$
1 1RY
'3
2;<&2'21(+<'52&+/25,'(2;(&7$
1 1RY
'3
2;<0253+21(+<'52&+/25,'(2;<0253+21(+<'52&+/25,'(
$ $
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$&/,7$;(/$%5$;$1(
1 5(
5(
5(
)HE
0DU
0DU
0DU
'HF
'HF
'HF
'HF
'HF
'HF
'HF
'HF
$XJ
$XJ
$XJ
8
'3 8
'3 8
'3 8
8
8
8
'3 8
'3 8
'3 8
8
8
8
8
8
3$/2126(7521+<'52&+/25,'($/2;,
1 !$! !$! -DQ
-DQ
-DQ
'3
'3
'3
3$/2126(7521+<'52&+/25,'($/2;,
1 !$! !$! -DQ
-DQ
-DQ
'3
'3
'3
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
,
2'(
6HS
6HS
0
1&(
-XO
$SU
3$5,&$/&,72/3$5,&$/&,72/
$ 3&
'HF
3$5,&$/&,72/3$5,&$/&,72/
$ 3&
'HF
3$1&5(/,3$6($0</$6(/,3$6(3527($6(&5(21
1 3$1&5(/,3$6($0</$6(/,3$6(3527($6(=(13(3
1 )HE
)HE
)HE
)HE
'3
'3
'3
3$1&5(/,3$6($0</$6(/,3$6(3527($6(=(13(3
1 )HE
)HE
)HE
)HE
'3
'3
'3
3$1&5(/,3$6($0</$6(/,3$6(3527($6(=(13(3
1 )HE
)HE
)HE
)HE
'3
'3
'3
3$1&5(/,3$6($0</$6(/,3$6(3527($6(=(13(3
1 )HE
)HE
)HE
)HE
'3
'3
'3
3$1&5(/,3$6($0</$6(/,3$6(3527($6(=(13(3
1 )HE
)HE
)HE
)HE
'3
'3
'3
3$1&5(/,3$6($0</$6(/,3$6(3527($6(=(13(3
1 )HE
)HE
)HE
)HE
'3
'3
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$5,&$/&,72/3$5,&$/&,72/
$ 3$52;(7,1(0(6</$7(3(;(9$
1 )HE
'6 '3
3$52;(7,1(0(6</$7(3(;(9$
1 )HE
'6 '3
3$52;(7,1(0(6</$7(3(;(9$
1 )HE
'6 '3
3$52;(7,1(0(6</$7(3(;(9$
1 )HE
'6 '3
3$52;(7,1(0(6</$7(%5,6'(//(
1 -XQ
)HE
'6
'6
3+(17(50,1(+<'52&+/25,'(6835(1=$
1 0DU
'3
3+(17(50,1(+<'52&+/25,'(6835(1=$
1 0DU
'3
3+(17(50,1(+<'52&+/25,'(6835(1=$
1 0DU
'3
3+(17(50,1(+<'52&+/25,'(723,5$0$7(46<0,$
1 0D\
-XQ
'3
3+(17(50,1(+<'52&+/25,'(723,5$0$7(46<0,$
1 0D\
-XQ
'3
3+(17(50,1(+<'52&+/25,'(723,5$0$7(46<0,$
1 0D\
-XQ
'3
3+(17(50,1(+<'52&+/25,'(723,5$0$7(46<0,$
1 0D\
-XQ
'3
8
8
8
8
3,7$9$67$7,1&$/&,80/,9$/2
1 'HF
)HE
'6
3,7$9$67$7,1&$/&,80/,9$/2
1 'HF
)HE
'6
3,7$9$67$7,1&$/&,80/,9$/2
1 'HF
)HE
'6
8
'6 '3
3/(5,;$)2502=2%,/
1 5(
'HF
32/,'2&$12/9$5,7+(1$
1 !$! !$! !$! !$! !$! !$! !$! !$! !$! !$! !$! !$! !$! 5(
!$! 5(
0D\
-XO
0D\
0D\
0D\
0D\
1RY
1RY
0D\
0D\
6HS
0D\
2FW
2FW
8
'3
8
'3
'3
8
'3
'3
'3 8
8
'6 '3 8
'6 '3 8
'3 8
8
'3
'3
'6
'6 '3
'6 '3 8
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
3&
'HF
13
-XQ
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
320$/,'20,'(320$/<67
1 !$! -XO
$XJ
2FW
$XJ
-XO
$XJ
2FW
2FW
$XJ
$XJ
2FW
$XJ
2FW
$XJ
8
8
8
'3 8
'3 8
8
8
8
8
'3
8
8
8
8
1&(
2'(
)HE
)HE
320$/,'20,'(320$/<67
1 !$! -XO
$XJ
2FW
$XJ
-XO
$XJ
2FW
2FW
$XJ
$XJ
2FW
$XJ
2FW
$XJ
8
8
8
'3 8
'3 8
8
8
8
8
'3
8
8
8
8
1&(
2'(
)HE
)HE
320$/,'20,'(320$/<67
1 !$! -XO
$XJ
2FW
$XJ
-XO
$XJ
2FW
2FW
$XJ
$XJ
2FW
$XJ
2FW
$XJ
8
8
8
'3 8
'3 8
8
8
8
8
'3
8
8
8
8
1&(
2'(
)HE
)HE
320$/,'20,'(320$/<67
1 !$! -XO
$XJ
2FW
$XJ
-XO
$XJ
2FW
2FW
$XJ
$XJ
2FW
$XJ
2FW
$XJ
8
8
8
'3 8
'3 8
8
8
8
8
'3
8
8
8
8
1&(
2'(
)HE
)HE
321$7,1,%+<'52&+/25,'(,&/86,*
1 2'(
'HF
321$7,1,%+<'52&+/25,'(,&/86,*
1 2'(
'HF
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
326$&21$=2/(12;$),/
1 -XO
$XJ
'6 '3 8
'6 '3 8
35$/$75(;$7()2/27<1
1 -XO
'6 '3 8
35$/$75(;$7()2/27<1
1 -XO
'6 '3 8
35$68*5(/+<'52&+/25,'(()),(17
1 1RY
1RY
8
35$68*5(/+<'52&+/25,'(()),(17
1 1RY
1RY
8
35('1,621(5$<26
1 $SU
'3 8
0
-XO
35('1,621(5$<26
1 $SU
'3 8
0
-XO
35('1,621(5$<26
1 $SU
'3 8
0
-XO
,
-XQ
35(*$%$/,1/<5,&$
1 35232)2/',35,9$1
1 3('
'HF
-XQ
'6 '3
5$%(35$=2/(62',80$&,3+(;635,1./(
1 0D\
3('
1RY
'6 '3 8
1')
3('
0DU
6HS
5$%(35$=2/(62',80$&,3+(;635,1./(
1 0D\
3('
1RY
'6 '3 8
1')
3('
0DU
6HS
1&(
0D\
!$! 1')
'HF
5$',805$',&+/25,'(;2),*2
1 -DQ
8
5$/7(*5$9,5327$66,80,6(175(66
1 5(*$'(12621/(;,6&$1
1 -XQ
-XQ
8
8
5(*25$)(1,%67,9$5*$
1 ,
2'(
)HE
)HE
5(3$*/,1,'(5(3$*/,1,'(
$ 3&
-DQ
5(3$*/,1,'(5(3$*/,1,'(
$ 3&
-DQ
1&(
2'(
2'(
2FW
2FW
2FW
5(3$*/,1,'(35$1',1
1 -XQ
'6 '3 8
<
5(3$*/,1,'(35$1',1
1 -XQ
'3 8
<
5,)$;,0,1;,)$;$1
1 0DU
'3
5,)$;,0,1;,)$;$1
1 0DU
'3
5,2&,*8$7$'(03$6
1 -XO
$SU
'6 '3
'6 '3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
5,2&,*8$7$'(03$6
1 -XO
$SU
'6 '3
'6 '3
1&(
2'(
2'(
2FW
2FW
2FW
5,2&,*8$7$'(03$6
1 -XO
$SU
'6 '3
'6 '3
1&(
2'(
2'(
2FW
2FW
2FW
5,2&,*8$7$'(03$6
1 -XO
$SU
'6 '3
'6 '3
1&(
2'(
2'(
2FW
2FW
2FW
5,2&,*8$7$'(03$6
1 -XO
$SU
'6 '3
'6 '3
1&(
2'(
2'(
2FW
2FW
2FW
$XJ
)HE
6HS
0DU
'3
5,9$67,*0,1((;(/21
1 133
-XQ
5,=$75,37$1%(1=2$7(5,=$75,37$1%(1=2$7(
$ 3&
-XQ
5,=$75,37$1%(1=2$7(5,=$75,37$1%(1=2$7(
$ 3&
-XQ
5,721$9,51259,5
1 3('
3('
'3
52)/80,/$67'$/,5(63
1 !$! )HE
0DU
0DU
523,9$&$,1(+<'52&+/25,'(1$523,1
1 6HS
'6 '3 8
523,9$&$,1(+<'52&+/25,'(1$523,1
1 6HS
'6 '3 8
523,9$&$,1(+<'52&+/25,'(1$523,1
1 6HS
'6 '3 8
523,9$&$,1(+<'52&+/25,'(1$523,1
1 6HS
'6 '3 8
527,*27,1(1(8352
1 !$! -XO
'3 8
527,*27,1(1(8352
1 !$! -XO
'3 8
527,*27,1(1(8352
1 !$! -XO
'3 8
527,*27,1(1(8352
1 !$! -XO
'3 8
527,*27,1(1(8352
1 !$! -XO
'3 8
527,*27,1(1(8352
1 !$! -XO
'3 8
58;2/,7,1,%3+263+$7(-$.$),
1 'HF
'6 '3
58;2/,7,1,%3+263+$7(-$.$),
1 'HF
'6 '3
58;2/,7,1,%3+263+$7(-$.$),
1 'HF
'6 '3
'3
8
8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
58;2/,7,1,%3+263+$7(-$.$),
1 'HF
'6 '3
58;2/,7,1,%3+263+$7(-$.$),
1 'HF
'6 '3
6$35237(5,1',+<'52&+/25,'(.89$1
1 1RY
'3
6$48,1$9,50(6</$7(,19,5$6(
1 6$48,1$9,50(6</$7(,19,5$6(
1 6$;$*/,37,1+<'52&+/25,'(21*/<=$
1 5(
-XO
'6 '3 8
6$;$*/,37,1+<'52&+/25,'(21*/<=$
1 5(
-XO
'6 '3 8
6(575$/,1(+<'52&+/25,'(=2/2)7
1 3('
2FW
$SU
6,0(35(9,52/<6,2
1 !$! !$! !$! 0D\
6HS
-XO
'6 '3
'6 '3 8
'6 '3 8
62',801,75,7(62',801,75,7(
1 'HF
'6 '3
62',801,75,7(62',807+,268/)$7(1,7+,2'27(
1 0DU
'HF
62',802;<%$7(;<5(0
1 !$! 3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
0
3('
1RY
0D\
0
3('
1RY
0D\
1&(
1RY
!$! 1&(
'HF
'3
'6 '3 8
'6 '3
'HF
'HF
8
8
62',807+,268/)$7(62',807+,268/)$7(
1 0DU
'6 '3 8
62)26%89,562/9$',
1 !$! !$! !$! 0DU
0DU
0DU
'6 '3 8
'6 '3 8
'6 '3 8
625$)(1,%726</$7(1(;$9$5
1 !$! -XO
8
,
!$! 2'(
1RY
1RY
68&52)(55,&2;<+<'52;,'(9(/3+252
1 !$! 'HF
8
!$! 13
1RY
680$75,37$168&&,1$7(680$9(/'26(352
1 2FW
'6
'3
680$75,37$168&&,1$7(=(&8,7<
1 )HE
$SU
$SU
$SU
$SU
$SU
'3
7$&52/,086$67$*5$);/
1 0DU
0DU
0DU
0DU
'3
'3 8
'3 8
'3
1')
-DQ
1')
-XO
8
8
8
8
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(17
(;3,5$7,21
'$7(
3$7(1712
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
7$&52/,086$67$*5$);/
1 0DU
0DU
0DU
0DU
'3
'3 8
'3 8
'3
1')
-XO
7$&52/,086$67$*5$);/
1 0DU
0DU
0DU
0DU
'3
'3 8
'3 8
'3
1')
-XO
7$3(17$'2/+<'52&+/25,'(18&<17$(5
1 2FW
1RY
6HS
'3
'3
7$3(17$'2/+<'52&+/25,'(18&<17$(5
1 2FW
1RY
6HS
'3
'3
7$3(17$'2/+<'52&+/25,'(18&<17$(5
1 2FW
1RY
6HS
'3
'3
7$3(17$'2/+<'52&+/25,'(18&<17$(5
1 2FW
1RY
6HS
'3
'3
7$3(17$'2/+<'52&+/25,'(18&<17$(5
1 2FW
1RY
6HS
'3
'3
<
8
<
8
<
8
<
8
<
8
7(&+1(7,807&07,/0$12&(37/<03+26((..,7
1 !$! 0D\
'6
1&(
0DU
7('8*/87,'(5(&20%,1$17*$77(;.,7
1 $SU
6HS
1RY
'6 '3 8
'3 8
8
2'(
'HF
7(/$35(9,5,1&,9(.
1 0D\
$XJ
7(/$9$1&,1+<'52&+/25,'(9,%$7,9
1 6HS
'6 '3 8
,
-XQ
7(/$9$1&,1+<'52&+/25,'(9,%$7,9
1 6HS
'6 '3 8
8
8
,
-XQ
7(/%,98',1(7<=(.$
1 0
-DQ
7(/%,98',1(7<=(.$
1 0
-DQ
7(12)29,5',62352;,/)80$5$7(9,5($'
1 0
-XO
7(12)29,5',62352;,/)80$5$7(9,5($'
1 0
-XO
7(12)29,5',62352;,/)80$5$7(9,5($'
1 0
-XO
7(12)29,5',62352;,/)80$5$7(9,5($'
1 0
-XO
7(12)29,5',62352;,/)80$5$7(9,5($'
1 0
-XO
7(06,52/,086725,6(/
1 3('
-XO
-DQ
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
7(5,)/8120,'($8%$*,2
1 $SU
8
7(5,)/8120,'($8%$*,2
1 $SU
8
7(67267(521($1'52*(/
1 2FW
2FW
2FW
2FW
'3
7(67267(521($1'52*(/
1 2FW
2FW
2FW
2FW
'3
7(67267(521($1'52*(/
1 2FW
2FW
2FW
2FW
'3
7(67267(521($;,521
1 )HE
-XO
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
8
8
'3
8
8
'3
8
8
'3
8
8
7(67267(521(7(67267(521(
1 13
-DQ
7(67267(521(7(67267(521(
1 13
-DQ
7(67267(521(7(67267(521(
1 13
-DQ
13
0DU
7+$/,'20,'(7+$/20,'
1 !$! $XJ
8
7+$/,'20,'(7+$/20,'
1 !$! $XJ
8
7+$/,'20,'(7+$/20,'
1 !$! $XJ
8
7+$/,'20,'(7+$/20,'
1 !$! $XJ
8
7,&$*5(/25%5,/,17$
1 'HF
'3
7,*(&<&/,1(7<*$&,/
1 2FW
'3
7,02/2/0$/($7(,67$/2/
1 1RY
'3
7,52),%$1+<'52&+/25,'($**5$67$7
1 0D\
7,52),%$1+<'52&+/25,'($**5$67$7
1 -XQ
7,52),%$1+<'52&+/25,'($**5$67$7
1 -XQ
7,52),%$1+<'52&+/25,'($**5$67$7
1 -XQ
72%5$0<&,172%,32'+$/(5
1 $SU
'HF
0D\
-DQ
2FW
6HS
0D\
'3
'3 8
'3
'3
'3
'3
'3
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
72%5$0<&,1%(7+.,6
1 6HS
0DU
-XQ
'3
'3
72/7(52',1(7$575$7('(752//$
1 3('
1RY
0D\
'3 8
72/7(52',1(7$575$7('(752//$
1 3('
1RY
0D\
'3 8
72/9$37$16$06&$
1 1RY
6HS
'6 '3
'6
1RY
6HS
'6 '3
'6
1RY
6HS
'6 '3
'6
723,5$0$7(752.(1',;5
1 0DU
1RY
'3 8
'3 8
723,5$0$7(752.(1',;5
1 0DU
1RY
'3 8
'3 8
723,5$0$7(752.(1',;5
1 0DU
1RY
'3 8
'3 8
723,5$0$7(752.(1',;5
1 0DU
1RY
'3 8
'3 8
72/9$37$16$06&$
1 (;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
8
72/9$37$16$06&$
1 3$7(17
'(/,67
5(48(67('
75$0(7,1,%',0(7+</68/)2;,'(0(.,1,67
1 6HS
-DQ
'6 '3
'3
1&(
2'(
0D\
0D\
75$0(7,1,%',0(7+</68/)2;,'(0(.,1,67
1 6HS
-DQ
'6 '3
'3
1&(
2'(
0D\
0D\
75$0(7,1,%',0(7+</68/)2;,'(0(.,1,67
1 6HS
-DQ
'6 '3
'3
1&(
2'(
0D\
0D\
3&
-XO
75$1(;$0,&$&,'75$1(;$0,&$&,'
$ 75$1(;$0,&$&,'/<67('$
1 0DU
'3 8
75$923526775$9$7$1=
1 6HS
'3
75(35267,1,/5(02'8/,1
1 0DU
'HF
'6
75(35267,1,/5(02'8/,1
1 0DU
'HF
'6
75(35267,1,/5(02'8/,1
1 0DU
'HF
'6
75(35267,1,/5(02'8/,1
1 0DU
'HF
'6
'3 8
'3 8
'3 8
'3 8
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
75(35267,1,/7<9$62
1 'HF
75(35267,1,/25(1,75$0
1 !$! !$! !$! !$! !$! !$! !$! !$! 2FW
2FW
$XJ
-XO
0D\
-DQ
)HE
'HF
75(35267,1,/25(1,75$0
1 !$! !$! !$! !$! !$! !$! !$! !$! 2FW
2FW
$XJ
-XO
0D\
-DQ
)HE
'HF
75(35267,1,/25(1,75$0
1 !$! !$! !$! !$! !$! !$! !$! !$! 2FW
2FW
$XJ
-XO
0D\
-DQ
)HE
'HF
75(35267,1,/25(1,75$0
1 !$! !$! !$! !$! !$! !$! !$! !$! 2FW
2FW
$XJ
-XO
0D\
-DQ
)HE
'HF
75,$0&,12/21($&(721,'(1$6$&257$//(5*<+285
1 -XO
-XO
-XO
3$7(17
&2'(6
8
!$! 1')
'HF
!$! 1')
'HF
!$! 1')
'HF
!$! 1')
'HF
8
'3
'3
'3
'6
8
'6
'6
8
'3
'3
'3
'6
8
'6
'6
8
'3
'3
'3
'6
8
'6
'6
8
'3
'3
'3
'6
'3
'3
'3
3&
-XQ
)HE
1RY
(;&/86,9,7<
(;3,5$7,21
'$7(
'6
'6
8
'3
80(&/,',1,80%520,'(9,/$17(52/75,)(1$7$7($1252(//,37$
1 !$! )HE
'3
!$! 0DU
'6 '3 8
!$! 6HS
'6 '3 8
!$! $SU
'6 '3
!$! $SU
'6 '3
!$! 6HS
'3
!$! 2FW
'3
!$! )HE
'3
!$! -XO
8
!$! $SU
8
!$! 1RY
'3 8
!$! $XJ
'3
8123526721(,623523</5(6&8/$
1 (;&/86,9,7<
&2'(6
'6
75263,80&+/25,'(75263,80&+/25,'(
$ 8/,35,67$/$&(7$7((//$
1 3$7(17
'(/,67
5(48(67('
'3 8
$SU
$
3$7(17$1'(;&/86,9,7<'58*352'8&7/,67&808/$7,9(6833/(0(17'HFHPEHU
$33/352'
12
3$7(1712
3$7(17
(;3,5$7,21
'$7(
3$7(17
&2'(6
3$7(17
'(/,67
5(48(67('
(;&/86,9,7<
&2'(6
(;&/86,9,7<
(;3,5$7,21
'$7(
9(/$*/8&(5$6($/)$935,9
1 0
1RY
9(/$*/8&(5$6($/)$935,9
1 0
1RY
1&(
133
3('
3('
$XJ
2FW
)HE
$SU
1&(
133
2'(
3('
3('
3('
$XJ
2FW
$XJ
)HE
)HE
$SU
3&
0DU
9(085$)(1,%=(/%25$)
1 $XJ
8
9,*$%$75,16$%5,/
1 9,*$%$75,16$%5,/
1 925,&21$=2/(925,&21$=2/(
$ 925,1267$7=2/,1=$
1 5(
-XO
'6 '3
9257,2;(7,1(+<'52%520,'(%5,17(//,;
1 -DQ
2FW
'6 '3 8
'3 8
1&(
6HS
9257,2;(7,1(+<'52%520,'(%5,17(//,;
1 -DQ
2FW
'6 '3 8
'3 8
1&(
6HS
9257,2;(7,1(+<'52%520,'(%5,17(//,;
1 -DQ
2FW
'6 '3 8
'3 8
1&(
6HS
9257,2;(7,1(+<'52%520,'(%5,17(//,;
1 -DQ
2FW
'6 '3 8
'3 8
1&(
6HS
=2/('521,&$&,'5(&/$67
1 2FW
8
=2/3,'(07$575$7(('/8$5
1 6HS
8
=2/3,'(07$575$7(('/8$5
1 6HS
8
Footnote:
1. Patents are published upon receipt by the Orange book Staff and may not reflect the official receipt date as
described in 21 CFR 314.53(d)(5).
2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and
submitted by the sponsor. They may not be flagged with respect to other claims which may apply.
B-1
PATENT AND EXCLUSIVITY TERMS
Due to space limitations in the patent and exclusivity columns,
abbreviations and references have been developed. Refer to the APPROVED DRUG
rd
PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS, 33 Edition for a full listing of
patent and exclusivity terms (Abbreviations, Dosing Schedule, Indications,
and Patent Use Codes).
The current complete list of patent terms is available at
http://www.accessdata.fda.gov/scripts/cder/ob/docs/pattermsall.cfm
The current complete list of exclusivity terms is available at
http://www.accessdata.fda.gov/scripts/cder/ob/docs/excltermsall.cfm

APPROVED DRUG PRODUCTS

Transcription

Similar documents

Medac Exhibit 2087 Frontier Therapeutics v. Medac

Illinois Formulary for the Drug Product Selection Program

Brand Generic Guide

BD Medical Product Catalog 2014 – 2015 Sections

Buca di Peppo - Exercise for Weight Loss

Standard Pack Solutions